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ABSTRACT
The majority of women of reproductive age experience physical and / or
emotional changes during the week to ten days before menstruation . In a
proportion - probably 3 - 5 % - these changes are severe , and constitute the
Premenstrual Syndrome ( PMS ) . The occurrence of these changes in the
premenstrual phase has caused many theorists to postulate an aetiological
link with the female reproductive cycle . The purpose of this research is to
investigate the relationship between premenstrual symptoms and the
ovarian hormones .
A review of the literature suggests that previous research has been
inconclusive for largely methodological reasons . These studies have
focussed on PMS and normal cycles , attempting to delineate
endocrinological differences between women with and without the
syndrome. Inconsistencies have arisen in the definition and diagnosis of
PMS and the frequency and type of assessment of ovarian activity . The
occurrence of symptoms in anovulatory or otherwise abnormal menstrual
cycles has received little attention . In this research , it was hypothesized that
a link between premenstrual changes and ovarian hormones would be
demonstrated by a change in symptomatology if the menstrual cycle were
naturally or artificially abnormal . Hence , the focus in these studies is on
premenstrual symptoms and their degree of change between cycles rather
than on the diagnosis of PMS .
Two studies were designed to investigate the hypothesis . The first
involved the observation of naturally occuring abnormal menstrual cycles ,
comparing them symptomatically with normal cycles in the same individual .
The second approach involved the comparison of women whose menstrual
cycles had been artificially manipulated by the long term use of low-dose
oral contraceptive ( oc ) pills , with matched women experiencing natural
cycles . In both of these studies, symptoms were assessed by daily
subjective ratings of eight physical and emotional variables using visual
analogue scales . In the first study , ovarian activity was assessed by the
analysis of daily , early morning urine samples for the major ovarian
hormone metabolites - oestrone-3-glucuronide and pregnane- diol-3a-
glucuronide . In the second study , various components of the ovarian cycle
were assessed by the comparison of combined oc's having a constant dose
regime with oc's designed to mimic the normal cycle . In both studies daily
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ratings were continued for at least two complete cycles , and frequently
longer. The data were analysed in several ways , taking cognisance of the
inadequacy of conventional inferential statistical methods in this area .
Clear evidence emerged from these studies to show that neither
ovulation nor adequate luteal function are necessary for premenstrual
symptom occurrence . A relationship did emerge between the symptom of
breast tenderness and luteal hormones in approximately half of the women
studied . Absolute hormone levels did not seem to be involved in this effect,
suggesting a potential role for some other endocrine or biochemical factor
associated with luteal function .
The conclusions drawn from the study were that several different
aetiological mechanisms may be involved in the manifestation of
premenstrual symptoms . The relationship between symptoms and the
ovarian cycle would appear to be purely temporal in the majority of cases .
However , some symptoms , i.e. breast tenderness , may be more closely





The picture normally painted of the Premenstrual Syndrome (PMS )
is of a combination of symptoms ranging from irritability , tension and
depression to breast tenderness , body swelling and migraine headaches
which occur regularly before menstruation and cause untold havoc to
marriages , family life and society in general . Although many studies have
attempted to describe and define exactly which symptoms constitute the
Syndrome , when they occur and how common they are , little success has
been achieved . The reasons for this are largely vested in the degree of
variability of symptom experience between women , and potentially between
menstrual cycles . This has led to the postulation of a number of different
definitions of PMS and hence a variety of estimates of its prevalence . A
general consensus would appear to be that the majority of women
experience some changes in well-being premenstrually , which achieve a
level of severity meritting clinical attention in about 2 - 4 % .
The causes of both " normal " premenstrual symptoms and the
"abnormal" Premenstrual Syndrome remain obscure . Many different
mechanisms have been postulated with greater or lesser validity . The
common theme of all of these theories however , and the most widely held
belief about PMS , is the relationship between the occurrence of symptoms
and the events of the female reproductive cycle . Symptoms have been
observed to occur regularly in the second half of the menstrual cycle , the
luteal phase , and to be absent from the first half, the follicular phase . This
has led to the widely hald assumption that the presence , timing and severity
of symptoms is related in some way to an endocrine factor present in the
luteal phase but absent from the follicular phase . The most obvious
candidate for this being the hormone progesterone , which is only present in
the luteal phase of normal ovulatory cycles . Further to this belief is the
assumption that symptoms cannot occur in the absence of progesterone, i.e.
in the follicular phase or in anovulatory cycles . This assumption is so widely
held that some studies cite premenstrual symptoms as evidence of ovulatory
cycles (e.g. Magyar, Boyers, Marshall & Abraham 1979 ) .
Scientific evidence relating premenstrual symptoms to specific
events of the hormonal cycle , and particularly to the presence or absence of
progesterone, is limited however , partly by incompatabilities between
studies in the definition of PMS used and partly by technical inadequacies in
the measurement of hormone levels . Accurate studies of this kind are
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however crucial to the further understanding of the nature and aetiology of
premenstrual symptoms and how the Premenstrual Syndrome should best
be approached clinically . Such a study is the subject of this thesis . The
assessment of any relationship is however restricted by the level of
knowledge of its constituent parts . Hence , in the first part of this thesis ,
consideration will be given to the nature of both premenstrual symptoms and
the ovarian cycle seperately before previous studies of the relationship
between them are discussed . The design , analysis , discussion and
implications of the studies which constitute this research will then follow .
3
CHAPTER ONE
PREMENSTRUAL SYMPTOMS AND THE PREMENSTRUAL
SYNDROME
4
1.1 DESCRIPTION OF THE PREMENSTRUAL SYNDROME
" I can only describe my feelings before a period as ' bottled up '.I get
more and more uptight and irritable as the week goes on . The minute my
period starts it feels as if a cork is released and all the tension floods away "
" I feel very lethargic and disinterested in things around me . I want to be
alone , not talk to anyone either on the 'phone or face-to-face . I can't bear
being touched . Physical contact ( even by my children ) annoys me
intensely"
" The symptom I feel and fear the most is the violent one . I don't actually do
anything violent - but I feel so pent-up like a dam ready to explode ."
" The most severe symptom is general fluid retention . Apart from grossly
swollen stomach and very painful breasts , I often experience pain and
numbness in my hands and arms ."
" The thing I find most difficult to cope with is the feeling of hopelessness .
In the ten days prior to my period I feel as if there is no point in living . I hate
my job,I hate my boyfriend , I hate where I live and I hate myself. Then when
my period arrives I feel great - it's as if a huge weight has been taken off my
shoulders
" For about ten days prior to a period I become a compulsive eater -1 never
feel full ! Also I get a raging thirst."
" I get so angry and worked up with my husband and children for no
reason. Stupid things start me off like leaving the top off the shampoo . I
know I am doing these things but I cannot stop myself . I then feel guilty at
doing this to my family , I make their life hell . They do try and understand
most of the time but sometimes it gets too much for them ."
"
Apart from generally feeling bad about myself /tension/depression in the
few days before my period starts ( and this will happen even if my period is
unexpectedly early ) and a bad headache just before it begins , the most
pronounced pre-menstrual feeling I have is a strong desire to tidy up/pay
bills / file /tie up loose ends ."
" PMS its like wanting to crawl into a corner away from everything but
at the same time not knowing what you want to go into the corner for."
" I undergo a complete personality change . From a capable , efficient ,
able secretary and housewife I become withdrawn , ultra-clumsy and
accident prone . I normally have a lively , bubbly personality but
premenstrually I lack confidence , feel old and fat and prefer to be alone . I
get everything out of perspective and have at times become paranoid and
obsessional . "
" It astonishes me how much better I feel once my period has arrived . The
physical symptoms may be worse perhaps with backache and fatigue
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particularly for the first three days , but at least the irrational anger and
distorted and depressed view of reality evaporates ."
These extracts are all taken from letters submitted to a national women's
magazine " Woman " in August 1985 . The women wrote in response to a
questionnaire survey on menstrual health which attracted 7,500 replies .
The results of the questionnaire are reported elsewhere (Bancroft & Warner:
unpublished ). They are all describing symptoms which they experience in
the week or ten days before a menstrual period and provide a fairly typical
picture of what has recently become known as the "Premenstrual
Syndrome " (PMS) . The symptoms of the syndrome are many and various
ranging from depression and irritability to painful breasts and skin disorders.
Moos (1969 ) identified over 150 different symptoms from a review of the
literature , although this was reduced to 47 by eliminating redundancy ( see
Table 1.1).
The first user of the term " Premenstrual Tension " was R.T.Frank (1929,
1931 ) . He described the condition as
"
a feeling of indescribable tension from ten to seven days
preceding menstruation These patients complain of unrest ,
irritability , " like jumping out of their skin " , and a desire to find relief by
foolish and ill-considered actions Within an hour or two after the
onset of the menstrual flow complete relief from both physical and mental
tension occurs
( Frank1931)
The discussion following the paper makes it clear however that Frank's
observations were by no means unique . Dr. Josephine Kenyon , for
instance says
"
any suggestion of other ways to combat the depression and
emotional tension so commonly seen will be of value ."
( Kenyon 1931- my italics)
In fact disturbances of one sort or another associated with menstruation
have been recognised throughout history and usually considered to be
normal and worthy of little comment ( Norris 1987 ) . For instance Hamilton
(1813 ) in his description of menstruation states that:-
" It continues for a certain number of days , different in different individuals,
and its approach is generally preceded by certain feelings of oppression or
deviation from the ordinary state of health , which warn the individual of what
is to happen . There is in particular , a sensation of fulness about the lower
part of the belly and of relaxation about the uterine system "
( Hamilton 1813 p.25)
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TABLE 1.1
SYMPTOM SCALES MADE UP FROM MENSTRUAL . PREMENSTRUAL .
INTERMENSTRUAL AND WORST SYMPTOM FACTOR ANALYSIS
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Ringing in the ears
Heart pounding
Numbness tingling
9 . CHANGE IN EATING HABIT
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In a section discussing " hysterical complaints " he describes
symptoms including
" violent sudden fits of crying and laughing often followed by
stupor and faintings in many cases a violent pain in the head "
which occur " most frequently about the time of the periodical evacuation "
( Hamilton 1813 p. 47 )
Even the Greeks and Romans had observed the phenomenon
Hippocrates wrote that
" the blood of females is subject to intermittent 'agitations ' and as a
result the ' agitated blood ' finds its way from the head to the uterus whence
it is expelled "
( Chadwick & Mann 1950 p. 267 )
Soranus of Ephesus ( quoted by Symonds 1981 ) stated that
the menses are about to occur when a woman feels somewhat
uneasy on walking , when a feeling of heaviness appears in the loins .
Some develop a torpor , yawning and pondiculation while others develop
nausea and a loss of appetite "
(Symonds 1981 )
So there is nothing new about the phenomenon of menstrually related
changes in mood and behaviour . However for several reasons the
premenstrual syndrome has received much attention and even notoriety in
recent years.
Firstly menstruation has " come out of the closet" as it were . Women and
men are now able to discuss such issues openly - at least in scientific
circles. Secondly - the female reproductive lifespan in the Western World is
now longer than ever before (i.e. from puberty to menopause ) and
interrupted by fewer pregnancies . Hence many more episodes of
menstruation are experienced allowing correlations to be drawn . Thirdly -
since the Second World War, women, and particularly middle class women,
have been involved in paid work outside the home much more than in
previous generations . This third reason , together with the general
controversy about the role of women in society raised by the Women's
Movement and their opponents - has led to concern about possible
increases in absenteeism rates or reduced work efficiency in relation to
female biology i.e. the menstrual cycle . This concern has shown itself by a
flurry of research and media activity into the effects of the menstrual cycle on
various aspects of women's health and social functioning . In this thesis
however the major concern is the " Premenstrual Syndrome " , rather than
dysmenorrhea or other menstruation- related phenomena , hence a
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consideration of the social impact of PMS is appropriate in order to establish
reasons for studying the phenomenon and the difficulties inherent in such
research .
1.2 THE IMPORTANCE OF RESEARCH INTO PMS
The description of PMS given above has several potentially critical
implications . If it is in fact the case that some proportion of women in
Western Society suffer debilitating symptoms in a regular cyclical manner ,
and that these changes are outwith their control , then the effects in the
home , workplace , courtroom and political arena could be far-reaching .
1.2.1 THE CRIMINAL LAW AND PMS
The research and discussion in this area can be divided into two sections,
attempting to answer two seperate but interdependent questions . Firstly - do
more crimes committed by women occur during the premenstrual phase of
the cycle ? Secondly - can a medical diagnosis of PMS be used as a legal
defence to , or mitigation of , a crime which was committed in the
premenstruum ?
a) Do more crimes occur in the premenstruum ?
Evidence for a link between the premenstrual phase of the cycle and crime
comes in the most part from the work of Katharina Dalton . (eg Dalton 1961 ,
1980) . She showed that of 156 regularly menstruating women admitted to a
London prison , having committed their crimes within the last 28 days , 49%
were in the "paramenstruum" at the time of the crime. ( The paramenstruum
is defined as the four days immediately preceding and the first four days of
the menstrual flow . ) (Dalton 1961 ). However, not all of these women were
PMS sufferers . By her own definition only 27% of the total ( 43 women )
suffered from PMS of " incapacitating severity of whom 63% (27 women )
offended during the paramenstruum . At first sight this would appear to be
fairly impressive evidence that there is a link between the paramenstruum
and the commission of crimes - however, three points must be made about
the research . Firstly - no account is taken of the possible effects that the
stressful events surrounding the commission of the crime and subsequent
capture may have had upon the onset of menstruation ( Parlee 1973 ;
Sommer 1978 ). Secondly - no differentiation was made in this study
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between impulsive and/or violent crimes , which might be expected to result
from the symptoms of PMS , and premeditated or organised crimes . The
women in Dalton's study had been involved in offences as diverse as
shoplifting , embezzlement and prostitution . No data are given , either ,
about whether the women were " first - offenders " or habitual criminals.
Thirdly - the comparisons used by Dalton to test the significance of her
results can be argued to be inappropriate . Sherif (1980 ) , for instance ,
argues that the correct methodology to assess the relationship between
crime and the pre- or paramenstruum would be to compare the proportion of
paramenstrual women committing crimes for all women committing crimes
with the number of paramenstrual women not committing crimes for all
women not committing crimes in the same time interval i.e.
Number of PM offenders vs Number of PM non-offenders
Number of offenders Number of non-offenders
Research in the United States by Morton et al (1953) provides support for
this evidence with their findings that of 42 women sentenced for crimes of
violence , 62 % had committed the offence during the premenstrual week .
However this study is also methodologically flawed ( Parlee 1973 ; d'Orban
1983) . A study by Epps (1962 ) of 200 shoplifters in the same prison did not
uphold the relationship between crime and PMS since only 27 ( 13.5 % ) of
her sample suffered from PMS and they did not tend to commit their crimes
more frequently when premenstrual than at any other time . D'Orban &
Dalton ( 1980) in a more detailed study of 50 consecutive admissions to a
female remand prison showed that 22 of the offences ( 44 % ) occurred in
the paramenstruum . In this sample 17 women ( 34 % ) suffered from PMS
but they did not show any significant tendency to offend in the
paramenstruum . In fact of the 22 women who offended premenstrually -
only 5 ( 23 % ) had premenstrual symptoms . This is particularly interesting
since all the crimes in this study were violent ones against either property or
people .
Hence it would appear that the data in this area is inconclusive about the
relationships between crime , PMS and the premenstruum . It would seem
that more violent crimes tend to be committed in the premenstrual phase
(d'Orban 1983 ) - however there is no established link between a past or
present diagnosis of PMS and a premenstrual crime . This adds weight
perhaps to the hypothesis that the stressful events leading up to the crime
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together with subsequent imprisonment etc. may have caused a premature
onset of menses . Perhaps the assumptions should be changed from
menstruation causing the crime to crime causing the menstruation.
b) Can PMS be used as a legal defence ?
The use of PMS as a legal defence has been a highly controversial area .
To date three British trials have accepted PMS as mitigation of sentence .
Two of the cases involved a murder charge , whilst the third was attempted
murder , and all three resulted in non-custodial sentences (Regina v
Craddock 1981 , Regina v English 1981 ,Regina v Smith 1982 reviewed by
Boorse 1987 ) . In each case the offence was committed in the
paramenstruum and evidence given showed that the women were PMS
sufferers . The basis of the defence or mitigation was that their legal
responsibility was diminished by the Premenstrual Syndrome . However the
use of this type of defence is hotly debated and still has not gained credence
in the United States for instance . In law , the use of PMS as a defence
depends upon whether the sufferer is considered to be responsible for her
actions when premenstrual . Responsibility for actions can be broken down
into two major components - " causation responsibility " and " liability
responsibility " ( Houlgate 1987 ) . The difference between the two being the
absence or presence of the intention to cause the event. It is the intention to
commit the crime which is the crucial part of the defence . The insanity and
automatism defences are based on two implied conditions of " liability
responsibility " - namely i) mens rea - literally " evil mind " but usually
interpreted to mean the absence of the necessary mental element to cause
or intend to cause the particular event to happen by virtue of mental disease
or handicap etc. This is the basis of the " insanity defence " ; and ii) Actus
rea - literally " evil action " - this means performing an action under the
influence of some external agent , for instance , under compulsion from
another person , during an epileptic attack , whilst sleepwalking etc. This is
the basis of the "automatism defence " and does not imply any long-term
mental instability .
There are arguments for the use of PMS as a complete defence on both of
the above grounds - as a mental disease or as a physical illness causing
temporary automatism . However much of this depends upon the definition
of PMS , its incidence in the general population ( it would be meaningless if
90 % of the female population were considered to suffer from PMS ) and the
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relationship between PMS and the commission of crimes - evidence for
which is weak at present ( see section 1.2.1 (a) ) . Boorse (1987 ) argues that
knowledge of this latter criterion is essential before PMS can even be
considered in a legal respect. He says
"... such correlations may show a weak causal influence i.e. that
premenstrual changes contribute to antisocial behaviour in some women .
But mere contributory causation cannot be sufficient for legal compulsion or
loss of control . Many mental , physical and environmental factors favour
criminal behaviour. Similar or stronger correlations exist between crime and
weather , time of day , level of fatigue , hunger or satiety , sexual tension
etc."
( Boorse 1987 p. 101 )
He then goes on to suggest several potential syndromes which might
account for the above conditions e.g. " MDS - Meteorologic
Decompensation Syndrome " to account for murder on a hot day I
However it is possible that PMS is valid as a partial defence or mitigation
resulting in a reduction of the charge from murder to manslaughter for
instance . The " mens rea " defence also allows for mental abnormality as
well as insanity resulting in a plea of " diminished responsibility " or
diminished capacity for responsibility for actions rather than loss of capacity
for responsibility ( Boorse 1987 ).
Evidently the whole area of PMS , crime and legal responsibility is
controversial . On the one hand there are those who argue that a woman
with PMS is not responsible for her actions and should be absolved of any
guilt ( e.g. Dalton 1977 ) whilst on the other hand there are those who
suggest that PMS may become a " bandwagon " defence allowing women to
do anything they like and blame it on PMS ( e.g. Holtzman 1984 in Boorse
1987 ).
Further and more detailed information is needed on the definition ,
diagnosis and incidence of PMS as well as the precise relationship between
crime , PMS and the menstrual cycle before its status as a legal defence can
be debated and decided .
1.2.2 PMS AND THE WORKPLACE
Many reviews of the PMS literature begin by justifying research on the
basis of the potential costs of PMS in terms of work disruption , absenteeism
etc. ( e.g. Reid & Yen 1981 ) . Symptoms of PMS such as loss of
concentration , impaired motor coordination , irritability etc. might be
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expected to cause decreased work efficiency whilst symptoms such as
depression , tension or physical changes might be expected to lead to an
increased absenteeism rate. Parker ( 1960) reports that
" in large factories employing 1500 or more women , as many as
one-third have been found to take sedatives , analgesics or both
premenstrually"
(Parker 1960)
However he gives no information about the effects of this on the quality of
the womens' work - whether they made up for any losses at other times of
the cycle for instance - or how many of them were dysmenorrheic . Dalton
(1966 ) showed a greater than expected absenteeism rate in days 1-4 of the
menstrual cycle - however this may be due to physical period pain rather
than emotional symptoms since the incidence in the days immediately
preceding menses is no more than expected . Texas Industries , who rely on
accuracy in the assembly of electrical components showed a reduction from
the normal production rate of 100 components per hour to 75 components
per hour during the paramenstruum of their female employees (Dalton
1977). Whether or not these women were PMS sufferers is unknown . Smith
(1950 ) studied absenteeism in three different factories - aircraft , parachute
and garment manufacturers. He found increased absenteeism
premenstrually in the aircraft and parachute - making industries , but lower
than expected absenteeism during menstruation . However in the garment
factory the position was reversed ( i.e. low premenstrual absenteeism and
high menstrual absenteeism) . The suggested reason for this is socio¬
economic differences between the factory employees . The most likely
explanation however would be an age difference between the employees -
if the garment workers were younger they might be expected to display a
higher incidence of dysmenorrhea resulting in more menstrual absences .
No diagnosis of PMS was used in this study hence no conclusions can be
drawn from it about the effects of PMS per se on absenteeism . A recent
study of absenteeism rates in Swedish insurance statistics ( Hallman &
Georgiev 1987 ) suggested that women with severe PMS are more inclined
to be absent from work and were likely to be diagnosed in the " mental
disorders " category during these absences than were women with no or
mild premenstrual symptoms . It was not apparent from this study whether
such women were absent regularly in the premenstrual phase , or were
prone to lengthy absences due to depression for instance . Since the
diagnosis of severe PMS was made on the basis of a large retrospective
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menstrual health survey , the possibility exists that the women selected were
those most likely to complain , or have an external locus of control , rather
than that women with severe PMS are more prone to mental disorders or
absenteeism .
Studies which have attempted to show specific objective cognitive deficits
in the premenstrual phase of the cycle have generally been inconclusive
(see Sommer 1973 ) . In 81 performance tests , carried out by 35
independent research groups , and reviewed by Sommer (1982 ) only 14
showed any evidence of menstrual or premenstrual changes . However ,
there may be reasons which account for this lack of findings . For instance ,
Redgrave (1971) argues that on simple reaction time tasks women may be
working harder in the premenstrual phase to compensate for the lack of
concentration they feel , thereby reducing any performance deficit . She
suggests that cyclical decrements in performance will only be seen when
subjects are working at their limits . This over compensation effect would
explain the lack of evidence of cyclical change on simple reaction time tasks
( e.g. Loucks & Thompson 1968 ; Kopell et.al 1969; Zimmerman & Parlee
1973 ; Little & Zahn 1974 etc. ) as compared to studies which involve
batteries of tests or more demanding test combinations ( e.g. Wuttke et.al
1973 ; Gamberale et.al 1975; Jensen 1982 etc.)
Although a number of studies have looked at changes in various
performance measures across the menstrual cycle - few have attempted to
objectively assess the reported performance changes in PMS sufferers .
Jensen (1982 ) studied two groups of women - a " distress " group who had
high to severe levels of PMS (on the Moos Menstrual Distress
Questionnaire) and dysmenorrhea , and an asymptomatic group . The study
showed significant premenstrual performance deficits on a pursuit-tracking
task . These deficits were independent of distress group . On the other hand
performance on a choice reaction time task seemed to be influenced by both
cycle phase and distress group as well as variables such as task load , time
on task , signal frequency etc. So it would appear that there may be a
difference between PMS sufferers and controls on some tasks but not
others. Since " distress " was based on retrospective reports and was a
global diagnosis , not discriminating between premenstrual depressives for
instance and women who suffer physical symptoms, no conclusions can be
drawn about the potential effects of specific PMS symptoms on performance.
Possibly if subtypes of PMS were defined more explicable results would be
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obtained . A recent study has found that women with PMS show lower
performance on the Crawford Small Parts Dexterity Test - Part II, a measure
of fine motor coordination, in the luteal phase compared to the follicular
phase . This contrasted with asymptomatic controls who performed better in
the luteal phase . No differences were found between the groups on any of
the other functional tests assessed . ( Posthuma,Bass,Bull & Nisker 1987 ).
It would appear therefore that menstrual cycle variables may be involved
in absenteeism rates and loss of performance on certain specific tasks .
However , the relative contributions of PMS and dysmenorrhea to these
rates is not known . Some evidence suggests that there may be an increase
in cortical arousal premenstrually (Asso 1978 ) causing better performance
on boring , repetitive tasks but poorer performance on tasks involving high
levels of concentration .
In a review of the effects of menstruation on work Harlow (1986 ) points out
that the quoted figures of absenteeism due to menstruation in the United
States for 1979 represent only 3 hours per woman per year , in fact the
greatest cause of lost work time is influenza . In this field too , further
research on the exact nature of PMS and its effects , beneficial or otherwise
on task performance and the workplace needs to be done before sweeping
statements about its potential effects can be made .
1.2.3 PMS AND THE FAMILY
The reported symptoms of PMS ( see Section 1.1 ) would suggest that
implications for marital harmony and family life might be severe . Lever ,
Brush and Haynes ( 1979 ) describe a vicious circle of wifely moodiness and
husbandly misunderstanding , supported by anecdotal evidence but no
data. They also state that
"
nobody knows how many divorces or seperations PMT has
occasioned because no research has been done to find out ."
( Lever, Brush & Haynes 1979 p.85 )
Some research has been done however on the relationship between
maternal menstrual cycle phase and child battering or child ill-health .
Dalton (1966 ) showed in a survey of 100 mothers attending her surgery
with children suffering minor ailments , 54 % were in the paramenstruum . In
a similar study of mothers whose children had been admitted to hospital as
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emergencies , 49% were in the paramenstruum at the time of admission
(Dalton 1970 ) . There may be several reasons for this - an inability of the
mother to cope with her child being even slightly ill when she is
premenstrual ( Lever et al 1979 ) , an increase in maternal accident-
proneness resulting in injuries to the child (Dalton 1977 ) and an increase in
"
baby-battering " as a result of premenstrual irritability ( Dalton 1975 ) . An
alternative view is that menstruation was precipitated by worry over the
child's health (Parlee 1973) . No evidence is given of the type of malady the
children were suffering - although accidental or non-accidental injury may
logically be attributable to the pre or paramenstruum, illnesses in the child
e.g. appendicitis etc. would be more difficult to ascribe to the effects of the
maternal menstrual cycle . No evidence is given of whether the mothers in
these studies were PMS sufferers.
To date there is little evidence of the often cited drastic effects of PMS on
family life and personal relationships ( e.g. Sharma1982 ; Chakmakjian
1983; Shreeve 1983 ; Brush 1984 etc. ) . Although these effects may be
difficult to document and demonstrate their presence or absence is very
important. Dalton ( 1975 ) for instance suggests that up to 50 % of mothers
who batter their babies could suffer from PMS , a fact the truth of which could
obviously influence legal decisions on mothers accused of injuring their
children .
Rome ( 1986 ) has discussed this aspect of PMS in detail , considering its
implications for the role of women . She argues that PMS symptoms cause
conflict about the traditional wife and mother role and that the work of Dalton
and others like her , whilst reflecting the social atmosphere at the time ,
serves only as an attempt to reinforce the stereotyped roles of women . She
argues
" It becomes painfully clear that Dalton's goal is to help women function
more smoothly in their traditional stereotypical role , subordinate to men .
She wants to help women do what they " ought " ; function as housewives
and mothers in an uncomplaining , cheerful way . "
Rome ( 1986 )
Rome argues that justifying PMS treatment on the basis of its potential
effects on family life is making assumptions about the social status of women
which are no longer relevant.
However , as with other aspects of PMS , the lack of an agreed definition
and delineation of the syndrome hampers research - it may be that only a
subtype of PMS leads to a greater vulnerability to baby battering or marital
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disharmony . Basic research is needed before sweeping statements can be
made about PMS in this respect.
1.2.4 PMS AND PSYCHIATRIC DISORDERS
a) Suicide and the menstrual cvcle
The type of symptomatology associated with PMS e.g. depression , violent
feelings etc. might be expected to lead to a higher rate of suicides and
suicide attempts during the paramenstruum in women who suffer from it. The
literature in this field is difficult to interpret however due to the inherent
experimental design limitations of both PMS research and suicide research
(see Clare 1982). Studies of completed suicides provide little data about the
menstrual history of the women concerned although the precise cycle phase
at the-time of death can be determined (e.g. Mackinnon et al 1959 ) . These
studies also usually require the consent of the next of kin introducing some
bias in subject selection on religious , economic or social grounds ( Wetzel
& McClure 1972 ) . Studies of attempted suicides ( e.g. Wetzel , Reich &
McClure 1971 ) may involve a different group of people from those actually
committing suicide - the 'cry for help ' phenomenon - and those who contact
a suicide prevention service may not be representative of suicide attempters
as a whole . Problems of definition of cycle phase and PMS are also
involved here . Overall, in both the case of completed and attempted
suicides several studies have shown an increased risk in the
paramenstruum ( e.g. Mackinnon et al 1959 ; Ribeiro 1962; Tonks et al
1968; Wetzel et al 1971 ) . However, these studies are all methodologically
flawed and give little information about whether their subjects suffered from
PMS . Birtchnell & Floyd ( 1974 ) in a study of 76 consecutive attempted
suicides found no significant differences between the observed and
expected numbers of paramenstrual women when the expected frequency
was calculated with an allowance for cycle irregularity . They also point out
that suicidal behaviour may be associated with a woman knowing or fearing
that she is pregnant . Thirteen young unmarried women in their sample were
either pregnant or beyond the expected date of their next menstrual period
at the time of the suicide attempt supporting the proposition that
premenstrual suicides may occur because of a late period and fear of
pregnancy ( i.e. social reasons ) rather than physiological PMS reasons . In
a later study ( Birtchnell & Floyd 1975 ) the incidence of attempted suicide in
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the group admitting to "premenstrual emotional disturbance " was not
significantly different from those who did not . However a high proportion of
these women were beyond the expected date of menstruation suggesting
further support for a fear of pregnancy motivation .
Hence there is very little sound evidence to link PMS or the
paramenstruum per se with suicide or attempted suicide . This does not of
course rule out suicides committed by PMS sufferers at other times of the
cycle as a result of guilt about their repeated premenstrual behaviour -
however no data is available in this area .
b) PMS and affective disorders
The nature of PMS symptoms has led researchers to hypothesize that
PMS sufferers are more vulnerable to mental ill-health in general ( e.g.
Clare 1983 ) or that PMS might be an appropriate model for other
psychiatric disorders. To date several studies have been undertaken
assessing either the rate of occurence of affective disorders in women
diagnosed as PMS sufferers (e.g. Wetzel , Reich , McClure & Wald 1975 ;
Schukit , Daly , Herrman & Hineman 1975 ; Mackenzie,Wilcox & Baron
1986; Hart, Coleman & Russell 1987 ) or the rate of occurence of PMS in
women suffering affective and/or personality disorders ( e.g. Coppen 1965 ;
Diamond , Rubinstein Dunner & Fieve 1975 ; Hurt, Friedman , Clarkin , Corn
& Arnoff 1982 ; Halbriech & Endicott 1985 ) . In some of these cases the
whole syndrome of PMS was discussed , involving physical symptoms as
well as psychological , whereas in others only a " premenstrual affective
syndrome " ( PAS ) is considered based on diagnostic criteria outlined by
Kashiwagi et al ( 1976 ) (see Table 1.2 ) . However, whatever the diagnostic
criteria of PMS or PAS there generally appears to be a trend linking
premenstrual depression with a lifetime diagnosis of a major depressive
disorder. For instance in a study of 558 freshmen and sophomores (Wetzel
et al 1975 ) who were assessed for PMS on the basis of the Kashiwagi et al
criteria at the start of their college careers , 20 % of those diagnosed having
PMS visited a psychiatric clinic during their four year course compared to
only 14 % of those diagnosed as not having PMS . When these figures were
further broken down - 75 % of the clinic attenders without a PMS diagnosis
were given an affective disorder diagnosis compared with 89 % of the PMS
suffering clinic attenders . Wetzel et al then conclude that a diagnosis of
premenstrual affective disorder can predict the subsequent seeking of
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TABLE 1.2
CRITERIA FOR PREMENSTRUAL AFFECTIVE SYNDROME (PAS1
( From : Kashiwagi , McClure & Wetzel 1976 )
1. At least one of the following behavioural symptoms
a ) Sad , blue or depressed
b ) Tense or nervous
c) Cry easily
d ) Decreased energy
e ) Increased mood or energy
2 . At least one of the following somatic symptoms
a ) Swelling of legs
b ) Swelling of abdomen
c) Tenderness of breasts
d) Weight gain
3. Subjective rating of symptoms as moderate or severe
4 . Objective recognition of symptoms as moderate or severe
psychiatric care for affective disorders ( It should be borne in mind here that
80 % of their PMS positive women made no visits to the psychiatric clinic so
that their conclusions seem somewhat overstated . It would be fairer to say
that a previous diagnosis of PAS might be considered a contributory factor
in an affective disorder diagnosis during their college careers in young
women). Similarly a high prevalence of PMS or PAS is often found in
women with a current or lifetime diagnosis involving a major depressive
disorder ( MDD ). Halbriech & Endicott ( 1985 ) showed that 57 % of their
sample of 110 women with a lifetime MDD diagnosis met the criteria for
premenstrual depression set out in the PAF ( Premenstrual Assessment
Form ) . This compared to a rate of 14 % in a group of 37 women who were
"never mentally ill".
Overall it would appear that about 50 - 65 % of women with affective
disorders experience premenstrual depression or premenstrual
exacerbation of a current depressive episode . The proviso should be added
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that the majority of studies involving psychiatric patients or ex-patients are
retrospective and make no comment on whether this group of people are
more or less likely to complain in response to such instruments than are the
general population . It would also seem that women who suffer regular
premenstrual depression are more likely to have had or to develop an
affective disorder than their asymptomatic sisters . Hence some researchers
have argued that PMS - and particularly premenstrual depression - could be
useful as a model to study the various concomitants of clinical depression
(Rubinow & Roy-Byrne 1984 ; Halbriech & Endicott 1985 ) - or possibly
could be related to manic-depressive illness (Coppen 1965; Kashiwagi et al
1976). This latter phenomenon has recently been suggested to have a
genetic basis in some populations (Egeland et al 1987 ) but as Stone
(1982 ) points out - isogenic conditions need not always be isophenic, the
possibility being that PMS and recurrent affective disorders are different
phenotypic expressions of a common genetic source . If this were the case
then treatments shown to be effective in manic-depressive illness might be
expected to be therapeutic in PMS . Sletton & Gershon ( 1966 ) report
positive results in 8 cases of PMS who were given lithium carbonate , an
effective treatment in manic depression. However no quantitative data were
given to substantiate this report . Subsequent studies (Mattson & von
Schoultz 1974 ; Singer, Cheng & Schou 1974 ; Steiner, Haskett , Osmun &
Carroll 1980 ) have failed to demonstrate any consistently beneficial effect of
lithium carbonate as compared to placebo in PMS. This does not rule out
the possibility that different phenotypic expressions of the same genetic
disorder may not respond to the same treatment , however some doubt must
be cast upon the relationship between PMS and cyclical affective disorders .
This still leaves the possibility of an aetiological link between dysphoric
PMS and endogeneous depression on the basis of the literature reviewed
above ( for a full exposition of this point of view see Halbriech & Endicott
1987). Steiner & Haskett (1987 ) argue that PMS is not a model for
endogeneous depression (ED) since the typical dysfunction of the
hypothalamo-pituitary-adrenocortical axis seen in patients with ED cannot
be demonstrated in patients with PMS . It is known that some depressed
patients secrete ACTH (Adrenocorticotrophic hormone ) , and hence Cortisol
in a different way to the normal population , and that this secretion of Cortisol
is not abolished by normal negative feedback mechanisms . This can be
demonstrated by giving dexamethazone as a challenge . Approximately
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50% of hospitalized depressed patients will suppress their Cortisol levels in
response to dexamethazone whereas virtually all non-depressed people
will (Green & Costain 1981 p.56 ) . Steiner & Haskett measured 24 hour
urinary free Cortisol levels in 38 women with PMS , before and after giving
the dexamethazone suppression test (DST) , in the follicular and the late
luteal phases of their menstrual cycles . None of the women showed
evidence of hypersecretion of Cortisol before DST on either occasion and
none of the women showed an abnormal response to DST on both
occasions . Four women gave abnormal DST results in the follicular phase
and 3 in the luteal phase but there was no trend towards abnormal results in
either phase . Despite the absence of control groups of depressed patients
with or without PMS and non-depressed women without PMS, they argue
that PMS does not appear to be a model for ED and that hypothalamo-
pituitary- adrenocortical activity is not a neuroendocrine marker for PMS .
However there were clearly individual differences here - and since only 50%
of patients with ED show abnormal DST results , some caution should be
used in the interpretation of this study .
So it would seem that the relationship between PMS and affective
disorders and the possible importance of PMS as a model for the study of
clinical depression is more controversial than first thought. As in most areas
of PMS research , lack of concordance between studies about the definition
of PMS and the selection of subjects makes the data easy to criticize and
difficult to interpret.
1.2.5 SUMMARY OF SECTION 1.2
The existence of a cyclical pattern of mood and behaviour in women
associated with the menstrual cycle has been established by folklore and
case history reports . Studies of the effects of the menstrual cycle and
subsequently PMS on various aspects of women's social functioning have
produced what at first sight appear to be dramatic associations between the
premenstrual and menstrual cycle phases and antisocial behaviour with the
resultant implication that if women could only be treated so as to behave as
if they were always in the follicular phase then all would be right with the
world . Media " panic " about the influence of hormones on women's
behaviour and the attendant implications for women's role in society has led
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to a flurry of research activity in the field .
Closer inspection of the studies in all the fields reviewed above reveals
major methodological flaws in experimental design and lack of consensus
between research studies about exactly what is meant by the term PMS .
Further research is needed in order to discover precisely what proportion of
the female population suffer premenstrual symptoms and just what it is that
they are experiencing before conclusions about the causes and effects can
be drawn .
1.3 PREVALENCE OF PREMENSTRUAL SYNDROME
Attempts to establish the prevalence and incidence1 of occurence of
premenstrual problems in the general population have produced
inconclusive results when considered as a whole . The large number and
variety of symptoms associated with the premenstruum has led to a lack of
terminological concordance between questionnaire studies and the
variability in symptom severity between individuals and between cycles has
led to possibly erroneously high prevalences of PMS being reported .
Pennington (1957 ) for instance reported that 95 % of a sample of 1000
mostly high school and college girls , suffered at least one premenstrual
symptom . However , no indication of the severity of these symptoms was
given and the age group studied may not be representative of PMS sufferers
in general . Other studies (e.g. Woods , Most & Dery 1982 ) have avoided
giving prevalence rates for PMS but rather have reported on individual
symptoms such as irritability or breast pain . These studies give lower
prevalence rates for each symptom , but little indication of the proportion of
women suffering symptom combinations . Still other studies (e.g. Moos
1968; Rouse 1978 ; Abraham & Hargrove 1980 ) concentrate on symptom
categories or clusters which may be clinically useful but provide little
comparison with other studies.Some of the symptoms commonly assessed
for prevalence are described in tables 1.3 - 1.8. The differing terminology in
different studies , means that tension for instance has been omitted . Only
studies reporting data for specific single symptoms have been included to
1 The distinction should be made here between prevalence - the proportion
of a population affected by a disease at any one time - and incidence , the
number of new cases diagnosed within a particular time period ( Barker &
Rose 1979 ). Although studies of PMS often discuss "incidence" , the data
they present is actually describing prevalence rates .
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give some degree of comparability . It would appear from this summary that
depression , irritability , breast pain and abdominal swelling are fairly
common premenstrually and show a reasonably consistent prevalence rate
across all the samples studied. Those studies which have assessed
premenstrual symptom severity ( e.g. Moos 1968: Woods , Most & Dery
1982 ; Andersch et al 1986 ) are consistent in finding a very small proportion
of the sample indicating severe symptoms . This latter group is arguably the
one to which the label PMS should be assigned giving a prevalence rate of
about 2 - 12 % of the general population depending on symptom . The
generally accepted belief that premenstrual symptoms are relieved at the
onset of menstruation does not seem to be borne out in those studies which
have assessed menstrual symptoms . Possibly these figures represent a
different group of women , however the only symptom showing any
consistent trend is "period pain " which not surprisingly increases during
menstruation .
The studies outlined above can all be criticized on several counts. Firstly -
the use of a retrospective questionnaire to assess premenstrual symptoms
may introduce response bias ( Parlee 1973 ) . Prospective studies of
prevalence tend to give lower rates generally supporting the idea that
cyclical psychological change is a relatively common phenomenon and that
a small percentage suffer a clinical syndrome ( Slade 1984 ; Taylor et al
1986 ) . Secondly - many studies only asked about premenstrual symptoms .
Since the symptoms may also be present during menstruation either as a
continuation of PMS or as a seperate 'syndrome ' - some confusion may
exist in subjects ' minds leading to excess symptom reporting . Thirdly -
littleaccount is taken of the possible effects of oral contraceptives ( oc's ) on
premenstrual symptoms . Rouse ( 1978 ) showed that as a rule women
taking oc's reported fewer premenstrual and more menstrual symptoms than
women not taking oc's . However effects of the length of time for which the
oc has been used or of being an ex -oc user have not been assessed.
Fourthly - few studies assess symptom prevalence intermenstrually , hence
the possibility of premenstrual exacerbation of underlying symptoms is
ignored . Finally - few studies take into account the woman's cycle phase at
the time of questionnaire completion . Although Moos ( 1968 ) and Rouse
(1978 ) show no cycle effects on symptom reporting on the MDQ , this was
based on a comparison between a group of" premenstrual " women and a
group of "midcycle " women not on a repeated measures design within an
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TABLE 1.3
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oc - oral contraceptive user, sev - severe .
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TABLE 1.4
STUDIES OF PREMENSTRUAL IRRITABILITY PREVALENCE
STUDY
Premenstrual Menstrual Postmenstrual
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44% 12 % 38% 11 % 14% 4%
Mao &Chang
1985
52 % - -
Andersch et al




65 % 37% 3%
MEAN 58.4 % 32.8 % 3.0 %
RANGE 32 % - 75 % 8 % - 49 % 2 % -18 %
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TABLE 1.5
STUDIES OF PREMENSTRUAL DEPRESSION PREVALENCE
STUDY
Premenstrual Menstrual Postmenstrual
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STUDIES OF PREMENSTRUAL BREAST SYMPTOM PREVALENCE
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MEAN 49.3 % 26.4 % 6.1 %
RANGE 25 % - 84 % 21 % - 30 % 4%-10%
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TABLE 1.7
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RANGE 27 % - 86 % 7 % - 39 % 1 % -11 %
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TABLE 1.8
STUDIES OF PREMENSTRUAL PERIOD PAIN PREVALENCE
STUDY
Premenstrual Menstrual Postmenstrual
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MEAN 37% 50 % 6%
RANGE 13%-67% 35 % - 75 % 1 % -14 %
29
individual . It therefore seems illogical to conclude that the individual cycle
phase at the time of questionnaire completion has no effect on the individual
responses to the questionnaire .
Correlational analyses of various social and personal factors and their
relationship to premenstrual symptoms has been undertaken in several
prevalence studies . Age has been shown to be negatively correlated with
dysmenorrhea ( Kessel & Coppen 1963 ; Woods , Most & Dery 1982 ; Boyle,
Berkowitz & Kelsey 1987 ) however premenstrual mood symptoms show no
clear pattern . Some studies cite no correlation between age and PMS
(Kessel & Coppen 1963 ; Boyle , Berkowitz & Kelsey 1987 ) . Andersch et al
(1986 ) showed increases in premenstrual anxiety and peripheral swelling
with age and Rouse ( 1978 ) showed overall MDQ score increases with age.
However Woods, Most & Dery ( 1982 ) showed a decrease in premenstrual
irritability,crying and napping in older subjects . No effects of marital status
have been reported , except for Kessel & Coppen 's ( 1963 ) report of
increased premenstrual irritability in married women . Andersch et al ( 1986)
demonstrated increased anxiety and abdominal swelling in divorced
women. Parity seems to have a similar effect to age on premenstrual and
menstrual cramps - the effect remaining significant when the confounding
factor of age is removed ( Kessel & Coppen 1963 ; Woods , Most & Dery
1982 ; Andersch et al 1986 ; Boyle , Berkowitz & Kelsey 1987 ) . However no
correlation with psychological symptoms has been shown . Woods,Most &
Dery ( 1982 ) and Boyle , Berkowitz & Kelsey ( 1987 ) suggest that race may
be an important factor , with white women generally reporting more
premenstrual changes and black women more menstrual changes ( except
for cramps ) . Cross-cultural prevalence studies , however tend to show fairly
similar premenstrual symptoms across different cultural groups with
variations in the frequency and severity of symptoms (Janiger, Riffenbergh &
Kersh 1972 ; W.H.O. 1981; Mao & Chang 1985 ) . Friedman & Jaffe ( 1985)
suggest an association between lifestyle and PMS , with housewives and
less well educated women in their sample consistently reporting higher
scores on fluid retention , autonomic and negative affect scales . Cycle
regularity does not appear to be correlated with premenstrual symptoms or
dysmenorrhea , but oral contraceptive use does have an effect on menstrual
symptoms , particularly cramps and skin disorders, and a slight effect on
premenstrual symptoms , although this may become more marked after
prolonged use ( Sheldrake & Cormack 1976 ; Rouse 1978 ; Woods, Most &
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Dery 1982 ) . The effects of being an ex-oc user are not assessed in any
study .
Overall then it would seem that the incidence of PMS per se is difficult to
assess due to definitional problems . However the symptoms of it have been
assessed both retrospectively and prospectively, suggesting that a large
number of women experience some symptoms to some degree
premenstrually. The number apparently suffering severe symptoms is small -
about 2-12 % and this figure may give a reasonable estimate of PMS
prevalence . Although dysmenorrhea is significantly correlated with such
factors as age , parity and oc use , no consistent correlations have emerged
for premenstrual mood symptoms . These findings have led some
researchers to describe premenstrual mood changes as a physiological
rather than a pathological process and possibly independent of physical
changes . (Sutherland & Stewart 1965 ; Taylor, Alexander & Fordyce 1986 ).
1.4 DEFINITION AND DIAGNOSIS OF PREMENSTRUAL
SYNDROME
The above description and discussion of PMS forms the rather untidy
picture of the syndrome as a mixture of symptoms occuring with some
temporal relationship to the menstrual cycle in some proportion of the
female population. The concept has attracted the attention of the media as
well as the medical / scientific fraternity resulting in many hypothetical claims
being made on the basis of very little sound evidence about the
phenomenon . A plethora of studies have been undertaken mostly within
the medical / treatment framework, using a variety of diagnostic criteria for
PMS and instruments for its assessment, and producing conflicting results .
Few of these studies can withstand methodological criticism resulting in
even more confusion about the exact nature of PMS . This has led several
reviewers (e.g. Ginsberg 1987 ; Clare 1982 etc. ) to the conclusion that little
progress will be made in the field in the absence of a universally acceptable
and meaningful definition of the syndrome . This conclusion is easy to draw
but less easy to act upon . The assumption that it is possible to define PMS
as a clinical entity may prove to be unfounded .
It would appear from a consideration of the nature of definitions ( see
Appendix One ) , that the term " Premenstrual Syndrome " may be difficult
to define , or even practicably indefinable . However, before dismissing the
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concept as such , some of the known parameters of PMS should be
discussed to give some idea of the current ' convention ' on the subject.
1.4.1 THE NATURE OF PMS
Although there may be little agreement between studies on the precise
criteria upon which to select PMS sufferers - there does seem to be some
general consensus about the constituents of the
syndrome . The major features are : -
i) A large number of possible symptoms .
ii) Individual differences in the number and type of symptoms reported .
iii) Inter-cycle differences in the number and type of symptoms within an
individual .
iv) Symptom onset during the " premenstrual phase " ranging from 3 days
before menses to 3 weeks before menses and varying between individuals
and between cycles .
v) Symptom relief at some time during or immediately after menses ,
varying between individuals and betwen cycles .
vi) Variable symptom severity between individuals and between cycles .
vii) Premenstrual exacerbation of underlying chronic conditions e.g.
affective disorder.
viii) Effects of other life events e.g. bereavment , heavy workload ,etc. on
experience of premenstrual symptoms .
ix) Lack of knowledge about aetiology .
To include all of these factors in a definition conforming to the rules
outlined in Appendix 1 , would give a rather unwieldy and ambiguous result.
In response to this , researchers have concentrated on specific aspects of
PMS which they have defined to their satisfaction . For instance , Halbriech ,
Endicott & Lesser (1985 ) postulate a "premenstrual affective disorder "
which involves only depression based symptoms . They make little
specification about the the symptom timing but insist upon particular
symptom clusters . On the other hand Dalton ( 1977 etc. ) emphasizes that
symptoms must occur in the week before menses with complete remission
during the first day of menstrual flow . Hence in this definition , timing of
symptoms is the crucial factor.
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In this case it is necessary to go back to one of the basic premises and
limitations of any definition i.e." it is not possible to define concepts - only
linguistic phenomena " . The problem here is that by giving a name , "PMS",
to the observed phenomena of cyclical changes in women , researchers
have attempted to create a linguistic phenomenon from what is essentially
an open concept . Simply giving something a name does not change the
essential nature of the "something " . In fact naming a phenomenon which
we do not understand can have dangerous consequences . In this case the
label Premenstrual Syndrome has aetiological implications i.e. the
syndrome is caused by some parameter of the menstrual cycle or even
menses perse which may be misleading .
There are two possible solutions to this problem . Either
i) The phenomenon known as PMS is not a single entity but rather many
different entities or syndromes which have been " lumped together "
because of a coincident correlation with the menstrual cycle .If this is the
case , then the subtypes of other syndromes occuring premenstrually need
to be isolated and defined before aetiological work can progress . If we
assume that there is at least one syndrome for each of the currently
recognised symptoms i.e. approximately 50 , in each of their temporal
possibilities and add to that all the possible interactions with each other both
symptomatically and temporally the total number of syndromes is practically
infinite . Or
ii)The phenomenon known as PMS is not an entity at all but could be
better described as the extreme of a continuum of premenstrual symptoms .
1.4.2 PMS AS THE EXTREME OF A CONTINUUM
Many human attributes form a continuum in the population . One of the
most obvious examples is height .which is normally distributed . This pattern
however can be subject to environmental pressure - for instance in countries
deficient in dietary Vitamin D , bone problems may cause an excess of
people at the shorter end of the spectrum i.e. the distribution may become
skewed . A problem arises however when we wish to define " tall " . If we
assume a normal distribution of height (fig. 1.1a ) where is the dividing line
between " tall " and " not tall "? The same argument could apply to PMS . If
the x-axis is relabelled number/severity/timing of premenstrual symptoms









































Figure 1.1 Graphical Explanations of PMS as a Continuum
a ) The Normal Distribution Curve
b ) The Definition Of PMS
c) Lifetime Symptom Profile Qf Woman A
d ) Lifetime Symptom Profile Of Woman B
34
complain of premenstrual syndrome . The question is where to put the
dividing line . If this hypothesis of an underlying normal distribution of
premenstrual symptoms is true - then generally they are no more of an
illness than height is . However in this respect premenstrual symptoms are
better likened to intelligence. Women whose symptom severity , for example,
falls at the right hand end of the continuum are undoubtedly suffering and
need help in the same way that people falling at the left hand end of the
intelligence continuum need help . The different criteria used in different
research studies have assigned different cut-off points for PMS explaining
why , for instance , there is a lack of consensus in studies of incidence ( see
fig. 1.1b ) . The picture is further complicated if we take into account
variability between cycles in each individual woman . It is possible to
hypothesize that each individual also experiences symptoms on a
continuum skewed according to how she fits into the general population If a
woman with an overall symptom severity of A (fig. 1.1b ) is considered then
her lifetime profile of , for instance, premenstrual depression would probably
be a skewed distribution as in figure 1.1c. Whereas if a woman with overall
severity B (fig. 1.1b ) were chosen her distribution might be skewed in the
opposite direction as in figure 1.1 d. This hypothesis explains the variation
between and within individuals,and has quite important implications for
aetiological studies . If PMS is just a name given to symptoms at the end of a
continuum , then searching for some factor present or absent in women with
PMS and not in women without PMS would be fruitless. The implication is an
underlying predisposition whose expression may be dependent on both
biological and environmental factors ( cf. intelligence ) . It is possible that
certain environmental factors may cause an upward or downward shift in the
whole distribution in particular populations . It may be that in our Western
culture either the menstrual symptom curve has become skewed to the right
as a result of some environmental pressure or the subjective threshold for
symptom reporting has shifted to the left as a result of media exposure ,
meaning that there is a preponderance of women with symptoms at the
severe end of the scale . If this is the case then the argument for symptomatic
treatment is advocated . However it may be that although a normal
distribution curve is obtained , an individual woman does not stay at the
same point on the curve for the whole of her reproductive life . Certain events
in her life e.g. pregnancy , oral contraceptive use , bereavment etc. may
cause her to switch from position A to position B for instance ( fig. 1.1b ). If
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that were the case then some manipulation might be possible to cause a
shift downwards in severe sufferers .
This analysis is purely hypothetical and raises as many questions as it
answers . However it is eminently testable - simply by longitudinal studies of
normal unselected women and by large epidemiological studies .
1.4.3 SUMMARY OF SECTION 1.4
One of the major problems of research into PMS is the lack of an adequate
definition . The reason for this may be that PMS is an open concept rather
than an entity and as such will not fit into any practicably definable category.
There are two possible solutions to this problem , either PMS is a blanket
term subsuming many other syndromes occuring premenstrually , all of
which'are entities in their own right and definable ; or PMS represents the
extreme of a continuum of menstrual symptoms and as such is virtually
indefinable . The latter position is favoured for two reasons
i) If PMS is a blanket term then the number of sub-syndromes and the
interactions between them approaches infinity , making their delineation and
interpretation a practical impossibility .
ii) The continuum theory is a more flexible explanation of the observed
phenomenon and involves few inherent assumptions about it.
1.5 THE AETIOLOGY OF PREMENSTRUAL SYNDROME
The diverse and elusive nature of PMS has led to nearly as many
aetiological theories as there are potential symptoms . These theories range
from the genetic to the psychological and none can be proven beyond
doubt. The most obvious candidate for a syndrome correlating with the
menstrual cycle is a malfunction of the ovarian hormone system which
regulates the female cycle . Although the evidence for this is controversial
most of the physiological theories of PMS assume that the substance in
question e.g. dopamine or prostaglandin is producing systemic and/or
central effects in response to ovarian hormones and as such shift the burden
of guilt as it were back on to oestrogen and progesterone. The nature and
role of the ovarian hormones is a major part of this thesis and will not be
discussed in detail here . However a brief resume of the alternative
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hypotheses is outlined below .
1.5.1 THE GENETIC HYPOTHESIS
Recent evidence of a genetic linkage in some affective disorders (e.g.
Egeland et al 1987 ) is suggestive that there may be some genetic influence
in PMS ( Clare 1985) . There is very little evidence to support or deny such a
theory. Dalton ( 1977 ) dogmatically states that a familial tendency for the
syndrome exists and that mothers and daughters are likely not only to both
experience PMS but to exhibit the same premenstrual symptom cluster .Two
surveys of premenstrual symptoms ( Widhlolm & Kantero 1971 ; Chern,
Gatewood & Andersen 1980 ) have reported significant relationships
between mothers , daughters and sisters on various cycle parameters
including "premenstrual tension " - although these results could easily have
explanations other than genetic , especially if the women were living
together . A study by Paulson (1961) found that 58% of the mothers of a
group of "high premenstrual tension" sufferers also experienced
premenstrual and menstrual symptoms , compared to only 27% of a " low
premenstrual tension " group . He argues that maternal feelings and
attitudes predispose later premenstrual problems in their daughters .
However the explanation could equally as well be a genetic predisposition
rather than a sociocultural one . To date no good data exists from studies of
dizygotic or monozygotic twins . Dalton ( 1987 ) reports such a study in
progress whose preliminary results support the hypothesis , however all
such studies will require very close scrutiny and careful replication before
conclusions can be drawn .
It could be argued that since PMS only affects women ( as far as we know)
it is essentially a genetic condition in the same way that menstruation is a
genetic condition , and that the underlying genotype can be influenced by
the environment to cause variable phenotypic expression (see Section
1.4.2). This argument is suggesting , not a genetic malfunction or genetically
carried disease - such as Down's syndrome , but rather a normal underlying
genetic predisposition whose expression can be influenced by the
environment . If this were the case then traditional genetic studies of twins
would reveal nothing more than studies of sisters who had shared the same
early environment .
An alternative view of this is that offered by sociobiology . Rosseinsky &
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Hall (1974 ) argue that PMS - or at least premenstrual hostility - may have
evolved in order to repel male advances at a time of the menstrual cycle
when the female is likely to be infertile - thus intensifying male ardour during
the next fertile phase , optimizing the chances of conception . If the female
does not conceive then repeated bouts of premenstrual hostility may cause
the breakdown of an infertile pair-bond . They answer the criticism that the
thwarted male need only turn to another female to satisfy his sexual needs
by citing evidence of menstrual cycle synchronicity in cohabiting females
(McClintock 1971 ). They then go on to state
" The primary corollary to the thesis is that PMT is intrinsic and
ineradicable although symptomatic treatment may be appropriate "
( Rosseinsky & Hall 1974)
Hence the theoretical possibility of a genetic basis for PMS is accepted but
little evidence to support or deny the theory is available .
1.5.2 THE MONOAMINE NEUROTRANSMITTER HYPOTHESES
a) Catecholamines
The three catecholamine neurotransmitters are dopamine ( DA ) ,
norepinephrine (NE ) and epinephrine . The first two of these ( DA & NE )
have been implicated in the expression of various mood states and
psychiatric disorders ( Schildkraut & Kety 1967 ; Stein & Wise 1971 ) ,
although the exact nature of the involvement is unclear and remains
controversial . The catecholamines have also been implicated in the control
of the reproductive cycle, and particularly of LH release in the rat ( Meyerson
& Sawyer 1968 ; Schneider & McCann 1969 ; Kamberi 1970 ; Kalra &
McCann 1973 ) . Oestrogen and progesterone have been shown to be
effective in modulating uptake and passive effux of NE and DA from
synaptosome (Janowsky & Davis 1970 ) and in altering absolute levels of
NE and turnover rates of NE and DA in rat brain ( Janowsky , Berens &
Davis 1973 ; Pfaff & McEwen 1983 ) . In these respects oestrogen and
progesterone appear to have opposite effects . Three major areas of
evidence suggest a possible link between catecholamines and the
menstrual cycle in humans:-
i) Increased levels of urinary NE in the luteal phase ( Wiener & Elmadjian
1962 ; Feichtinger et al 1979 ; Goldstein, Levinson & Keiser 1983).
Measures of total urinary NE include amine from both central and peripheral
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sources. However a study of urinary 3-methoxy-4-hydroxphenyl -glycol
(MHPG ) purported to be the major urinary metabolite of central NE found
elevated levels in the late luteal phase followed by a rapid drop two days
premenstrually and rebound elevation during menses ( DeLeon-Jones,
Steinberg , DeKirmejian & Garver 1978 ) .
ii) Decreased Dopamine-B-Hydroxylase (DBH) in the premenstrual /
menstrual phases ( Lamprecht , Matta , Little & Zahn 1974 ) This enzyme
converts DA to NE and a decrease suggests an alteration in the synthetic
pathway of NE and a reduction in NE levels .
iii) Increased sensitivity to tyramine premenstrually ( Ghose & Turner
1977). Tyramine is a measure of NE receptor sensitivity and this increase
suggests reduced NE activity .
So , in the immediate premenstruum there would appear to be a reduction
in NE-activity possibly leading to psychological disturbance . This may be in
response to levels of oestrogen and progesterone , or it may be causal, or
both may be mediated by other factors .
A recent study of urinary MHPG levels in carefully diagnosed PMS
sufferers and controls has suggested that women with PMS excrete higher
levels of MHPG throughout the cycle ( Schrijver, Louwerse , Bruinse & Van
den Berg 1987 ) . In this study , no cyclical changes in urinary MHPG were
seen - however, levels were only assesed at five points during the cycle
and hence , subtle variations may have been missed . The levels seen were
comparable to those suggestive of depression , hence the authors argue
that it is tempting to view PMS as a manifestation of an affective disorder.
b) Indoleamines
The major indoleamine is serotonin ( 5-hydroxytryptamine ;5HT ) . This has
been implicated in major theories of depressive illness ( Lapin & Oxenkrug
1969; Curzon 1969 ) and is responsive to progesterone withdrawal
(Hackman, Wirz-Justice & Lichtsteiner 1973 ; Ladsisch 1977 ) Several
studies have demonstrated cyclicity of 5HT action by measuring appropriate
indices e.g. tryptophan levels ( Wirz-Justice , Puhringer , Hole & Menzi
1975); platelet 5HT uptake ( Wirz-Justice & Chappius-Arntt 1976 ; Taylor et
al 1982 ); urinary 5-HIAA levels ( LerdodeTejade etal 1978 ) [ N.B. 5-HIAA ,
5 hydroxyindole- acetic acid , is the major metabolite of 5HT however only a
small fraction of urinary 5 HIAA originates from the CNS , therefore such
studies should be treated with caution ( Green & Costain 1981 p.67 ) ] .
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These studies suggest that platelet uptake of 5HT is decreased
premenstrually . Taylor et al (1982 ) correlated platelet uptake negative
affect and cognitive deficit , showing a strong positive correlation , lower
platelet levels being associated with lower mood levels .
Ladsisch ( 1977 ) suggested that 5 HT levels drop in response to
progesterone withdrawal as opposed to low progesterone levels per se .
leading to increased reactivity to stress premenstrually . Labrum ( 1983 )
argues that serotonin values fall in response to oestrogen withdrawal - the
higher the relative oestrogen level in the early luteal phase , the more
pronounced the withdrawal effect on 5HT and the worse the PMS
symptoms.
One of the cofactors involved in the synthesis of 5HT from tryptophan
(and dopamine from tyrosine ) is pyridoxal phosphate , derived from
pyrido'xine (Vitamin B6 ) in the diet. A relative deficiency of this vitamin has
been noted in oral contraceptive ( oc ) users ( Green , Bloomfield , Woods &
Seed 1978 ) and has been related to oc induced depression ( Adams ,
Rose, Folkard , Wynn , Seed & Strong 1973 ). On the same basis pyridoxine
has been prescribed for PMS , although its therapeutic efficacy has not been
fully demonstrated (Stokes & Mendels 1972 ; Winston 1973 ; Hagen,
Nesheim & Tuntland 1985 ; Williams , Harris & Dean 1985 ) . This does not
of course rule out a part for serotonin in PMS . Labrum ( 1983 ) argues for
possible interactions between oestrogen , serotonin and other factors e.g. a
MSH or Bendorphin whilst Rausch & Janowsky (1982) suggest that the
serotonin hypothesis may bear some relation to the mineralocorticoid
theory.
1.5.3 OTHER ENDOCRINE HYPOTHESES
a) Prolactin
Prolactin is a pituitary hormone and is involved in milk synthesis and
breast development . Some studies have shown variations in prolactin
across the menstrual cycle ( e.g. Halbriech , Assael , Ben-David & Bernstein
1976 ) whilst others have shown no overall change ( McNeilly , Evans &
Chard 1973; Epstein , McNeilly , Murray & Hockaday 1975 ) . Whilst some of
these discrepancies may be related to experimental method and diurnal
variation in prolactin secretion , most of the confusion is explained by large
individual differences . Although some women show little variability , others
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have clear mid-cycle and late luteal elevations . ( McNeilly & Chard 1974 ;
Steiner & Carroll 1977 ) .
Horrobin ( 1973 ) reports an experience of PMS like symptoms ( fluid
retention, irritability and depression ) after an injection of prolactin and
suggested that elevated levels in the late luteal phase might explain the
premenstrual syndrome. Studies of prolactin levels in PMS sufferers have
not demonstrated any clear difference between women with PMS and those
without ( Benedek- Jaszman & Hearn-Sturtevant 1976 ; Assael , Ben-David
& Bernstein 1976 ; Carroll & Steiner 1978 ) . An alternative way of testing the
hypothesis is by use of bromocriptine - a dopamine antagonist and prolactin
suppressant . However although some results have been encouraging
(Benedek-Jaszman , Lequin & Sternthal 1975;Cole,Evered,Horrobin,
Manku, Mtabaji & Nassar 1975; Benedek-Jaszman & Hearn-Sturtevant
1976; Eisner,Buster, Schindler.Nessim & Abraham 1980 ; Ylostalo,Kauppila,
Puolakka ,Ronnberg & Janne 1982 ) , careful double blind control trials
have failed to show a significant effect over placebo ( Andersen, Larsen,
Steenstrup, Svendstrup & Nielsen 1977 ; Ghose & Coppen 1977 ; Graham,
Harding, Wise & Berryman 1978 ; Steiner,Haskett.Osmun & O'Carroll 1983).
The only symptom to consistently show any improvement being breast pain
(Kullander & Svanberg 1979 ; Andersch1983 ).
Although prolactin may be involved in PMS - or cyclical mastalgia
(Mansel, Preece & Hughes 1980 ) it does not appear to have a direct effect
on cyclical mood change . The possibility of an effect due to increased tissue
sensitivity to prolactin (Horrobin 1983 ) is discussed later( Section 1.5.5 ) .
b) Insulin
DePirro , Fusco , Bertoli , Greco & Lauro ( 1978 ) have demonstrated
cyclicity in the specific binding of 125 I Insulin to circulating monocytes
coincident with the menstrual cycle . An inverse relationship exists between
insulin binding and levels of 178 oestradiol , progesterone and 17-
hydroxyprogesterone ( Bertoli, DePerro,Fusco,Greco,Magnatto & Lauro
1980) . Since other researchers have reported subclinical hypoglycaemia
premenstrually ( Morton 1950 ) and the symptoms of PMS are similar to
those of transient hypoglycaemia ( Clare 1985 ) ; Rausch & Janowsky
(1982) suggested that PMS may be explicable by changes in insulin
receptor binding and glucose tolerance in response to ovarian hormones .
A recent study of oral glucose tolerance tests in normal women and
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women with PMS and premenstrual hypoglycaemic attacks found no
evidence of significant menstrual cycle related differences in glucose
metabolism or glucose intolerance in either group of women ( Reid,
Greenaway & Hahn 1986) . However four of the six PMS women did show
manifestations suggestive of hypoglycaemia coincidentally to the glucose
nadir, even though this was never low enough to be considered abnormal .
Reid et al point out that although these manifestations occured in both the
follicular and luteal phases , none of the women complained about them in
the follicular phase . They say
" whether women with alleged PMHA truly experience symptoms
only during the luteal phase when cravings for sweets may abruptly
increase the amounts of chocolate and refined carbohydrate in their diet , or
whether they are merely more aware of symptoms due to the heightened
anxiety and tension of Premenstrual Syndrome is not known "
(Reid , Greenaway & Hahn 1986 )
c) Melatonin
Melatonin is a hormone secreted from the pineal gland in the brain . Its
isolation is fairly recent ( Lemer et al 1958 ) and its role as the major pineal
hormone remains controversial . It has been shown to play a part in
seasonal breeding in several species ( see Lincoln 1984 ) forming a link
between photoperiod and the reproductive axis , in sleep disturbances
(Jimerson, Lynch,Post.Wurtman & Bunney 1977 ) ,and in mood ( Carman,
Post & Buswell 1976 ) . Melatonin excretion has also been shown to vary
across the menstrual cycle with highest values premenstrually and during
menstruation (Wetterburg, Arendt,Paunier,Sizonenko,von Konselaar &
Hepden 1976) . This evidence suggests that melatonin may be a candidate
for the aetiology of PMS ( Rausch & Janowsky 1982 ) .
Parry,Rosenthal,Tamarkin & Wehr (1987) have recently published a case
report of a patient experiencing severe premenstrual depression only during
the autumn and winter months . The symptoms were alleviated by high
intensity light and inhibitors of melatonin synthesis and release ( propanolol
and atenolol) . The beneficial effects of light being reversible by exogeneous
melatonin administration . The results of this study raise the possibility of an
interaction between seasonal and menstrual rhythms , potentially mediated
by melatonin . However the results of one case study cannot be generalized
to all women , further investigations are required to extend these findings .
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d ) Androgens
The androgens are the " male " hormones - dihydroepiandrosterone ,
androstenedione and testerone . In the ovary they are a midway point in the
synthesis of oestrogens from progesterone ( see Chapter 2 ) and their
function in women is unknown ( Baird 1984 ) . Plasma levels of these
hormones generally show a midcycle peak ( Judd & Yen 1973 ) . As a result
of this , evidence showing an association between testosterone , sexual
drive and aggression ( Rose 1972 ) and reports of premenstrual acne
exacerbation (Sutherland & Stewart 1965 ) Steiner & Carroll (1977 )
suggested a role for the androgens in PMS .
Studies measuring absolute plasma androgen levels in women with PMS
have found no differences when compared to controls or normal ranges
(Adamopoulos, Loraine,Lunn,Coppen & Daly 1972 ;Backstrom & Aakvaag
1981 ' Backstrom,Sanders,Leask,Davidson,Warner & Bancroft 1983 ) .
However , levels of androgen in women ( especially testosterone ) are low
compared to male levels and relatively difficult to measure on a regular
basis . Hence subtle differences between the groups may have been
obscured .
e) Gonadotrophins
Coulson ( 1986 ) argues that elevated levels of gonadotrophins ( LH and
FSH ) in PMS patients may lead to inteference with the action of parathyroid
hormone and a temporary state of hypoparathyroidism .The symptoms of
this condition being tension, anxiety , lassitude , inability to concentrate ,
insomnia and depression .
FSH and LH are excreted in a cyclical fashion reflecting their role in
controlling ovarian function . Backstrom, Wide,Sodergard & Carstensen
(1976) have shown significantly higher plasma FSH levels in PMS patients
but no differences in LH levels . Other studies have shown no difference or
even lower than normal LH/FSH levels in women with PMS ( Adamopoulos,
Loraine,Lunn,Coppen & Daly 1972 ; Backstrom,Baird,Bancroft,Bixo,
Hammarback,Sanders, Smith & Zetterlund 1983 ). Young, Brownjohn,
Chapman & Lee ( 1983 ) demonstrated abnormal LH responses to a
thyrotropin releasing hormone and luteinising hormone releasing hormone
challenge in patients with cyclical oedema , suggesting that there may be a
disturbance of the hypothalamic-pituitary axis in this condition and hence
possibly in PMS . Some studies have reported beneficial results with anti-
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gonadotrophic agents such as danazol (Day 1979; Watts , Butt & Edwards
1987) or with LHRH agonist (Muse,Cetei, Futterman & Yen 1984 ) .
However these drugs also remove the effects of the peripheral ovarian
steroids . The possibility of an aetiological role for gonadotrophins remains
and will be discussed further in Chapter Three.
1.5.4 THE ADRENAL CORTEX HYPOTHESES
The adrenal cortex secretes several hormones , among them aldosterone,
Cortisol and deoxycorticosterone . These three are involved in the
metabolism of water and electrolytes including sodium and potassium
("mineralocorticoid" activity ) and the metabolism of carbohydrate and
protein ( " glucocorticoid " activity ) . All three are involved in both of these
activities to a greater or lesser extent , and both of the functions have been
implicated in PMS .
a) The mineralocorticoid hypothesis
Aldosterone is the most potent mineralocorticoid . It acts in the kidney ,
gastrointestinal tract , salivary and sweat glands to promote sodium
resorption and potassium secretion . Aldosterone itself is produced in the
adrenal cortex in response to angiotensin and renin - hence the renin-
angiotensin- aldosterone system controls sodium and water levels in the





ANGIOTENSINOGEN ► ANGIOTENSIN ALDOSTERONE
Figure 1.2 Diagrammatic representation of the renin-anoiotensin-
aldosterone system
( From :- Vander, Sherman & Luciano (1980 ) p. 382 )
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pressure , toxic effects on cardiac muscle and decreased excitability of brain
tissue . A mineralocorticoid deficiency will have the opposite effects and is
known as hypoadrenal corticalism .
Early studies of PMS subscribed to an aetiological model based on fluid
retention as the major symptom , all others being the result of it . Thus the
syndrome was caused by a cyclical malfunction of the renin-angiotensin-
aldosterone system . This in turn was thought to be under the control of
ovarian steroids . Greenhill & Freed (1941) wrote
" We have postulated that premenstrual distress and premenstrual tension
are the result of changes in the electrolyte and water balance of the various
tissues of the body which are probably the result of cyclic ovarian activity .
Thus , under the influence of certain ovarian steroids , sodium is retained by
the tissues with a subsequent increase in extracellular fluid . When this
occurs to a significant degree in the brain , headaches develop ; when the
gastrointestinal tract is involved , distention occurs ; and when the edema is
located in the labia , pruritis may appear. With the subsidence in activity of
the ovary coincident with menstruation , the various tissues lose their
retained sodium and water and the respective symptoms disappear"
Greenhill & Freed (1941 )
This hypothesis was supported by a report of relief of PMS in 34 of 40
sufferers treated with a diuretic , ammonium chloride .
Several assumptions are made by the hypothesis
i)The renin-angiotensin-aldosterone system is sensitive to ovarian steroids.
ii) Malfunction of the renin-angiotensin-aldosterone system can lead to
psychological disturbance .
iii) All women with PMS retain sodium and water premenstrually and hence
gain weight .
A vast body of literature has arisen investigating all of these asumptions
and the overall hypothesis , and has been amply reviewed elsewhere ( Reid
& Yen 1981 ; Rausch & Janowsky 1982 ) . The results are contradictory and
inconclusive ( Munday , Brush & Taylor 1977 ; Andersch , Hahn, Andersen &
Isaaksson 1978 ) . The lack of any reports of psychpathology in cases of
chronic aldosterone elevation e.g. Conn's Syndrome ( Rausch & Janowsky
1982 ) argues against an aldosterone hypothesis - although changing levels
may be the key factor rather than an excess of aldosterone as such .
bl The glucocorticoid hypothesis
Cortisol , the most potent glucocorticoid , has wide-ranging effects
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including metabolism of carbohydrates , proteins and nucleic acids , lipids
and calcium ; inflammatory and allergic responses ; epithelial cell
proliferation ; fluid and electrolyte balance ; gastric secretions ; and
resistance to stress . A deficiency in cotrisol can lead to impaired vascular
tone and cardiac output ; hypoglycaemia on fasting ; muscle weakness ;
decreased ability to excrete water; disturbed gastro-intestinal function ; loss
of appetite and increased susceptibility to even minor stresses . The reverse
effects are centripetal obesity , fatigue and hyperglycaemia .
Genazzani , Lemarchand-Beraud , Aubert & Felber (1975) observed
increases in plasma Cortisol ten days after ovulation . However other studies
have failed to show such cyclicity ( Saxena , Dusitsin & Lazarus 1974 ;
Ablanalp, Livingston , Rose & Sandwisch 1977 ) . Cortisol secretion is
abnormal in cases of endogeneous depression and is increased in
response to stress . Ablanalp et al ( 1'977 ) failed to demonstrate any
cyclical change in Cortisol levels in response to stress at different cycle
phases and Steiner & Haskett (1987) have shown that women with PMS do
not exhibit responses to the dexamethazone suppression test characteristic
of depressed patients (see section 1.2.4 ) . Hence it seems unlikely that
Cortisol is implicated in PMS - although further studies are necessary .
1.5.5 THE PROSTAGLANDIN HYPOTHESIS
Interest in the prostaglandins in relation to PMS has arisen from two
sources:
i) Recent evidence has implicated the prostaglandin 2 series in the
aetiology of primary dysmenorrhea ( e.g. Lumsden.Kelly & Baird 1983 ; Abel
1985 ; Lumsden 1985 ) - although this may not be the case in women
suffering premenstrual pain only ( Stromberg,Akerlund,Forsling,Granstrom &
Kindahl 1984) .
ii) One of the effects of prolactin is the stimulation of prostaglandin E1
formation ( Manku,Horrobin,Karmazyu et al 1979 ) . This appears to control
further prolactin secretion by a negative feedback mechanism . Horrobin
(1983) has argued that a failure in this feedback mechanism could lead to
physiological consequences after even small doses of prolactin - hence the
symptoms of PMS - caused not by an excess of prolactin but by increased
tissue sensitivity to it as a result of deficient PGE1 .Both of these arguments




Figure 1.3 Synthetic pathways of monoenoic and dienoic prostaglandins
Key PG - prostaglandin Tx - Thromboxane
synthetase inhibitors e.g. mefenamic acid , or a dietary precursor of PGE1 -
gammalinolenic acid .
The first randomized double blind placebo controlled trial of mefenemic
acid (Wood & Jacubowicz 1980 ) showed some efficacy of the anti-
prostaglandin on all symptoms except breast tenderness . They did note
however that the drug was only effective in those women who only had
premenstrual symptoms as opposed to symptoms continuing into the
menses. This would fit in with the Stromberg et al observation that
premenstrual pain is not associated with excess prostaglandin whereas
menstrual pain is . Budoff (1983 ) reports a single blind randomized placebo
controlled crossover study of mefenemic acid in which a significant effect
was seen on breast symptoms and other physical parameters but not on any
of the psychological or mood symptoms . She argues that the dosage of
medication and length of treatment (an average of 2.8 days before the onset
of flow until menses ) may have been insufficient to affect psychological
symptoms . In a study measuring plasma prostaglandins and metabolites as
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well as being a double-blind placebo controlled trial of mefenemic acid
Jacubowicz , Godard & Dewhurst (1984 ) , PMS patients were found to have
serum prostaglandin levels significantly lower than control subjects in both
the secretory and proliferative phases of the cycle . This suggested to
Pariser.Stern , Shank , Falko , O'Shaugnessy & Friedman (1985 ) a possible
enhancement of PGI synthesis leading to precursor depletion.
The alternative prostaglandin theory involves the therapeutic use of
Evening Primrose Oil . This substance is rich in gammalinolenic acid , an
essential fatty acid and precursor of monoenoic PG's .
Florrobin ( 1983 ) reports four studies ail showing a substantial
improvement in PMS symptoms when compared to placebo ( N.B. only three
of the studies were placebo controlled ) . These effects were particularly
striking in patients whose primary symptom was cyclical breast pain . Fie
argues that
"
a functional deficiency of essential fatty acids either due to
inadequate linoleic acid intake or absorption or to failure of normal
conversion of linoleic acid to GLA leads to abnormal sensitivity to prolactin
and the features of PMS "
(Florrobin 1983)
These results are supported by a study of fatty acids in total plasma
phospholipids of PMS patients ( Brush , Watson , Florrobin & Manku 1984 )
which showed elevated levels of linoleic acid and significantly diminished
levels of gammalinolenic acid compared to normal suggesting an
abnormality in the metabolic conversion of LA to GLA . This abnormality was
present in both follicular and luteal phases - although the women were
asymptomatic in the follicular phase .
A recent study ( Ylikorkala , Puolakka , Makarainen & Viinikka 1986 ) has
shown no differences between women with PMS and controls in the
synthesis of the vasoconstrictory and proaggregatory thromboxane A2
(TxA2) . They also show a beneficial effect of Evening Primrose Oil with
accompanying inhibition of TxB2 - generated by platelets in response to
TxA2 . Flence they suggest that GLA is acting in two ways - to compensate
for the endogeneous defect in the monoenoic pathway and to inhibit the
actions of the relative excess of dienoic PG's produced by the body in
response to a monoenoic deficit.
The efficacy of prostaglandin synthetase inhibitors may also be due to the
reduction of the excess dienoic PG's produced in response to an
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abnormality in the monoenoic PG pathway . If this were the case then PMS
should be expected to correlate well with primary dysmenorrhea . However
Dalton (1977, 1982 ) remarks that a characteristic of PMS is pain-free
menstruation .
In summary - the reasons for studying PG's in relation to PMS are not very
clear. PG's are produced locally in the body in response to some stimulus -
it is difficult to see which site of origin might lead to the diversity of PMS
symptoms . It is possible that PG effects are secondary to some other
mechanism e.g. endogeneous opiates or catecholamine systems and hence
symptomatic treatment of PG imbalance may be partially helpful . Further
careful research is needed to assess the relationship between PG's and
PMS.
1.5.6 THE ENDOGENEOUS OPIOD PEPTIDE ( EOP 1 HYPOTHESIS
The possibility of endogeneous substances having morphine like
properties was first proposed by Kosterlitz & Hughes ( 1975 ) . Since then
much work has been done to isolate and characterize these peptides and
their neurotransmitter properties . The endogeneous opiates are involved in
analgesia , mood and neuroendocrine modulation ( Miller 1978 ) . Evidence
has been given that the opioid peptides - and especially 8- endorphin are
involved in the neuroendocrine regulation of the menstrual cycle and
particularly in the regulation of LH pulse frequency and menstrual cyclicity
(Quigley & Yen 1980 ; Blankstein , Reyes , Winter & Faiman 1981 ; Ferin
1984; Ferin , VanVugt & Wardlaw 1984 ).
Reid & Yen ( 1981 ) proposed a model of PMS utilizing the relationship
between the gonadotrophic hormones , EOP's and mood . They suggest
that
. an aberrant release of or sensitivity to a-MSH and G-endorphin
during the luteal phase may be the central event which triggers a cascade of
neuroendocrine changes leading ultimately to the varied manifestations of
PMS."
Reid & Yen (1981 )
The suggestion is that (3-endorphin levels rise in the luteal phase in
response to oestrogen and progesterone , alone or in combination . This
increase in EOP activity may lead to activation of inhibitory presynaptic
opioid receptors on catecholaminergic systems leading to fatigue and
depression . The EOP increase could also account for increased appetite
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and constipation through other mechanisms . An abrupt fall in EOP activity
ummediately before menstruation leads to classic symptoms of opiate
withdrawal - irritability , tension, anxiety , hostile behaviour , Gl and
vasomotor disturbances . These symptoms are relieved by a return to
normal neurotransmission after the withdrawal phase (Reid 1983 ) .
Differing levels of gonadal steroids - and hence differing levels of 3-
endorphin from month to month and between individuals can account for the
variability seen in symptom manifestation and severity ( Reid & Yen 1981 ) .
This theory is tempting - it accounts for almost all the manifestations of
PMS and the observations of other theorists since the EOP's interact with so
many other physiological systems e.g. prostaglandin synthesis (Coupar
1978);catecholaminergic systems ( Schwartz 1979 ) ; glucose metabolism
(Reid & Yen 1981b ) and hypophyseal hormone secretion ( Ferin, VanVugt
& Wardlaw 1984 ) . However there is little direct evidence for a role in PMS
as yet.
Chuong,Coulam,Kao,Bergstralh & Go ( 1985 ) demonstrated lower levels
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of (3-endorphin on day 25 in patients with PMS when compared both to
their own day 7 values and to asymptomatic luteal phase control values .
This data could fit with the Reid & Yen ( 1981 ) hypothesis , suggesting a
greater fall in EOP levels immediately before menstruation in women with
PMS . However, the intermittent sampling schedule used , and the relative
impermeability of the blood-brain barrier to (3-endorphin , disclaiming a
relationship between peripheral measures and central nervous system
activity , reduce the validity of this study .
Reid , Greenaway-Coates & Hahn ( 1986 ) failed to show any effects of
naloxone (an EOP antagonist ) on glucose , insulin or glucagon responsesto
an oral glucose tolerance test at any point in the menstrual cycle in women
with or without PMS and premenstrual hypoglycaemic attacks . They
suggest that either the naloxone dosage (an infusion rate of 1mg/h for 6h )
was insufficient ; the glucoregulatory effect of EOP's is at a receptor site
unaffected by naloxone ; or else EOP's do not exert a glucoregulatory effect.
There would not appear to be any evidence from this study that EOP's are
involved in the carbohydrate craving / hypoglycaemia aspects of PMS.
Tulenheimo , Laatikainen & Salminen ( 1987 ) studied plasma 3-
endorphin immunoreactivity in twelve women complaining of PMS and
fourteen controls. They were unable to demonstrate any cyclical changes in
6-endorphin which could be related to the presence or absence of PMS ,
although the mean plasma level of G-endorphin was slightly lower in the
PMS group . They suggest that PMS may be related to significant changes
in central EOP activity which are not reflected in peripheral plasma . They
also point out that daily sampling might reveal more than their intermittent
samples .
Hence there would appear to be little support for the theory as yet - and
few therapeutic applications of it . Difficulties in the measurement of
centrally active EOP's and the lack of an appropriate animal model for PMS
make research in this area problematic .
1.5.7 THE PSYCHOGENIC HYPOTHESES
The lack of consensus about a physiological aetiology of PMS coupled
with an increase in interest in women's health and social position generally
has led to a number of psychological hypotheses of aetiology of PMS .
Although these are all interlinked they can conveniently be considered
under three headings .
a) Personality
The possibility that PMS is a manifestation of an underlying personality
maladjustment or neuroticism has been suggested and tested by several
authors. Rees ( 1953 ) found a higher frequency of PMS in neurotic than
normal subjects - although he noted some very neurotic women with no
PMS. He concluded that physiological factors were also involved . The
majority of studies have shown significant relationships between PMS and
particular personality variables (Coppen & Kessel 1963 ; Levitt & Lubin
1967 ; Gough 1975 ; Gruba & Rohrbaugh 1975 ; Halbriech & Kas 1977 ;
Taylor 1979 ; Mira , Vizzard & Abraham 1985 ) . However the instruments
used are variable e.g. the MMPI , EPI, California Personality Inventory,
16PF, Taylor MAS , STAI etc. and therefore the results are not strictly
comparable . Gannon ( 1981 ) points out that some items on standard
personality questionnaires e.g. the MMPI are virtually repeated on
instruments such as the Moos MDQ . Hence the results of using two such
instruments are confounded and significant correlation coefficients are a fait
accompli . Coppen & Kessel ( 1963 ) have provided the only research
accounting for this factor by eliminating all the MMPI questions with a
periodic component e.g. " Are you sometimes bubbling over with energy and
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sometimes very sluggish ? " . Their overall results were however unchanged
- premenstrual psychological symptoms correlated significantly with
neuroticism . Gannon (1981) also points out the large number of
correlational analyses undertaken by most studies in this area - and hence
the increased likeliehood of significant relationships occuring by chance .
Gruba & Rohrbaugh ( 1975 ) for instance found 16 significant correlations
from 160 analyses . Asso ( 1983 ) echoes these criticisms and draws
attention to the fact that most of the subjects in these studies were students .
Since PMS is most likely to occur in the thirties - a student population may
not be representative of women and PMS sufferers in general . Another
source of error is the effect of cycle phase at the time of questionnaire
completion . Although personality questionnaires are generally accepted to
be stable instruments - this may not be the case for PMS sufferers . Mira ,
Vizzard & Abraham (1985 ) showed significant differences between luteal
and follicular phase scores on the State Trait Anxiety Inventory ( STAI ) for
PMS sufferers but not for controls . This was true for both the state and trait
scales.
Hence early research indicates a link between PMS and personality ,
particularly neurotic personality . However recent methodological criticisms
have cast doubt on the relationship . Whilst the possibility remains that PMS
is a manifestation of a particular personality type , it should also be borne in
mind that PMS could cause a particular expression of personality or both
may be reflections of an underlying mechanism .
b) Attitudes towards menstruation and femininity
This area of research has received much attention from two points of view:-
i) The psychoanalytic approach . The psychoanalytic view of menstruation
is of a regular reminder to women of their lack of a penis
" The girl's initial high estimation of her body is shattered by her sense of
mutilation ( castration ) when at a time when a child is jealous of all
possessions , she finds she has no penis ; this notion of a wound is
confirmed by menstruation and defloration "
(Mitchell 1974 p. 123)
Hence PMS is a reflection of hostility towards menstruation , which itself is
a symptom of conflict about femininity . Homey ( 1967 ) links PMS with
ambivalent or contradictory attitudes towards motherhood e.g.if a fear of
childbirth or fear of coitus is linked with a strong desire for children . PMS
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can be seen as one manifestation of underlying penis envy and conflict
about the female role resulting from incomplete superego development .
In a careful psychoanalytic study of 15 neurotic patients over 125
menstrual cycles , Benedek & Rubenstein ( 1939b ) showed a correlation
between the menstrual cycle and " instinctual tendencies " . The
premenstrual phase is characterized by conflicts about femininity and
sexuality , fears of pain , mutilation and childbirth . They emphasize that
menstruation itself is usually associated with emotional relief - although
occasionally a feeling of loss may occur - as if menstruation represented a '
lost child 1. Skultans ( 1970 ) implicates the quality of the marital and sexual
relationship in women's attitudes towards and level of complaint about
menstruation . Differential experiences of menstruation are due to the
expression of unconscious emotional attitudes generated by conflict about
the female role and reflected in problematic sexual relationships .
ii) The sociocultural approach . The sociocultural view of PMS is also
based on conflict about the female role and menstruation . However the
sources of the conflict are claimed to be entrenched in society rather than in
the individual . ( A psychoanalytic theorist might argue that this is just a
reflection of individual psychosexual development i.e. society has
developed menstrual taboos etc. as a consequence of individual penis envy
and fear of mutilation ). Society 's attitudes towards women's role and
menstruation and the response of women to them have been discussed
extensively ( e.g. Parlee 1974,1976; Brattesani & Silverthorne 1978 ;
Rohrbaugh 1979 ; Ruble & Brooks-Gunn 1979 ; Brown & Woods 1986 etc. ) .
However evidence of such an interplay is hard to obtain. Several studies
have suggested that "traditional" women with high femininity scores indicate
more premenstrual distress ( Paige 1973; Gough 1975 ; Slade & Jenner
1980 ) , whilst other studies suggest that ambivalence about female role
leads to greater symptomatology ( e.g. Berry & McGuire 1972 ) and still
others have found no relationship between sex role and symptoms ( Watts ,
Dennerstein, De & Home 1980 ; Spencer-Gardner , Dennerstein & Burrows
1983) .
The presence of negative attitudes towards menstruation in Western
Society has been substantiated in studies of adolescents ( Dunham 1970 ;
Brooks-Gunn & Ruble 1982 ; Abraham et al 1985 ; Stoltzman 1986 ) , men
(Parlee 1973; Brooks-Gunn & Ruble 1986 ) and women in general ( Paige
1971 ;Schneider & Schneider-Ducker 1974 ; Brooks , Ruble & Clark 1977 ;
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McKeever 1984 ; Woods 1986 ; Ericksen 1987 ) . These attitudes have been
linked to religious beliefs (Paige 1971 ; Paige-Ericksen 1987 ) suggesting
that the notion of menstruation is associated with the concept of 'pollution '
in most cultures . However PMS as such only appears to be prevalent in the
west whilst menstrual symptoms are similar everywhere . Religious beliefs
are also important - Catholic women showed an extreme jump in anxiety
premenstrually compared to Protestant women who showed little cyclicity
and Jewish women who were anxious all the time ( Paige 1973 ) .
Hence attitudes and beliefs about menstruation and conflicts about the
female role appear to be involved in PMS . There is insufficient evidence as
yet of a causal link in either direction , however these psychological factors
should be taken into account when considering other theories .
c ) Arousal and Attribution
The cognition-arousal theory of emotion states that an emotional state is
the result of an interaction between physiological arousal and cognitions
about the arousing situation ( Schachter & Singer 1962 ) . These two
components are linked by labelling the arousal in terms of emotional
cognitions .In normal situations the cues arousing the person also provide
the cognitive labels for that arousal . However this is not always the case . If
a case of unexplained physiological arousal occurs without an appropriate
emotional label a " cause " must be found by reinterpreting the situation .
The theory has been described as the " Juke-Box " theory ( Mandler 1962 ).
To play a juke-box a coin must be inserted and a tune selected . Arousal is
analagous to the coin which activates the machine , a physiological
condition necessary for emotion to occur but not specifically programmed for
any particular emotion . Interpretation of the social situation is analagous to
the tune - if others are laughing the tune will be happiness , if others are
frowning the tune will be anger.
Koeske & Koeske ( 1975 ) suggest that an attribution pattern exists linking
negative moods to the paramenstruum . Hence any increase in sympathetic
arousal at that point in the menstrual cycle will be attributed to cyclical mood
changes and labelled negative e.g. anxiety or irritability . This hypothesis
can be tested on several counts
i) Social conventions exist linking negative moods to the paramenstruum
ii) Women with PMS experience some degree of elevated physiological
arousal in the premenstruum .
iii) Women with PMS will attribute negative mood states to premenstrual
arousal .
iv) Women with PMS are more likely to feel that their lives are outwith their
own control hence are more likely to use a biological attribution for
premenstrual arousal
The first point has been discussed in the previous section ( 1.5.7 ( b) )
showing a significant social convention that negative moods are associated
with the premenstruum . The second point has been investigated by Doreen
Asso (Asso & Beech 1975 ; Asso 1978 ; Braier & Asso 1980 ; Asso & Braier
1982 ) suggesting raised premenstrual levels of autonomic arousal on
some measures but not others in the normal menstrual cycle . The third point
has been addressed in a classic study by Ruble ( 1977 ) in which women
were misled about their cycle phase . Women who thought they were
premenstrual reported more symptoms than women who thought they were
intermenstrual even though both groups were tested at the same time
relative to menses . Rodin ( 1976 ) found that premenstrual and
menstruating women do attribute task produced arousal and frustration to
symptoms of menstruation . However the level to which they do this depends
upon the usual severity of premenstrual symptoms , women who usually
have strong premenstrual symptoms attribute task-induced arousal to the
menstrual cycle whereas women who have mild symptoms usually do not .
The fourth point has been investigated by Spencer-Gardner, Dennerstein &
Burrows (1983 ) . They assessed locus of control and found a tendency
towards externalization in women with PMS although this did not achieve
significance. Harding ( 1987 ) has also shown that women with severe
premenstrual and menstrual symptoms , especially pain , were less likely to
see the locus of control as lying within themselves .
There is some evidence then to suggest that the cognition-arousal theory of
emotion may be applicable to PMS . However the theory itself is open to
criticism (e.g. Reizenzein 1983 ) and any derivation from it should be treated
with caution .
1.5.8 SUMMARY OF SECTION 1.5
A wide variety of aetiological models have been suggested to account for
cyclical changes in well-being . Apart from the methodological inadequacies
and diagnostic inconsistencies inherent in studies attempting to test the
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various hypotheses , all of the theories outlined above can be criticized on
two theoretical or conceptual grounds:-
i) Few of the hypotheses take into account the variability of symptoms, both
between women and between cycles . Neither the timing nor the severity of
symptoms is considered , nor the possibility that seperate aetiological
mechanisms exist for different symptoms or subgroups of symptoms .
ii) Several , potentially important , observations about PMS are rarely
taken into account . The first of these is the apparent relationship between
premenstrual symptoms , particularly depression , and affective disorders
(see section 1.2.4 ). The second is the high rate of placebo effects in studies
of PMS. This observation , usually dismissed as an experimental " thorn in
the side " , may be an important indicator of the psychosomatic nature of
some premenstrual symptoms .
In other words , research in this area has tended to assume that a
homogeneous cyclical phenomenon known as the " Premenstrual
Syndrome" occurs , which , although it may be manifest by a variety of
symptoms , has a single physiological cause . As Bancroft & Backstrom
(1985) point out , the failure of many models of premenstrual symptom
aetiology may be due to their failure to take into account the inherent
complexity of the phenomenon , resulting in conflict and confusion . In
response to this they propose a "systems model " of PMS ( fig 1.4),
suggesting that causation of the syndrome is vested both in a peripheral
response to ovarian steroid levels , and in a central mediation of , and
response to , ovarian cyclicity and mood change . Factors such as
predisposition to affective disorder are included as modifiers of the type of
mood change experienced . Possible modifications to the model might
include the incorporation of present " stress " , with its potential effects both
on emotional experience and ovarian cyclicity ( Parlee 1973 ) , and the
addition of personality factors and attitudes towards menstruation as
modifiers of the type of mood change experienced .
This type of interactive model is testable by interference and observation at
various levels and may prove to be more constructive and instructive about





Figure 1.4 Hypothetical " Systems Model" of Premenstrual Symptoms
( From : Bancroft & Backstrom 1985 )
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1.6 SUMMARY AND CONCLUSIONS OF CHAPTER ONE
This chapter has given an outline of the syndrome under study and its
possible social and medical importance . PMS is a complex phenomenon,
manifested in many ways . Its prevalence is difficult to assess since the
syndrome is either practically indefinable as a single entity or the reflection
of an extreme of premenstrual symptoms . The problems of definition have
led to a lack of concordance across research studies , some researchers
opting for a purely stipulative definition for use in that particular study ,
offering no comparability with other research - whilst others offer no
definition at all . (The problems of PMS assessment will be discussed in
Chapter 4 ). The search for cause and cure of PMS has largely been
fruitless . No single biochemical or psychological factor has yet been found
to distinguish PMS sufferers from non-sufferers . This may be a reflection of
definitional problems and the nature of PMS . The failure of many
aetiological models to take into account the complex nature of the
syndrome and its relationships with many other factors , has led to an over
simplistic view of the phenomenon . Current thinking supports a more
interactive , psychosomatic type approach to research , with less emphasis
on a unitary underlying mechanism . The label premenstrual has led to the
assumption that aetiological factors are inherent in the menstrual cycle or
women's response to it . However the possibility of cyclical mood changes,
in men and women , whose timing has synchronized about the menstrual
clock in women has not been investigated .
The social and political repercussions of a potential cyclic deficit in
women's performance together with the more humanitarian desire to relieve
suffering means that further careful and thoughtful research is indicated in
this field in order to clarify the situation .
CHAPTER TWO
THE HUMAN MENSTRUAL CYCLE :
NORMALITY . ABNORMALITY AND DISRUPTION
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2.1 INTRODUCTION
" There are a few days each month during which a very high
percentage of women cannot become pregnant . These sterile periods as a
rule extend from about the twelfth or fourteenth day after the cessation of
each menstrual flow to a day or so preceding the next menstruation ."
Sperry ( 1900 ) " Confidential Talks With Husband And Wife " p.156
" The periodicity of menstruation and ovulation are not however
necessarily synchronous . They do not always occur together, though they
both occur once in the month ."
Wrench (1916 ) " The Healthy Marriage " p. 152
" for the ordinary " safe period " which comes at the
intermenstrual phase "
Stopes (1932 ) " Contraception " p. 95
These quotations give an idea of the amount of
confusion and lack of knowledge about the female reproductive cycle and
the relationships between ovulation , menstruation and conception which
prevailed in popular literature even at the beginning of this century . The
anatomy of the female reproductive system has been long characterized -
detailed diagrams exist from the fifteenth and sixteenth centuries . However,
the functional significance of the various components was not realized until
much later . During the nineteenth century , the phenomena of ovulation ,
menstruation and fertilization were described independently . However , the
temporal relationships between them were the subject of many
misconceptions. Ovulation was thought to occur either in response to coitus
or during menstruation ( see Short 1977 ). This latter view led to the
recommendation of the " safe period " , in terms of contraception , as being
midway between episodes of menstruation - exactly the time when women
are most likely to conceive . It is little wonder that Marie Stopes reports a
100 % failure rate of this method of birth control (Stopes 1932 p.25 ) - not
from an inability to adhere to the proscribed period of sexual abstinence , but
from a misunderstanding of the female reproductive cycle .
Knowledge of the menstrual cycle and the manner by which it is
controlled , is largely a product of the twentieth century . The development of
medical technology has allowed the reproductive system to be visualized
and its endocrinology characterized , removing much of the myth and
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folklore surrounding it . The story is , however , far from complete . For
example , the potential interactions between the female reproductive system
and her physical and mental state have been little explored . One
manifestation of this possible interaction is the subject of this thesis .
However , before an examination of this interaction is undertaken , it is
perhaps relevant to discuss the characteristics of the normal menstrual cycle
the mechanisms by which abnormalities occur and the manner by which the
cycle may be disrupted .
2.2 THE NORMAL MENSTRUAL CYCLE
The normal menstrual cycle is the result of a complex interaction
between the central nervous system ( CNS ) and the ovaries . As Short
(1972 et seq ) has pointed out - the menstrual cycle is a consequence of
infertility and hence the system which modulates it is geared to the
optimization of physiological conditions for a possible conception . If
pregnancy does not occur , then a series of signals from the ovary to the
CNS and back again lead to renewed preparations for another " pregnancy
attempt" . Hence the control of the menstrual cycle can be divided into two
sections
1 ) Those events which occur in the ovary and are indicated by
changes in the peripheral levels of messengers to and from the ovary .
and 2 ) Those events in the central nervous system which occur in
response to , or mediate the transmission of, ovarian messages .
Both of these aspects are essential to ovarian function and fertility and
therefore to the control of the menstrual cycle .
2.2.1 OVARIAN EVENTS DURING THE NORMAL MENSTRUAL CYCLE
The ovary essentially has two functions . Its primary role is oogenic ,
allowing the primitive oocytes , present in the ovary from birth , to mature
within ovarian follicles , until they are ripe for ovulation . The second function
is as an endocrine gland , providing a suitable environment for follicular
growth , supporting the ovum after ovulation and maintaining the
reproductive tract and secondary sexual characteristics . These functions
can be considered seperately, however they are intimately interconnected
and mutually dependent ( Baird 1984 ) . Although the time taken for the
ovum to develop is the major determinant of menstrual cycle length , the
60
endocrine function of the ovary is a more accurate reflection of menstrual
cycle control . The ovary secretes a variety of hormones , including the
female sex steroids , oestrogen and progesterone . These are the most
important ovarian hormones with respect to menstrual cycle regulation and
have frequently been measured in human peripheral blood samples (e.g.
Landgren , Unden & Diczfalusy 1980 ) . They are both synthesized from
cholesterol (Figure 2.1) within different ovarian structures , the follicle , in
which oestrogen alone is produced , and the corpus luteum , which
produces both oestrogen and progesterone . These structures are transitory
within the menstrual cycle , and hence measurement of peripheral hormones
reflects different stages in the oogenic function of the ovary as well as its
endocrine function .
Figure 2.2 illustrates the changing levels of the ovarian steroids
throughout the menstrual cycle . The rise in oestradiol during the first half of
the cycle , the follicular or proliferative1 phase , reflects its increasing
secretion by the growing follicle . This hormone provides support for the
growing oocyte and maintains and prepares the reproductive tract , breasts
etc. for conception . Oestradiol 178 , the major form of oestrogen , reaches a
peak at about midcycle indicating that the follicle is mature . This peak is
shortly followed by ovulation , the release of the ovum from the follicle ,
marking the end of the follicular phase . The remainder of the cycle is
dominated by the actions of the corpus luteum . This structure arises ,
phoenix-like , from the ashes of the ruptured follicle . It continues to secrete
oestradiol throughout the luteal , or secretory 1, phase but also produces
another hormone , progesterone . This is essentially a pregnancy hormone .
It acts on the oestrogen primed uterine lining in preparation for conception
and implantation and is active in the maintenance of pregnancy when it
occurs . If pregnancy does not occur, progesterone and oestradiol levels fall
in phase with the declining corpus luteum , the falling levels of ovarian
steroids , acting directly on the endometrium , being the trigger for
menstruation 2 •
1
1 The terms proliferative and secretory phase refer to characteristics of the
uterine endometrium at different menstrual cycle stages
2 The actual trigger for menstruation remains a controversial issue . Hertz (
1986 ) , for instance , argues that falling steroid levels cause a change in the
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19-OH-Androstenedione
Figure 2.1 The Synthesis of Oestrogen and Progesterone from
Cholesterol in the ovary . From Baird (1984 ).
autoimmune system resulting in physiological rejection of the endometrium ,
and hence menstruation .
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As mentioned above , the ovary is not an independent organ . An
interaction exists between the gonads and the brain , in the form of the
hypothalamus and pituitary gland . This latter gland secretes luteinizing
hormone ( LH ) and follicle stimulating hormone ( FSH ) to act as
messengers from the brain to the ovary ,as oestrogen and progesterone are
messengers from the ovary to the brain . As can be seen from figure 2.2 ,
FSH levels are highest at the beginning of the cycle, literally stimulating a
follicle to grow and produce oestrogen . When oestrogen reaches a certain
level , suggestive that the follicle is now mature , a surge of LH is released
which signals the follicle to ovulate . Progesterone and oestradiol from the
corpus luteum then in turn signal to the brain that ovulation and/or
pregnancy has occured , allowing the cycle to be repeated .
At present , the potential role of FSH in the control of ovulation itself is
unclear , as is the potential role of LH in follicular development . It is
possible that the two hormones act synergistically rather than independently
( Shaw 1978 ) .
The changes in these four hormones then , characterize the
endocrinology of the menstrual cycle at the ovarian level . The more subtle
control of the menstrual cycle and the feedback mechanisms involved
requires a consideration from the neuroendocrine point of view .
222. THE NEUROENDOCRINE CONTROL OF THE NORMAL MENSTRUAL
CYCLE
In most species , reproduction is not an independent event. If it were ,
then neural involvement would only be necessary at the most basic level .
However , several factors are important in governing when an animal should
breed , and hence its reproductive function . For instance , seasonality is
important in many species . In order for the maximum number of young to
survive the cold and nutritionally sparse winter in a species such as the
sheep, they must be born in the early spring to ensure that fat reserves have
built up over the summer months. Hence some method of fertility control is
needed to allow for this survival factor . Similarly if an animal is itself
undernourished , unhealthy or under some other kind of stress , it makes
sense for there to be a temporary closure of the reproductive axis .
Therefore, a delicate balance must be maintained between ovarian
conditions and the status of other physiological systems .
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Figure 2.2 Diagrammatic changes in serum levels of LH , FSH ,
Oestradiol- 17(3 and progesterone during the menstrual cycle .
( From Shaw (1978 )).
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This balance is maintained by a complex feedback mechanism
between the ovaries , the anterior pituitary gland (adenohypophysis ) and
the hypothalamus . The release of LH and FSH from the anterior pituitary is
under the control of gonadotrophin releasing hormone (GnRH ) from the
hypothalamus .This structure contains cell bodies which have axonal
projections to many areas of the brain allowing for an extremely complex
network of neuronal communication between neural and endocrine
regulatory centres ( see Karsch 1984 ) . Hence , factors such as day length ,
nutritional status and so on can influence reproduction through the
hypothalamus . GnRH is secreted in a pulsatile fashion from the
hypothalamic GnRH pulse generator. GnRH is active in the brain and does
not cross the blood-brain barrier to any measurable extent. Hence , attempts
to measure GnRH in the peripheral circulation are fruitless . GnRH release
can however be inferred by measures of LH , reflecting a pituitary response
which is almost instantaneous ( Clayton 1987 ) . The characteristics of LH
pulses vary across the menstrual cycle ( see Crowley et al 1985 ) . Thus the
follicular phase is characterized by low amplitude pulses of increasing
frequency, forming a saw-tooth pattern , which dramatically increase in
amplitude at midcycle . After ovulation , the pulses become large and slow ,
with increased bimodality as the cycle progresses ( Figure 2.3 ) .
Control of the menstrual cycle is not a one-way process . Levels of
GnRH and consequently LH and FSH are sensitive to ovarian events by a
system of positive and negative feedback of the ovarian steroids . Negative
feedback describes a situation in which levels of one hormone lead to an
inhibition of release of another . This occurs at the beginning of the cycle
when oestrogen levels cause an inhibition of LH and FSH release . This
effect appears to be at the level of the anterior pituitary , modulating its
sensitivity to GnRH andsuppressing LH pulse amplitude ( Goodman &
Karsch 1980 ) . Increasing levels of oestrogen through the follicular phase
appear to increase the frequency of GnRH pulses , although the mechanism
for this is not yet understood . A point is reached as the follicle matures , by
which high levels of oestrogen act on the anterior pituitary by a process of
positive feedback , stimulating LH and FSH release . Hence a surge of LH is
seen at midcycle which causes ovulation and luteinization of the follicle .





























































Figure 2,3 Changes in LH pulsatilitv across the normal menstrual cvcle
( From Crowley et al ( 1985 ))
A - Early follicular phase (day 2 )
B - Mid-follicular phase
C - Late follicular phase ( day of LH surge )
D - Early luteal phase ( LH surge + 1 day )
E - Mid luteal phase ( LH surge + 8 days )
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gonadotrophin release . Progesterone would appear to act directly on the
hypothalamic GnRH pulse generator , slowing the frequency of GnRH
pulses and hence of LH pulses ( Soules , Steiner , Clifton ,Cohen , Aksel &
Bremner 1984 ) . Oestrogen , presumably continues to exert its primary
action at the pituitary level . Progesterone secretion is also pulsatile in the
luteal phase , Crowley (1985 ) commented that the timing of these pulses
correlated well with that of the smaller LH pulses forming the second phase
of the bimodal wave pattern . A careful study by Steele , Braund & Judd (
1986 ) however, failed to find any relationship between progesterone pulses
and either LH or prolactin secretion . The mechanism producing this pattern
of progesterone secretion and its physiological significance remain to be
explained . In the absence of pregnancy , the corpus luteum degenerates ,
oestrogen and progesterone levels fall , reducing gonadotrophin inhibition
and thus stimulating a new follicle to grow . This follicle starts to secrete
oestrogen , inhibiting gonadotrophins , and the cycle begins again . Thus
between puberty and menopause , in the absence of pregnancy , the female
reproductive rhythm is a true cycle , with no beginning and no end .
Hence , although our knowledge of female reproductive
neuroendocrinology is gradually increasing , we are still a long way from
being able to specify the exact control mechanisms involved in the menstrual
cycle . The biological importance of hormone pulsatility is not yet
understood, nor the trigger factors for menstrual onset . The relative
importance of other physiological systems in governing reproduction through
the hypothalamus has not been assessed , nor the potential effects of
reproductive functions on other systems . The mechanism of selection of
one follicle to grow and ovulate in each cycle from a pool of primordiol
follicles remains an enigma as do the relative roles of LH and FSH and their
, common or diverse , releasing hormone(s) . The potential roles of other
ovarian products , for instance prostaglandins , inhibin , testosterone etc. ,
in menstrual cycle control also remain to be explored .
2.3 THE ABNORMAL MENSTRUAL CYCLE
The complex neuroendocrine control of the menstrual cycle leaves ample
scope for disruption . The results of this disruption can be manifest in several
ways - for instance , primary or secondary amenorrhea , short or inadequate
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luteal phase , polycystic ovary syndrome etc . These abnormalities can
however be divided into two categories which are pertinent to this thesis -
those states in which ovulation is present and those in which it is absent.
2.3.1 THE ANOVULATORY MENSTRUAL CYCLE
The incidence of anovulatory cycles , that is apparently normal
menstrual cycles in which ovulation is absent ( as opposed to amenorrhea
in which both ovulation and menstruation are absent ) , varies across the
reproductive lifespan . This type of cycle is most common in the early and
late menstruating years , after childbirth and in response to stress ( Doring
1969 , Vollman 1977, Metcalf & MacKenzie 1980 , Metcalf 1983 ) . Two types
of anovulatory hormonal patterns have been described ( Newton 1972 ) .
The first type consists of a constant low excretion of oestrogen and
progestagens , in the absence of a midcycle LH surge. The second type
shows cyclical changes in oestrogen levels but constantly low levels of
progesterone.
In puberty , it would appear that the positive feedback mechanism by
which oestrogen induces the LH surge does not mature as quickly as the
rest of the reproductive axis . Hence although follicles may grow and
become mature , they cannot ovulate and hence become atretic .The
subsequent fall in oestrogen levels may be sufficient to cause menstruation .
Hence the second type of cycle mentioned above is seen . Gradually
through adolescence the feedback mechanism becomes operational and
the cycles become ovulatory (see Figure 2.4) .This pattern also occurs in the
higher primates , e.g. chimpanzees , and may have some adaptive
significance (see Short 1984 ) . The neuroendocrine mechanism , although
speculative , suggests that maturation of the GnRH pulse generator is
independent of the gonadal steroids ( Clayton 1987 ) and is a reflection of
the changing pattern of neural control over the hypothalamus . Hence
although follicles may be stimulated to grow in the ovary , the pulse
generator is unable to evoke an appropriate GnRH response to the
oestrogen they produce . This proposed mechanism requires further
assessment . Hypothalamic maturation may also be confounded by the




































Figure 2.4 Urinary oestrogen and pregnanediol excretion in a girl going
through puberty. ( From Short ( 1984 )).
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At the opposite end of the reproductive lifespan , the perimenopause ,
anovulatory cycles are also common . At this stage the hormonal milieu
tends to be characterized by rising LH and FSH levels ( Adamopoulos ,
Loraine & Dove 1971 ; Sherman , West & Korenman 1976 ) reflecting
changes in pituitary gonadotrophic function and an alteration in feedback
mechanisms . The primary cause of anovulation is , however , probably
ovarian . A shortage of viable oocytes may lead to insufficient follicular
development and hence lower than normal levels of follicular phase
oestrogen . As above a follicle may begin to grow , but produce insufficient
oestrogen for positive feedback to occur , hence no LH surge and no
ovulation . As the follicle becomes atretic , falling oestrogen levels , although
slight , may be enough to cause menstruation . As in puberty , cycles are
seen with cyclical oestrogen levels but no progesterone .
Post-partum anovulatory cycles usually follow a period of lactational
amenorrhea . Ovarian activity resumes gradually during lactation in direct
proportion to suckling frequency and hence prolactin levels ( Howie ,
McNeilly , Houston , Cook & Boyle 1982b ) . Only about one -third of breast¬
feeding mothers ovulate before their first post-partum menstruation ( Howie,
McNeilly, Houston, Cook & Boyle 1982 a ) . Even after the first menstruation
, cycles may be anovulatory or exhibit a luteal phase deficiency , although
this effect is variable ( Howie et al 1982b) . The neuroendocrine
mechanism of this effect is unknown . Although differences have been
demonstrated in LH pulsatility between amenorrheic lactators and
subsequent normal cycles (Glasier, McNeilly & Howie 1984 ) , and the
hypothalamic-pituitary axis of post-partum women has been shown to be
hypersensitive to the negative feedback effects of oestradiol (Baird,
McNeilly,Sawers & Sharpe 1979 ) , little investigation has been conducted of
the anovulatory cycles following lactational amenorrhea. These cycles
probably reflect an inter-individual variability in adaptation from the post¬
partum state to normal . Lactational amenorrhea itself appears to be the
result of two potential actions of prolactin . Firstly , a direct block of LH action
at the ovarian level , and , secondly , an inhibition of the ability of the
hypothalamic-pituitary axis to maintain pulsatile LH secretion in response to
oestrogen negative feedback ( Glasier, McNeilly & Howie 1984 ). This latter
effect is unlikely to be operational in anovulatory post-partum cycles since
Glasier et al ( 1984 ) showed normal LH secretion in such cycles . However
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the block of LH action at the ovarian level may still be present in the later
anovulatory cycles . Hence , adequate follicular development cannot result
in ovulation or adequate corpus luteum formation . Falling oestrogen levels
from the atretic follicle would then lead to a withdrawal bleed . Present
knowledge of the action of prolactin on the ovary (eg Baird 1984) do not
allow this theory to be any more than speculative .
Metcalf & MacKenzie ( 1980 ) demonstrated a remarkably high
incidence of anovulatory cycles in the 20 - 24 years age group of their
sample , with only 62 % of 254 women showing consistently ovulatory cycles
over a three month period , lower than any other age group . This
phenomenon appeared to be related to the living conditions of the women .
Those who lived in flats or hostels , as opposed to living with their families ,
were less likely to be ovulatory ( only 45% of the group were consistently
ovulatory compared to 76 % of the family living group ) . This suggests that
the ovary is sensitive to stresses at that time of life . Another example of the
effects of a different kind of stressor is the common phenomenon of
amenorrhea and anovulation in anorexia nervosa sufferers . In this latter
case , loss of body weight has had a suppressive effect on the hypothalamic-
pituitary-ovarian axis ( see Halmi 1982 for review ) . The precise
mechanisms by which these factors exert their effects are unknown ,
although they are likely to be supra-hypothalamic , hence suppressing the
GnRH pulse generator itself rather than acting by a disruption of ovarian
feedback. Menstrual cycle disruption is also often seen in air hostesses ,
whose internal" clock " is frequently out of synchrony with the outside world
(e.g. Iglesias , Terres & Chavarria 1980 ) , and in athletes , where strenuous
exercise seems to have a similar effect to anorexia ( e.g.
Shangold,Freeman,Thysen & Gatz 1979 , Prior 1985 )1,2 . Hence ,
1 Cumming & Rebar ( 1985 ) point out that athletes , particularly young
runners , gymnasts and ballet dancers tend to be preoccupied with their own
body image . Hence their eating habits tend to be frugal and sporadic . The
apparent effect of exercise may actually be due to malnutrition.
2 Borghi et al ( 1976 ) observed that ovarian disruption had occurred before
weight loss in one-third to one-fifth of anorexics . This led Halmi ( 1982 ) to
postulate a subgroup of women whose hypothalamus is " vulnerable " to
environmental stress during the late teens and early twenties . The age
range of poor ovulators due to stress observed by Metcalf & Mackenzie (
1980) above , adds weight to this idea . Is this " vulnerable " hypothalamus
also reflected in the numbers of young women who react badly to oral
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anovulatory cycles can occur in a variety of physiological situations due to
suppression of the reproductive axis . This suppression can either be from
external sources acting directly on the hypothalamus or from inadequacies
within the axis itself.
2.3.2 THE ABNORMAL LUTEAL PHASE
This section deals with those abnormalities of the menstrual cycle in
which ovulation has occurred . In this case , there is a deficiency in the
second half of the cycle , the luteal phase .
The definition of ovulation depends upon the index used to asses the
menstrual cycle . This may be basal body temperature ( BBT ) , endometrial
biopsy, cervical mucus changes , plasma or urinary progesterone
measurements or LH measurements . All of these , except LH measurements
, are progesterone dependent1 .
Abnormalities of the luteal phase can fall into two categories - the short
luteal phase ( SLP ) and the inadequate luteal phase ( ILP ) (Moszkowski ,
Woodruff & Jones 1962 ; Sherman & Korenman 1974 a,b ) . These terms
reflect the possibilities of abnormalities in both the duration of progesterone
secretion (SLP) and the amount of progesterone secretion ( ILP ) from the
corpus luteum . Coutts ( 1985 ) points out that a major problem in the
evaluation of the abnormal luteal phase is the precise definition of a normal
luteal phase in terms of the minimum requirement for maintenance of a
conception . Hence , definitions are usually made with reference to some
normal range . The normal luteal phase is itself variable in length both
between cycles and between different assays . Basal body temperature
studies suggest an average length of 12.7 (± 1.7 ) days (Doring 1966 quoted
in Friedrich & Kemeter 1979 ) and a median of 11.8 days ( Vollman 1977 ) ;
intermenstrual pain studies suggest a median of 14.3 days ( Vollman 1977 ) ;
contraceptives ? - or thosee who are predisposed to PMS or post-natal
depression ?
1 Any assay of ovulation using a measure of progesterone secretion runs the
risk of Type II errors due to the possibility of a " luteinized unruptured follicle
"
( LUF ). In this case , although luteinization occurs , the ovum is not
released . Hormonally , a LUF cycle may be indistinguishable from a normal
cycle - Kerin et al ( 1983 ) found a LUF frequency of 4.9 % in a series of
otherwise normal cycles studied laparoscopically . A high incidence of
LUFhas however been found in patients with luteal insufficiency ( Hamilton,
Evers & DeHaan 1987 ) suggesting that this may be one cause of apparent
luteal inadequacy .
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whilst studies of cervical mucus suggest median lengths of 16 days (Vollman
1977 ) or an average of 13.5 ( ±2.8 ) days ( WHO 1983 ) . Lenton , Landgren
& Sexton ( 1984 ) studied 327 luteal phases from overtly ovulatory cycles by
daily blood sampling for LH . The mean normal luteal phase length was
14.13 ±_1.41 days with 95 % confidence limits of 11.3 to 17 .0 days 2 . A
subpopulation of short luteal phase cycles was found with an average
length of 9.21 ± 1.41 days . All luteal phases of < 9 days were found to be
abnormal on the basis of endometrial biopsy as well as 74 % of those lasting
10 days and 22 % of those lasting 11 days . Hence they defined a short
luteal phase as one of 11 days or less . Other studies have however used
different criteria . Coutts (1985 ) , for example , recommends a cut-off point of
10 days whilst Sherman & Korenman ( 1974 ) advocate an 8 day maximum
for a diagnosis of SLP . The definition of inadequate luteal phase is
dependent upon the method of assay . However usually , values lying
consistently below a normal range are described as inadequate . A
diagnosis of ILP is often made on the basis of a single midluteal
progesterone value . The pulsatile nature of progesterone secretion in the
luteal phase ( Healy , Schenken , Lynch ,.Williams & Hodgen 1984 ;Steele ,
White & Judd 1985; Steele , Braund & Judd 1986 ) suggests that this
diagnostic criterion may be susceptible to both false positives , due to the
sample being taken at the nadir of a normal pulse and false negatives , the
apex of a pulse from an inadequate luteal phase may be within the normal
range . Hence studies using such a diagnostic tool should be treated with
caution . A luteal phase, then , can fall into one of four categories
a ) Normal length and adequacy
b ) Normal length and inadequacy
c ) Shorter than normal and adequate
d ) Shorter than normal and inadequate
The latter three of these could be described collectively as defective luteal
phases .
Defective luteal phase cycles tend to occur during puberty and the
perimenopause , and during resumption of ovarian cyclicity post partum ,
post abortion or after discontinuance of oral contraceptives . They are also
2 Luteal phase length is defined as the number of days after, but not
including , the day of maximum LH up to and including the day before
menstrual bleeding . Midnight was used as the dividing point between days .
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common in patients with recurrent miscarriage , hyperprolactinaemia ,
hypothyroidism , hyperstimulation of the ovary , " unexplained " infertility ,
hyperandrogenism and women who undergo strenuous athletic conditioning
or have been treated with clomiphene citrate ( Lee 1987 ) . In the context of
the effect of exercise on the menstrual cycle , Shangold ( 1985 ) describes
an orderly progression of dysfunction resulting from any insult to the female
reproductive axis ; from luteal phase defects through anovulatory cycles and
euoestrogenic anovulatory oligomenorrhea to hypoestrogenic amenorrhea .
This progression , although not proven , possibly reflects an increasing
suppression of the hypothalamo-pituitary- gonadal axis .
The endocrine profiles of patients with defective luteal phases have
been the subject of several studies ( e.g. Sherman & Korenman 1974 a, b ;
Lenton,Adams & Cooke 1978 ; Lenton,Lawrence,Coleman & Cooke 1983 ;
Smith, Lenton & Cooke 1983 ; Lenton.Landgren & Sexton 1984 etc. ) .
However the aetiology of the phenomenon remains obscure .
Adequate follicular maturation in the preovulatory phase would appear
to be an important determinant of corpus luteum function . Sherman &
Korenman ( 1974 ) found low follicular phase FSH and oestradiol-173 in
cycles which had simultaneously short and inadequate luteal phases .
Hence they suggest that corpus luteum adequacy is dependent on follicle
adequacy .This finding is supported by Wilks.Hodgen & Ross ( 1979 ) who
show abnormal follicular phase FSH and LH levels in defective luteal phase
cycles of rhesus monkeys , and by Stouffer & Hodgen ( 1980 ) who report
luteal phase deficiencies in rhesus monkeys treated with porcine follicular
fluid (pFF ) in the early follicular phase ( pFF selectively suppresses monkey
FSH levels without changing serum LH ) . However , Lenton , Adams &
Cooke (1978 ) in a study of infertile women with normal length but
inadequate luteal phases , found no differences in follicular plasma LH ,
FSH or oestradiol levels when compared to a control group .
An alternative view of luteal phase adequacy is offered by Lee (
1987). The corpus luteum consists of " large " and " small " cells derived
from the granulosa and theca cells of the follicle respectively . As corpus
luteum function progresses , the large cells degenerate and the small cells
become larger, forming practically the entire functional CL during pregnancy
. The granulosa cell of the follicle responds to the LH surge at ovulation in a
non-reversible fashion . Hence after luteinization , the LH receptors of the
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large CL cells are blocked . These cells produce large quantities of
progesterone during the early luteal phase , but degenerate since they are
unresponsive to LH , and become non-functional by about day 10 of the
luteal phase . The theca derived small cells produce small amounts of
progesterone in the early luteal phase , but are responsive to LH stimulation
, grow and are ready to assume the major secretion of progesterone in
conception cycles . Lee (1987) suggests that luteal phase inadequacy is
caused by a deficiency in the response of granulosa cells to the LH surge .
The entire progesterone production of the CL is then the responsibility of the
small cells - resulting in a physiological shortfall . This theory is however
untested .
The short luteal phase is a similar enigma . Smith , Lenton & Cooke
(1983 ) have shown that short luteal phase cycles have higher progesterone
levels at menstrual onset than control cycles , this finding being true in both
adequate and inadequate luteal phase cycles . This suggests that
mechanisms which initiate menstrual bleeding may be different in short
luteal phase cycles rather than any follicular or corpus luteum defect. Other
studies have suggested that prolactin levels may be involved in short luteal
phase cycles . Corenblum , Pairaudeau & Shewchuk ( 1976 ) observed
short luteal phases in women with galactorrhea , an expression of excess
prolactin levels. After bromocriptine therapy , both prolactin levels and luteal
phase length normalized . Seppala , Hirvonen & Ranta ( 1976 ) also found
short luteal phases in women with elevated prolactin levels who later
became galactorrheic and amenorrheic . Elevated prolactin levels are often
seen in runners and athletes after exercise ( e.g. Russell , Mitchell , Musey &
Collins 1984 ; Cumming & Rebar 1985 ) . This effect may be related to the
type and amount of exercise undertaken as well as subjective fitness
beforehand (Howlett 1987 ) , and does not seem to cause sustained
hyperprolactinaemia (Shangold 1985 ) . However , luteal phase defects ,
and especially short luteal phase are common amongst athletes ( Prior 1985
) . Defective and short luteal phases are also seen in the gradual
resumption of fertility post-partum , another occasion in which prolactin may
be active ( Howie .McNeilly , Houston , Cook & Boyle 1982 b ) . Little solid
evidence exists however linking prolactin with the short luteal phase , and
both would appear to be able to exist independently as for instance in the
perimenopause when short luteal phase cycles are common but there is little
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evidence of hyperprolactinaemia . A deficiency in the ovarian or
hypothalamo-pituitary response to normal prolactin levels cannot of course
be ruled out , neither can the possibility of a third factor causing changes in
both luteal function and prolactin levels . The mechanism by which prolactin
might produce the short luteal phase is as yet unknown .
Although little is known about the endocrinology , aetiology or
implications for fertility of the deficient luteal phase cycle , it can be said that
they tend to occur under similar conditions to anovulatory cycles .
Inadequate luteal phases also appear to be consistent within women . The
assumption has been that this correlation of incidence implies a common
aetiology i.e. partial suppresion of the hypothalamo-pituitary-gonadal axis ,
however endocrinological studies have not consistently supported this
hypothesis . The problems of definition and diagnosis of both short and
inadequate luteal phases and the frequent confounding of these two
variables leads to confusion in the interpretation of endocrinological data .
Whether the short and inadequate luteal phase have the same or diverse
aetiologies is unknown , and will remain so until studies are more specific
about the type of defects observed in any particular group .
2.4 ARTIFICIAL DISRUPTION OF THE OVULATORY CYCLE
In section 2.3 a variety of " natural " events were seen to disrupt the
normal female reproductive cycle . A similar number of pharmacological
interventions can also cause disruption , either deliberately or inadvertently ,
to a greater or lesser extent . The most common and reliable deliberate
intervention is the oral contraceptive . The history of the development of the
modern oral contraceptive (oc ) has been thoroughly reviewed elsewhere
(e.g. Drill 1966 ; Greenblatt 1980) . They have become one of the most
widely used drug groups in Western society , the subject of much
controversy about their ethical and long-term medical significance .
The effects of oral contraceptives on a varietry of physiological systems
have been extensively studied ( see Greenblatt 1980 ) , however their
precise effects on the reproductive axis , especially in the case of the newer
"low-dose " oc's are perhaps less well characterized . The overall
mechanism of action of oral contraceptives, and the potential residual activity
of the ovary despite this , are the subjects of this section .
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2.4.1 ORAL CONTRACEPTIVES AND THEIR MECHANISM OF ACTION
Two major classes of oral contraceptives are currently available in this
country - the combined oral contraceptives , containing an oestrogen and a
progestagen , and the progestagen -only contraceptives ( British National
Formulary 1987 ) . A subgroup of combined oc's is also available containing
a phased formulation of oestrogen and progestagen , designed to mimic the
natural hormonal cycle . The combined oc's are usually administered on a
"
twenty-one day on - seven day off" schedule , a withdrawal bleed occuring
during the pill free week to mimic normal menstruation . The progestagen
only pills are administered continuously , and bleeding patterns are usually
erratic.
Several varieties of combined oral contraceptives exist , containing
different doses of synthetic oestrogens and progestagens . The synthetic
oestrogens most commonly used are mestranol ( ME ) and ethinyloestradiol
( EE ). These compounds have similar oestrogenic effects , although
mestranol is metabolized to ethinyloestradiol before it becomes active . A
wider variety of progestagens are used at different doses ( Table 2.1 ) .
These compounds differ both in their progestational effects and in the
degree to which they are oestrogenic and / or androgenic . For instance , the
progestagen used in Enovid™ , the first oc , norethynodrel, is slightly
oestrogenic but not androgenic , whereas norethindrone used in Ortho-
Novum 10 ™ was slightly androgenic but not oestrogenic ( Drill 1966 ) .
Some progestagens are highly anti-oestrogenic , for instance norgestrel,
one of the most widely used modern progestagens ( Upton 1980 ) .
The mechanism of action of all combined preparations is essentially
similar. They were originally thought to act directly on the pituitary gland to
inhibit LH and FSH release , utilizing the negative feedback effects of
ovarian steroids ( Drill 1966 ) . Recent evidence has suggested that they may
also be active at the hypothalamic level , suppressing GnRH release
(Mishell.Kletzky, Brenner,Roy & Nicoloff 1977 ; Fraser & Jansen 1983 ) .
However , the relative amounts of hypothalamic and pituitary suppression
may be variable , both between individuals and between dose regimen .
The varying doses of steroids in the phased oc's do not imply a differential
mode of action , but only an attempt to provide the reproductive system with
a more " realistic " hormonal milieu .
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The progestagen - only pill ( P-O-P ) utilizes the negative feedback effects
of progesterone on the hypothalamus and pituitary to suppress ovarian
activity . However , without the synergistic actions of oestrogen , the degree
of ovarian suppression is incomplete and unpredictable ( Landgren &.
Diczfalusy 1974 ; Elstein, Briston,Hewitt,Kirk & Miller 1976 ) . Peripheral
effects of progestagens on cervical mucus , endometrium and possibly tubal
function are therefore likely to play a large part in the contraceptive efficacy
of these drugs ( Fraser & Jansen 1983 ).
Mishell ( 1982 ) has pointed out that the oral contraceptives have many
other physiological functions than the disruption of ovulation . Those
progestagens with anti-oestrogenic actions may reduce the proliferative
effects of oestrogen on the endometrium and breast tissue . Hence , lighter
menstrual bleeding and reduced levels of benign breast disease can be
beneficial side-effects of oc use . Effects on carbohydrate metabolism , liver
function , blood pressure, plasma lipid levels and tendencies to blood
clotting have also been observed ( Greenblatt 1980 ) . This latter aspect has
received much attention in the lay press after reports of increased risks of
thromboembolic disease and myocardial infarction amongst pill users
(Vessey, McPherson & Johnson 1977 ) . Use of the pill has also been linked
with the development of various types of cancer , for instance endometrial
cancer ( Silverberg & Makowski 1975 ) , however incidence rates of other
types of cancer , e.g. ovarian cancer have revealed protective effects of oc
use ( Casagrande,Pike, Ross,Louie,Roy & Henderson 1979 ).
Hence , the oral contraceptives , and particularly the combined oral
contraceptives , are widely used and widely studied inhibitors of ovulation
and / or reproductive function .
2.4.2 RESIDUAL OVARIAN ACTIVITY IN COMBINED ORAL
CONTRACEPTIVE USERS
Worries about the long term effects of oral contraceptive administration ,
particularly with respect to oestrogen levels , have led to reductions in the
dosages of both oestrogen and progestagen and the introduction of
formulations phased to mimic the normal menstrual cycle . The new " low-
dose " brands of oc are defined on the basis of their oestrogen content i.e. <
35 p.g per tablet . This introduces the possibility that suppression of the
hypothalamo- pituitary-ovarian axis is incomplete in users of these brands .
78
Since the subject of this thesis is the relationship between cyclical mood
changes and ovarian steroid levels , and a large part of the experimental
data is concerned with users of low-dose oc's , an understanding of the
hormonal fluctuations experienced by such users is essential to the
interpretation of later results .
Two main areas of query arise here Firstly - what are the endocrinologic
sequelae of the pill free week ( pfw ) ? - and secondly - how much ovarian
activity is present during the period of pill ingestion ?
The placebo or pill free week was introduced when oc's were first
marketed since it was thought that the total absence of menstruation would
be unacceptable , to reduce the possibility of troublesome " breakthrough
bleeding" and to guard against potentially deleterious endometrial side-
effects ( Drill 1966). The current data on endocrine activity during the pfw
has been amply reviewed elsewhere ( Fraser & Jansen 1983 ; Guillebaud
1986 ) . Follicular development can occur during the pfw in users of low-
dose pills such as Microgynon™ or Trinordiol™ ( Molloy, Coulson,Lee &
Watters 1985 ) - with atresia of the follicles occuring by the seventh day of
pill taking . Guillebaud (1986 ) cites a study of 120 women scanned
ultrasonically on the seventh day of the pfw . 23 % of them had follicles
greater than 10mm in diameter , suggestive of substantial follicular
development . It would appear that a significant rise in FSH occurs during
the pfw , followed by a small but significant rise in oestradiol , suggestive of
follicular growth ( Fraser & Jansen 1983 ) . A dose dependent effect of
oestrogen would seem to be involved . Dericks-Tan,Krog,Akteries & Taubert
( 1976 ) found that pituitary suppression to a 50pg ethinyloestradiol based oc
lasted up to two weeks after discontinuance , the length of this suppression
being greatly reduced for the lower dose pills and non-existent for the
progestagen only brands .
The amount of follicular activity and hypothalamo-pituitary suppression
during the course of the low dose oral contraceptives has been studied in
several ways . Firstly , indices of ovulation and corpus luteum activity have
been assessed e.g.cervical mucus changes , basal body temperature and
luteal phase plasma progesterone levels . Secondly - assessments of the
relative involvement of pituitary and hypothalamic factors in gonadal
supperession have been measured by pituitary stimulation tests . Thirdly -
measures of ovarian and follicular activity have been made using
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ultrasound, and fourthly - measures of peripheral plasma or urinary
gonadotrophin and steroid levels have been made to assess follicular
endocrine function . Several factors have led to confusion in the literature
about the levels of residual ovarian activity in low-dose oc users
1) The variety of synthetic oestrogens and progestagens used in
contraceptive formulations , whilst all being effective in terms of ovulation
inhibition , also all have differing potencies and , in the case of
progestagens, oestrogenic or androgenic properties .
2) The absolute dose of oestrogen and progestagen varies even
within the " low-dose " category . Perhaps more importantly , the ratio of E to
P varies between brands .
3) Individual differences in the absorption rates of and sensitivity to
exogeneous hormones .
4) The length of time the particular oc has been in use
5) Technical differences in the administration of the pituitary
stimulation test.
6) The absence of a suitable control group or baseline measurement in
many studies .
Hence , some studies suggest that there is no ovarian activity during low-
dose oc use ( e.g. Elstein,Morris,Groom,Jenner, Scarisbrick & Cameron
1976; Schneider,Spona & Matt 1974 ; Colau et al 1983 ) whilst others
suggest that there is ( e.g. Dericks-Tan,Krog,Akteries & Taubert 1976 ;
Spellacy.Kalra, Buhi & Birk 1980 ; VanderVange,Bruinse,Tweel,Coelingh-
Benink & Haspels 1985 ) and still others show individual variation in
response ( e.g. Scott,Kletzky, Brenner & Mishell 1978 ; Spona,Schneider &
Lachnit-Fixson 1980 )
Few studies have yet been undertaken of the biphasic and triphasic
oral contraceptives . These drugs were formulated with the objective of lower
overall oestrogen levels and more naturalistic cycle control ( Greenblatt
1980; Upton 1980 ) . Their efficacy in terms of ovulation inhibition , subject
tolerance and compliance , and side effects is comparable with that of the
low dosed monophasic oc's (Spona, Schneider & Lachnit-Fixson 1980 ;
Woutersz, Butler, Cohen,Korba & Canavan 1987 ) . A recent study by
Smith,Kirkman, Arce, McNeilly,Loudon & Baird ( 1986 ) suggests that
follicular activity is maintained ar a greater level in triphasic pill users than in
monophasic pill users , and that ovarian activity is restored more quickly
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after triphasic use . However, only the first treatment cycle was considered
in this study . The question of whether long term triphasic users experience
cyclical follicular activity to a greater extent than comparable monophasic
users remains unanswered . The possibility remains , as mentioned above ,
that a subgroup of women exist whose reproductive axes are less
adequately suppressed by low-dose oc's than the majority in terms of
follicular activity , although they do not ovulate .
In conclusion it can be said that , all of the currently available combined
oral contraceptives suppress ovulation by disrupting the hypothalamo-
pituitary axis . Hence , no user of these drugs will experience a true luteal
phase in terms of corpus luteum formation and endogeneous progesterone
secretion . The degree of follicular activity experienced may however be
variable , both during the pill free week and the duration of pill
administration.
2.5 SUMMARY
The female reproductive cycle is controlled by a complex and sensitive
sequence of endocrinological events . The hypothalamus , pituitary and
ovary communicate their respective physiological statuses one to another by
means of the hormones GnRH , LH , FSH , Oestrogen and Progesterone .
The potential roles of other hormones such as prolactin or inhibin are little
understood in this context . This system can suffer disruption at any one of
the three control levels , evidenced by menstrual and ovulatory disturbance .
Deliberate disruption can also occur , having the beneficial contraceptive
effect of reliably suppressing ovulation . However , the precise endocrine
and physiological parameters of either type of disruption are poorly
understood . As Short ( 1977 ) said - " Although much is known , much still
remains to be discovered ; and much of what has already been discovered
needs to be uncovered
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CHAPTER THREE
THE RELATIONSHIP BETWEEN PREMENSTRUAL SYMPTOMS
AND THE OVARIAN CYCLE
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3.1 INTRODUCTION
In the previous chapters , the two components of this thesis have been
discussed independently . In this section , an attempt will be made to draw
them together and assess the interaction between them .
The causal nature of the correlation between premenstrual symptoms
and the ovarian cycle has been an inherent assumption throughout PMS
research. Aetiological theories take the temporal features of the menstrual
cycle to be causally meaningful even if a role for the ovarian hormones per
se is rejected . The problems of empirical research in both fields of human
female endocrinology and psychology have resulted in very few attempts to
elucidate the nature of the link between them.
The first step in most physiological studies would be to establish an
animal model for the syndrome under investigation . As yet , however , no
appropriate in vitro or animal system has even been hinted at in this field .
The possibility that some apes i.e. free living Yellow Baboons (Papio
cvnocephaius ) experience perimenstrual changes in behaviour has
however been observed ( Hausfater & Skoblick 1985 ) , and further
investigations of this may be informative . For the most part however ,
research into PMS and the ovarian cycle is restricted to in vivo studies on
humans , with all the attendant problems of interpretation and validation .
Three major approaches have been used to a greater or lesser extent
in the investigation of the PMS / ovarian hormones relationship .
1 ) The observation of the ovarian cycles of PMS sufferers and the
comparison of such to menstrual cycles in asymptomatic women.
2 ) The observation of hormonally unusual menstrual cycles and
the assessment of such for PMS symptoms .
3 ) The observation of artificially disrupted menstrual cycles either
to assess the prevalence of PMS or to assess the efficacy of the intervention
in the alleviation or exacerbation of premenstrual symptoms .
Since PMS is now a recognised clinical condition , the major purpose
of research is not only to find a cause but , perhaps more emphatically , to
effect a cure . Hence the most popular avenue of research involves the
administration of various hormonal preparations either with the object of
abolishing endogeneous hormonal fluctuations, or of supplementing some
supposed hormonal deficiency. As will be seen later, this may not be the
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most fruitful approach to the aetiology of PMS from a theoretical point of
view .
The recent literature pertaining to the relationship between PMS and the
ovarian cycle will be discussed according to these three major approaches .
The outline of the research pursued in this thesis project will then be
outlined .
3.2 HORMONAL PROFILES OF WOMEN WITH PMS
The relationship between ovarian steroids and PMS can be examined
in two ways by a consideration of the endocrinology of the PMS sufferer.
Firstly - a detailed study can be made of the temporal relationship between
premenstrual symptoms and hormonal events in an attempt to elucidate
potential trigger mechanisms or consistent pattern correlations . Secondly -
endocrinological comparisons can be made between women diagnosed as
suffering from PMS and those who don't . Some endocrinological studies
have employed both of these methodologies , however for the sake of
clarity, they will be considered seperately .
&2Jl THE TEMPORAL RELATIONSHIP BETWEEN PMS AND OVARIAN
HORMONES
The crude relationship between PMS and the ovarian cycle has long
been established , i.e. the symptoms tend to occur in the second half , or
luteal phase , of the cycle . However the finer details of this relationship
remain elusive . Few reported studies have assessed psychological and
hormonal parameters at sufficiently frequent intervals to allow conclusions
to be drawn . One of the earliest studies to attempt to relate
"psychodynamic processes " with ovarian activity was that of Benedek and
Rubenstein ( 1939 ) . Although the patients in this study were not strictly
diagnosed as PMS sufferers , they were under treatment for " various
neurotic disturbances " , some of them show classic PMS symptoms in the
premenstruum ; e.g. craving for sweets (Case R.E. ) , depression and
insomnia ( Case R.R. ) , anger, disorientation and hostility ( Case X ) ; which
are absent in the postmenstrual phase . These women were studied by
daily psychoanalytic sessions and vaginal smears . Although a clear cyclic
pattern is demonstrated , and the authors assert strong correlations
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between psychological processes and hormonal state , it must be said that
their estimates of hormonal milieu were insensitive by current standards .
More recent studies have used plasma or urinary measures of hormone
secretion or excretion . Ablanalp,Donnelly,Rose & Livingston-Vaughan
(1979) studied fourteen " psychologically healthy " women by means of
daily questionnaires and thrice weekly blood sampling . No correlation was
found between oestradiol or progesterone levels and mood states.
However, none of these women were diagnosed as having PMS .
A study of daily measures of mood and ovarian hormones in women
with PMS is reported by Backstrom,Sanders, Leask, Davidson,Warner &
Bancroft ( 1983 ) . Maximum levels of depression and irritability were found
to occur during the last five premenstrual days and to decrease rapidly
during menses. The symptoms began to increase 2 or 3 days after the LH
surge , and continued to increase up to menstruation , even after oestradiol
and progesterone levels had fallen . Similar temporal relationships were
shown for symptoms of swelling and breast tenderness . Positive moods
followed the opposite pattern , peaking at the time of the preovulatory
oesrtradiol peak . Hence , the premenstrual symptoms were seen to be
closely related to the premenstrual phase but not directly to absolute
oestrogen or progesterone levels ( Bancroft & Backstrom 1985 ) .
Halbriech.Endicott,Goldstein & Nee ( 1986 ) studied the temporal
relationship between plasma steroid levels and mood changes in 17 PMS
sufferers . In this study , a time-lag of 4 - 7 days was found between changes
in progesterone levels and changes in clinical features , suggesting a
delayed or priming action of gonadal hormones on some brain mechanism .
Variability was observed between subjects however , with some women
starting to show clinical changes as progesterone levels begin to increase ,
before the peak , whilst others showed changes only after the progesterone
peak . Most women had their most severe symptoms immediately before
menses .
These studies reinforce the observations that premenstrual symptoms are
related to that part of the cycle in which progesterone is present. However,
they do not appear to be related to either progesterone or oestradiol levels
on a day-to-day basis . The possibility of a time-lag between hormone levels
and symptom manifestation has been suggested but requires further
investigation.
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2uZ2 ENDOCRINOLOGICAL COMPARISONS BETWEEN WOMEN WITH
AND WITHOUT PMS
Several studies have now been undertaken in this area . All of them
involve the identification of women with , or without , premenstrual
symptoms, and regular monitoring of ovarian hormone levels . However ,
both of these procedures are open to methodological problems . Firstly - no
standard definition of, or diagnostic procedure for, PMS yet exists . Hence ,
the inclusion criteria, both for the PMS group and the control group vary
between studies . In some cases , high and low levels of symptomatology
are identified on the basis of prospective assessments and compared
endocrinological^ (e.g. Backstrom et al 1983 ; Watts,Butt & Logan-Edwards
1985) . Other studies identify symptomatic and asymptomatic women in a
similar manner, but with no measure of the degree of symptom experience
(e.g. O'Brien,Selby & Symonds 1980 ) . Still others diagnose PMS on the
basis of clinical interviews - involving essentially retrospective reporting
(e.g. Andersch,Abrahamsson, Wendestam.Ohman & Hahn 1979 ) .Whilst it
is probably true to say that some subjects would be identified as
symptomatic or otherwise by any procedure , others may not . Hence
comparability across studies is reduced . Another important issue here is
the use of an appropriate control group . At present the mechanisms of
PMS are not identified . If the syndrome is caused at all levels of severity by
the same hormonal abnormality , then the use of a control group who
experience low levels of symptoms would not be meaningful .
Secondly - recent evidence suggests that ovarian hormones show
diurnal variations in secretion rate ( Younglai, Smith,Cleghorn & Streiner
1975 ) and that progesterone particularly is secreted in a pulsatile fashion
(Steele, Braund & Judd 1986 ) . This raises two issues . Firstly - as Reid
(1985 ) has pointed out , diurnal variations in plasma hormone levels
invalidate to a large extent studies utilizing an infrequent plasma sampling
schedule , or failing to standardise collection times across subjects . Any
differences which occur with standardized collection times may be due to a
shift in the circadian rhythm of steroid secretion in PMS sufferers (or non -
sufferers ! ) rather than a difference in the absolute levels of oestrogen or
progesterone . Secondly - the physiological significance of progesterone
pulsatility is not yet understood . It is conceivable that women with PMS may
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exhibit a different pulse profile to women without PMS - in terms of pulse
frequency , amplitude etc. These factors will be obscured if only single
samples are considered , but may result in spurious differences between
groups in terms of absolute hormone levels . Research into the actions of
progesterone on tissues such as the uterus , suggests that adequate
oestrogen priming is necessary before progesterone can be effective ( e.g.
Baird 1984 ) . This possibility has been neglected in PMS research . Few
studies have assessed follicular hormone levels with any degree of
regularity .
Hindsight indicates that the variability occuring between studies of PMS
endocrinology may be explicable . Several studies have failed to
demonstrate any consistent differences between symptomatic and
asymptomatic women (e.g. Andersch et al 1979 ; Taylor 1979 ; Backstrom
et al 1983 ) . Other studies have suggested differences between groups at
specific points in the luteal phase . For instance , higher progesterone levels
have been found in the immediate postovulatory phase in symptomatic
women ( O'Brien, Selby & Symonds (1980); Watts, Butt & Logan-Edwards
1985 ). However , Munday,Brush & Taylor (1981) demonstrated lower
progesterone levels in the early to mid luteal phase in their series of PMS
sufferers . Several studies have suggested that late luteal phase oestrogen
levels may be elevated in PMS ( Backstrom & Carstensen 1974 ;
Backstrom , Wide.Sodergard & Carstensen 1976 ; Taylor 1979 ; Munday,
Brush & Taylor 1981 ) . In some studies an increase in the oestrogen /
progesterone ratio has been implicated ( Backstrom et al 1976 ; Munday et
al 1981 ) , whilst others have failed to substantiate this finding ( Taylor 1979;
Sanders 1981). Halbriech,Endicott, Goldstein & Nee ( 1986 ) have
suggested that the rate of change of gonadal hormones is a key factor in
the differentiation of women with or without PMS . Women with clinical PMS
had differential rates of decrease of oestrogen and progesterone in the late
luteal phase , whereas non-sufferers showed parallel curves . This data
however only represents 6 sufferers and 3 non-sufferers and hence can
only be treated as anecdotal.
Watts , Butt & Logan - Edwards ( 1985 ) in a careful study utilizing both
endocrine assessments and ultrasonic visualization of developing follicles,
found that a subgroup of PMS sufferers showed evidence of early ovulation
(i.e. more than 14 days before menstruation ) . These women also showed
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an earlier progesterone rise than control women , possibly due to the earlier
ovulation . This pattern occured in 18 of 35 women with PMS compared to
only 2 out of 11 controls . The two groups were indistinguishable on the
basis of overall cycle length . Ultrasound scanning of follicular growth
suggested that follicles were smaller throughout the preovulatory phase in
PMS patients and consequently , follicle diameters were significantly lower
at the time of ovulation . Oestradiol concentrations were also lower in the
PMS group correlating with follicle diameter . Hence , they suggest that
PMS is associated with premature ovulation and an elongated luteal phase
, but no apparent abnormality in steroid production during the luteal phase .
Backstrom,Smith,Lothian & Baird ( 1985 ) studied the follicular phase in
PMS and control patients after hysterectomy and corpus lute-ectomy . The
rise in FSH following enucleation of the corpus luteum was delayed in the
PMS group resulting in a significantly longer time to ovulation ( 21 days
compared to 19 days ) . Once FSH had begun to rise , the follicular phases
were indistinguishable between the two groups in terms of oestradiol ,
although serum FSH levels were lower in the late follicular phase in PMS
patients . No information is given about the level of symptomatology
experienced by the women ion these cycles . The authors suggest that
these results imply a more sensitive " feedback " in PMS patients i.e. the
hypothalamus and pituitary are more sensitive to normal levels of
oestradiol.
The literature in this field is confused due to the current paucity of
knowledge about endocrinological normality and the nature of PMS . The
normal menstrual cycle and the actions of ovarian hormones are still
subjects of controversy . Hence , an attempt to associate mood changes
with ovarian activity in this manner is inevitably inconclusive . No evidence
has been found to link PMS with an overall luteal progesterone deficit ,
although finer measures of corpus luteum dysfunction have not been
assessed . The temporal link with the latter part of the menstrual cycle
suggests an involvement for some factor associated with corpus luteum
function , possibly independently of either oestrogen or progesterone , or
alternatively some follicular deficit which is not apparent endocrinological^
in the luteal phase .
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3.3 PMS AND THE ABNORMAL MENSTRUAL CYCLE
Abnormal menstrual cycles , in terms of anovulation or suboptimal
luteal function , tend to occur at either end of the reproductive lifespan and
after some hormonal disruption e.g. pregnancy and lactation , oral
contraceptive use , physical and emotional stress etc . ( see Section 2.3 ) . If
PMS is associated with an endocrine abnormality , then a high prevalence
of the problem might be expected to occur amongst women who are
experiencing hormonally unusual cycles . As yet, little research has centred
upon this aspect of PMS .
Studies of the menopausal transition and the post-partum phase have
largely been concerned with psychiatric morbidity . In the first case , the
relationships between diminishing ovarian activity and the " climacteric
syndrome " , in the latter case the phenomenon of post-partum depression
(e.g. Ballinger 1975 , 1976 ; Nott,Franklin,Armitage & Gelder 1976 ; Steiner
1979; Greene & Cooke 1980 etc. ) . Some authors have suggested that a
history of post partum depression may be associated with the later
appearance of premenstrual symptoms ( Nott et al 1976 ; Dalton 1984 ) ,
however there is little prospective evidence to support this assertion .
Adolescence is also an under researched phase of development from this
point of view . Although the hormonal profiles characteristic of puberty are
gradually being described , no attempts have yet been made to correlate
adolescent moodiness with ovarian cyclicity ( Hays 1978). Another time of
"raging hormones " in women is pregnancy . Few studies have been made
of mood changes during pregnancy , a time of relative excess rather than
deficiency . Kyger & Webb ( 1972 ) compared scores on various
psychological tests from groups of women assessed during normal menses,
at the time of the normal cycle progesterone peak , during oral contraceptive
therapy or in the third trimester of pregnancy . The hypothesis being that
these times of differing progesterone levels should reveal different
psychological states. Of the 57 variables analyzed , only two varied
significantly between the groups , suggesting increasing emotional
vulnerability with increasing progesterone levels . However , the probability
of these results occuring by chance in such a large test battery is high .
Several researchers have commented on the presence of premenstrual
symptoms in anovulatory cycles ( Adamopoulos.Loraine, Lunn,Coppen &
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Daly 1972 ; Andersen,Larsen.Steenstrup.Svendstrup & Nielsen 1977 ) or
the lack of symptomatic differences between ovulatory and anovulatory
cycles in different women ( Persky,O'Brien & Kahn 1976 ) . Backstrom et al
(1983 ) , however failed to find any cyclical mood changes in five anovular
cycles , although significant increases in breast tenderness and body
swelling were noted premenstrually . However , these women werenot
diagnosed as PMS sufferers . Magyar,Boyers,Marshall & Abraham ( 1979 )
suggest that regular menstrual cycles coupled with premenstrual molimina
can be considered to be indicative of ovulation . However , all their
measures of PMS were retrospective , their subjects were aged between 20
and 40 years , and therefore likely to be ovulating regularly , and they make
no comment about the presence or absence of symptoms in the cycles
studied . The findings then are probably due to the age group studied and
the high prevalence of PMS when assessed by retrospective questionnaire.
One subject in this series did experience anovulatory cycles , despite a past
history of regular menses and PMS . No comment is made on whether or
not these cycles were symptomatic . No evidence is yet available comparing
ovulatory and anovulatory cycles within the same subject , although such
data is likely to be informative .
The co-presence of PMS and luteal phase defects was the subject of a
recent study by Ying.Soto-Albors, Randolph, Walters & Riddick ( 1987 ) . In
a study of 83 infertile patients , they assessed luteal phase adequacy by
endometrial biopsy and PMS by a retrospective questionnaire of symptoms
and moods in the previous 24 hours . Both assessments were made on day
12 of the luteal phase . Their results suggest a lack of correlation between
luteal phase abnormalities and somatic premenstrual symptoms . However,
less severe psychological symptoms were observed in women with
abnormal luteal phases . Hence they suggest that PMS is unlikely to be
associated with suboptimal luteal function . The lack of prospective and
frequent data in this study , however, reduces its conclusiveness .
As yet , little more than circumstantial evidence links PMS with
abnormalities of the menstrual cycle . Although times of hormonal change
are traditionally associated with a higher incidence of psychological
problems , no data has been reported to link PMS with such life events . The
effects of pregnancy , lactation , and the perimenopause on the PMS
sufferer have not been documented .
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3.4 PMS AND THE MANIPULATION OF THE
HORMONAL ENVIRONMENT
The third major source of information about the relationship between
PMS and the ovarian steroids derives from studies of the effects of hormone
administration and / or menstrual cycle manipulation . These studies can be
divided into four categories based on broad aetiological notions of PMS
1) Disruption of the menstrual cycle with conservation of the
ovarian cycle . These studies assess the relative contribution of menses per
se to cyclical changes in mood and physical symptoms .
2) Suppression of the ovarian cycle . In these studies
endogeneous cyclical changes in all ovarian hormones are suppressed
due to interference at the hypothalamic or pituitary levels .
3) Supplementation of hormones in the luteal phase . These
studies assume a physiological deficit of luteal hormones i.e. progesterone ,
and attempt to remedy the deficiency by exogeneous administration .
4) Suppression of the ovarian cycle with selective hormonal
supplementation . In these studies , the precise hormonal milieu is
manipulated to produce PMS like symptoms .
These four approaches will be considered in turn .
3.4.1 DISRUPTION OF THE MENSTRUAL CYCLE
These studies assess the effect of hysterectomy , removal of the uterus ,
on the manifestation of PMS . Since the ovaries may be conserved , the
ovarian cycle remains intact . However , the temporal marker of
menstruation is removed as are any biochemical factors deriving from the
uterus . The psychosocial and emotional effects of non-cancer
hysterectomies have been extensively studied and reviewed elsewhere
(Dennerstein & Ryan 1982; Kav-venaki & Zakham 1983; Wijma 1984 ) .
However few studies have assessed the effects of hysterectomy on cyclical
symptoms. In a prospective study of 7 hysterectomized patients who
showed ovulatory cycles on the basis of thrice weekly plasma assessments,
small fluctuations in psychological and physical symptomatology were
found ( Beumont,Richards & Gelder 1975 ) . These differences were not
significant although premenstrual symptom peaks were seen . The authors
give no information about the previous premenstrual history of their
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hysterectomized women and conclude that the presence of premenstrual
symptoms in normally menstruating women is due , at least in part , to the
woman's awareness of her position in the menstrual cycle .
In a similar study of women with PMS before and after hysterectomy ,
Backstrom,Boyle & Baird ( 1981 ) demonstrated that cyclical mood changes
persist in the late luteal phase , although the symptoms were slightly but
significantly improved . Hence , they assert that PMS can occur in the
absence both of menstruation and of the uterus . The improvement in
symptoms may be due to the removal of troublesome menstrual bleeding ,
the reason for the operation , leading to a better overall state of health ; the
removal of the ' zeitgeber' , menstruation ; a placebo effect of the operation
or the removal of some aetiological uterine factor. The women in this study
were monotored in the immediate post-operative period . It would be
interesting to study a group of women longitudinally as adaptation to the
operation occured - the possibility that "phantom " menstruation i.e." this is
the time when my period used to occur " , can still have a zeitgeber effect
is not considered . The authors of this paper argue that their data support
the view of a hormonal aetiology of PMS . A more appropriate
demonstration of this might be a comparison of PMS sufferers who undergo
either hysterectomy with bilateral oophorectomy ; hysterectomy alone ; a
non-gynaecological abdominal operation ( e.g. gall bladder removal ) or
nothing at all in the same age groups . The relative effects of ovarian
hormones , menstruation , the potential placebo effect of the operation and
time itself might then be elucidated .
3.2 SUPPRESSION OF THE OVARIAN CYCLE
Studies of medical ovarian suppression can themselves be divided
into two categories according to the type of drug used :-
a ) Those drugs which temporarily abolish ovarian activity without
the addition of steroids ; and
b ) Those drugs which manipulate the ovarian cycle via the steroidal
feedback pathways .
In the first category , two drugs have been used - Danazol and GnRH
agonist. Danazol is an isoxazole derivative of 17- ethinyl testosterone , and
is a powerful antigonadotrophic agent , probably acting at the hypothalamic
level (Asch, Femandez,Smith,Siler-Khodr & Pauerstein 1979 ) . The
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GnRH agonist , administered by injection , subcutaneous implant or nasal
spray , acts by down regulation of pituitary gonadotrophin secretion ,
thereby producing a " medical ovariectomy " . In the second category fall
the oral contraceptives . These drugs act by maintaining the negative
feedback inhibition of gonadotrophin release and blocking the positive
feedback effects of high oestrogen levels ( see Section 2.4) . However ,
exogeneously administered synthetic steroids are present throughout the
cycle
3,4,2 a) Ovarian Suppression Without Exogeneous Steroids
Several studies have now been conducted to assess the therapeutic
efficacy of danazol for PMS . Day ( 1979 ) found a good response in
patients with severe PMS , particularly if the main symptom was breast
tenderness . However a high incidence of side effects was observed ,
especially weight gain , nausea and abdominal distension . Similar good
effects were found by McKay-Hart , Hawthorn & Gilmore ( 1985 ) in a double
blind placebo controlled crossover trial of danazol in patients who had
previously been unsuccessfully treated with other drugs . In this study only 3
women withdrew due to side effects . Watts,Butt & Logan Edwards ( 1987 )
have also found positive benefits of danazol for breast symptoms and for
irritability , anxiety and lethargy by the third month of a double blind trial .
Although this trial assessed the effects of different doses of the drug , the
high dropout rate disallowed a dose response comparison . Hence it would
seem that danazol can reduce some symptoms and in particular breast
symptoms . The lack of endocrine assessment in these studies however
makes interpretation of the results difficult. The level of ovarian suppression
may be variable between women , resulting in differential symptom
responses . No temporal relationships been symptoms and danazol
suppressed endocrine states have yet been reported .
The use of GnRH analogues is a very recent advance in endocrinology
research . The first published study of their use in PMS was by Muse.Cetel,
Futterman & Yen ( 1984 ) , although they have found practical applications
in other clinical conditions e.g. precocious puberty , hormone dependent
tumours etc ( Sandow 1983 ) . In the Muse et al study .daily self
administered subcutaneous injections of 50 pig of GnRH agonist were used.
The trial was completed in a double blind crossover manner , using a
placebo, over six months , although only 8 patients were studied . All
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symptoms , both behavioural and physical were significantly improved
compared to placebo , and this improvement was coincident with ovarian
suppression in all cases . Studies with the LHRH nasal spray , buserilin ,
have shown less clear cut results (Bancroft,Boyle,Davidson,Gray & Fraser
1984 ; Bancroft,Boyle & Fraser 1986 ; Bancroft,Boyle,Warner & Fraser
1987). These studies assessed responses to the drug in a non-blind ,
exploratory , clinical fashion . The treatment consistently resulted in an effect
on PMS , however this effect was not always a suppression of premenstrual
symptoms . In all cases , an initial stimulatory phase of the drug is evident ,
producing aggravation of premenstrual symptoms if it is begun in the luteal
phase , and precipitating symptoms in the normally asymptomatic follicular
phase , in the absence of corpus luteum activity . In some cases , these
symptoms became persistent , whilst in others they subsided and remained
at low levels throughout treatment. The control of ovarian cyclicity was also
variable. Although ovulation was consistently suppressed , follicular
development was not . In some cases menstruation continued to occur
during treatment , and these women also continued to show mild physical
symptoms premenstrually although no changes in mood . In all cases mood
symptoms lost their relationship to menstruation .These problems are
important from the therapeutic point of view, possibly reflecting individual
differences in absorption rates or sensitivity to the drugs . However , from
the theoretical point of view , studies with the GnRH agonist demonstrate a
link between mood states and the hypothalamo-pituitary- ovarian axis .
Bancroft et al (1984 ) argue that these effects cannot be due simply to the
removal of ovarian steroids , since symptoms were induced by the agonist
in the absence of luteal activity , although the presence of
superphysiological oestrogen levels . The possibility also arises that the
physical and psychological aspects of PMS are dependent on different
hormonal mechanisms .
Altogether, the use of danazol and GnRH agonists have suggested that
PMS symptoms can be improved , induced or disrupted by the removal of
ovarian steroids . The question of whether this effect is due to the absence
of oestrogen and progesterone , the disruption of the HPO axis or some
other , unrelated , action of the drugs themselves is uncertain .
Unfortunately, these drugs are not without problems of administration or
side effects . The possibility of variance in optimal dose regimes for ovarian
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suppression between women also clouds the issue . Bancroft & Backstrom
(1985 ) suggest that mood states in PMS are related to the " ovarian clock"
rather than specific ovarian factors . Hence disruption of the clock would
lead to disruption of the mood rhythm . This theory could account for the
variability seen in these studies . Further studies are needed with both of
these drugs to assess their precise effects on gonadotrophin and ovarian
steroid levels and the temporal relationship with sensitive symptom
measures . The possibility of diverse effects between symptoms has not
been assessed .
3.4.2 b ) Ovarian Suppression With Exoaeneous Steroids
Ovarian suppression by administration of exogeneous
steroids is commonly achieved in Western society by use of theoral
contraceptive pill ( oc ) . These drugs have been extensively reformulated in
recent years , leading to vast differences in the dosages of steroids used in
early studies compared to recent research . Depression and loss of libido
have often been cited as side effects of oc's , suggesting a relationship
between steroid levels and mood . However , studies of oc effects are
notoriously badly designed and open to a variety of alternative
interpretations ( see Glick & Bennet 1982 ) . Studies specifically assessing
the effects of oc's on PMS are few and far between . They can , however
be divided into two categories , those studies which assess the changes in
PMS in women starting oc's , and those studies which compare symptoms
in established pill users with non users .
The majority of PMS studies fall into the former category , and include
PMS as one of the potential side effects of , or parameters which may
change with , oc use . The means of assessment used in these studies is
usually a retrospective questionnaire administered before , and at various
points during , oc use . In this way the prevalence of premenstrual
depression and irritability has been shown to decrease with oc use (Nilsson
& Solvell 1967 ; Grant & Pryse-Davis 1968 ; Herzberg & Coppen 1970 ) .
However none of these studies used a control group, neither were the
effects of oc on the individual assessed . Cullberg ( 1972) in a double blind
placebo controlled crossover trial of several different oestrogen:
progestagen combinations showed a non-significant trend towards
improved premenstrual irritability with increasing progestagen . He did ,
however , identify a subgroup of women whose PMS appeared to be
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"hormone responsive " , who reacted positively to progestogen dominated
medication and negatively to oestrogen dominated pills . The use of
monthly retrospective questionnaires in this study , however reduces its
sensitivity.
Two studies have assessed the effects of oc's in a prospective fashion
(Silbergeld.Brast & Noble 1971 ; Morris & Udry 1972 ) showing no
differences in day to day feelings of well being between pill cycles and
placebo cycles . However , both of these studies were short term and
neither of them diagnosed subjects as PMS sufferers .
A recent study comparing monophasic and triphasic new pill users
(Bancroft, Sanders,Warner & Loudon 1987 ) found that those women who
had PMS before starting the pill were more prone to negative mood
changes on the triphasic pill . These changes started in the first half of the
cycle when progestagen levels were lowest and continued until the pill free
week , suggesting that PMS symptoms are more likely to occur
coincidentally with low progestogen levels .
The alternative approach to PMS and oc's is a cross sectional one ,
comparing established oc users with a control group . Arguably in this way
the placebo effects of oc use and the endocrine variability in response over
the first few cycles of use are avoided . These studies tend to include large
numbers of women receiving varied doses of steroids . Kutner & Brown
(1972) used a one-off retrospective questionnaire to assess the prevalence
of depression , premenstrual depression and premenstrual irritability
amongst 5151 pill users , ex- users and never users . They found that a
smaller proportion of pill-users reported premenstrual depression than
controls , and that combined pill users had lower rates of premenstrual
depression than sequential pill users . The higher the progestogen dose ,
the less severe the depression . This agrees with Cullberg's ( 1972 )
observations ( see above ) . The major problem with a study of this kind is
the " survivor effect " - possibly those women who experienced
premenstrual symptoms before starting an oc , were prone to side effects
and discontinued it . Hence a disproportionately low prevalence rate
amongst pill users . If this were the case , then past pill users might be
expected to show a higher rate of premenstrual depression than never
users . This hypothesis is substantiated in the Kutner & Brown (1972) study ,
although no distinction is made between ex-users who discontinued the pill
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because of side effects and those who stopped for other reasons e.g. the
desire for pregnancy or the ending of a sexual relationship .
Two studies have assessed pill users in a prospective longitudinal
fashion. Forrest ( 1979 ) studied twelve women using low dose combined
oc's (i.e. < 30(ig oestrogen ) over thirty days . Daily visual analogue ratings
were made of mood and anxiety . A steady increase in levels of depression
was shown across the pill cycle which fell during the pill free week . This
effect was also demonstrated in a cross sectional study by Abramson ,
Repezynski & Merrill (1976 ) with respect to self reports of sexual arousal in
response to an erotic story. The second longitudinal study is that of Paige
(1971 ) . She compared combined pill users , sequential pill users and
controls at four points during the menstrual cycle , using the Gottschalk
method of content analysis of speech samples . In this study the control
group showed a typical U shaped pattern of negative affect , with
premenstrual and menstrual peaks of depression . The combined group
showed a much flatter pattern and the sequential group fell partway in
between . Total negative affect scores did increase from day 4 to day 16 ,
although not significantly , in the combination pill users suggesting a similar
trend to that seen by Forrest . This may suggest a cumulative effect of oc
steroids on psychological states , with relief during the pill free week .
Although both of these studies give some clues about the effects of oc's
on mood , neither of them diagnosed the presence or absence of PMS in
their subjects either currently , or retrospectively . The available evidence
would suggest that women using the combined pill especially , show a
different pattern of symptoms from women who are not influenced by
exogeneous steroids .
The studies of the effectsof oc's on PMS , or the presence of PMS
during oc use , provide only fragmentary data . Two suggestions arise .
Firstly - that women with PMS are more likely to become chronically
depressed when they start to use an oc , and that this effect is itself more
likely with decreasing levels of exogeneous progestogen . This might
suggest that women with PMS are more sensitive to ovarian steroid levels ,
and particularly to low levels of progesterone . This adds weight to the
hypothesis that PMS is due to, or coincident with , a physiological deficiency
of progesterone ( see Section 3.4.3 ) . The second suggestion is that the
pattern of symptoms (i.e. negative affect) in pill users is different from that in
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controls , with the possibility of a cumulative effect of oc constituents . No
longitudinal assessments have yet been made , however , of women who
have PMS before and during oc use , the patterns of symptoms
experienced by those women on the pill who feel they have PMS , or the
effects of the new lower dosed oc's . Studies of this type are likely to be
informative .
3.5 CONCLUSIONS AND OUTLINE OF RESEARCH PROPOSALS
The literature reviewed in both this chapter and its predecessors ,
reveals many areas of inconsistency and inadequacy in both the basic
aspects of research into PMS and the menstrual cycle , and in the quest to
elucidate the link between them . That there is a link is still an assumption
rather than a proven finding , however more and more evidence is
suggesting that the ovarian cycle has some role to play at least in the
temporal manifestation of the so called PMS .
Two major approaches to the area have been neglected . Firstly
observational studies of temporal links between symptom patterns and
hormonal events in normal menstrual cycles and hysterectomized ovarian
cycles, and secondly - studies of links between symptom patterns and
abnormal menstrual cycles i.e. cycles which are anovulatory or incorporate
a luteal phase deficiency . The latter approach forms the theoretical basis
for this thesis . The major question arising from this approach being Can
PMS occur in endocrinological^ abnormal cycles ? In order to investigate
this question , six sub-questions were formulated allowing a practical
approach to the problem .
1 ) Can PMS symptoms occur in the natural absence of ovulation
and / or menstruation ?
2 ) Can PMS symptoms occur in naturally ovulatory and anovulatory
cycles in the same woman ? - and if so , are they similar in type , intensity ,
timing of onset or duration ?
3 ) Are PMS symptoms similar or different in totally ovulatory versus
totally naturally anovulatory women of the same age group ?
4 ) Can PMS symptoms occur in artificially anovulatory cycles ? -
and if so are they similar in type , intensity , timing of onset or duration to
matched ovulatory cycles ?
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5 ) If PMS symptoms can occur in artificial menstrual cycles , are they
related to levels of exogeneous hormones ?
6 ) Is symptom timing or severity related to the adequacy of corpus
luteum activity ?
Regular monitoring of cycles in which anovulation or luteal phase
inadequacy are likely to occur, may allow answers to these questions to be
drawn . In these studies , the definition of PMS is not an issue . The
selection of women who feel they have PMS is preferential since
demonstrable mood changes are more likely to occur in these women . The
studies described in this thesis do not endeavour to answer questions about
the nature of PMS , its epidemiology or prevalence rates in certain
situations , nor do they attempt to demonstrate endocrinological differences
between women who have PMS and those who do not. The purpose of this
thesis is twofold . Firstly - to investigate the possibility that PMS symptoms
can occur in anovulatory or otherwise unusual cycles and secondly - to
relate the occurence of such synptoms to specific hormone variables .
In practical terms , this purpose can be achieved in two ways . Firstly
by the study of women who are likely to experience hormonally unusual
cycles , and secondly by the comparison of women whose menstrual cycles
have been rendered anovulatory with women having normal menstrual
cycles. The materials and methods used to achieve these aims , the data







In this chapter , those materials and methods which were used
routinely, or whose description in the text would interfere adversely with data
presentation are described . The recruitment and selection of subjects for the
two studies is described at the beginning of the appropriate chapters .
Hence, the routine materials and methods fall into three categories . Firstly ,
the manner by which mood and symptom data was collected in order to
assess premenstrual symptoms . Within this category also fall those
instruments used to investigate symptoms reported retrospectively , to
assess personality characteristics and to collect demographic data . The
second section describes the assessment of ovarian function in those
subjects for whom hormonal data was collected , together with the
descriptions used for abnormality . The third section refers to the statistical
analysis of this type of daily rating scale data generally and the particular
methods used in this thesis.
4.2 THE ASSESSMENT OF PREMENSTRUAL SYMPTOMS
4.2.1 THE DAILY DIARY
Early studies of premenstrual symptoms , with occasional exceptions ,
used retrospective questionnaire or interview techniques to collect data on
the type and intensity of symptoms experienced . However , within the past
ten to fifteen years , concern has been expressed that ratings in such a
context may be influenced by subjective attitudes and beliefs about the
menstrual cycle and menstrually related mood changes . Evidence has been
put forward in support of this observation to show that both men and women
do have specific ideas about the way in which menstruation is experienced
generally ( e.g. Parlee 1973 , 1974) . Hence , the use of daily self rating
scales has become an important feature of scientifically rigorous research in
this area 1 . The number and type of symptoms assessed and the manner in
1 Those studies which have attempted to directly relate retrospective and
prospective ratings ( e.g. McCance , Luff & Widdowson 1937 ; May 1976 ;
Ablanalp , Donnelly & Rose 1979 ; Endicott & Halbriech 1982 etc . ) have
shown that daily ratings can either confirm or deny the premenstrual
symptoms expressed in a retrospective questionnaire . This lack of
uniformity between individuals is usually cited as evidence that some
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which they are measured varies considerably between studies . The
majority of researchers have used a daily version of the Moos Menstrual
Distress Questionnaire ( MDQ ) ( e.g. Parlee 1974; Wilcoxon , Schrader &
Sherif 1976; Sampson & Jenner 1977 ; Rogers & Harding 1981 ; Van den
Akker & Steptoe 1985 etc. ) which measures symptoms on a six-point scale .
Other studies have used idiosyncratic groups of symptoms in attempts to
investigate particular aspects of mood change e.g. depression ( Endicott &
Halbriech 1982 ) . However , in all of these studies , numerical category
scales are used, requiring the subject to describe her symptoms or feelings
in terms of defined numbers . These scales have the advantage that the
researcher always knows precisely what the subject meant , and they are
relatively easy to score . However , such scales have been criticised
generally in the field of measurement of feelings for being too restrictive .
Aitken ( 1969 ) argues eloquently that exact feelings are often beyond the
scope of words to describe:-
"
Feelings are states of the self , and incorporate moods
and sensations . Although a person may appreciate precisely his state on a
selected dimension , words may fail to describe the exactness of the
subjective experience. The paucity of suitable quantitative terms in common
speech limits the amount of information which can be transferred .
Continuous phenomena have to be graded in artificial categories ."
Aitken (1969)
This argument is particularly relevant in the case of daily ratings in
which sometimes small and undefinable changes in subjective feelings are
being assessed . A potential solution to this problem is the use of a " visual
analogue scale " . These scales consist of a line of a defined length ( usually
100 mm ) with defined end-points . The lines can be either unipolar or
bipolar. The subject can place a mark at any point along the line , allowing
subjects may be responding according to cultural stereotypes and hence
retrospective questionnaires are of dubious validity . However , one
potentially important point is neglected - that is that variability in symptoms
may occur between consecutive cycles in the same individual . If the
retrospective questionnaire is completed before the prospective data are
collected , then the two are referring to different time periods , and hence
both could reflect true symptom experience without necessarily being
concordant. As yet no good data is available to compare retrospective and
prospective reports of the same cycle . However , such data might yield
valuable information about the accuracy of retrospective data and the
potential influence of attitudes and beliefs .
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even slight alterations in mood to be expressed . Such scales have been
shown to be valid and reliable in the regular measurement of mood states
(e.g. Zealley & Aitken 1969 ; Luria 1975 ) , and have now been used in
several studies of premenstrual symptoms ( e.g. Sanders et al 1983 ;
Rubinow , Roy-Byrne , Hoban , Gold & Post 1984 ) . The use of such scales
is not however without problems . The first of these is interpretation . The
conceptual possibility exists that " drift" may occur, particularly if the scales
are used over an extended period of time ( Warner : personal
communication ). That is ; the subject may unconsciously recentre herself on
the scale particularly after a period of changeable mood such as may occur
premenstrually . Hence , a score near the beginning of a dataset may not
necessarily be comparable to the same score near the end of a dataset .
Unfortunately little can be done to control for this type of error , although the
removal of any trend in the data may to some extent reduce it . The second
problem arises from the scoring of such scales . This is usually done by
measuring the distance of the mark made from the origin and expressing the
result in millimetres , or centimetres to one decimal place , or as a proportion
of the total length of the line , hence taking into account the sensitivity of the
measure . If multiple scales are being completed each day over a prolonged
length of time , this scoring technique rapidly becomes unwieldy and time
consuming . Little can be done to account for this whilst maintaining the
scale sensitivity .
Visual analogue scales were used throughout this thesis and take the
form of a " daily diary " ( Figure 4.1 ) . It consists of eleven named unipolar
scales , which are reduced to eight during scoring by combining " cheerful &
happy " with " depressed & unhappy " to give an overall mood score , and "
energetic & active " with " fatigued & tired " to give an overall energy score
. The part of the diary measuring moods has been assessed previously and
all the scales have been found to demonstrate face and construct validity ,
and cross validity when compared to the Lorr-McNaire Mood Adjective
Check List ( Sanders 1981) . Blank lines were incorporated to allow
flexibility , the subjects can score regularly any particular feelings or
symptoms which are an important part of their premenstrual experience . In
this thesis , however, only the eight major symptom scales were analysed .
The scales of sexual interest and activity were made optional for all study

















Code No: □ □□ Date: □ □□□□
Menstrual Period
(leave blank if not bleeding) 0
MOODS
Cheerful and happy 0
Irritable 0
Energetic and active 0
Depressed and unhappy 0
Fatigued and tired 0









Sexual activity (leave blank if n
no activity)
Self | | Partner [ | Both j^~ j
Note any significant events which occurred
Note any physical changes or symptoms (other than those mentioned above)
Note any drugs or medication
Dd8865858 20M 7/86 (18023)
Figure 4.1 The Daily Diary
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Daily Mood Diary Instruction Sheet
This 'diary' has been designed to compare your feelings from day to day. Since
we are trying to build up an accurate picture of how your moods change, it is
most important to mark each scale every day. If you have not experienced that
mood or symptom at all that day, mark the scale at zero, please do not leave it
blank.
A mark at zero means that you did not experience any of this emotion or symptom
on this day. Further along the line shows more of the mood has been experienced
until a mark at '10' means that you have experienced that mood or symptom as
strongly as you can remember ever having experienced it.
So: for example:
If a diary was marked like this:-
Cheerful and happy 0 j 10
Irritable j) 10
Energetic and active 0 ^ 10
Depressed and unhappy 0 | 10
Fatigued and tired 0 j 10
Breast tenderness 0
Body swelling j) 10
Period type pain {) 10
we would say that the woman was very cheerful, not at all irritable, not very
energetic, a little bit depressed, quite tired had very very tender breasts, no
body swelling and no period pain.
Please make sure that if you have had no experience of a symptom at all, you put
a mark through zero (or circle it), not just near it, or you will be given a
score which may be wrong.
The menstrual period line should be used to indicate the heaviness of bleeding in
the same way (eg, a score of 10 means the heaviest bleeding you can ever
remember). Please mark any 'breakthrough bleeding' or spotting on this line too,
and leave it blank when there is no bleeding at all.
I would be grateful also if you could make a note on the bottom of the diaries of
any drugs etc you have been taking and any major events in your life - all of
which can influence your mood quite independently of your menstrual cycle.
It is important that the diaries should be filled in at approximately the same
time each day, eg, just before going to bed; and that each line should be marked
every day.
Figure 4.2 The Daily Diary Instruction Sheet
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Sexual activity and its instigation ( indicated in the self , partner , both
boxes) is also not assessed in this study .
The large amounts of data collected necessitated that some method of
scoring be devised to increase the speed with which each individual diary
could be assessed . A template was devised for this purpose , fitting
precisely over the diary sheet , and having each line divided into ten equal
sections . Marks were categorised according to the section in which thy fell .
Arguably , this system defeats the purpose of the sensitivity of visual
analogue scales , however the definitional problems are still avoided and
even a ten point scale allows considerably more flexibility than a numerical
six-point scale .
The diaries were printed on both sides of A5 sheets and were collected at
regular intervals , either by post or by personal contact with the researcher.
All of the diaries were identified by code numbers only . An instruction sheet
was provided in each case , which is displayed in Figure 4.2 .
4,2.2 OTHER PSYCHOMETRIC TESTS USED IN THE ASSESSMENT OF
SUBJECTS
The main purpose of the studies described in this thesis is the
assessment of changes in mood over time . Hence , little importance was
attached to the retrospective measurement of symptoms etc. .However ,
several instruments were used in a descriptive capacity . These were a
modified version of the Moos MDQ ; the Menstrual Health Questionnaire
(MHQ ) designed for use in a national magazine survey ( Bancroft & Warner
1987 ) , and earlier versions of it ; the Eysenck Personality Inventory ( EPI )
Form B ; and an informal questionnaire for the collection of personal and
demographic details . The data obtained from these instruments were used
in subject selection and in the description of particular subject groups .
i) The modified Moos MDQ
This questionnaire assesses the twenty most common items from the
original 47 item MDQ , with the addition of " repeated illnesses " (Figure
4.3). They are completed retrospectively according to symptom frequency
and severity . The scores were assigned by considering only those
symptoms occuring every month ( i.e. a score of 0 was assigned to those
occuring with lesser frequency ) . The one to five scale was then used to
assess symptom severity . Symptom scores were collected within seven
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PREMENSTRUAL QUESTIONNAIRE (adapted Moos 1968)
This is a list of things that some women notice a few days before their periods
Please tick if you have noticed any of these and say 1. how often and
2. how strongly
Please leave out any you have never felt.



































Hqurg 4,3 The Mortified Moos MHO
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TABLE 4.1



































EATING HABITS Shange in Fating habits 0-5
REPEATED ILLNESS Repeated Illnesses 0-5
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categories , approximating to five of the original Moos classifications , with
the addition of repeated illnesses and change in eating habits . The clusters ,
and range of scores are described in table 4.1 .
ii ) The EPI
The Eysenck Personality Inventory , Form B , was used to assess
personality characteristics on those occasions when such an instrument was
suitable ( i.e. the questionnaire was not used in postal studies ) The
suggestion has been made in previous studies that women with PMS are
likely to have high neuroticism scores ( see Section 1.5.7 ), hence it was felt
that this possibility should be investigated wherever possible . The EPI was
chosen for its brevity , since this was not a major part of the study . The
resulting forms were scored using the published template . The appropriate
normal range in this case is probably that of " housewives " in the EPI
manual, i.e. on the measure of extraversion ( E ) , a mean of 13.92 with a
standard deviation of 4.22 ; and on the measure of neuroticism ( N ) , a mean
of 9.42 with a standard deviation of 5.19 . the normal mean for the Lie ( L )
scale is 1.38 ( standard deviation 1.35 ) (Eysenck & Eysenck 1964 )
iii 1 The Menstrual Health Questionnaire ( MHQ 1
This is a descriptive instrument designed for the retrospective
assessment of menstrual and premenstrual symptoms , together with the
collection of a certain amount of demographic data ( Figure 4.4) . The MHQ
was designed for use in a national survey of menstrual health published in
"Woman " magazine in August 1985 . The results of this study and the
design of the questionnaire are described elsewhere ( Bancroft & Warner
1987 ) . An earlier version of the MHQ was completed by all the subjects
described in Chapter Five . The survey version was used in the selection of
subjects for the study described in Chapter Six . The data accruing from this
questionnaire with regard to premenstrual symptoms have not been
analysed in this context1 .
The Menstrual Health Questionnaire Part II ( MHQ II ) was completed by
all the participants in the Pill study ( Chapter Six ) . This questionnaire is
1 The premenstrual symptom data collected from those women who took
part in the " Woman " survey has been analysed as part of the total pool of
participants . However, individual results from this are not available .
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WOMAN readers have been asked Co help with a very important medical
research study, by Dr John Bancroft, a leading expert in women's health
problems. After years of experience Dr Bancroft believes chat changes in
health and feelings in relation to the woman's cycle are poorly understood.
Dr Bancroft needs the largest number of women he can get to answer this
questionnaire. WOMAN were happy to assist with this very vital research.
Please persevere with the questionnaire and answer as honestly as you can.
By completing it you will be helping doctors to help all women.
Circle the number next to your answer








2 How regular are your periods
now?
Regular (start within 2/3 days each
month) 1
Irregular (start within 4/10 days
each month) 2
Very irregular (start varies by more
than 10 days each month) 3
3 How long do your periods
usually last?
write in days




5 What date did your last period
start?
wnte in
6 What is today's date?
■ CHILDREN




Yes, write in how many
8 How old is your youngest child?
write in years
9 Did you get depressed after your
last childbirth?
Yes—a short time in first week
after childbirth 1
Yes—for more than a week but
not severe 2
Yes—n was bad enough to see





10 In the next column is a list of
feelings, symptoms and changes
which you may or may not have
experienced. Before, During and
After your last period. If you are
having a period at the moment or
finished one less than five days
ago, report on previous period.
Please put a NUMBER in each box
to indicate whether you have
experienced that symptom and if
so how severe it was.
The number will indicate how
severe the symptom is at that
time.
Put 0 in the box for NO SYMPTOM
at that time.






EXAMPLE OF HOW TO ANSWER
If you feel moderately nauseated
and sick during the week before your
period but find the nausea starts to
improve during the period and you
are free of it in the week following













PlfT A NUMBER IN EACH
BOX TO INQICATE HOW YOU
HAVE BEEN FEELING
Headaches







































Any other particular symptom or feeling
—please describe on a separate sheet
11 During the month around this
last period, were the unpleasant
changes you experienced:
as bad as usual 1
better than usual 2
worse than usual 3
no unpleasant changes 4
12 Which is the worst type of
change you usually experience
13 Normally, do your levels of the
following change during the month?
NOT
CHANGES YES NO APPLICABLE
Energy 1 2 —
Feeling of well
being 1 2 —
Sexual interest 1 2 —














































































14 Considering the month around your last period:
Week Week Never
Before During After Other High/ Not
Period Period Period Time Low Applicable
In which pan ol the month is
your energy level at its
highest? 1 2 3 4 0 X
When is it at its lowest? 1 2 3 4 0 X
When are your leehngs ot
well being at their best? 1 2 3 4 0 X
When are they at theirworst? 1 2 3 4 0 X
When are you most interes¬
ted in having sex? 1 2 3 4 0 X
When are you least interes¬
ted in having sex? 1 2 3 4 0 X
When doyoumostenjoysex? 1 2 3 4 0 X
When do you least enjoy sex? 1 2 3 4 0 X
■ PREMENSTRUAL
SYNDROME





No—go to 22 3
Don't know 4
■ IF YES/MAYBE
16 For how long do you think you
have suffered from PMS?
years
17 What suggests to you that you
have PMS?
GP told me 1
Husband told me 2
Friend/relative told me 3
After reading about it 4
The changes are so regular it must
be 5
I have been checking on myself 6
Other—write in
18 What is the worst thing that
has happened when you were
suffering from PMS?
write in
19 What worries you the most
about PMS?
write in




If YES what is it?
21 How understanding is your
husband/partner about your PMS?
Very understanding 4
Fairly understanding 3
Not very understanding 2
Not at all understanding 1
22 How happy is the relationship




Not very happy 2
Not at all happy 1
23 Are you personally undergoing
any unusual stress at the moment?
Yes a great deal of stress 1





24 How old were you when your
first period started?
years
25 Which method of contraception
are you using at the moment?
None—no sexual relationship 1
None—pregnant 2
None 3
Oral contraceptive (The Pill) 4
IUD or Coil 5







26 How long have you used this
method of contraception?
years
27 If you are taking the
contraceptive Pill what is it called?
28 If you are not taking the Pill
now but have taken it in the past,
how long ago did you stop taking
it?
Write in years ago
Never taken the Pill 2
29 What age are you?
years




31 If YES what is your job?
For twin sisters only. Others go to 33
32 Does your sister experience





PLEASE WRITE ON A SEPARATE
SHEET IN MORE DETAIL
33 In which region do you live?
North England 1




■ WILL YOU HELP?
Would you be prepared to help
research further by answering other
questions about how you feel? If so,
please write your name, address and
telephone number (if you have one)
and you will be contacted. Dr
Bancroft is particularly interested to
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essentially an extension to the MHQ and collects detailed data about
pregnancy, childbirth and post-partum experiences , previous medical and
gynaecological complaints , and contraceptive history as well as more
demographic details and has only been used in a descriptive context.
iv) Demographic Questionnaire
An informal questionnaire / interview was used to collect personal details
from those subjects seen individually . Essentially its contents were similar to
those of the MHQ II , in terms of medical history etc. , however a little more
emphasis was placed on current life events ( see Appendix ) . These data
were also used in a purely qualitative way , although the reporting of
multiple disruptive life events could potentially lead to the exclusion of that
subject's data from the study . ( In practice , those who were experiencing
such events excluded themselves by dropping out) .
4.3 THE ASSESSMENT OF OVARIAN FUNCTION
Ovarian function can be assessed in a variety of ways ; by visualisation of
changes occuring in the ovary , or by measurement of some dependent of
adequate function e.g. changes in body temperature , cervical mucus or
peripheral hormone levels . The most appropriate of these for repeated use
and accuracy is the assessment of ovarian steroid levels in plasma or urine .
The recent demonstrations that the ovarian cycle can be accurately
assessed by means of the hormone - creatinine1 ratio in small regular urine
samples (Collins , Collins , Kilpatrick , Manning , Pike & Tyler 1979 ;
Stancyk, Miyakawa & Goebelsmann 1980 ; Metcalf , Evans & Mackenzie
1 Creatinine is a nitrogeneous waste product , similar to urea , the end
product of the metabolism of muscle creatine . It is excreted in fairly large
and measurable quantities in urine , with the amount excreted remaining
approximately constant per 24 hours . Endocrine results from small urine
samples are usually corrected for the amount of creatinine present , hence
taking account of the " concentration " of the sample , and producing a
result closely approximating to that from a 24 hour urine collection . This
method has previously been shown to give a more accurate representation
of the ovarian cycle than the use of uncorrected oestrone and pregnanediol
values (Cekan , Beksac , Wang , Shi , Masironi , Landgren & Diczfalusy
1986).
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1984 etc. ) have further eased the problem of the regular monitoring of
ovarian functon .
In this study , early morning urine ( EMU ) samples were collected daily in
standard 30ml plastic Universal Containers . They were frozen as soon as
possible after collection in domestic freezers or refrigerator freezing
compartments . Samples were collected from subjects in batches , either
weekly or monthly depending upon individual storage arrangements ,
thawed and 5ml aliquots obtained . These aliquots were stored at -4 degrees
centigrade , before being assayed for ovarian steroids and creatinine at the
end of the study period .
4.3.1 ASSAY TECHNIQUES
The urine samples were assayed for two ovarian steroid major
metabolites, oestrone-3-glucuronide ( E1G ) and pregnanediol- 3-
glucuronide ( PdG ) , and creatinine . The creatinine levels were measured
using an autoanalyser technique by the staff of the NHS Reproductive
Endocrinology Laboratories in Edinburgh . The steroids were measured by
radioimmunoassay ( RIA ) and enzyme linked immunosorbent assay (ELISA)
techniques .
RIA and ELISA are essentially derived from the same conceptual
framework . They both exploit the reactions between antigens , or foreign
bodies , and antibodies , proteins which help protect an organism from
invasion by foreign bodies ( see Loraine & Bell 1971 ; Rodgers 1974 etc. ). If
an antigen is introduced into a system , antibodies will be produced which
are highly specific to the particular antigen and will bind closely to it - in
order to reduce its effectiveness . ( N.B. Antibodies can also bind to
compounds which are similar to the original antigen - a process described
as cross-reactivity) . The basis of an RIA or ELISA system are the antibodies
raised to the particular substance to be measured , in this case oestrone and
pregnanediol glucuronides . Usually these antibodies are raised in
domestic animals such as rabbits , sheep or donkeys . They are then
labelled with antigen which has been rendered measurable in some way ,
either by means of a radioactive ligand , in the case of RIA , or an enzymatic
ligand which converts the substrate into a coloured product, the intensity of
which can be measured , in the case of ELISA . When a mixture of antibody
and labelled antigen is added to a solution containing a known or unknown
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quantity of unlabelled antigen , the two will compete for antibody binding
sites , with the resultant amounts of " bound " and " free " antigen being
proportionate to the ratios of their concentrations . In order to measure the
amount of labelled antigen attached to antibody , and hence the relative
concentration of unlabelled antigen, the " bound " and M free " labelled
antigen fractions must be seperated . This can be done , either by the
addition of a neutral absorptive substance , e.g. charcoal , which will " mop
up " all the " free " molecules and leave the " bound " ones in solution , or by
the use of a second antibody technique . In this case , a second antibody is
raised which is specific to the first . This is usually generated by injecting
serum from the species in which the first antibody was raised into another
species , e.g. if the first antibody was raised in rabbits , the second might be
raised in donkeys - hence DARS , Donkey- anti-Rabbit-Serum . The second
antibody , when added to the system attaches itself to the first antibody ,
making a bulky molecule which precipitates , leaving the " free " fraction
undisturbed in solution . Hence , the amounts of " bound " and " free "
labelled antigen can be measured using a suitable device , e.g. a
radioactivity counter or optical density meter. The calculation of quantity of
antigen in an unknown sample is performed by the incorporation into the
system of a number of standards of known concentration , covering the
range in which the samples are expected to lie . The results from these
standards are plotted on a dose-response curve, allowing unknown doses to
be calculated .
The RIA techniques used to assess both E1G and PdG followed
methods which have been described previously ( Collins et al 1979;
Samarajeewa, Cooley & Kellie 1979 ; Stancyk.Miyakawa & Goebelsmann
1980 ; Branch , Collins & Collins 1982 etc. ) . These assays are both based
on the measurement of the " bound " fraction of a trittiated antigen , having
seperated bound from free by use of dextran coated charcoal, radioactivity
was assessed in a Rackbeta scintillation counter . The antisera and
radioactive labels were as follows :- Oestrone-3-Glucuronide 6,7 - 3H -
specific activity 38 Ci/nmol ; Anti-oestone-3- glucuronide-BSA-sera ; [ 6,7 -
3H]-Pregnane-diol-3-glucuronide , specific activity 42 Ci/mmol ; Anti-
pregnanediol-3-glucuronide-BSA-sera . Both radioactive labels were
supplied in 9:1 v/v ethanol: water, whilst the antisera were freeze dried . All
labels and antisera were stored at 4 °C before dilution and use according to
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the suppliers instructions . All labels , antisera and reference preparations
were supplied by Dr. P Sammarajeewa at the Cortauld Institute of
Biochemistry . The inter-assay and intra-assay coefficients of variation were
10.14 % and 5.65 % respectively for E1G and 10.86 % and 6.94% for PdG .
These compare well with those reported by Stancyk , Miyakawa &
Goebelsmann ( 1980 ).
Partway through the study , an ELISA system became available for the
measurement of pregnanediol glucuronide . Several technical aspects of
ELISA are superior to the RIA system , e.g. the use of a second antibody
rather than the often messy and occasionally inaccurate charcoal
seperation, the elimination of the centrifugation step , shortened incubation
times , and the use of non radioactive labels , hence eliminating the need for
cumbersome , messy and slow scintillation counting . Comparison of
samples assayed by both systems showed a high level of correlation
between them , and hence this method was used for approximately half of
the pregnanediol samples in the study . The first antibody was as described
above , the second antibody - protein A purified Donkey-anti-Rabbit-serum
(DARS ) , supplied by the Scottish Antibody Production Unit ( SAPU ). The
enzyme label used was PdG - Horseradish peroxidase , prepared from
reagents supplied by Sigma , by Mr. Ian Swanston of the MRC Reproductive
Biology Unit , who also developed the assay system . The precise
methodology of the assay is described in the Appendix . Inter and intra
assay coefficients of variation were 7.57 % and 5.92 % respectively .
In both types of system , an assay consisted of appropriate standards and
quality controls , together with all the samples obtained from one subject .
The only exceptions to this occured when the number of samples for one
subject was too large for incorporation into one assay (i.e. > 100 samples ) ,
in which case , two assays were performed .
4.3.2 THE DEFINITION OF OVULATION AND LUTEAL FUNCTION
The changes in levels of ovarian steroids throughout the human
menstrual cycle have been well characterized in several assay systems (see
Chapter Two) . However, as with many physiological systems , the problem
of individual variability in terms of absolute levels of ovarian steroids , makes
the definition of specific endocrine events or abnormalities a difficult task .
Frequent sampling procedures assist definition since events can be
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described in terms of changes in absolute levels within an individual .
Abnormalities in terms of the general population are more difficult to define ,
and require reference to a standard or control group .
Three parameters of ovarian function required definition for the purpose
of this study ovulation , short luteal phase and inadequate luteal phase , in
terms of urinary E1G and PdG . The first of these was defined in accordance
with the criteria set out by Sanders (1981 ) . That is , a cycle is considered to
be ovulatory if a peak in urinary E1G levels is followed within two days by a
sustained rise in PdG levels .
The terms inadequate luteal phase and short luteal phase were defined
with reference to the literature and a series of eight normal cycles , collected
and assayed by Mr. Harry Boyle and the staff of the NHS Reproductive
Endocrinology Laboratories in Edinburgh1 . Both of these definitions first
require an assignment of the day of ovulation . in the study data , only E1G
values would be available to assess this parameter . In the eight cycles
studied , the urinary E1G peak occured 2 days before the urinary LH peak in
four cases and one day before in the other four cases . A previous study has
shown that the urinary E1G peak occurs either on or one day after the
plasma LH peak ( Cekan , Beksac , Wang , Shi , Masironi , Landgren &
Diczfalusy 1986 ) . If it is assumed that the urinary LH peak occurs one day
later than the plasma peak ( Roger, Grenier, Houlbert , Castanier, Feinstein
& Scholler 1980 ) , then the majority of women in this study showed their
urinary E1G peak one day before their urinary LH peak. This evidence
suggested that for the purposes of the current study , day 0 , the day of the
LH peak and ovulation , should be defined as one day after the day of the
E1G peak . Although this definition was potentially wrong in as many as 50
% of the cycles assessed , it was only likely to be wrong by one day in either
direction.
1 Daily EMU samples were collected in the normal cycles and were
assayed for LH , E1G and PdG . Although E1G was assessed by the RIA
techniques described earlier, PdG was assessed by gas chromatography .
This latter technique produces results which correlate closely with those
produced by RIA for the same samples , however it should be borne in mind
that the use of these control values may be a source of some error in the
assessment of inadequate luteal phase . All results were expressed as
creatinine ratios .
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The length of the luteal phase was assigned by counting from one day
after the defined day of the LH peak (i.e. day +1 ) up to and including , the
day before the onset of menses . Reference to the literature ( see Chapter
Two ) suggested that a length of < 9 days would probably indicate a short
luteal phase . This length appeared the most appropriate taking into account
the potential error of one day in the assessment of the LH peak .
The levels of PdG in the eight normal cycles were used as a baseline for
the assessment of inadequate luteal phase . All values were logarithmically
transformed before calculations were conducted . One method of definition
has been suggested by Coutts ( 1985 ) with reference to plasma
progesterone levels . In this system , a normal range is set up for the
cumulative progesterone values from day 2 to day 6 of the luteal phase
(inclusive ) , counting the day of the LH peak as day 0 . This score provides
a " progesterone index " , a measure of the amount of progesterone present
during the middle section of the luteal phase . Since the timing of day 0
would be assessed from the day of the E1G peak in the study subjects , this
marker was also used to pinpoint luteal phase onset in the normal group .
After log. transforming and summing the appropriate scores , the mean PdG
index for the normal group was found to be 2.5 with a standard deviation of
0.77 . Significant deviations from normal are often considered to have
occurred statistically , if a value falls more than two standard deviations away
from the mean . This criterion was applied in this case . Hence the definition
of an inadequate luteal phase became any luteal phase having a PdG index
of less than 1.0 .
4,4 STATISTICAL ANALYSIS
4.4.1 THE ANALYSIS OF DAILY DIARY DATA IN PMS RESEARCH
The use of daily self rating scales in the study of premenstrual symptoms
has now become widespread , forming at least a part of most of the recent
studies . Little attention has been paid , however , to the appropriate
statistical analysis of such data . One of the reasons for this may be the lack
of consensus about the purpose of such analysis . Four major purposes for
the analysis can be delineated
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i) In order to diagnose the presence of PMS in particular
subjects or particular menstrual cycles ( usually on the basis of one cycle of
data)
ii) In order to assess changes in moods and symptoms with time
iii ) In order to relate changes in moods and symptoms to
changes on some other physiological measure , e.g. ovarian hormone
levels.
iv ) In order to assess the efficacy of a particular treatment.
Most of the effort in the field has been directed towards the achievment
of the first of these purposes , and by extension the last . This approach has
necessitated a definition of PMS and a statistical method of satisfying the
definition . ( As outlined in Chapter One , this process may itself be of
dubious validity in this particular field . ) Dalton's ( 1977 , 1984) definition is
the one most popularly followed , implicitly or explicitly , i.e.
" Premenstrual Symdrome is the reccurence of symptoms
in the premenstruum with their absence in the postmenstruum "
Dalton (1977)
Hence - the statistical analysis of daily data attempts to demonstrate the
presence of a " significant rise " in symptoms premenstrually or a significant
difference between premenstrual and postmenstrual phases . In some
cases this analysis is conducted by the observation of charts showing the
presence or absence of specific symptoms , e.g. migraine or breast pain .
The timing of these symptoms and their frequency of occurence are the
major diagnostic pointers . A favourable response to a drug , for instance , is
demonstrated if symptom episodes become less frequent or unrelated to
menstruation . This approach is epitomised in Katharina Dalton's research .
Although it is useful in a clinical setting , it is rather subjective and
insensitive for use in most research studies , allowing no measure of change
in symptom severity , exacerbation of chronic symptoms or degrees of
change in continuosly present mood variables . However , this approach is
often used for the " confirmation " of retrospective ratings ( e.g. Halbriech ,
Endicott & Lesser 1985) .
An alternative approach has been the imposition of various cycle
"phases" onto the data - producing a mean score for each phase .
Comparisons can then be conducted between the defined phases to detect
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significant differences . These phases are usually defined in relation to
menstruation and / or hypothesized or known hormonal variables . The
number of phases usually varies between three ( e.g. Wilcoxon , Schrader &
Sherif 1976 ) and seven ( e.g. Englander-Golden , Schleitner , Whitmore &
Corbley 1986 ) , although occasionally more are used . These phases are
usually compared within and / or between groups by means of Analysis of
Variance ( ANOVA ) . This type of approach makes several assumptions , -
firstly , that any changes seen will be menstrually related ; secondly , - that
hormonally defined phases are meaningful and thirdly that ANOVA will
provide conceptually useful results in this context . As yet little evidence has
been presented to suggest that these assumptions are either meaningful or
not.
Maitland-Schilling ( 1981 ) showed considerable variability between
subjects in the symptom patterns reported - patterns which were lost when
the whole group data was meaned together . Hence she argues that the
application of a mean difference model , with large numbers of subjects , to
this type of research is of questionable validity if the relationship between
affective states and the menstrual cycle is to be explored and described ,
rather than being confined into a preconceived pattern .
This criticism does not however negate the use of this approach in the
study, or clinical treatment of , a particular individual . In this situation the
factor of time becomes all important . The temporal relationship between
consecutive daily ratings means that the scores obtained are not necessarily
independent of each other. In fact the reverse may be true - mood scores on
one day are highly likely to be positively correlated with mood scores on the
next day .This factor, known as autocorrelation , together with the fact that
data collected sequentially over time are highly likely to show a general
trend, either upwards or downwards , makes the application of conventional
statistics , such as the mean and standard deviation of dubious interpretable
validity . Hence , the use of ANOVA in this context may be questionable .
Quite apart from the stringent statistical viewpoint , the meaning behind a
significant or non-significant ANOVA result is difficult to conceptualize in this
case . The test basically compares group means , assuming that the
dispersions are equal . If we consider the case of an individual having
constant moderate levels of , for instance , irritability in the follicular phase ,
but fluctuating high and low levels of irritability in the premenstrual phase - a
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comparison between the two on the basis of ANOVA or t-test etc. might yield
little difference , whilst in fact the experience is very different .However , as
Sollberger ( 1965 ) points out , a positive outcome is proof that at least
something occurs in the series of values , but does not specify what kind of
changes occur nor in what temporal sequence .
Some of the problems of ANOVA usage can be reduced by grouping data
along the time domain ( i.e. reducing the effects of autocorrelation )
(Sollberger 1965 ) . The use of non-parametric versions of the test has also
been advocated , especially if the data collected was of an ordinal rather
than interval nature (Zimmerman & Parlee 1973 ) . The major problem here
is the paucity of non-parametric tests which can cope with complex designs
and repeated measures . The Friedman test is potentially applicable in this
context ( Winer 1971 ) , and this is the method suggested by Zimmerman &
Parlee (1973 ) . This test involves the assignment of ranks to the data .
Hence , if four phases were defined , they would be ranked in terms of their
mean values from one to four . Therefore , in this case , the use of a non-
parametric test has made no allowance for the potentially different levels of
variability in diferent cycle phases . Another ignored possibility here is the
occurence of premenstrual and periovulatory symptoms . Two or three bad
days at both times could lead to a tied rank situation, and potentially no
overall cycle effect. This approach is also not suitable for the assessment of
an individual , or one particular menstrual cycle , factors which are important
if individual diagnosis is the purpose of the analysis .
In all cases in which the daily ratings are grouped much of the original
data is lost , allowing no measure of differential symptom timing or severity
between cycles , or the possibility of different symptom patterns between
subjects , or non menstrual symptom patterns . Hence , the conclusions
which can be drawn from such a study are limited .
Two attempts have been made to cope with some of these problems ; to
make use of all the data gained in terms of symptom onset and severity , to
allow for the effects of time , to avoid the use of conventional statistics and to
allow individual analysis . Both of these methods are aimed at the clinical
diagnosis of PMS rather than the investigation of symptom patterns etc. from
a theoretical point of view .
The first method is that described by Sampson & Jenner ( 1977 ) . In this
technique , sine waves are fitted to daily rating data , by the method of least
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mean squares . Various parameters of the fitted sine wave can then be
described , e.g. its amplitude and its acrophase1 ,and can be assigned
confidence limits . Hence , the number of datasets for which a significant
curve can be fitted gives an estimate of the number of people experiencing
premenstrual changes . The size of the amplitude of each wave gives an
index of individual symptom severity , and the acrophase allows the timing of
maximal symptoms to be related to menses . This method is useful in the
detection of both premenstrual changes and cycles occuring out of phase
with the menstrual cycle , however it also has several drawbacks . Firstly -
the technique of harmonic analysis calculates many potential curves for the
data and then fits the best one in terms of the variance between the raw data
and the fitted curve , i.e.
" the sine wave (chosen) is the one for which the sum of
squares of the deviations of the sine wave from the crude data is minimal"
Sampson & Jenner (1977)
Although this curve may have a statistically descriptive meaning as
opposed to white noise, this does not imply that it has a biological meaning
(Sollberger 1965 ) - especially if only one ( purported ) cycle was used in its
construction . Secondly - the method does not allow any measure of
symptom onset or duration . Thirdly - no account is taken of other factors
which might influence moods etc. for a sufficient length of time to produce a
significant result ( e.g. illness of a family member etc . ) - however , in
fairness , none of the other techniques take this factor into account either.
The second method used on daily data is that described by Magos &
Studd ( 1986 ) . They point out that a branch of statistics exists specifically to
analyse observations made sequentially in time , that is Time Series
Analysis ( TSA )1 . One method used by some time series analysts is
1 The acrophase is defined as " the time of maximum value of the best fit
curve compared to the onset of menses M. Although it is calculated in
radians , it can be converted to days for each individual.
1 It should be borne in mind that TSA as a branch of statistics was set up to
address the needs primarily of economists and other financial analysts .
Hence the major function of such analysis is the provision of a model
enabling the accurate prediction of future events . The variables which are
taken into account in building such a model , e.g. trend , seasonality etc. are
crucially important in the analysis of the data for which the method was
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"Triggs technique for measuring significant trends ". This is an adaptation of
a method of trend analysis originally described by Brown ( 1963 ) for
monitoring and forecasting long term changes in a mean . In essence , the
technique exponentially smooths the data , using each of the preceding
observations to predict the next.
The difference between the forecast and actual observation is then
assessed to give an index of the degree of change in the forecast
observations (the " forecast error" ) , and the degree of random variation in
the data (the " mean absolute deviation ") . The " tracking signal" ( TS ) is
then defined as the ratio between these two measures . When the forecast
error becomes larger , so does the tracking signal . The significance of this
TS can then be assigned according to confidence limits . Hence ,
significantly different changes in symptom levels over a ' baseline ' can be
seen , allowing for the normal level of fluctuation in the data . This method
would appear to be logical and reasonable . It adds statistical rigorousness
to simple ' eyeballing' of the data. However , it is not a method by which
significant cyclicity can be assessed in long term data , nor which can
distinguish between changes due to physiology and those due to coincident
life events .
In summary , several attempts have been made to analyse statistically
daily symptom data collected from individuals and / or groups . It cannot be
said that the ideal method has yet been found to cope with the many reasons
for which the data is being analysed . The majority of techniques formulate
criteria for distinguishing between a " significant" premenstrual change, i.e.
PMS , and a nonsignificant change , using statistical methods . Two
problems arise from this . Firstly - the lack of certainty that a statistically
significant change necessarily implies a biologically significant change .
Secondly - the lack of an appropriate definition of PMS . Without the correct
definition , the variety of techniques are simply converting linguistic
confusion into statistical jargon , and are not increasing our knowledge or
understanding of the phenomenon . In order to appropriately define PMS in
statistical terms , methods are needed to investigate and describe long term
daily data , delineating any cyclical changes seen and their association with
designed . Although it has been used for biological and psychological data ,
little is yet known about its applicability .
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physiological events . In the meantime , all of the methods outlined above
are likely to provide comparable results which are clinically useful , but may
not be methodologically or physiologically accurate or meaningful.
4A2 STATISTICAL TECHNIQUES USED IN THIS THESIS
The previous section gave some indication that little consensus exists
about the appropriate statistical tools to use in the analysis of daily symptom
ratings . A variety of methods have been used throughout this thesis to
investigate particular hypotheses , and the details of these are described in
the appropriate sections . Several methods are , however , either used
recurrently and routinely , or would be clumsy to describe in the text , and
hence will be discussed here . It should be borne in mind that this is not an
exhaustive list of the methods used in data analysis .
i) Cvcle Standardization
One of the inherent problems of menstrual cycle research , in terms of
statistical analysis , is the normal variability in length of the ovarian cycle .
This is particularly true in those parts of this research in which women were
chosen from age groups or categories particularly for the likely abnormality
of their hormonal cycles - a factor often associated with unusually long or
short cycle lengths . Several of the comparisons undertaken require that
cycle lengths should be identical between groups , producing the same
number of " bits " of information per subject . Hence some method of
extending or reducing cycles to some arbitrary length was required .
Two major approaches have been made to this problem in the literature .
Either a 35 day cycle , for instance , is converted to an arbitrary length
(usually 28 days ) , whilst losing any relationship with ovarian events ( e.g.
McCance , Luff & Widdowson 1937 ) - or the cycle is centred around a
particular point (usually ovulation ) and the two limbs of it are converted to
arbitrary lengths (Doty 1979 ; Abraham , Mira , McNeil , Vizzard , Fraser &
Llewellyn-Jones 1985 ) . In the latter approach , the timing of ovulation and
menstruation are fixed , with the intervening days being divided into seven
points , being the average of the appropriate number of days - such that the
cycle is described by 14 points . This method is admirable in that it
maintains the association with the menstrual cycle , preventing distortions
due to abnormally long
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TABLE 4.2
EXAMPLES OF THE FRACTIONS USED FOR CYCLE
STANDARDIZATION
a ) 23 Davs to 28 Davs
DATA CONVERSION
A 23A/28
B 5A/28 + 18B/28
C 10B/28 + 13C/28
D 15C/28 + 8D/28
E 20D/28 + 3E/28
F 23E/28
G 2E/28 + 21 F/28
H 7F/28 + 16G/28
I 12G/28 + 11H/28
J 17H/28 + 61/28
K 22 I/28 + 1J/28
L 23J/28
M 4J/28 + 19K/28
N 9K/28 + 14L/28
o 14L/28 + 9M/28
P 19M/28 + 4N/28
Q 23N/28
R 1 N/28 + 22 0/28
S 6 0/28 + 17P/28
T 11P/28 + 12Q/28
U 16Q/28 + 7R/28







b ) 33 Davs to 28 Davs
DATA CONVERSION
A A + 5B/28
B 23B/28 + 10C/28
0 18C/28 + 15D/28
D 13D/28 + 20E/28
F 8E/28 + 25F/28
F 3F/28 + G + 2H/28
G 26H/28 + 7 I /28
H 21 I/28 + 12J/28
I 1RJ/2R + 17K/28
J 11K/28 + 22L/28
K 6L/28 + 27M/28
L 1M/28 + N + 4 0 /28
M 24 O /2R + 9P/28
N 19P/28 + 14Q/28
0 14Q/28 + 19R/28
P 9R/28 + 24S/28
Q 4S/28 + T + 1 U/28
R 27U/28 + 6V/28
S 22V/28 + 11W/28
T 17W/28 + 16X/28
U 12X/28 + 21Y/28
V 7Y/28 + 26Z/28
w 2Z/28 + AA + 3BB/28
X 25BB/28 + 8CC/28
Y 20CC/28 + 13DD/28
z 15DD/28 + 18EE/28
AA 10EE/28 + 23FF/28






This table shows examples of the tractions used to convert cycles of various lengths to
an arbitrary but comparable 28 days . The letters in the left hand columns represent the
original data points , whilst the fractions in the right hand columns represent the conversion
factor required to produce 28 data points The two lengths chosen as examples are 23 and
33 days , however fractions were developed for all cycle lengths . The procedure used
involves stretching short cycles and contracting long ones uniformly i.e. altering the
scale of time . If a 23 day cycle is taken as an example , the 23 intervals are replaced by 28
intervals . The new scores are obtained from fractions of two adjacent points in the
original 23 day cycle , as shown above
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or short follicular phases . This quality can also have the effect of
"highlighting " premenstrual changes and playing down follicular phase
symptoms in long follicular phase cycles . However, the method is not usable
in anovulatory cycles or in cycles without hormonal data .
In this thesis , the method described by McCance , Luff & Widdowson
(1937 ) was used . By this method , a cycle is defined as the interval between
the onset of one menstrual flow and the next . The cycles were then
stretched and squeezed by altering the scale of time , such that 23 data
points for instance were converted into 28 data points - with each of the final
data points being 23 / 28 of the original ( see Table 4.2 for an example ) .
The fractions appropriate to this calculation were applied by means of the
Apple Macintosh Plus " Excel" program . As mentioned above , this method
is not ideal due to the loss of information about the menstrual cycle ,
however it proved adequate for the purpose of this analysis .
iil Cvcle Division
Several forms of cycle division are used throughout the analysis to
satisfy particular requirements , for instance , in Chapter Six , four phase and
five phase divisions are used . these are described in the text . In Chapter
Five , however , cycles are divided according to hormonal criteria. This
division is performed essentially according to guidelines laid down by
Sanders ( 1981), with the inclusion of a three day " menstrual" phase , in an
attempt to differentiate the effects of vaginal bleeding and the follicular
phase . The phases are described in Table 4.3 . The design of the study
necessitated the provision of criteria to apply in the case of anovulatory
cycles . These were as follows
a ) In the case of an anovulatory cycle with a midcycle E1G peak - the
mid-luteal and late-luteal phases are assigned by dividing all remaining
days into two equally , or with the mid-luteal phase being longer in the case
of an odd number.
b ) In the case of an anovulatory cycle with no E1G peak - the day of
ovulation was arbitrarily assigned 14 days before the onset of menstruation ,
and the phases calculated as above .
c ) In the case of first post-partum cycles , in which the beginning of the
follicular phase is unclear , the first day of the cycle was assigned 28 days
before the onset of menstrual bleeding .
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TABUE 4,3
THE CRITERIA USED TO DEFINE CYCLE PHASES
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being longer in the









2 days before and















From the end of
the early luteal phase







From the end of the
Mid-luteal phase
to the day before
menstruation
25-28
N.B. A standard cvcle is 28 davs in length with ovulation on dav 14 and the
progesterone peak on dav 24 .
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iii) Statistical Tests
The statistical methods and tests used included simple descriptive
statistics , i.e. mean , standard deviation etc. calculated by hand or by use of
Apple Macintosh Plus programs " Excel " and " Statworks " . Multifactorial
Analyses of Variance , with repeated measures as appropriate were also
performed on the Apple Macintosh Plus , by use of the Clear Lake Research
" CLR ANOVA " program . In such analyses , simple effects were assessed
using methods described by Winer ( 1971 ) , and a posteriori comparisons
were conducted by means of the Tukey (hsd) test.
Chi-square tests , differencing and cross correlational procedures were
conducted by use of " Minitab - Version 81.1 " accessed through Edinburgh
University's Mainframe computer. All significance levels were assigned by
reference to standard tables ( Fisher & Yates 1963 ) .
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CHAPTER FIVE





The postulation of a relationship between premenstrual symptoms and
the ovarian cycle allows several testable hypotheses to be formulated . if
PMS is seen as an " illness " or abnormal state of affairs , then it might be
predicted that some physiological abnormality would be a causative factor.
The assumption has been that this factor is to be found in the endocrinology
of the menstrual cycle. However, the discussion in Chapter Three , suggests
that attempts to identify and isolate this factor have met with only limited
success.
In order to test the hypothesis that premernstrual symptoms are
associated with some unidentified endocrine factor , two major approaches
can be used . These could be described as the " inclusionist " approach
and the "eliminationist" approach . The former is the method most often
used in research to date . The " inclusionist" approach essentially compares
endocrinologically women who experience PMS , or premenstrual
symptoms, with those who do not, in an attempt to identify some factor or
group of factors present in one group , but absent in the other. In this type of
study , the minimum of interference to the normal cycle is necessary - the
subjects are selected on symptomatic criteria rather than endocrine ones .
Any cycles which are suspected to be abnormal are excluded .
The " eliminationist " approach takes a slightly different view . In this
method various aspects of endocrine function are eliminated systematically ,
in order to identify which factors are associated with symptom occurence .
This can be achieved pharmacologically , or by the observation of symptom
patterns at times of naturally occuring endocrine abnormalities .
The first approach is largely observational in nature , and hence the risks
of introducing extraneous factors by the means of factor elimination ( e.g. the
problem of side effects when ovulation is eliminated by oral contraceptive
means) are reduced . However, in this context the approach is fraught with
definitional complexities . In the absence of a standard definition or
diagnosis of PMS , groups of sufferers and controls are difficult to identify ,
leading to a lack of comparability between studies and hence confusion in
the interpretation of the evidence . The second approach allows for
comparison both between groups who experience different endocrine milieu
, and between differing menstrual cycles within the same individual. The use
of endocrinology as the selection criteria , reduces some of the definitional
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problems , and therefore enhances comparability . This approach also
allows definite conclusions to be drawn about any particular factor, assisting
the interpretation of " inclusionistM type studies .
Hence the two approaches to PMS research are complementary .
However , as mentioned above , the " eliminationist " approach has
arguably been under utilised . Hence , this was the method of choice for this
study . The major factor to be eliminated is ovulation . Concomitant with the
elimination of ovulation , however is the removal of luteal function . Therefore
, it can be seen that some confounding of variables is present . This could
be avoided in two ways . Firstly - it would be possible , pharmacologically ,
to suppress ovulation but replace luteal hormones exogeneously . Secondly
- observations could be made of cycles of varying degrees of luteal phase
normality , ranging from absent through deficient to normal . The first
approach is discussed in relation to the oral contraceptive pill in Chapter Six
. The second approach , however, forms the basis for this chapter.
5.2 STUDY DESIGN
5.2.1 SUBJECT RECRUITMENT
The aims of the study involved the recruitment of groups of women likely
to be experiencing hormonally unusual or anovulatory menstrual cycles .
The endocrinological literature suggested three phases during the female
reproductive lifespan when such abnormalities might be common , i.e.
puberty , perimenopause and the post-partum period ( see Chapter 2 ) .
Hence recruitment for the study was directed at these three groups . The use
of an adolescent group proved not to be feasible in this context , hence the
study concentrated on women immediately after childbirth, or lactation, and
during the menopausal transition .
a ) The Post-Partum Group
Since the purpose of the study was to investigate the relationship
between mood changes and ovarian hormones , attempts were made to
recruit women with some evidence of premenstrual symptoms before the
current pregnancy . The assumption being made that such women would be
more likely to experience such symptoms on resumption of cyclicity . Three
sources were identified for such selection . The first of these was the
Premenstrual Syndrome clinic at the Royal Infirmary of Edinburgh . Women
who became pregnant during the course of their clinical assessment were
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approached , with the co-operation of Dr. John Bancroft and research sisters
Jenny Gray and Ann Cook . The second source of post-partum volunteers
was a breast feeding and sexuality study being conducted at the
Reproductive Biology Unit by Dr. Beth Alder. With her co-operation , women
who scored highly on the modified Moos Menstrual Distress
Questionnaire,administered retrospectively in the early stages of pregnancy ,
were approached and asked to participate in the current study . The third
source of women was a national survey in "Woman " magazine in August
1985 , ( see Chapter Six ) . Women responding to the survey , who were
pregnant or lactating at the time , felt that they had PMS before pregnancy ,
and lived within a reasonable radius of Edinburgh were approached and
asked to participate in the study .
b ) The Perimenopausal Group
Recruitment in this age group was undertaken with the co-operation and
assistance of Dr. Maureen Roberts and the staff of the Edinburgh Breast
Screening Clinic ( EBSC ) . Women within the perimenopausal age range
from selected city general practices are referred to the EBSC for screening .
The majority of these women are not experiencing any known pathological
condition . After gaining the appropriate ethical clearance for the study , a
poster was displayed in the clinic waiting room for three months , from April
to June 1985 (Figure 5.1 ) . Respondents left their names and telephone
numbers with the clinic receptionists , from whom they were collected on a
weekly basis . The median reported age of menopause ( i.e. the last
menstrual period ) in most Western studies is 50 years . Hence women were
only asked to respond if they were between the ages of 45 and 54 years ,
still menstruating and not using steroidal methods of contraception .The
poster also requested women who felt that they had recently experienced
premenstrual symptoms .
c ) The Clinic Group
A third small group of women were recruited from the PMS clinic , falling
into neither of the above categories, but from whose case histories it seemed
possible that abnormal menstrual cycles might occur with a greater than
usual frequency . These women were also self diagnosed PMS sufferers .
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DO YOU SUFFER FROM
PREMENSTRUAL TENSION ? ( PMT )
Many women notice changes in their physical and emotional well-being in
the few days before their period . For some women , these changes can be
very disabling . This is usually known as Premenstrual Tension ( PMT ).
The cause of PMT is not yet known , nor is there a cure at present. Dr. John
Bancroft and Mrs. Anne Walker in the Department of Reproductive Biology
are carrying out research to find the cause of PMT and need some help.
YOU MAY BE ABLE TO HELP
If you are 45 - 54 years old , still menstruating , not using the oral
contraceptive pill , have suffered from PMT recently and would volunteer to
help with the study , we would be very grateful . If you can help , please put
your name, address and telephone number on the bottom of this paper and
hand it in at the desk . Mrs. Walker will then contact you to give you further
details .
Thank you very much indeed .
Dr. M. Maureen Roberts .
Figure 5.1 The Recruitment Poster Used in The Breast Screening Clinic
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5.2.2 PROCEDURE
a ) The Post-Partum Group
All of the women were contacted as early as possible during their
pregnancy . At this first contact , during a PMS clinic attendance or by letter,
they were given outline information about the study and asked if they would
be willing to participate after the baby was born . If a positive response
occurred , the women were asked the expected date of delivery and their
preferred method of feeding for the baby . The next contact occurred as
closely as possible to the time of delivery . At this point , all the women were
visited at home , or occasionally in the post natal ward . The requirements of
the study were discussed again , with ample opportunity being given for the
women to change their minds if they no longer desired or felt able to
participate . The course of the study from this point was decided by the
method of infant feeding used . If the mothers were bottle feeding , the
collection of daily early morning urine samples and daily mood diaries
commenced immediately and continued until the third menstruation after
childbirth , unless other factors intervened e.g. use of an oral contraceptive
or removal from the area . If the mothers were breast feeding , regular
contact (usually monthly , but occasionally more often ) was maintained to
determine the time at which night feeds were eliminated and/or breast
feeding was reduced to a frequency of 2 or 3 times a day . At this point ,
ranging from three to nine months after childbirth , daily collections began
and continued until the third menstrual period after childbirth . Monthly visits
continued throughout the study period to maintain interest and co-ordinate
urine and diary collections . Urine samples were usually stored in a domestic
freezer and collected monthly . In cases where this was not possible , they
were stored in the freezing compartment of a domestic refrigerator and
collected weekly . At the final visit , a detailed interview covering medical ,
gynaecological and psychiatric history .demographic data and recent life
events was conducted . The modified Moos MDQ and the Eysenck
Personality Inventory ( EPI) Form B were also administered at this point.
b ) The Perimenopausal Group
All of the respondents to the EBSC poster were contacted by telephone or
letter within ten days of their clinic visit . The response slips were previously
examined by clinic staff , with the removal of any woman for whom a
diagnosis of a malignant condition was suspected . Little information was
given about the study at this first contact, but arrangements were made for a
132
home visit . The option of meeting on " neutral ground " at the Simpson
Memorial Maternity Pavilion was always offered . During the first visit , more
information was given about the study and a Menstrual Health Questionnaire
administered . The women were asked to consider their participation
carefully and were contacted about a week later to give their decision .
Those who did volunteer began daily urine and diary collections as soon as
possible , continuing for three complete menstrual cycles , or for as long as
they were willing to continue . In several cases the start date was delayed to
avoid holidays etc. when urine collections might be difficult . As in the post¬
partum group , visits were maintained on a monthly basis throughout the
study , with the same interview and questionnaire schedule being conducted
at the final visit . No clinical assessment of the psychiatric or menopausal
status of these women was made for this study .
c ) The Clinic Group
In this group the study regime coincided with the standard two-cycle
baseline symptom assessment normally conducted at the PMS clinic , with a
third cycle being considered wherever possible . Throughout this
assessment, diaries were completed daily and urine samples collected
thrice weekly . This latter precluded the use of this data in some of the
analytic techniques described later , but reduced to a minimum any
interference with the subjects' treatment regime . As before , all of the
participants were seen monthly , usually during their clinic attendance .
5.3 RESULTS
5.3.1 RESPONSE RATES . DEMOGRAPHIC AND ENDOCRINOLOGIC
DATA
i) Response rates
a ) The Post-Partum group
A total of seven women attending the PMS clinic became pregnant and /
or delivered between October 1984 and December 1985 . These women
were all approached and agreed to participate in the post-partum study .
Only two of these subsequently produced sufficient data for inclusion . The
reasons for this included lack of time to pursue the study - this reason usually
occuring if the new baby was the second or third in the family , moving away
from the area , illness of the baby , use of a progestagen only oral
contraceptive and inadvertent loss of diary sheets .
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Three women were recruited from Dr. Alder's Breast feeding study , all of
whom completed the appropriate urine and diary assessments , although
one was slightly curtailed due to emigration .
TABLE 5.1
REASONS GIVEN FOR NON PARTICIPATION IN STUDY






Lack of time 1
Baby ill 1
Use of P-O-P 1
Diaries lost 1
Removal from area 1
Number providing usable data 8
2 ) PERIMENOPAUSAL GROUP




For Lack of time 10
Non Bereavment 2
Participation Family problems 2
Unwilling to collect urine 2
Not a PMS sufferer 1
Number providing usable data 17
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Three women were recruited from the " Woman " survey , living within
reasonable distance of Edinburgh . All three of these completed the study .
Hence a total N of 8 was achieved in this group .
b ) The Perimenopausal Group
A total of 38 women responded to the Breast Screening Clinic poster.
One of these proved uncontactable , despite repeated efforts , and three
others declined to participate on the basis of the first telephone contact .
Hence , a total of 34 initial home visits were carried out . As a result of this ,
twenty-three women agreed to continue with the study . The most common
reason for refusal being shortage of time , for instance being employed in a
job which involved frequent travel away from home , making regular urine
collections difficult . Of the 23 who agreed to continue , 17 completed the
study . The others dropped out for unforseen reasons e.g. a sudden
bereavment involving a period of time away from home , or family problems
with subsequent disruption of mood patterns .
c) The Clinic Group
The selection of baseline data from clinic attenders makes the
discussion " response rates " meaningless in this context. Ten women were
considered from the clinic population to have a history suggesting the
possibility of a proportion of abnormal menstrual cycles , for instance , a
recent change in cycle regularity , the description of symptoms in alternate
months , unilateral oophorectomy , or symptoms suggestive of early
menopause . Five of these completed two or more cycles of baseline
untreated data . The rest either commenced treatment before the completion
of two cycles or did not produce complete data and were therefore excluded
jl) Demographic Data
The personal and gynaecological data gathered from these women is
represented in tables 5.2 to 5.4 . The majority are in Social Classes I and II
and are equally divided into part-time , full-time or unpaid occupations . As
might be expected , the post-partum group were more likely to be occupied
athomeorina part-time capacity .
The perimenopausal group were more likely to experience irregular
cycles and heavy periods , although the prevalence of the latter was small
.The majority of the perimenopausal group were sterilized , with the
remainder tending towards barrier methods of contraception . These latter
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TABLE 5.2
DEMOGRAPHIC & GYNAECOLOGICAL DATA FOR ALL
SUBJECTS
Perimenopausa Post-Partum Clinic Overall
N 17 8 5 30
Mean Age ( sd ) 47.6 ( 2.7 ) 30.0 ( 3.2) 32.2 ( 2.0) 41.5 ( 8.5 )
Occupation
Full
time 8 0 2 10
5art
time 7 3 0 10




I & II 11 4 2 17
III 6 4 2 12
IV & V 0 0 0 0




18c II 12 5 1 18
III 3 3 3 9
IV 8c V 0 0 0 0
Unclass 2 0 1 3
Age at
Menarche
Mean 13 yrs 14 yrs 13.4 yrs 13.3 yrs




Reg 11 8 4 23
Irreg 4 0 1 5
V. Irreg 1 0 0 1





Light 0 0 0 0
Mod . 11 7 5 23
Heavy 3 0 0 3
Varied 2 1 0 3
N/A 1 0 0 1
Current
Dysmenorrhea
Yes 6 4 1 11
No 10 4 4 18
N/A 1 0 0 1
EPI
Scores
E 15.7(2.9) 15.2 (3.3) - 15.6(3.0)
N 12.1 (4.9) 11.6 ( 6.3 ) - 11.9 ( 5.4)
L 1.3 (0.9) 1.6 ( 0.8) - 1.4(0.9)
KEY sd - standard deviation ; Unclass - unclassifiable ; Reg - regular; Irreg - irregular
V. Irreg - very irregular; N / A - not applicable ; Mod - moderate ; E - extraversion scale
N - Neuroticism scale ; L - Lie scale
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TABLE 5.3
CONTRACEPTIVE HISTORY OF ALL SUBJECTS




None 1 2 0 3
Rhythm 1 1 1 3
Bam'er 5 4 3
12





0 1(1) 0(0) 1(0) 2(1)
1 2(1) 5(5) 1 (2) 8(8)
2 11 (9) 2(2) 3(1) 16 ( 12)
3 1(4) 1 (3) 0(1) 2(8)





N/A 1 0 1 2
0 6 1 0 7
1 2
4 1 7
2 6 2 3 11
3 0 1 0 1




N/A 1 0 1 2
No 11 6 2 19




Yes 13 6 5 24





N/A 4 2 0 6
CR/DK 9 2 2 13
Worse 0 1 1 2
None 2 1 2 5
Better 2 2 0 4
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TABLE 5.4
MEAN ( STANDARD DEVIATION ) MOOS MDQ SCORES OVERALL AN[
WITHIN THE PERIMENOPAUSAL AND POST-PARTUM GROUPS .
Perimenopausal Post-Partum Overall
Pain 5.4(3.2) 6.6(4.1 ) 5.8 (3.6)
Concentration 2.5 ( 2.9) 2.8 (3.7) 2.6(3.2)
Water Retention 5.7 (3.3) 2.4 (1.4) 4.6 ( 3.2 )
Negative Affect 10.2(5.7) 11.2(5.8) 10.5(5.7)
Arousal 2.8 (3.1 ) 1.2(2.4) 2.3 ( 3.0)
Control 0.2 (0.6) 0(0) 0.13 ( 0.5)
Change in eating
nabits 1.2(1.5) 1.2 ( 1.6) 1.2 ( 1.6)
Repeated Illness 0(0) 0(0) 0(0)
TOTAL 28.0 ( 15.1 ) 25.6 ( 13.9) 27.2 (14.8)
( Score ranges etc. are described in Chapter 4)
methods of contraception were also popular in the younger age groups .
Most of the women were parous , with two children being the most common
number. The majority had breast fed one or more of their children , with this
proportion being higher in the younger age group, probably reflecting
general changes in policy towards infant feeding . Approximately 30 % had
experienced an episode of depression during the post partum phase ,
with this proportion being higher in the clinic group . Almost all of the women
had used an oral contraceptive at one time or another. The effects of the pill
on premenstrual symptoms were mixed with both positive and negative
effects being reported .The majority however were unable to recall the the
effects of the pill on PMS . This was particularly true in the perimenopausal
group where pill taking ended an average of ten years beforehand .
EPI scores suggest a group of slightly extraverted , slightly neurotic
women , although all scores fell within the normal range .
None of the women reported any serious medical , gynaecological or




All of the urine samples collected were assayed using the routine RIA and
ELISA techniques described in Chapter Four , the final results being
expressed as hormone per creatinine ratios . Twenty five of the the thirty
women collected daily urine samples , whilst the other five , all PMS Clinic
attenders , complied with a thrice weekly collection regime in accordance
with the clinical baseline assessment . Each cycle was then considered
seperately and described as normal , anovulatory , short luteal phase ( SLP)
or inadequate luteal phase (ILP) according to the criteria described in
Chapter Four.
The hormonal profiles produced are described in table 5.5 . Three of the
women failed to produce any complete cycles despite keeping records for
upwards of three months .Two of them menstruated only once during the
period of the study , the third was hysterectomized and also proved to be
anovulatory .
The remaining 27 women produced eighty complete cycles . Seven of
these were pill cycles , twenty had deficient or absent luteal phases , and in
one conception occurred . Two women failed to have a normal cycle during
the course of the study , and their data are excluded from the analysis
described in section 5.3.2 , but included in section 5.3.3 .
Cycle lengths varied from 16 to 49 days ( Figure 5.2 ) with the majority
falling within the " normal " 21 - 35 day range . Those cycles occuring
before the first menstruation in the post-partum group have been assigned
an arbitrary 28 day length and are not included in this distribution . A study
time of less than 28 days before the first post-partum menstruation is
described as an incomplete cycle in the context of this study , and is not
included in section 5.3.2 .
5.3.2 ANALYSIS OF DATA BY MENSTRUAL CYCLE PHASE
Two forms of analysis are applied to the data collected to investigate the
relationship between mood changes and the ovarian cycle . In this section ,
individual cycles are classified endocrinologically according to standard
gynaecological criteria , as described in chapter four and section 5.3.1 .The
mood and symptom data are then collected , within each individual cycle ,
















1 2 3 4 5 6
002 PP 198 5 N SLP Pill Pill Pill -
003 PP 130 4 SLP N N N -
012 PP 95 3 N N N - - -
013 PP 135 4 N ILP Pill Pill - -
043 PP 104 2 N N - - - -
046 PP 115 4 ILP Pill Pill ILP - -
047 PP 172 5 Incomp N N slp,lp SLP Con.
050 PP 89 2 Incomp N N - - -
015* PM 81 0 Incomp Incomf - - - -
016 PM 90 3 N N N - - -
018 PM 52 2 N N - - - -
020* PM 130 0 Incomp - - - - -
021 PM 96 3 N A A - - -
022 PM 94 3 N N SLP - - -





024 PM 112 4 ILP SLP SLP N - -
025 PM 90 3 ILP N N
- - -
027 PM 84 3 N N N - - -





035 PM 98 3 N N N - - -
038 PM 109 2 N N - - - -
039 PM 84 3 N N N - - -
042 PM 77 2 N N - - - -
044 PM 97 3 N N N _
- -
045 PM 94 3 N N N _
-
-





026 C 80 3 N N N - - -









053 c 76 3 ILP ILP slp,l+p - - -
KEY PP - Post-Partum ; PM - Perimenopausal; C - Clinic .
N - Normal; SLP - Short luteal phase ; ILP - Inadequate luteal phase ; A - Anovulatory
Con - Conception ; Incomp - Incomplete
*




15678920123434 Cyclelength(days) Figure6.2Distributionofcvclelengthsthroughoutt dy (N.B.Allpill,conception,incompletea dfirsp st-partumyc srexclud d)
cycles . Two forms of cycle division are used in this section . The first breaks
the symptom data into segments representing changes in ovarian hormone
levels. These phases are identical to those used by Sanders (1981) , with
the addition of a three day " menstrual phase " at the beginning of the cycle .
Hence seven cycle phases are defined menstruation ( M ) , early follicular
(EF ) , mid-follicular ( MF ) , late-follicular ( LF ) , early luteal ( EL ), mid-luteal
(ML ) and late luteal ( LL ) . These phases are defined in more detail in
Chapter Four . The day of the urinary oestrone peak is one of the crucial
temporal markers in this cycle division , and was fortunately present in all of
the anovulatory cycles studied . This allowed the differentiation of the
follicular phase from the " luteal" phase in all cases . Since no pregnanediol
peak was present in anovulatory cycles , the mid and late luteal phases were
assigned by dividing the appropriate days into two sections , with the mid-
luteal phase being longer in the case of an uneven number. Some difficulty
arose in the case of those post-partum women for whom data was available
for the time period before the first menses after childbirth . Although an
oestrone peak (and usually ovulation ) occuring before menses allowed the
delineation of the late follicular and luteal phases , the early part of the "
cycle " was more difficult to assess . In these cases it was decided to count
back an arbitrary 28 days from the first day of menstruation , defining the day
reached as day one of the cycle . If a period of less than 28 days was
available before menstruation , the cycle was described as incomplete and
discarded for analytic purposes . This methodology may be a source of error
in the discussion of follicular phase symptomatology , however in the
absence of defined hormonal markers for the follicular phase , it was felt that
a reasonable approximation to reality would be achieved in this way .
The second method of cycle division was incorporated for two reasons .
Firstly, some concern was expressed that abnormal cycles may be more
likely to fall outside the normal range in terms of cycle length than do "
normal " cycles . Hence the use of the cycle division outlined above may
produce distortions , especially in the comparison of a seven day luteal
phase divided into three portions with a fourteen day luteal phase divided
into three portions for instance . Therefore it was felt that a method
incorporating temporally comparable portions within different groups should
be employed . The second reason came from the demands of the Analysis
of Variance package used . To assess changes within a particular individual
, a multifactorial repeated measures design is required . The package used ,
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whilst being able to cope with such designs , is unable to cope with unequal
cell sizes within them . Hence , each cycle must be divided into equal
portions . Variability in cycle length within a particular individual again made
this a problem . An arbitrary 28 day cycle length was assigned , with all
cycles being adjusted to this by the methods outlined in Chapter Four. The
subsequent data were divided into seven four day blocks . This method is by
no means perfect on cycles of such variable length and losing as it does any
relationship to the hormonal cycle . However, it does provide the means for
a comparison , however crude .
Two comparisons were conducted using the " hormonally defined " and
"standardized cycle " phases described above . These can be described as
"Group " comparisons and " Individual " comparisons.The Group
comparisons involved the assignment of individual cycles to categories
according to their particular hormonal pattern ; i.e. normal , anovulatory ,
short luteal phase or inadequate luteal phase . ( The category of short +
inadequate luteal phase was not used in this analysis due to the small
number of cycles falling into it , such cycles were not used in the group
analysis ) . It was felt that a straight comparison between all of the normal
cycles and each of the abnormal categories would be inappropriate in this
case for two reasons . Firstly , because of the small numbers of abnormal
cycles , and secondly , because of the possibly confounding factor of
symptom variability between normal cycles within an individual . Hence an
analysis of variance design was developed utilising groups of paired cycles .
Cycles were formed into normal-normal and /or normal-abnormal pairs
within each subject , leading to the exclusion from the analysis of those
subjects who only experienced abnormal cycles during the course of the
study . A 2x2x7 ANOVA was developed ( Figure 5.3 ) , with repeated
measures on the latter two factors , and no subject being included in both
groups . This analysis was performed for each of the eight symptoms within
the three abnormality categories utilising both types of cycle division , and
was followed up with 2x7 ANOVA's with repeated measures on both factors ,
within each of the two groups to assess simple effects .
The second analysis is described as the " Individual" comparison . This
was conducted as a result of concern that grouping of cycles , especially with








Figure 5.3 Analysis of variance design ( 2x2x7 ) for group comparison .
( see text for details )
differences in the response to the hormonal milieu . Hence Xx7 ANOVA's
with repeated measures on both factors were conducted for each individual ,
with
X being the number of cycles experienced by her during the course of the
study . In this case , only standardized cycle phases were used , and only
those women having combinations of normal and abnormal cycles were
assessed . Only two subjects showed cycles with different abnormalities
during the study ( see Table 5.5 ) , hence the results will be presented
according to the three major abnormalities under consideration , with the
different analyses as subgroups .
i ) Ovulatory vs Anovulatory Cycles
a) Group Comparison
Three women showed normal - anovulatory cycle pairs with 19 providing
the normal - normal cycle comparison . The mean scores within each group
across the hormonally defined and standardized cycle phases for each
symptom form figures 5.4 to 5.6 inclusive , with the ANOVA results being
displayed in table 5.6 . Standardized cycle results are presented in the
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Figure 5.4 Comparison of mood , irritability and energy scores across
7 hormonally defined cycle phases in normal / normal cycle
pairs and normal / anovulatory cycle pairs .
Key M = menses ; EF = early follicular, MF = mid-follicular, LF = late follicular, EL = early luteal
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Figure 5.5 Comparison of breast tenderness , body swelling and period pain
scores across 7 hormonally defined cycle phases in normal / normal
cycle pairs and normal / anovulatory cycle pairs
Kev M = menses ; EF = early follicular; MF = mid follicular; LF = late follicular
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Figure 5.6 Comparison of tension & anxiety and sexual interest scores
across 7 hormonally defined cycle phases in normal / normal
cycle pairs and normal / anovulatory cycle pairs .
Kev M = menses ; EF = early follicular; MF = mid follicular; LF = late follicular ;
EL = early luteal; ML = mid luteal; LL = late luteal.
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TABLE 5.6
THREE-WAY AND TWO-WAY ANOVA RESULTS ( F-VALUES ) FOR
NORMAL AND ANOVULATORY CYCLES DIVIDED BY MENSTRUAL
CYCLE PHASE
i) Three-wav ANOVA
G C GxC P GxP CxP GxCxP
Mood 2.83 0.04 0.26 1.25 1.85T 0.78 1.21
Irritable 2.27 0.64 0.92 1.24 0.79 1.63 2.12*





tenderness 3.23T 0.32 0.11 1.75 2.25* 3.10 1.85T





Period pain Insufficient Data
Sexual
interest 0.26 0.32 0.13 2.32 0.81 0.44 1.15
DF 1 1 1 6 6 6 6
ii) Two-wav ANOVA between normal cycles
C P CxP P@C1 P@C2


































DF 1 6 6 6,108(78)
iii) Two-wav ANOVA between normal and anovulatory cycles
C P CxP P@C1 P@C2
Mood 0.43 1.10 0.60 0.25 1.25
Irritable 0.94 0.35 2.16 0.89 0.63
Energy 0.18 0.73 0.66 0.55 0.86
Tense
& anxious Insufficient data
Breast
tenderness 0.11 0.89 0.54 1.00 0.16
Body swelling 0.38 2.70T 0.28 2.84* 0.81
Period pain Insufficient data
Sexual
interest 241.13 0.58 1.06 0.54 0.80
DF 1 6 6 6,12 ( 12)
Kev DF - degrees of freedom ; G - Group ; C - Cycle ; P - Phase T - trend ( p < 0.10 )
*
- p < 0.05 ; ** - p < 0.01 ( Figures in brackets indicate DFe for sexual interest)
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to the absence of sufficient data on measures of tension & anxiety and
period type pain.
The graphs show a reasonably clear , if mild , premenstrual pattern in
both control cycles on measures of irritability , breast tenderness and body
swelling , with only slight differences in severity between the two cycles .
Mood shows little change across the cycle , although a slight trend towards
lower mood in the luteal phase is apparent. In the case of energy , tension &
anxiety and sexual interest , some discrepancy exists between normal cycles
in terms of symptom patterns . In both cycles , energy scores show a marked
dip in the late follicular phase , coincident with ovulation . In the first cycle ,
these levels recover to produce a biphasic energy cycle , falling only in the
late luteal phase .In the second cycle , the levels recover only slightly during
the early luteal phase and show a more gradual decline to identical late
luteal levels. Tension & anxiety scores similarly differ between the two
normal cycles - in one cycle gradually increasing levels of tension are seen ,
whilst in the other the behaviour appears more erratic with peak scores in
the EF and EL phases . Sexual interest also shows a slight difference in
symptom timing between normal cycles - in one cycle , interest rises from a
trough during menses to a peak in the LF phase, then fails sharply ,
remaining reasonably static throughout the luteal phase . In the other cycle ,
interest peaks slightly earlier in the MF phase , declining gradually to the ML
phase and showing a marked resurgence in the LL phase . Hence it would
appear that some difference in symptom pattern and severity at various
points in the cycle can occur between normal cycles .
The normal - anovulatory cycle pairs show a greater degree cf diversity in
symptom patterns . Only two can be said to be similar between the two
cycles, these are period pain , with an N of 1 and present only during
menstruation , and body swelling . Although the symptom pattern here is
consistent across the cycles , it is different from the controls in several
respects . Firstly , the levels of body swelling are higher throughout the cycle
. Secondly , a peak of symptoms occurs in the MF phase in both cases ,
declining to a minimum in the EL phase before a premenstrual rise . This
peak of symptoms in the MF phase also occurs in the normal cycles on
measures of irritability and energy and in the anovulatory cycles in the case
of mood , and to a lesser extent, irritability .
Most of the symptoms measured , with the exceptions of mood and energy
are fairly consistent between the two cycles during the follicular phase . The
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symptom of breast tenderness shows the most dramatic difference in the
luteal phase . In the normal cycles , levels are lowest in the LF phase rising
gradually to a ML phase peak . Lowest levels in the anovulatory cycle occur
earlier , in the MF phase , suddenly rising to a LF peak , with only slight
decline during the luteal phase . Sexual interest shows a more clearly
cyclical pattern in the anovulatory compared to the normal cycles , rising to a
LF peak and gradual decline . Generally lower levels of sexual interest are
displayed throughout the luteal phase in normal cycles .
The results of 2x2x7 ANOVA's suggest a trend towards a group difference
only in the case of breast tenderness , supported by a GxCxP interaction on
this parameter. A significant GxCxP interaction also occured on the measure
of irritability . Examination of 2x7 ANOVA's show no cycle differences in the
normal-normal cycle pairs . However , when phase effects are assessed
within each cycle , differences were seen , with irritability , energy and sexual
interest having significant phase effects in one cycle but not the other. Few
phase effects were observed in the normal - anovulatory pairs , possibly due
to the small size of the sample and the large degree of individual variation .
Sexual interest did however reveal a cycle difference , suggesting that
overall levels of sexual interest are higher in anovulatory cycles . In the case
of body swelling , a marginally significant phase effect was observed in the
normal cycle which was absent in the anovulatory cycle . This probably
reflects a difference in absolute symptom levels between the cycles , since
no difference in symptom profile is observed graphically .
The results obtained after standardized cycle division were essentially
similar in the control group , with the exception of tension & anxiety . In this
case a midcycle improvement in tension was replaced by a deterioration . In
the ovulatory - anovulatory group the patterns were also similar to those
found in the hormonal analysis . The major discrepancy in this case being on
the measure of mood , in which both normal and anovulatory cycles
displayed low mood during the follicular phase .
Analysis of variance results were also comparable , although the
significant GxCxP interaction on the measure of irritability was lost , as were




The data for the three women falling into this category are represented
graphically in figures 5.7 , 5.8 and 5.9 , with the ANOVA results in table 5.7 .
Subject 051
In the case of mood and energy in this subject , a cyclical pattern
seemed to emerge, supported by significant ANOVA phase effects .However
,in neither cycle could these measures be said to fit a classical premenstrual
pattern . Rather , lowest levels of mood and energy are found at the
beginning of the cycle . A significant cycle difference also occurs in the case
of energy , indicating a lower mean energy level in the anovulatory cycle
.Cycle x phase interactions are non-significant . Body swelling similarly does
not show the classic premenstrual pattern in either cycle , with highest levels
occuring coincidentally with low mood and energy . Overall levels of swelling
are lower in the anovulatory cycle , sufficient to produce a significant C x P
interaction .
In contrast to this , measures of irritability , breast tenderness and sexual
interest show a more conventional pattern in one or both cycles . Sexual
interest is highest in phase 3 of both cycles , although the levels are still low
and insufficient to produce a phase effect. " Luteal" levels of sexual interest
are slightly higher in the anovulatory cycle . Measures of irritability and
breast tenderness show a similar pattern . In the normal cycle they gradually
decline from a menstrual peak to a premenstrual trough . In the anovulatory
cycle , breast tenderness gradually increases to a peak in phase 5 then falls
. Irritability is also high during the first half of the normal cycle , levelling off at
midcycle and falling off sharply towards the end . The anovulatory cycle also
shows relatively high levels of irritability in the follicular phase , falling to a
trough in phase 5 and rising again premenstrually . These pattern
differences are supported by significant C x P interactions in the latter two
cases and significant cycle effects , since the overall levels are higher in the
normal cycle.
In summary three symptoms , mood , energy and sexual interest show
little difference between the two types of cycle . However, although all three
would appear to be cyclical , only the latter shows a typical premenstrual
pattern , and this may be a postmenstrual increase rather than a
premenstrual decline . Body swelling shows a difference between cycles in
















Figure 5.7 Changes in symptom levels with time across 7 standardized cycle
phases in one woman ( 051 )
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TABLE 5.7
INDIVIDUAL ANOVA RESULTS FOR SUBJECTS 021.
051 AND 052
SUBJECT 021














































7.94 3.97 1.56 2.09 2.45 T 0.85









DF 2 6 12 6,18
SUBJECT 051






































interest 2.13 2.19T 0.23 0.83 1.46
DF 1 6 6 6,18
SUBJECT 052
C P CxP P@C1 P@C2





































DF 1 6 6 6,18
Kev ns - not significant; * P < 0.05 ; ** P < 0.01 .













phase . Irritability and breast tenderness differ in both timing and severity
between the cycles , both showing a more typical premenstrual pattern in
the anovulatory cycle , although at lower levels of severity than were seen in
the normal cycle .
Subject 052
In this subject , a slightly more typical pattern is seen , although the
picture is
far from clear . In the case of mood , a cyclical pattern is seen in the
anovulatory cycle , with high levels at midcycle and low levels at the
beginning and end of the cycle . However, in the normal cycle this is lost ,
with mood showing a gradual decline from phasel to phase 7 . A similar
energy pattern is observed in the anovulatory cycle , however energy is
clearly cyclical in the normal cycle too , being at its peak in phase 3 and
trough in phase 6. The 'shape ' of the symptom is quite different between
the two cycles , leading to a significant interaction .
Irritability appears to show a biphasic pattern which does not differ greatly
between the two cycles . This symptom is increased at midcycle ( phase 3 )
falling to a nadir in phase 5 or 6 and rising again premenstrually . Body
swelling also shows a cyclical pattern which is similar in both cycles . This
symptom increases gradually from its lowest point in phase 5 to a peak
during menstruation , then falling again . Hence body swelling appears to
be centred around menstruation.This is also the case with breast
tenderness . In the normal cycle levels are relatively high during
menstruation and the early part of the cycle , falling to a trough in phase 5
and rising premenstrually .In the anovulatory cycle , although breast
tenderness is present early in the cycle , " luteal " levels are absent .
Sexual interest levels are also improved , i.e. higher , during the
anovulatory cycle , although they still show a premenstrual decline similar to
that in the normal cycle .
In summary , it would appear that all the symptoms measured occurred in
both cycles in this subject , except for breast tenderness , which was absent
from the second half of the anovulatory cycle .
Subject 021
In this subject , two anovulatory and one normal cycle were observed .
Hence , a difference in symptomatology might be manifest by the
























Figure 5.8 Changes in symptom levels over time across 7 standardized cvcle
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Figure 5.9 Changes in symptom levels with time across 7 standardized cycle
phases in one woman ( 021 )
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to be the case . The symptom of mood , for instance , would appear to show
a more pronounced menstrually related decline in cycle two than in either
cycle one or three .
The physical symptoms of breast tenderness and body swelling appear to
occur premenstrually during the first anovulatory cycle rather than
menstrually following the ovulatory cycle , suggesting a possible alteration in
symptom timing . However , this observation is not substantiated in the
second anovulatory cycle . Period pain also seems to be less pronounced
following an anovulatory cycle , but this difference was insufficient to cause a
cycle effect.
Examination of the ANOVA results reveals cycle and cycle x phase effects
on measures of energy , breast tenderness and sexual interest. Once more ,
no evidence appears to suggest that the first cycle is in any way different
from the other two in terms of phase effects or average symptom levels . In
terms of the latter, cycle two is significantly different from both of the others
on measures of mood , energy , tension , breast tenderness , body swelling
and sexual interest. The phase effects also suggest that in those cases for
which the three cycles do not produce similar effects , cycle two is the odd
one rather than cycle one .
In summary although mild cyclical changes would appear to be present
on most of the symptoms measured for this subject whose timing and
severity vary between cycles , this variability does not seem to be
systematically related to the presence or absence of ovulation .
c ) Summary
No consistent trend appeared in the Group comparison to suggest that
anovulatory cycles are necessarily symptomatically different from normal
cycles in this group of women . Two provisoes should be borne in mind -
firstly , there would appear to be a certain degree of variability between
normal cycles , especially on measures of energy , tension and sexual
interest , suggesting a potential role for factors other than ovarian hormones .
Secondly - the normal cycles in the normal - anovulatory group bore little
resemblance to the controls . This may be a reflection of the discrepant
sample sizes or may suggest that cyclical patterns are somehow different in
women who are regularly experiencing anovulatory cycles from those who
experience a consistently ovulatory pattern .
The examination of individuals within the normal - anovulatory group
emphasizes the difference between the patterns shown by these subjects
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and the typical premenstrual pattern . Premenstrual symptoms did occur in
the anovulatory cycles , but these were not always concordant with those
experienced by the same woman in a normal cycle . Breast tenderness is the
only symptom to show a consistent reduction , in two out of the three women
. The observation of symptomatic variability between two anovulatory cycles
in the same subject suggests that interpretation of this type of data should be
treated with caution .
ii ) Normal vs Short Luteal Phase Cycles
a) Group Comparison
Sixteen normal - normal cycle pairs formed the control for this comparison
with five normal - short luteal phase subjects . The mean scores within each
group form figures 5. 10 to 5.13 inclusive , with ANOVA results in table 5.8 .
As before , results from the standardized cycle phase analysis are presented
in the Appendix.
The control group exhibited essentially the same patterns as described
above ( Section 5.3.2 i ( a ) ) , with between cycle differences in symptom
profiles evidenced for measures of energy and to a lesser extent sexual
interest . Larger cycle differences were seen between the normal and SLP
cycles . It should be emphasized here that the normal profile obtained from
those women experiencing SLP cycles rarely coincided with that observed
in the control group. Only measures of breast tenderness and period pain
showed any degree of similarity .
Mood scores showed a marked luteal phase decline in both normal and
SLP cycles . However , the fall commenced at an earlier stage in the SLP
cycles - towards the end of the follicular phase . In the normal cycles , mood
levels remained buoyant until the mid-luteal phase . A slightly biphasic
pattern was observed in normal cycles with respect to irritability , with high
levels occurring in both mid-to-late luteal and follicular phases . Hence the
suggestion of a short period of symptoms at mid-cycle appears . However ,
in the SLP cycles , irritability levels remain constant throughout , with no
evidence of cyclicity . Energy levels similarly show a slightly less marked
premenstrual pattern in the SLP cycle , with levels falling in the late follicular
phase to a trough in the early luteal phase but rising again before
menstruation .This is in contrast to the normal cycles where levels start to fall
in the MF phase and continue to fall until menstruation .
A flatter symptom profile in SLP cycles is also observed with respect to
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■d— Short Luteal Phase Cycle
Figure 5.10 Comparison of mood , irritability and energy scores across 7
hormonally defined cycle phases in normal / normal cycle pairs
and normal / short luteal phase cycle pairs .
Kev M = menses ; EF = early follicular; MF = mid follicular; LF = late follicular;
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Figure 5.11 Comparison of breast tenderness , body swelling and period
pain scores across 7 hormonally defined cycle phases in
normal / normal cycle pairs and normal / short luteal phase cycle
pairs .
Kev M = menses ; EF = early follicular; MF = mid follicular; LF = late follicular;
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Short Luteal Phase Cycle
Figure 5.12 Comparison of tension & anxiety and sexual interest scores across
7 hormonally defined cycle phases in normal / normal cycle
pairs and normal / short luteal phase cycle pairs .
Kev M = menses ; EF = early follicular; MF = mid follicular; LF = late follicular;
EL = early luteal; ML = mid luteal; LL = late luteal.
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TABLE 5.8
THREE-WAY AND TWO-WAY ANOVA RESULTS FROM NORMAL
AND SLP CYCLES DIVIDED BY MENSTRUAL CYCLE PHASE
i ) Three-wav ANOVA
G C GxC P GxP Cx P GxCxP
Mood 0 0.39 0.01 2.34* 0.72 1.67 1.79
Irritable 2.21 2.59 2.37 1.13 0.79 0.43 0.55
Energy 0.04 4.04 * 1.67 0.92 0.65 0.43 0.88
Tense
& anxious 0.27 1.49 0.002 0.25 0.91 0.65 0.95
Breast
tenderness 0.02 0.32 0.52
**
5.96 0.44 1.17 1.06
Body swelling 0.20 2.29 3.07T
★ *
2.89 0.47 1.75 2.24*






xinterest 2.59 1.68 0.07 2.48 1.42 1.87 T 0.94
DF 1 1 1 6 6 6 6
ifl Two-wav ANOVA between normal cycles
C P CxP P@C1 P@C2
Mood 0.25 0.99 0.55 0.99 0.39
Irritable 0.005
* *
3.06 0.32 2.00T 2.05T
Energy 0.61 0.28* 1.55 1.62 2.48*
Tense






















interest 1.53 2.65* 1.37
■k
2.39 1.44
DF 1 6 6 6,90(60)
iiil Two-wav ANQVA between normal and SLP cycles
C P CxP P@C1 P@C2
Mood 0.23 0.91 1.46 1.07 1.04
Irritable 8.83* 0.42 0.58 0.65 0.03
Energy 4.51 0.95 0.51 0.73 0.49
Tense
& anxious 1.06 0.72 1.46 0.75 1.46
Breast
tenderness 2.72 1.57 2.39T 1.04 2.15T
Body swelling 0.88 1.21 1.49 1.26 2.22T




interest 0.41 1.41 1.65 0.93 2.82 T
DF 1 6 6 6,18(12 )
Kev T-trend(p<0.10) ; * - p< 0.05 ** - p < 0.01
G - Group ; C - Cycle ; P - Phase ; DF -Degrees of freedom .
( Numbers in brackets indicate DFe for sexual interest)
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menstruation ) than the normal cycle , and do show a slight upward trend in
the luteal phase . Symptoms in the normal cycles show a rather more
idiosyncratic pattern too - falling from a menstrual peak to a mid-luteal
phase trough , but rising again in the late luteal phase . Tension and anxiety
scores are essentially similar in both cycles , except in the early and late
luteal phases in which the SLP data shows more and less tension than the
normal data respectively . Similarly in the case of sexual interest , a slightly
different profile is seen , with the midcycle peak and mid-luteal trough of
sexuality being absent from SLP cycles .
The 2x2x7 ANOVA results reveal no significant group differences and only
one GxCxP interaction - for body swelling . Two-way results indicate an
overall cycle difference between normal and SLP in the case of irritability .
Differences in phase effects between cycles occurred on measures of
energy and sexual interest in the control group and on breast tenderness ,
body swelling , period pain and sexual interest in the comparison group .
As in the normal - anovulatory group , the imposition of a 28 day cycle on
this data had little effect on its character.
b) Individual Comparison
Five subjects fall into the category of normal and short luteal phase cycle
pairs. One of these also experienced an inadequate luteal phase , and
hence will be discussed in both sections . The data are represented
graphically in figures 5.13 to 5.17 inclusive , and the ANOVA results
tabulated in table 5.9 .
Subject 002
In this subject , mood was the only symptom assessed . A clear
premenstrual pattern was seen , with lowest levels occuring immediately
before menstruation in both cycles . They did however begin to fall earlier in
the SLP cycle and reached a lower level . Analysis of Variance reveals
strong phase effects in both cycles , with a cycle x phase interaction . This
latter would appear to be related to the slightly different symptom timing ,
since no difference is seen in the overall mean mood scores between the
two cycles .
Subject 003
In this case , a short luteal phase was experienced before the first post¬
partum menstruation , followed by three normal cycles . Hence , the first
cycle might be expected to be symptomatically different from the others .
However , the potentially confounding psychological and physiological
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Figure 5.13 Changes in mood levels with time across 7 standardized
cycle phases in one woman ( 002 )
effects of being the first post-partum cycle should be borne in mind . In this
case , physiological effects associated with the cessation of breast feeding
may be involved . This is particularly true for the symptom of body swelling ,
high levels of which were experienced throughout lactation . After the first
menstruation , however , the symptom diminishes and shows signs of
becoming menstrually related in later cycles . Whether the high luteal levels
in cycle one are a function of the short luteal phase diagnosis or of some
other post lactational physiological change cannot be distinguished .
Some evidence for a difference between cycle one and the other three on
the basis of phase effects is apparent on measures of breast tenderness and
sexual interest. In the former case , breast tenderness is present in the early
stages of cycle one , not the luteal phase , resulting in a significant phase
effect . However, its presence is possibly more likely to be due to lactational
cessation . Arguably , too , the phase effects seen in sexual interest in cycles
two , three and four may have more to do with menstrual abstinence than
hormonal events .
Hence , although cyclical changes are seen in some symptoms , with
differences being apparent , potentially due to the presence of a short luteal
phase cycle , other explanations related to the temporal association with
lactation etc. are potentially more plausible .
Subject 022
In this subject a SLP cycle is preceded by two normal cycles , again
suggesting a possible " odd one out " scenario . This would appear to be
163
TABLE 5.9
INDIVIDUAL ANOVA RESULTS FOR SUBJECTS 002 . 003 . 022 . 024 & 047 .
SUBJECT 002










DF 1 6 6 6,18
SUBJECT 003























19.40 2.06 0.85 3.40
Body swellinc 827^9 34.0*4
**
55.73 3.19 123*4 9.50*
**
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3.77 0.86 0.78 2.29t 5.10
★ *
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SUBJECT 022
C P CxP P@C1 P@C2 P@C3
Mood
* *





13.35 3.16 1.67 3.08 2.36T 0.84










tenderness 6.92 * 2.95 *
★ ★
2.95 2.95 3.40 3.40
Body swelling 103.0 3.58
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interest 4.39T 1.56 3.32 2.33T
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3.16 3.14
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DF 3 6 18 6,18
Key C - Cycle ; P - Phase ; ns - not significant; T - trend (p < 0.10 )
- p < 0.05 ; - p < 0.01 DF - degrees of freedom .
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Cycle phase
Figure 5.14 Changes in symptom levels with time over 7 standardized
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Figure 5.15 Changes in symptom levels with time across 7 standardized
cycle phases in one woman ( 022 )
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the case with irritability , a much flatter picture being seen in the SLP cycle .
Closer examination reveals however , that the peaks evident in cycles one
and two are not coincident , with only the latter occurring premenstrually .
The measures of mood and energy also reveal similarities between the first
two cycles with cycle three being different on the basis of phase effects .
However, the same observation applies , that while the SLP cycle may have
a flatter profile than either of the others , the timing of symptom peaks in the
first two cycles is asynchronous . Differences in overall mean symptom levels
between cycles also do not appear to systematically suggest that the
presence of a short luteal phase necessarily makes any difference to
symptomatic experience .
One point of interest in this subject is the observation of cyclical changes
in sexual interest . These cycles are quite clear, having a " wavelength " of
approximately 4 - 5 phases ( N.B. the x- axis in this case refers to
standardized cycle phases , rather than " real time "). Hence the cycles are
shorter than the menstrual cycle and do not appear to be temporally linked to
it . Although the presence of such a pattern in only one symptom for one
woman reduces its theoretical significance , the possibility is raised that
feelings and moods may fluctuate independently of both the menstrual cycle
and each other.
Subject 024
A variety of endocrinological diagnoses are apparent for this subject . In
this context , however , cycle one - the inadequate luteal phase cycle , will
not be discussed . This leaves two short luteal phase cycles , which might be
expected to be symptomatically similar , followed by a normal cycle .
However , in this case a uterine polyp was removed under general
anaesthesia during cycle two , causing some disruption of her normal
lifestyle and leading to a great deal of tension and worry about the operation.
Therefore cycle two cannot be considered to be typical and was not included
in the group comparison . Hence a difference due entirely to the presence of
a short luteal phase might be expected to be manifest between cycles three
and four.
Very few differences in luteal symptom timing or severity are apparent
between these two cycles . Mean overall levels of mood , energy and
irritability are lower in the normal cycle . Phase effects are also present in
cycle four but not in cycle three on these measures . This observation
probably has more to do with the absence of a menstrually related drop in
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Cycle phase
Figure 5.16 Changes in symptom levels with time across 7 standardized
cycle phases in one woman ( 024 )
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Figure 5.17 Changes in symptom levels with time across 7 standardized cycle
phases in one woman ( 047 )
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mood and energy and rise in irritability during phase 1 of cycle three than
any difference in luteal symptoms . Tension & anxiety shows a similar
pattern although no difference occurs in mean levels . The physical
symptoms of breast tenderness and body swelling are virtually
indistinguishable .
Hence , there is a suggestion that this person may be happier and more
energetic , but also more irritable and more tense in a short luteal phase
cycle , although the symptoms experienced tend to be menstrually related
rather than premenstrual .
Subject 047
Once more a variety of diagnoses are present in this subject , with two
normal cycles being followed by a combined short and inadequate luteal
phase cycle and a short luteal phase cycle.
The first striking observation is the difference in symptomatology ,
particularly with respect to mood , between the two normal cycles . The
second is the marked difference in physical symptoms of breast tenderness
and body swelling in cycle three , compared with the other cycles . The
presence of these symptoms may perhaps be more closely related to the
inadequacy of the luteal phase , since they are less severe in cycle four .
Tension and anxiety levels are also higher in cycle three , although this
would appear to be a chronic rather than a cyclical phenomenon .
ANOVA produces significant cycle , phase and cycle x phase effects for all
parameters measured , except for sexual interest , in which the level of
significance is narrowly missed . An examination of phase effects within
each cycle emphasizes the lack of symptomatic concordance between
consecutive normal cycles . Cycle three is distinguished by strongly
significant phase effects on all measures . However, the patterns producing
these effects are only "premenstrual " in the case of breast tenderness ,
body swelling and sexual interest.
In summary , the degree of variability between the two normal cycles in
this subject makes data interpretation difficult . There seems to be little to
suggest , however , that symptoms in the SLP cycle are any different from
normal . The combination of SLP and ILP was however distinguished by the
presence of premenstrual breast tenderness and body swelling , absent
from other cycles .
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c) Summary
The group comparison suggested that symptom profiles may be flatter
in SLP cycles , although this is not necessarily associated with lower levels
of symptom severity . In the case of body swelling , a suggestion appears of
chronic symptoms throughout the SLP cycle . However , in the cases of
energy and irritability , a rather more constant and preferential symptom
level was observed (i.e. higher energy levels and lower irritability levels ) .
The examination of individual data reveals no consistencies between
subjects or symptoms . The presence of chronic body swelling ( above ) can
be explained by the post-partum status of one particular subject, rather than
by an effect of the SLP. There did not appear to be any suggestion that
symptom duration was necessarily shorter or intensity less than in normal
cycles in any subject.
iii 1 Normal vs Inadequate Luteal Phase Cycles
a ) Group Comparison
In this case seventeen normal - normal pairs formed the control group ,
with four normal - inadequate luteal phase ( ILP ) pairs forming the
comparison group. The mean scores for each symptom are described in
figures 5.18 to 5.20 inclusive , with ANOVA results in tables 5.10 . Results of
the standardized cycle phase analysis are presented in the Appendix . Any
differences and similarities in the control group are essentially as described
in section 5.3.2 i ( a ) .
The physical symptoms of breast tenderness and body swelling are
reduced in the luteal phase of ILP cycles compared to controls . This does
not however apply to period pain , which showed higher menstrual and late
luteal levels in ILP cycles . Lower levels of sexual interest also occurred
throughout the ILP cycles , although a very slight late follicular peak was still
present . A slightly increasing level of interest was shown throughout the
luteal phase in these cycles compared to the falling levels seen in the
normal cycles . Levels of tension followed almost exactly the same pattern in
both normal and ILP cycles , being slightly higher in the ILP cycles at all
points except the early luteal phase .
In the case of mood and energy , no premenstrual decrease was
observed in ILP cycles , this was also true for irritability , when no increase in
irritability was seen premenstrually . In ILP cycles , low mood and energy
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Inadequate Luteal Phase Cycle
Figure 5.18 Comparison of mood , irritability and energy levels across 7
hormonally defined cycle phases in normal / normal cycle
pairs and normal / inadequate luteal phase cycle pairs .
Key M = menses ; EF = early follicular; MF = mid follicular; LF = late follicular;














Inadequate Luteal Phase Cycle
Figure 5.19 Comparison of breast tenderness , body swelling and period
pain scores across 7 hormonally defined cycle phases in
normal /normal cycle pairs and normal / inadequate luteal phase
cycle pairs .
Key M = menses ; EF = early follicular; MF = mid follicular; LF = late follicular;
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Figure 5.20 Comparison of tension & anxiety and sexual interest scores acre
7 hormonally defined cycle phases in normal / normal cycle pair
and normal / inadequate luteal phase cycle pairs .
Key M = menses ; EF = early follicular; MF = mid follicular; LF = late follicular;





THREE-WAY AND TWO-WAY ANOVA RESULTS^ F-VALUES^ FOR
NORMAL AND ILP CYCLES DIVIDED BY MENSTRUAL CYCLE
PHASE
i) Three-wav ANOVA .
G C GxC P Gx P CxP GxCxP
Mood 1.49 0.27 0.99 0.23 0.84 0.57 0.99
Irritable 0.23 0.09 0.06 1.43 0.93 1.15 1.35
Energy 0.13 0.46 1.79 1.39 0.54 0.76 2.56
Tense
& anxious 1.15 0.08









Body swelling 0.03 1.43 2.11
* *
5.84 0.69 1.05 0.77
Period pain 0.28 0.003 1.21
* *
6.67 0.41 0.79 2.37
Sexual
,interest 1.32 0.89 2.05 1.06 0.66 0.47 0.26
DF 1 1 1 6 6 6 6
ii ) Two-wav ANOVA between normal cycles .
C P CxP P@C1 P@C2









































DF 1 6 6 6,96(72)
iii ) Two-wav ANOVA between normal and ILP cycles
C P CxP P@C1 P@C2
Mood 1.05 0.66 0.66 0.86 0.54
Irritable 0.004 0.50 0.76 0.91 0.29
Energy 1.77 0.69 1.09 1.40 0.67
Tense
& anxious 1.19 0.85 0.57 0.84 0.79
Breast
,
tenderness 6.37T 1.76 0.92 1.31 1.66
Body swelling 4.56
**
5.93 0.89 2.74* 5.07
Period pain 2.45 2.82* 0.86 1.02 1.85
Sexual
interest 2.43 0.59 0.35 0.45 0.39
DF 1 6 6 6,18(6)
DF-degrees of freedom; T-trend(p<0.10); -p<0.05;
**
- p < 0.01 ; G - Group ; C - Cycle ; P - Phase .
1 7fi
midcycle , rather than premenstrually . It is perhaps significant that maximal
symptom occurence in the equivalent normal cycles was in the mid-luteal
phase rather than the late luteal phase .
Three way ANOVA's give no evidence of group differences but do suggest
GxCxP interactions on measures of energy , breast tenderness and period
type pain . Two way ANOVA's suggest a cycle difference in the case of
breast tenderness but otherwise no significant differences between normal
and ILP cycles .
Standardization of cycles to a 28 day length , had little effect upon the
differences between normal and ILP cycles . A tendency emerged for the
normal cycles to show more variability in mood and the ILP cycles to have
lower mood scores premenstrually .
b ) Individual Comparison
Four subjects fall into the category of normal and inadequate luteal phase
cycle pairs . One of these also experienced a short luteal phase , discussed
above . The mean scores for these subjects are represented in figures 5.16 ,
5.21, 5.22 and 5.23 with ANOVA results in tables 5.9 and 5.11 .
Subject 013
Two cycles of data are available for this subject , the first being normal
whilst the second has an inadequate luteal phase . Premenstrual changes
are more evident in the normal than the ILP cycle on measures of mood ,
irritability , energy and sexual interest . The physical symptoms of breast
tenderness and body swelling would appear to be more closely related to
menstruation , rather than the premenstruum , however these symptoms are
present throughout the early and mid luteal phases in the normal cycle ,
being absent in the ILP cycle .
In terms of phase effects , cycle two is clearly different from cycle one on
all symptoms measured except energy . However, these effects do not seem
to relate to the luteal phase , but rather to symptoms in the follicular phase ,
or at midcycle . Generally , the presence of an inadequate luteal phase
appears to reverse the premenstrual symptoms , with an improvement in
mood etc. during the latter half of the cycle . It should be mentioned ,
however , that cycle one in this subject represents the first cycle after
childbirth , the relatively high levels of breast tenderness and body swelling
177
Cycle phase
Figure 5.21 Changes in symptom levels with time across 7 standardized
cycle phases in one woman ( 013 )
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TABLE 5.11
INDIVIDUAL ANOVA RESULTS FOR SUBJECTS 013 . 025 AND 026
Subject 013
C P CxP P@C1 P@C2
Mood 7.39 2.90* 1.49 1.75 2.73
Irritable 10.06* 1.44 1.90 1.35
*
2.71
Energy 0.07 2.11 1.29 1.91 1.37
Breast











Sexualinterest 7.84 0.48 1.20 0.59 3.28*
DF 1 6 6 6,18
Subject 025




































** ★ * ★ ★
Tense
& anxious 1.04 0.94 1.08 0.79 1.55
*
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Subject 026








































































2.40 3.58 0.27 0.84
** ** ns
DF 2 6 12 6,18
Key C - Cycle ; P - Phase ; DF - Degrees of freedom ; ns - not significant; T - Trend ( p < 0.10 ;
*
- p < 0.05 ; -p<0.01
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may therefore be related to lactation rather than ovarian hormone levels per
se ( see discussion of subject 003 ).
Subject Q24
Four cycles are available for this subject , three of which have been
discussed before due to the presence of short luteal phases . In this case ,
cycles one and four will be compared , the former being an ILP cycle whilst
the latter is normal.
Large differences can be seen between these cycles in terms of mood ,
energy and tension & anxiety . In each of these cases , the symptoms are
more pronounced in cycle one , the ILP cycle . However , they seem to be
maximal during menstruation rather than during the premenstrual phase .
Breast tenderness is also significantly different between the two cycles in
terms of overall levels . This difference is manifest by a later onset in the ILP
cycle, accompanied by slightly less severe levels .
As discussed in relation to the short luteal phase cycles , the removal of a
uterine polyp during cycle two may have been the cause of lower than
normal mood and higher than normal tension & anxiety i.e. an exacerbation
of menstrually related emotional symptoms due to stress . In this context, the
findings of less severe and prolonged breast tenderness in the ILP cycle
than the post-operative normal cycle may take on more significance . The
possibility that in this case , luteal phase adequacy was more closely
associated with breast symptoms than external events were must be
considered .
Subject 025
In this subject , the inadequate luteal phase cycle is followed by two
normal cycles . Hence cycle one might be expected to be the odd one out .
This would appear to be the case with respect to two symptoms, irritability
and breast tenderness . Levels of irritability are higher in the ILP cycle whilst
breast tenderness is absent . This latter observation is in contrast to the
resonably high levels of breast symptoms seen in the normal cycles . On
both of these measures, significant differences are seen between the cycles
in terms of overall mean levels . Phase effects are absent in cycle one with
respect to breast tenderness , but present in cycles two and three . There are
no differences between the three cycles in terms of phase effects on the
measure of irritability , since here the difference is one of severity rather than
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symptom timing . Mood also shows no phase effects in cycle one ,
suggesting a slightly flatter picture in the ILP cycle .
As with other subjects , it should be borne in mind that some variability is
seen between normal cycles , particularly in the case of energy, hence some
caution must be exercised in the attribution of symptom occurrence to
hormonal variability . However , fairly strong evidence emerges from this
subject that the occurence of some symptoms i.e. breast tenderness and
irritability , may be associated with luteal phase adequacy .
Subject Q2g
Three cycles are also available for this subject , two normal cycles
followed by an ILP cycle . Little evidence is seen here of cyclical changes on
any of the parameters measured . A biphasic mood pattern is seen in cycle
one , with low levels premenstrually and at midcycle . This pattern is not
present in cycle three , but neither is it present in cycle two . Generally
variations in symptom levels appear to become less marked with time ,
rather than in relation to the endocrine environment . Hence cycle one tends
to be odd rather than cycle three.
Breast tenderness and body swelling do show menstrually related
variations. The former would appear to be present premenstrually in cycle
one but not in cycle three . However as with mood , the symptom is also
much reduced in cycle two , suggesting that hormonal variations may not be
the key factor in this case .
In summary , this subject does not appear to show a consistent
premenstrual pattern , but rather gradually decreasing symptoms with time .
Although differences are seen in symptomatology between normal and ILP
cycles , the large differences observed between consecutive normal cycles
invalidate any obvious hormonal hypothesis .
c) Summary
Group comparisons suggest that ILP cycles may be chatacterized by lower
luteal levels of breast tenderness and body swelling , and the presence of
emotional symptoms at mid-cycle rather than in the premenstruum . Of all the
differences , breast tenderness appears to be the most marked .
Three of the individual analyses tend to support the observation of
reduced breast symptoms in ILP cycles , although in one of these alternative
explanations could be offered i.e. the potential exacerbation of breast
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Cycle phase
Figure 5.22 Changes in symptom levels with time across 7 standardized
cycle phases in one woman ( 025 )
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Cycle phase
Figure 5.23. Changes in symptom levels with time across 7 standardized eye
phases in one woman ( 026 )
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symptoms in the normal cycle due to lactation . The fourth subject , whilst
showing reduced breast tenderness levels in an ILP cycle , also
demonstrated some variability across normal cycles and therefore cannot be
said to show changes which can be related to luteal phase adequacy .
None of the other symptoms showed any degree of consistency across
subjects , although the suggestion of a premenstrual exacerbation of
irritability in ILP cycles was raised by one subject.
iv ) Summary of Section 5.3.2
In summary - there is little statistical evidence to suggest any greater
variability between normal and abnormal cycles than between consecutive
normal cycles in terms of overall symptom severity or differential phase
effects for most of the symptoms studied .
The major exception to this would appear to be the measure of breast
tenderness . This symptom tended to be diminished or absent in ILP cycles ,
compared to normal cycles . A trend towards this was also seen in
anovulatory cycles .
Several points should be made , arising from the data which may however
reduce the validity of any observations . Firstly - a large degree of variability
was seen between consecutive normal cycles on all parameters measured ,
and particularly the emotional ones . Secondly - none of the subjects can be
said to demonstrate cyclical changes which might be diagnosed as PMS ,
despite being self-diagnosed sufferers . This point may not be important if
the same aetiology is assumed for premenstrual symptoms as the PMS ,
however caution should be exercised before generalizations are made .
Thirdly - the statistical methodology used in this section is arguably
inappropriate to this type of data , leading to difficulties in the interpretation of
results , and fourthly - the imposition of gynaecological definitions of luteal
phase adequacy etc. may not be meaningful in the behavioural context . In
the next section , an attempt is made to accommodate for the latter two
points .
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5.3.3 CROSS CORRELATIONAL DATA ANALYSIS
The data analysis used in the previous section makes several
assumptions about the nature of hormone - behaviour relationships . The
major one of these is that a gynaecological diagnosis should be meaningful
in behavioural terms . For example , the diagnosis of inadequate luteal
phase is a purely arbitrary one , based on the description of a " normal "
range . A hypothesis could be put forward that premenstrual symptoms are
more common in ILP cycles . Hence all the ILP cycles would be expected to
be symptomatic , whilst the normal cycles were relatively symptom free .
Consider then the case of an individual who tends to have either very high
or normal range luteal progesterone levels, with the latter cycles being
symptomatic . In the analysis above , all of her data would be included in the
normal cycle category , tending to lead to a conclusion of no symptomatic
difference between cycles of differing luteal progesterone levels . In short -
the assumption has been made that group statistics are meaningful in the
individual case . The division of mood and symptom data into phases ,
dependent upon hormonal parameters could be similarly criticized , since
the current state of knowledge about premenstrual changes is arguably
inadequate to make the assumption that all women will respond in the same
way to hormonal events . This type of manipulation can produce distortions
in the data by grouping together different individual symptom patterns . For
example - if a four day premenstrual phase is considered , then a woman
who scores 4 on the day before menstruation will appear to show the same
pattern as one who scores 1 on each of the four premenstrual days . As yet
we have no information about the possibility that different symptom patterns
have different aetiologies , hence some caution should be exercised in the
interpretation of results using this type of methodology .
The other major reason for caution in the interpretation of the analysis
presented in the previous section is the dubious applicability of the statistical
methodology used . The data collected falls into the category known as
"Time Series " i.e. data which is collected serially at equal time intervals for
an extensive period . The statistical analysis of this type of data is as yet a
young science . Several characteristics of such data are known however to
increase the risks of erroneous results if conventional statistics are applied .
Examples of this are autocorrelation ( the tendency for consecutive data
points to be highly correlated ) , trend and seasonality . The statistical field
of Time Series Analysis ( TSA ) has developed , largely from the
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requirements of economists and financial analysts , to enable this type of
data to be mathematically modelled , with the ultimate aim of producing an
accurate forecast of future trends and variations in measures such as the
Share Index . However , little work has been done to demonstrate the
applicability of "pure", Box-Jenkins type TSA to physiological and
psychological data , where the purpose is vested in the analysis of
responses made to certain events , rather than the prediction of future
outcomes . The aim in this case was to find a statistically valid form of
analysis which would allow conclusions to be drawn with some degree of
confidence about the association between each of the symptomatic
variables and hormonal changes .
One form of bivariate analysis , which would appear to be appropriate in
this case is cross-correlation . In this form of analysis , two sets of data ,
collected at equal time intervals over the same period are correlated
together using conventional correlational methods . The method , however,
also lags one set of data allowing correlations to be made between , for
instance , mood and oestrone levels from one to twenty days beforehand
with an identical lag being incorporated in the opposite direction . Hence it
is possible to detect relationships between two variables at various temporal
distances . This form of analysis is most applicable to long term time series
biological data and is recommended by Sollberger ( 1965 ) , although it is
seldom used . The method has also found use in psychology , in the
analysis for instance of the interaction between members of a couple during
marital therapy ( Revenstorf, Kunert, Hahlweg & Schindler 1982 ) .
Several factors should be borne in mind before this method is applied
however . These largely fall into two categories - those relating to the
caution required in the interpretation of any type of correlational analysis ,
and those relating to the appropriate filtering techniques which should be
used before the data is analysed . The former are addressed by Kendall
(1976 ) , who points out that the number of correlations performed in the
analysis of any bivariate data set of reasonable length (i.e. not less than 35
data points per variable ) , rapidly becomes very large , with the attendant
increased probability of randomly occurring significant results by chance .
The potential pitfalls of inappropriate filtering are addressed by Chatfield
(1984 ) . As with all TSA , the data must be rendered " stationary" before
any analysis can be conducted i.e. any existing trend must be removed .
This can be achieved in a number of ways with perhaps the most intuitively
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obvious method being known as " differencing " . In this technique , each
data point is subtracted from its predecessor , in order to remove the trend .
An example of this would be in the case of the data set - 5,4,3,2,1 - which ,
when differenced produces - 1,1,1,1 - a detrended series . This method has
the advantage of retaining any cyclicity in the data . Care should also be
taken to remove any seasonal components in data covering several years ,
and to account for autocorrelation within the data . Chatfield recommends
the removal of all of these types of variability by forming the approprate Box-
Jenkins model , removing it from the data and performing the analysis on
the residuals , in order to avoid spurious correlations . However , in this
case , the examination of several data sets suggested that autocorrelation
and seasonality were not major sources of variability in this type of data .
Hence , only the trend was removed .
In this analysis , all the hormonal data was logarithmically transformed ,
to stabilise the variance . Three hormonal variables were assessed ,
derived from the hormone - creatinine ratios resulting from urinalysis .
These were Log 10 Oestrone ( Log 10 E1G ) ; Log 10 Pregnanediol ( Log
10 PdG ) ; and the logarithmic transformation of the oestrone - pregnanediol
ratio ( Log 10 (E/P ) ) . This latter variable had been implicated in previous
research studies of PMS ( e.g. Backstrom et al 1976 ; Munday et al 1981 ) .
These data were then differenced and cross correlated with each of the
differenced symptom variables to a lag of 19 places in most cases . Hence a
potential total of 24 (eight symptoms with each of three hormonal variables )
cross correlations were conducted for each subject . These analyses were
performed for all of those women who had provided daily data over at least
50 days and for whom no more than 10 % of any of the variables was
missing . This led to the exclusion of all of the clinic patients and one other
subject with inadequate amounts of data , but the inclusion of those subjects
whose menstrual cycles were absent or incomplete . Hence a total N of 24
was achieved . A significant result , it was anticipated , would be shown by a
peak in the cross correlation preceded and followed by gradually
decreasing values . In this type of analysis , a reasonably high frequency of
spurious high single correlations was expected .
Each woman was assessed individually , since there was no reason to
suppose that they would all show the same correlational patterns . The data
from a typical example are presented in tables 5.12 , 5.13 and 5.14 . This
particular subject was selected as an example since the previous analysis
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suggested that some of her symptoms may be hormonally related ( i.e.
irritability and breast tenderness ) . It can be seen that apart from the
occasional potentially spurious correlation , no association would appear to
emerge between any of the hormonal variables and any of the symptoms
assessed . The data here are presented only up to lag 15 , taking in any
possible relationship between premenstrual symptoms and hormone levels
around the time of ovulation , however, no higher correlations were seen up
to lag 19 . Only one woman showed very high correlations on measures of
breast tenderness and body swelling at lag -1 with all the hormonal
variables . However, these were not supported by the expected rise and fall
in value of the surrounding coefficients . Hence , it must be suggested that
the most likely explanation for these results is the occurence of "outliers " ,
i.e. one-off unusually high or low values on one or more of the measures
assessed . None of the other women studied showed any sign of the
expected pattern , no matter what type of hormonal cycle was experienced .
The correlations were so low that the possibility of a pure curvilinear
relationship at one or more of the lags was raised . Statistical tests for such
a relationship were not available , hence the possibility was examined by
plotting data selected from various subjects and lags at random ( Time
factors precluded the the examination of graphs for each subject at all the
possible lags - a potential total of 912 graphs per subject). The resulting
scattergraphs for subject 025 at lag -1 are presented in figures 5.24 , 5.25
and 5.26 . Once more , little evidence is seen of any kind of curvilinear
relationship in this case, and this was true of all the subjects assessed . The
observation does not of course preclude the possibility of such a
relationship occurring in the subjects or at the lags not assessed .
In summary - the method of cross correlation would appear to be the
most appropriate for data of this type if applied with caution . The results of
the analysis suggest an almost unbelievable degree of concordance
between women , showing very low levels of association between absolute
hormonal measures and absolute symptom measures at any of the lags
assessed . The explanation for this would not appear to be vested in anykind




CROSS CORRELATIONS BETWEEN SYMPTOMS AND LOG 10 E1G
FOR SUBJECT 025





-15 -0.05 -0.03 -0.04 -0.03 -0.009 0.12
-14 -0.01 0.02 -0.08 0.05 0.19 0.005
-13 0.095 -0.04 0.08 -0.07 -0.15 0.04
-12 -0.18 -0.03 0.04 0.06 0.09 0.07
-11 0.15 0.08 -0.104 0.04 0.15 0.06
-10 -0.18 0.04 -0.06 -0.08 0.002 -0.115
-9 0.16 -0.09 0.20 0.08 -0.02 -0.09
-8 0.03 0.04 -0.04 0.03 0.08 -0.05
-7 0.009 -0.05 -0.05 -0.07 -0.17 0.04
-6 0.02 0.08 0.04 0.006 0.005 0.05
-5 0.095 -0.002 -0.11 0.017 0.003 0.03
-4 -0.102 0.07 0.13 -0.001 0.04 -0 OR
-3 0.03 -0.097 -0.17 0.102 -0.03 0.14
-2 0.05 0.107 0.14 -0.23 0.16 0.09
-1 0.015 0.002 -0.20 0.16 0.004 -0.12
0 -0.12 -0.07 0.01 -0.004 -0.096 0.19
1 0.06 0.002 0.14 -0.13 0.35 -0.14
2 -0.08 0.08 -0.09 0.21 -0.17 0.08
3 -0.02 0.102 -0.04 -0.16 0.07 -0.14
4 0.02 -0.22 0.14 0.23 -0.18 0.03
5 0.03 0.10 -0.101 -0.17 0.04 -0.16
6 0.06 0.008 0.19 0.004 -0.16 -0.008
7 -0.03 -0.08 -0.16 0.008 -0.19 0.02
8 -0.11 0.06 0.20 0.06 0.03 -0.01
9 0.116 -0.03 -0.05 -0.05 0.003 0.011
10 0.05 -0.03 -0.15 -0.16 -0.13 0.07
11 -0.195 -0.03 0.12 0.08 0.097 0.016
12 0.19 -0.04 -0.18 -0.04 0.09 0.066
13 -0.21 0.09 0.07 0.07 0.07 0.032
14 0.17 0.011 0.105 -0.02 0.03 -0.24
15 -0.17 -0.06 -0.04 -0.007 -0.08 0.30
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TABLE 5.13
CROSS CORRELATIONS BETWEEN SYMPTOMS AND LOG 10 PdG
FOR SUBJECT 025





-15 -0.02 -0.07 0.15 0.03 -0.18 -0.01
-14 -0.07 -0.03 0.03 -0.05 -0.009 -0.06
-13 0.09 -0.006 -0.07 0.01 -0.03 0.07
-12 -0.12 -0.04 0.03 -0.13 -0.14 -0.015
-11 0.07 0.06 -0.004 0.17 0.06 -0.05
-10 -0.16 0.03 -0.06 -0.015 -0.04 -0.09
-9 0.17 -0.01 0.14 -0.112 -0.12 0.04
-8 -0.11 -0.07 -0.05 0.111 0.10 -0.07
-7 0.12 -0.03 -0.03 -0.21 -0.108 0.09
-6 -0.02 -0.102 0.08 0.07 0.12 -0.05
-5 0.101 0.19 -0.17 0.17 0.04 0.18
-4 -0.09 -0.07 0.21 -0.25 0.26 -0.07
-3 0.03 0.02 -0.28 0.298 -0.06 0.16
-2 -0.02 0.09 0.07 -0.22 0.23 -0.06
-1 0.06 -0.16 -0.05 0.17 -0.07 -0.04
0 0.08 0.03 -0.03 -0.09 0.05 0.26
1 0.06 0.17 0.11 0.02 0.18 -0.23
2 0.02 -0.24 -0.04 0.05 -0.09 0.09
3 -0.13 0.22 -0.09 -0.09 0.07 0.08
4 0.10 -0.07 0.15 0.13 -0.108 0.01
5 -0.07 0.11 -0.18 -0.02 0.09 -0.15
6 -0.07 -0.005 0.15 -0.007 -0.08 0.04
7 0.16 -0.05 -0.09 -0.02 -0.102 -0.06
8 -0.16 0.13 0.04 0.09 0.04 0.02
9 0.001 -0.09 -0.06 -0.106 -0.09 0.03
10 -0.02 0.05 0.008 0.04 -0.07 -0.07
11 -0.09 0.05 0.115 0.01 0.05 -0.07
12 0.09 -0.12 -0.05 -0.14 -0.22 0.005
13 -0.12 -0.06 0.06 0.08 0.05 0.09
14 0.15 0.09 0.12 -0.01 -0.009 -0.18
15 -0.07 -0.14 -0.15 -0.06 -0.07 0.08
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TABLE 5.14
CROSS CORRELATIONS BETWEEN SYMPTOMS AND LOG 10 ( E/P 1
FOR SUBJECT 025
LAG Mood Irritable Energy Tense& anxious
Breast
tenderness sSgfta
-15 -0.01 0.05 -0.19 -0.05 0.19 0.114
-14 0.06 0.05 -0.09 0.08 0.16 0.07
-13 -0.03 -0.02 0.13 -0.07 -0.09 -0.04
-12 -0.02 0.02 0.001 0.19 0.22 0.07
-11 0.04 0.001 -0.08 -0.16 0.06 0.095
-10 0.02 -0.002 0.02 -0.04 0.04 0.001
-9 -0.06 -0.06 0.009 0.18 0.11 -0.11
-8 0.14 0.104 0.02 -0.10 -0.04 0.03
-7 -0.12 -0.01 -0.003 0.17 -0.02 -0.07
-6 0.04 0.17 -0.06 -0.07 -0.13 0.095
-5 -0.03 -0.20 0.098 -0.17 -0.04 -0.17
-4 0.016 0.13 -0.13 0.27 -0.24 0.02
-3 -0.002 -0.097 0.17 -0.24 0.04 -0.06
-2 0.056 -0.014 0.04 0.06 -0.12 0.13
-1 -0.05 0.17 -0.105 -0.06 0.08 -0.06
0 -0.18 -0.08 0.041 0.09 -0.13 -0.12
1 -0.02 -0.18 -0.009 -0.13 0.08 0.13
2 -0.08 0.32 -0.03 0.116 -0.04 -0.03
3 0.13 -0.16 0.07 -0.03 -0.01 -0.19
4 -0.09 -0.101 -0.06 0.04 -0.02 0.01
5 0.10 -0.04 0.114 -0.12 -0.06 0.03
6 0.12 0.01 -0.006 0.011 -0.05 -0.05
7 -0.19 -0.009 -0.04 0.03 -0.05 0.08
8 0.09 -0.09 0.115 -0.05 -0.02 -0.03
9 0.09 0.07 0.02 0.08 0.10 -0.02
10 0.06 -0.08 -0.13 -0.17 -0.03 0.13
11 -0.06 -0.08 -0.03 0.05 0.02 0.09
12 0.05 0.097 -0.09 0.115 0.31 0.05
13 -0.04 0.14 -0.006 -0.04 0.004 -0.08
14 -0.03 -0.09 -0.05 0 0.04 0.009
15 -0.06 0.105 0.13 0.06 0.01 0.15
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Figure 5.24 ( a ) The relationship between mood , irritability , energy ,
tension & anxiety and Log 10 Oestrone Glucuronide
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Figure 5.24 I b ) The relationship between breast tenderness , body
swelling and Log 10 Oestrone glucuronide , using
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Figure 5.25 ( a ) The relationship between mood , irritability , energy ,
tension & anxiety and Log 10 Pregnanediol glucuronide
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Figure 5.25 ( b 1 The relationship between breast tenderness , body
swelling and Log 10 Pregnanediol glucuronide , using
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Figure 5.26 f a ) The relationship between mood , irritability , energy
tension & anxiety and Log 10 ( E / P ) , using differenced
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Log ( E/P) ( Differenced scores at Lag -1 )
Figure 5.26 ( b ) The relationship between breast tenderness , body
swelling and Log 10 ( E / P ) using differenced scores
at Lag -1 , for subject 025 .
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5.4 DISCUSSION
The study described in this chapter utilised an observational
"eliminationist " approach to the relationship between premenstrual
symptoms and the ovarian cycle . In this case , the factor to be eliminated
was ovulation . Hence an attempt was made to recruit subjects in whom
anovulatory cycles might occur. One of the confounding factors associated
with the removal of ovulation is the absence of luteal phase hormones , in
particular progesterone . In order to attempt to tease out the relative
components of these factors , normal cycles and cycles with deficient luteal
phases were studied . Hence , if the endocrine event of ovulation were
associated with symptom occurence , we would expect anovulatory cycles to
be different from normals and deficient luteal phases . If luteal phase
hormones are related to symptoms , then both anovulatory and deficient
luteal phase cycles should be different from normal cycles . The presence of
two sub-diagnoses of deficient luteal phase allows the hypotheses to be
extended . Hence , if absolute levels of luteal phase hormones are
important , then inadequate luteal phase cycles should be different from
normals whilst short but adequate luteal phase cycles should not - in terms
of severity ( although symptom timing may be expected to be altered ) . An
assessment of the time of onset of symptoms in SLP cycles might also
provide evidence against a role for either ovulation or luteal phase
hormones , if that onset were before the endocrine event i.e. symptoms
began > 9 days before menstruation .
The small number of abnormal cycles observed in this study requires that
some caution must be exercised in the interpretation of the results .
However, it would appear , from the first analysis that only one of the
symptoms measured shows any systematic variation with luteal phase
adequacy . This symptom is breast tenderness , levels of which were
reduced in both anovulatory and ILP cycles compared to normals , but not in
SLP cycles . (N.B. One subject ( 047 ) showed higher than normal levels of
breast tenderness in a cycle whose luteal phase was both short and
inadequate , although not in a SLP cycle suggesting that the inadequacy of
the luteal phase may be a key factor , and may have a stimulatory rather
than an inhibitory effect on breast tenderness in some women) . No
tendency emerged for symptoms in SLP cycles to begin later or to be less
severe than symptoms in normal cycles . Hence , it would appear from this
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analysis , that the presence or absence of ovulation is not associated with
symptom occurence . However , in the case of breast tenderness , a
relationship with luteal phase adequacy does appear.
The cross-correlational analysis showed no relationship between any of
the symptoms and absolute levels of oestrone or pregnanediol , or the E/P
ratio . This result held true for subjects showing all types of ovarian cycle ,
ranging from anovulatory to normal . In this case , breast tenderness did not
emerge as an exception . Hence , the possibility arises that premenstrual
breast tenderness may be related to some other aspect of luteal phase
adequacy than the ovarian steroids . The possibility that the breast is
responsive to the same physiological events which produce an ILP in the
ovary should be considered .
Two hormones which may be involved are LH and FSH (luteinizing
hormone and follicle stimulating hormone ) . FSH is involved in follicular
growth whilst LH is important in the endocrine mechanism of ovulation ( see
Chapter Two ) .Both of these are still present in the circulation during the
luteal phase , where their function is largely unknown . Recent evidence
from work with sheep suggests that adequate luteal function is dependent
upon adequate gonadotrophic stimulation of the developing follicle ( Stirling
1986) . However , LH levels during the luteal phase may also be involved
(Niswender et al 1985 ) . These aspects have been little investigated in the
human context.
Prolactin has also been implicated in the human luteal phase . Hunter
(1984 ) showed that prolactin significantly enhances hCG stimulation of
oestrogen and progesterone synthesis from human luteal tissue in vitro,
although it is not effective alone . Hence , prolactin may play a permissive
role in the control of steroidogenesis by the corpus luteum . This work is
supported by the observation that in most species , the maintenance of luteal
function in early pregnancy is dependent on a "luteotrophic hormone
complex" , whose chief components are prolactin and LH ( see Heap & Flint
1984 ) . The suggestion has arisen from work with rats , that a normal range
of prolactin levels are required for maintenance of CL function , with both
high and low levels acting to decrease steroidogenesis ( Rajkumar, Couture
& Murphy 1985 ; Lee 1987 ) . Hence , the possibility arises of two groups of
women , both with inadequate luteal phases , but one having higher than
normal prolactin levels, and the other lower than normal.
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Prolactin , as its name implies , is involved in milk secretion during
lactation . However it is present at reasonable levels throughout the normal
menstrual cycle ( McNeilly & Chard 1974 ) . It can be inhibited by the action
of bromocriptine , a dopamine agonist . This latter drug has been
successfully used in the treatment of cyclical breast pain ( Mansel , Preece &
Hughes 1980) and has shown favourable results on premenstrual breast
symptoms when prescribed for PMS ( Anderson & Larsen 1979 ; Kullander
& Svanberg 1979 etc. ) Hence , the possibility exists that premenstrual
breast tenderness is associated with prolactin , or some other aspect of
luteal function , rather than the ovarian steroids .
5.5 SUMMARY
The study described in this chapter involved the observation of naturally
occuring abnormal menstrual cycles in order to investigate the relative
effects of ovulation and luteal phase adequacy on premenstrual symptoms .
Only a small number of abnormal cycles were observed in women who did
not show very strong cyclical symptoms . However , for the majority of
symptoms studied , no greater variation was seen between normal and
abnormal cycles than between consecutive abnormal cycles . Breast
tenderness was different in this respect , being generally less severe in
anovulatory and inadequate luteal phase cycles . Cross correlation of the
symptoms with each of the hormonal measures indicates that none of them
are associated with absolute ovarian steroid levels .
Hence , premenstrual symptoms can occur in the absence of ovulation
and do not appear to be dependent upon luteal hormone levels . In the case
of breast tenderness , differential levels , either higher or lower than normal ,
are associated with an absent or deficient luteal phase . It is possible that
some other factor associated with luteal function may be involved for this
symptom . The implication of prolactin in this respect , plus the use of a
prolactin inhibitor, bromocriptine , to relieve cyclical breast pain , suggests
that this hormone may be worthy of study in this regard .
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CHAPTER SIX




The relationship between the Premenstrual Syndrome and ovulation can
be investigated in two ways . Firstly , observations can be made of naturally
occuring anovulatory cycles for comparison with ovulatory cycles , and
secondly , manipulations of the natural menstrual cycle can be undertaken to
induce a state of anovulation . The natural anovulatory cycle has been
discussed in Chapter 5 , in this section artificially manipulated cycles will be
considered .
The oral contraceptive pill ( oc ) is the most widely used inhibitor of
ovulation in Western society . The physiological effects of oc's on the
menstrual cycle have been discussed elsewhere ( Section 2 .4 ) as have the
reported effects of oc's on mood and PMS ( Section 3 .4.2 ) . Several
distinctions should however be borne in mind when considering the actions
of oc's on PMS .
1 ) As Cullberg ( 1972 ) points out - the oc has two effects , its pure
pharmacological effect of ovulation inhibition and its psychological effects
due to the prevention of conception . This latter " placebo " effect may be
involved in studies finding therapeutic effects of oc's on PMS .
2 ) A distinction should be made between the effects of oc's in an
individual and the characteristics of oc users as a whole compared to non-oc
users . A finding of similarity in PMS symptoms between users and non-
users does not imply that any one individual will not experience changes in
cyclical symptoms with oc use .
3 ) A distinction should be made between menstrual cycles
immediately after the beginning or end of a course of oc and those cycles
within a long-term oc regime . In the former case the effects of the
exogeneous cycle will be either unestablished or still present whilst in the
latter they will be a dominant influence . Present knowledge about
chronobiological and endocrinological adaptations to the oc does not allow
any precise definition of the time at which their effects become dominant.
The fundamental question in this study is whether ovulation is a
necessary prerequisite for premenstrual symptomatology to occur . If
ovulation and luteal function are necessary then pill-taking women reporting
" PMS " would be expected to differ from non pill-taking complainers when
compared on the basis of prospective daily ratings . The hypothesis would
be that pill users are attributing random mood changes to the premenstruum
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TABLE 6.1
HORMONAL DIFFERENCES BETWEEN GROUPS
( N.B. Changes during the pill free week are not considered )
HORMONAL PARAMETER














- - ? - -
Kev + = present - = absent ? = uncertain
in retrospective reports . The current availability of a triphasic oral
contraceptive designed to mimic the natural cycle allows a further
comparison which might be expected to differentiate between the effects of
ovulation perse and the effects of cyclical ovarian steroids .
Hence an experimental design utilizing the two pill-using groups and a
matched control group can be visualized . The differences between these
groups being on the basis of the presence or absence of the LH surge and
ovulation , cyclical FSH , oestrogen and progesterone ( Table 6.1 ) . If
ovulation and luteal function are both necessary for PMS to occur , then the
two pill groups would be expected to behave in a similar way , but differently
from the control group . If ovulation itself is not essential , but luteal
hormones are - then the triphasic and control groups might be expected to
act in a similar fashion with the monophasic users behaving differently .If
neither ovulation nor luteal function are important , then the three groups will
produce similar data .
Three major contaminating factors should however be borne in mind
1 ) The relative biological activity of endogeneous and exogeneous
hormones . It may be that synthetic oestrogens and progestagens will not
have the same physiological activity as those produced by the body itself.
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2 ) Most of the oral contraceptives currently prescribed are " low dose "
(i.e < 30 pg ethinyloestradiol) . The level of residual follicular activity in users
of these preparations is uncertain and may have some influence on the
expression of mood states etc..
3 ) Further to the above - the presence of a " pill free week " during




The insertion of a Menstrual Health Questionnaire in a national women's
magazine , " Woman " , in August 1985 , produced a large response with
approximately 7500 women returning completed questionnaires ( Bancroft
& Warner 1987 ) . The respondents were invited to volunteer their services
for further research work , producing a research " pool " of about 5000
women . Although epidemiological studies cannot be undertaken on this
group because of the biased nature of the original questionnaire and the
readership characteristics of the magazine , the presence of a large group of
volunteers on whom some descriptive data is available makes subject
selection on various criteria a possibility . All subjects in this study were
selected from this pool with the major criterion being their contraceptive use .
Several exclusions were made however before the selection was
undertaken .
1 ) Age - all respondents below the age of 18 years and above the age of
35 years were excluded from the selection . In this way the possible
contaminating factors of puberty and the climacteric were minimized . This
age group is also the peak range for oral contraceptive use , the pill being
rarely prescribed over the age of 35 for fear of long term side effects or under
the age of 16 for legal reasons .
2 ) Stress - all women who reported " a great deal of stress " or a
relationship which was " not at all happy " at the time of the original
questionnaire were excluded from the selection .
3 ) PMS - since the concern in this study is the potential difference
between pill-users and non users in respect to their premenstrual symptoms
- only those women who responded yes or maybe to the question " Do you
have PMS ? " were included.
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4 ) Relationship - as sexual interest and sexual activity were to be
assessed , women were only included if they reported stable heterosexual
relationships at the time of the original questionnaire .
5 ) Contraception - pregnant , lactating and hysterectomized women
were excluded from the selection .
After making these exclusions , three groups of women were chosen on
the basis of oral contraceptive use , one group using triphasic pills , one
using monophasic (combined ) pills and one group using non-steroidal
contraception . These groups were matched for age , parity ( i.e. with or
without children ) and occupation ( i.e. full time work , part time work or no
paid work outside the home ) . The distribution within each group is
described in Table 6.2 . The numbers within each cell took advantage of the
maximum number of available pill users in each category . Since the overall
number of pill users in the pool was small - this was a limiting factor in
deciding the number of women approached .
6.2.2 PROCEDURE
The study procedure followed a series of steps
1 ) All 422 selected women were contacted by post and asked to
complete a further questionnaire , the Menstrual Health Questionnaire Part II
( see Appendix ) , an example diary form , and to indicate their willingness to
participate in a prospective study . This step allowed an assessment to be
made of potentially crucial changes in the subjects' oral contraceptive use
and / or personal circumstances since the first questionnaire , due to a gap of
about 6 months . Further data was also collected , a check made that the
diary instructions were sufficiently clear for postal use and a " let-out "
clause made available to those women who were uncertain about their
participation .
2 ) Those women who responded and expressed willingness to
continue were then sent sufficient diary forms for 84 days ( three 28 day
cycles ) and instructed to start the diaries on the first day of their next
menstrual period , completing one each day until the end of the series . They
were asked to indicate on the diaries their current pill brand and the days on
which they began and ended each pill packet . A modified Moos MDQ
(MMDQ ) was also included , to be completed before the diaries were
started, and in a subgroup another copy of the Menstrual Health
Questionnaire ( MHQ ) was sent. The diaries were returned in fortnightly
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TABLE 6.2
FREQUENCIES OF WOMEN SELECTED
AGE
WITHOUT CHILDREN WITH CHILDREN
TOTAL
F/T P/T NPW F/T P/T NPW
20 10 1 0 0 0 0 11
21 13 0 2 0 0 0 15
22 10 0 2 0 0 0 12
23 11 0 1 0 2 0 14
24 13 0 1 0 1 1 16
25 5 1 1 0 1 1 9
26 7 1 0 1 1 2 10
27 3 0 0 1 2 3 9
28 5 0 0 0 1 4 10
29 7 0 0 1 3 3 14
30 2 0 0 0 1 3 6
31 1 0 0 0 3 1 5
32 3 0 0 1 1 1 6
33 0 0 0 0 3 0 3
34 0 0 0 1 0 0 1
35 1 0 0 0 0 0 1
TOTAL
91 3 7 5 19 19
144
101 43
Kev F / T - full-time work ; P / T - part-time work ; NPW - no paid
work outside the home .
Each cell represents the number of women selected in each experimental group
(i.e. the triphasic , monophasic and control groups ) who satisfied the various criteria
of age , parity and occupation . For example 10 full-time working , nulliparous 20 year
olds were approached in each experimental category . In this way the groups were
matched on the various parameters whilst allowing maximum usage of the pill-users
available.
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batches (the MMDQ and MHQ were to be included with the first batch ) in
Freepost envelopes .
3 ) At the end of the study - all women were sent a Thank-you letter and
a leaflet describing self-help strategies for coping with PMS . The subgroup
who received the second MHQ completed a further copy at the end of the
study to assess its relevance to prospective data . The results of this study
will be reported seperately ( Bancroft & Walker).
All subjects were encouraged to contact the researcher by telephone or
letter at any point during the study if they had queries about or problems with
the research - and this many of them did . No assessment of the hormonal
status of the control subjects was made at any point , due to logistic
difficulties . The assumption being that a high proportion of cycles in this age
group will be ovulatory . In addition no assessment was made of the
personality characteristics of the three groups due to the absence of a
suitable instrument for postal administration .
6.3 RESULTS
As outlined in the introduction , the purpose of this study was to assess
the importance of ovulation per se and natural or synthetic luteal function on
cyclical symptoms associated with menstruation . The hypotheses
generated by the experimental design were tested by three analytical
techniques . Firstly , each subject's data were divided according to
"menstrual cycle " phase and " pill cycle" phase . This analysis tested the
relative effects of menstruation as such and the " pill free week " on
symptom presentation , and allowed for comparison between groups directly
on the basis of the underlying hormonal milieu . Secondly, a non-parametric
analysis was performed to reduce errors due to inter individual differences
in scale usage . This analysis was conducted on a daily basis across each
cycle , allowing a more sensitive index of symptom onset to be obtained .
Thirdly , symptom patterns were further assessed within each of the three
groups by means of a crude comparison of premenstrual , menstrual and
postmenstrual score ratios . On the basis of several criteria , each subject
was categorized according to symptom pattern , and differences between
the frequencies of occurrence of different subtypes were assessed between
the three groups . Hence the two major variables of symptom expression ,
timing and severity have been analysed between the three groups .
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6.3.1 RESPONSE RATES AND DEMOGRAPHIC DATA
Approximately half of the women originally contacted returned the
Menstrual Health Questionnaire Part II , with almost all of these agreeing to
participate in the research ( see Table 6.3 ) . The reasons for this low
response rate in a group of apparently highly motivated volunteers are not
immediately obvious . The time lapse between the original magazine survey
and this study , of about six months , may have been a contributory factor in
that some proportion of the sample may have moved house and become
uncontactable. The differences between a one-off questionnaire and a long
term daily study may also be important.
TABLE 6.3
RESPONSE RATES WITHIN THE THREE GROUPS
TRIPHASIC MONOPHASIC CONTROL
Number
Contacted 146 146 146
Number returning








Usable Data 30 35
57
The majority of those who responded favourably did in fact return some
proportion of the daily diary series , however this proportion is much higher
in the control group than in either of the pill using groups . Once more the
reasons for this are not immediately evident . Arguably if the pill users
overall are experiencing fewer or less severe premenstrual changes than
the control group , then they may be less well motivated to continue with the
study . The lack of personal contact with the researcher in a postal study
may also be a contributory factor , although no evidence is available to
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support this contention . Data were selected for analysis from that collected
on several criteria . Firstly , an unbroken set of data covering at least two
TABLE 6.4
REASONS FOR UNUSABLE DATA
TRIPHASIC MONOPHASIC CONTROL
< 2 Cycles data 10 6 15
Diaries uncodable 1 0 0
Changed pill brand 2 0 0
Became pregnant 0 0 3
Cycles <23 or >35 days 0 0 4
TOTAL 13 6 22
menstrual cycles was considered necessary for the study to be meaningful .
Therefore any data set covering less than this time period was excluded .
Specific cycles were excluded if they were shorter than 23 or longer than 35
days in the case of the control group , to maintain comparability with the pill
using groups , or if pregnancy occured .
Data were also excluded if the respondent changed pill brand partway
through or if the diaries were uncodable . The proportion of data falling into
these categories is described in Table 6.4 .
Despite the relatively low response rates , the distribution of women
within the three analysed groups does not differ significantly from that in the
selected groups on the basis of the three selection criteria - age , parity and
occupation ( Figures 6.1 & 6.2 ) .
Demographic data was obtained from the three groups from the
Menstrual Health Questionnaire Part II ( Table 6.5 ) . The three groups of
women are very similar in age and social class . Perhaps surprisingly when
classed on their own present or previous occupations , the majority of
women fell into class III . However classification on the basis of partner's
occupation increased the numbers in classes I & II in all groups sufficiently to
cause a significant difference to arise between the triphasic group and the
others . The majority of women reported themselves to be in good health ,
with few chronic medical conditions . Some of the stable relationships used
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■ Selected N = 146
E3 Triphasic N = 30
13 Monophasic N = 35
E3 Control N = 57
Figure 6.2 Comparison of parity and occupation distributions
in the original selection with the final study groups
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TABLE 6.5
DEMOGRAPHIC DATA OF PILL STUDY PARTICIPANTS
PARAMETER TRIPHASIC MONOPHASIC CONTROL STATISTICS
N 30 35 57 —
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Kev SD - standard deviation N/A - not applicable ns - not significant
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TABLE 6.6
MENSTRUAL CYCLE CHARACTERISTICS AND REPRODUCTIVE
HISTORY OF ALL PILL STUDY PARTICIPANTS






























































































































































































































Kev SD - standard deviation ; ns - not significant ; N/A - not applicable
HBP - high blood pressure ; DEP - depression ; MS - morning sickness ;
TM - threatened miscarriage ; IND - induction ; EPID - epidural
anaesthesia ; EPIS - episiotomy .
However this number was reasonably small and consistent across all three
groups. Although the number reporting themselves to be under some
stress is apparently high , a very small proportion of these fell into the
category " a great deal of stress " and hence their data was included . The
majority had suffered some degree of depression in the past , although this
was usually related to an external event such as a broken relationship or a
bereavment . The majority of treatments given were sleeping tablets or
minor tranquilizers such as valium .
The reproductive history of the three groups is described in table 6.6 . All
three showed a slightly younger than expected age of menarche , ranging
from an average of 12 to 12.8 years . However since this was a retrospective
questionnaire, little weight can be attached to this . A higher proportion of the
control group suffered painful periods during adolescence , although this
factor was not present when current dysmenorrhea was considered . The
numbers of pregnancies and children were consistent across the groups .
The number of pregnancies resulting in abortions or miscarriages was also
consistent at about 30 % of the total number of pregnancies in each group .
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The majority were nulliparous but the proportion of parous women having
suffered at least one episode of post partum depression was approximately
50 % in all groups . No comment can be made about the relationship
between PMS and post natal depression on the basis of this due to the
absence of a non PMS group , however the incidence seems higher than
would be expected . Few of the women had experienced any serious
gynaecological problems although a fairly high incidence of vaginal
infections e.g. thrush ( Candida albicans ) was reported .
The contraceptive history of the subjects is described in table 6.7. The
most popular form of contraception amongst the control women was the
sheath although most of them had used an oral contraceptive at some time .
The majority in all groups used the oc purely for contraception , however a
substantial proportion of the women currently using the pill also found it
helpful for dysmenorrhea or cycle regulation . Most of the women had
experienced side effects of one sort or another from the oc . The most
common of these being headaches , weight gain and loss of libido .
Although the triphasic group had been using their current brand of pill for
slightly longer than the monophasic group , this difference was not
statistically significant . A very small number had experienced " post - pill
amenorrhea " , however the majority of the pill using groups had never
stopped taking the pill , although they had changed brands . The different pill
brands used in the study are outlined in table 6.8 , the most frequent being
the hormonally correspondent microgynon ™ and logynon™ . All pills used
can be described as " low - dose " with respect to oestrogen content.
Each of the women completed a modified Moos Menstrual Distress
Questionnaire at the beginning of the study . This questionnaire was scored
and its scales categorised on the basis of Moos' original Factor Analysis .
The scores on each scale were then subjected to one-way analysis of
variance between the three groups to assess any differences in their
retrospective reporting of premenstrual symptoms ( Table 6.9 ) . Scores
were indistinguishable between the three groups on any of the scales ,
although water retention scores were less marked in the monophasic group.
Interactions between the scales were not assessed .
Overall , then , a picture emerges of three groups of reasonably well
matched women , differing only on their choice of contraception.
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TABLE 6.7
CONTRACEPTIVE HISTORY OF PILL STUDY PARTICIPANTS
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18.36 (2.18) 18.03 (2.55) 17.94 (2.34)
N = 50









































































































FREQUENCY OF PILL BRANDS USED IN STUDY
PILL
TYPF
BRAND NAME CONSTITUENTS NUMBER INSTUDY




LOGYNON/ 5 x Levenorgestrel 75 jig/ EE 40 jig 22





TRINOVUM 7 x Norethisterone 500jrg /EE 35jig
7 x Norethisterone 750 jig/EE 35jig
7x Norethisterone 1mg/EE 35 jig
8
MICROGYNON / 21 X Levenorgestrel 150 jag
21



















21 X Ethynodiol diacetate 2 mg
Ethinyloestradiol 30 jig
1




21 x Norethisterone 500 jag
Ethinyloestradiol 35 jag
1
Key:- EE = Ethinyl-oestradiol
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TABLE 6.9
MODIFIED MOOS MDQ RESULTS OF PILL STUDY PARTICIPANTS
( MEAN SCORES - STANDARD DEVIATIONS IN BRACKETS )
SCALE TRIPHASIC MONOPHASIC CONTROL STATISTICS
PAIN
( Headache , Fatigue ,
General aches & pains)




(Insomnia , Difficulty in
concentrating , More
accidents)




( Swelling , Weight gain ,
Breast tenderness)












( Overactivity , Bursts of
energy , Excitement)









(Appetite change ) 2.38(1.77)





0.48 ( 1.25 ) 0.76 (1.63 ) 0.31 ( 0.93)
F = 1.18
ns
TOTAL 38.86 ( 12.52 ) 35.97 ( 14.97) 37.92 (14.28 )
F = 0.34
ns
N 29 33 48
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6.3.2 CYCLE DIVISION ON THE BASIS OF MENSTRUAL CYCLE PHASE
The phenomena under investigation in this study are the cyclical
changes in female mood and well-being coincident with the menstrual cycle.
One of the most obvious effects of oc's is an alteration of the physical
parameters of the menstrual cycle . Usually they induce a state of regular ,
predictable , light and generally pain-free menstruation . The first method of
analysis then , is an attempt to distinguish between the three groups on the
basis of menstrual cycle phase - investigating the relationship between
menstruation itself and the classic timing of PMS in these groups . In order
to do this , a mean score for each of four arbitrarily defined menstrual cycle
phases was calculated for each woman . The four phases being :-
i) The menstrual phase - including all days on which bleeding occured.
ii ) The premenstrual phase - seven days immediately before the onset
of menstruation .
iii ) The postmenstrual phase - seven days immediately after the end of
menstruation .
iv ) The intermenstrual phase - the rest of the menstrual cycle .
All usable data were amalgamated for each woman to produce one
score for each phase for each subject .These scores were then averaged
within the groups , and the resultant means are represented graphically in
figures 6.3 and 6.4 , and numerically in table 6.10 . Although the data were
reduced to four points per symptom , they are here "double-plotted ", i.e. the
same data are repeated , to emphasize the cyclical nature of the
phenomenon . The data points are plotted at the mid-point of the phase they
represent in relation to the menstrual cycle to allow visual comparisons to be
made across different forms of analysis . Two-way analyses of variance for
repeated measures were carried out to determine the relative effects of
experimental group and menstrual cycle phase . The results of these are
summarized in tables 6.11 , 6.12 and 6.13 .
All three groups exhibited their lowest mood , energy and sexual interest ,
and highest irritability , tension & anxiety , breast tenderness , body swelling
and period pain scores in either the premenstrual or menstrual phases .The
timing of peak symptom occurence between these two phases was more
often congruent between the triphasic and control groups and different in the
monophasic group . For instance , in the cases of body swelling , irritability
and tension & anxiety , maximal monophasic scores occur during
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TABLE 6.10
MEAN MENSTRUAL CYCLE PHASE SCORES
( Standard deviations in brackets )
TRIPHASIC GROUP
PARAMETER POST INTER PRE MENS N of Women
Mood 14.81 (2.16) 14.76 (2.09) 13.49 (2.40) 13.68 (2.56) 29
Irritable 1.72 (1.28) 2.07 (1.47) 2.93 (1.69) 2.85 (1.73) 29
Energy 13.11 ( 2.84) 12.39 (2.84) 11.01 (2.94) 11.05 (3.19) 29
Tense
& anxious 1.85 (1.70) 1.92 (1.73) 2.70 (1.86) 2.46 (1.69) 29
Breast
tenderness 0.09 (0.19) 0.72 (1.00) 2.50 (1.96) 1.24 (1.32) 29
Body Swelling 0.43 (0.96) 0.81 (0.94) 2.78 (1.95) 2.41 (1.22) 29
Period Pain 0.05 (0.14) 0.10 (0.22) 0.65 (0.99) 2.27 (1.45) 29
Sexual Interest 3.81 (1.82) 3.10 (1.47) 2.86 (1.57) 2.82 (1.59) 24




PARAMETER POST INTER PRE MENS N of Women
Mood 14.08 (2.62) 13.82 (3.08) 12.72 (3.39) 12.11 (2.26) 35
Irritable 1.47 (1.24) 1.70 (1.71) 2.34 (1.84) 2.78 (1.68) 35
Energy 12.53 (2.72) 12.10 (2.71) 11.38 (2.54) 10.16 (2.17) 35
Tense
& anxious 1.61 (1.64) 1.88 (2.04) 2.46 (2.67) 2.59 (1.94) 35
Breast
tenderness 0.13 (0.30) 0.34 (0.62) 1.12 (1.34) 1.02 (1.18) 35
Body Swelling 0.51 (0.99) 0.91 (1.64) 2.27 (2.17) 2.64 (1.81) 35
Period Pain 0.11 (0.25) 0.17 (0.39) 0.65 (1.09) 2.08 (1.48) 35
Sexual Interest 3.71 (1.97) 2.94 (1.67) 2.76 (1.83) 2.50 (2.07) 30




PARAMETER POST INTER PRE MENS N of Women
Mood 15.88 (2.04) 15.00 (2.11) 13.78 (2.53) 13.40 (2.58) 57
Irritable 1.19 (1.16) 1.54 (1.32) 2.69 (1.64) 2.64 (1.80) 57
Energy 14.12 (2.53) 12.98 (2.52) 11.50 (2.56) 10.89 (2.95) 57
Tense
& anxious 1.29 (1.22) 1.53 (1.42) 2.23 (1.73) 2.22 (1.69) 57
Breast
tenderness 0.12 (0.32) 0.68 (1.04) 2.71 (2.32) 1.22 (1.17) 57
Body Swelling 0.23 (0.54) 0.66 (1.03) 2.45 (1.82) 1.94 (1.65) 57
Period Pain 0.05 (0.22) 0.06 (0.23) 0.46 (0.7) 2.11 (1.58) 57
Sexual Interest 4.25 (1.96) 3.46 (1.94) 2.52 (1.95) 2.79 (1.92) 49

































































Key M - Menstrual; Po - Postmenstrual; In - Intermenstrual; Pr - Premenstrual; Me - menses
Triphasic N = 29
Monophasic N = 35
Control N = 57
Figure 6.3 Comparison of monophasic , triphasic and control groups on
measures of mood , irritability , energy and tension & anxiety
divided by menstrual cycle phase ( double plotted ). .
221
Breast tenderness Body swelling


















Key M - Menstrual phase ; Po - postmenstrual phase ; In - intermenstrual phase
Pr - Premenstrual phase . ■■ - menstruation
-o- Triphasic N = 29 (24 )
Monophasic N = 35 (30)
-*• Control N = 57 (49 )
( Numbers in brackets indicate N values for sexual interest)
~i
Pr
Figure 6.4 Comparison of monophasic , triphasic and control groups on
measures of breast tenderness , body swelling , period type




OVERALL ANALYSIS OF VARIANCE SUMMARY TABLE ( F VALUES )















































Key * - p<0.05 ; ** - p<0.0l
menstruation whilst peak triphasic and control scores occur before
menstruation . This also applies in the case of energy and sexual interest ,
where the lowest monophasic scores occur during menstruation , whilst the
lowest triphasic and control group scores occur during the premenstrual
week . The parameters of period pain , breast tenderness and mood do not
differ in this respect. However a large difference in absolute scores of breast
tenderness is seen , with monophasic users producing scores suggestive
of much milder degrees of breast tenderness .
The overall analysis of variance results ( Table 6.11 ) show highly
significant phase effects for all measures , suggesting that the groups can
safely be considered to experience cyclical changes in well-being .
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TABLE 6.12
THE EFFECT OF MENSTRUAL CYCLE PHASE
WITHIN EACH GROUP





























































Freedom 3, 351 ( 297 )
Kev * - p < 0.05 ; * * - p < 0.01
( Figures in brackets indicate DFe for sexual interest)
Significant group effects were also found in respect of mood , energy and
breast tenderness .
An examination of pairwise comparisons between the groups ( Table
6.13) reveals that the monophasic group is significantly different from the
other two groups on measures of mood and breast tenderness and
significantly different from the control group for energy scores . The only
significant interaction between group and phase occured on the measure of
breast tenderness , however a difference in symptom timing by this analysis
does not appear to account for this , but rather an absolute difference
between the monophasic group and the other two , reflecting perhaps a
difference in scale usage , or a larger proportion of the monophasic group
experiencing very mild or noncyclical breast tenderness .
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TABLE 6.13
PAIRWISE COMPARISONS BETWEEN GROUPS ON THE BASIS











MOOD ns ns * *
IRRITABLE ns ns ns
ENERGY ns ns ns
TENSE &







SWELLING ns ns ns
PERIOD TYPE




Kev ns - not significant ; * - p < 0.05 ; * * - p < 0.01
An examination of the phase effects (i.e a measure of cyclicity ) within
each group symptom by symptom ( Table 6.12 ) , reveals no further points of
divergence between them . Significant phase effects are present for all
groups on all symptoms.
In summary then , group differences would appear to be small and
symptom specific when the data were analysed according to the menstrual
cycle. Examination of trends in the data suggests that the triphasic and
control groups tend to experience maximal symptoms during the
premenstrual phase , whilst monophasic users peaked during menstruation .
This pattern did not hold for all symptoms . Mood , breast tenderness and
period pain scores revealed a close similarity between the groups on the
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basis of peak symptom occurrence .On measures of mood and breast
tenderness the triphasic and control groups appear
to be convergent in terms of absolute symptom scores , with the
monophasic group being significanylt divergent .These findings are
particularly clear in the case of breast tenderness , with a markedly lower
level of severity occurring in the monophasic group despite a similar pattern
of symptom timing . The possibility that these findings are not related to the
real or perceived menstrual cycle , but in fact to the constituents of the oral
contraceptive pill is examined in the next section .
6.3.3 CYCLE DIVISION ON THE BASIS OF PILL CYCLE PHASE
The data analysis outlined in the previous section makes no allowance
for the potential physiological and psychological effects of the pill free week (
pfw ) on symptom manifestation . The changing levels of exogeneous
hormone in the triphasic pill are similarly unaccounted for . In order to
examine any differences reflecting these variables , each menstrual cycle
was divided into five phases according to the changing levels of hormone in
the triphasic pill following the method outlined by Bancroft , Sanders ,
Warner & Loudon ( 1987 ) ( see figure 6.5). All cycles in the control group
were standardized to 28 days to allow for comparison with the pill groups
following the method outlined in section 4.4 . An arbitrary pfw was assigned
to each control cycle by counting the first day of menstruation as day 3 of the
pfw . This assignment was made on the basis of the most common lag
between ending a course of oc and starting to bleed in the pill using groups .
The data were averaged within each phase for each woman and then
collected for each group . Graphical representations of the data form figures
6.6 and 6.7 . The data are double - plotted to emphasize cyclical effects ( see
Section 6.3.2 ) . The data are represented numerically in table 6.14 .Two-
way analyses of variance for repeated measures were performed on the
group data (Tables 6.15 , 6.16 and 6.17 ).
Seven of the eight variables show a similar pattern , with peaks of
irritability , tension & anxiety , body swelling and period pain , and troughs in
mood and energy occuring during the pfw whilst the converse was true in the
first five days of the pill cycle . This pattern holds for the control women too ,
suggesting an independence from exogeneous hormone levels . On these
parameters , the women felt at their worst during the pill free week and at
their best immediately after recommencing the pill. The rest of the cycle
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Figure 6.5 The doses of L-Norgestrel and ethinyl oestradiol in the
most common triphasic and monophasic pill with the
division of the cycle into five phases according to " pill
cycle phase ". ( Day 1 = first day of pill regime )
( Adapted from : Bancroft, Sanders , Warner & Loudon ( 1987 ))
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TABLE 6.14
MEAN PILL CYCLE PHASE SCORES
( Standard Deviations in brackets )
TRIPHASIC GROUP
PARAMETER P1 P2 P3 P4 P5
Mood 13.39 (2.35) 14.80 (2.22) 14.99 (2.30) 14.43 (2.39) 13.80 (2.36)
Irritable 3.02 (1.76) 1.71 (1.34) 1.74 (1.26) 2.18 (1.70) 2.62 (1.67)
Energy 10.73 (3.12) 13.19 (2.53) 12.70 (2.95) 12.40 (2.99) 11.33 (2.97)
Tense
& Anxious 2.77 (1.80) 1.76 (1.74) 1.67 (1.67) 2.08 (1.92) 2.36 (1.84)
Breast,
tenderness 1.92 (1.47) 0.05 (0.15) 0.19 (0.42) 0.95 (1.44) 2.15 (1.96)
3ody Swelling 3.08 (1.44) 0.41 (0.87) 0.35 (0.66) 1.03 (1.26) 2.24 (1.83)
Period Pain 2.04 (1.31) 0.14 (0.29) 0.03 (0.09) 0.13 (0.28) 0.42 (0.72)
Sexual
Interest 2.75 (1.55) 3.88 (1.63) 3.61 (1.82) 2.67 (1.35) 2.72 (1.43)
DAYS 5 7 5 6 5
PILL CYCLE ACTIVE PILL
MONOPHASIC GROUP
PARAMETER P1 P2 P3 P4 P5
Mood 12.06 (2.61) 14.17 (2.41) 13.98 (3.04) 13.88 (2.84) 12.97 (3.56)
Irritable 2.71 (1.57) 1.39 (1.11) 1.51 (1.57) 1.76 (1.68) 2.20 (1.89)
Energy 10.42 (2.09) 12.47 (2.50) 12.34 (2.75) 12.23 (2.55) 11.37 (2.89)
Tense
& Anxious 2.56 (2.08) 1.46 (1.47) 1.74 (1.99) 1.97 (2.04) 2.48 (2.57)
Breast
tenderness 1.22 (1.31) 0.14 (0.38) 0.17 (0.36) 0.47 (0.84) 0.95 (1.34)
Body Swelling 2.76 (1.89) 0.53 (0.90) 0.64 (1.34) 1.12 (1.88) 2.01 (2.26)
Period Pain 1.79 (1.38) 0.23 (0.54) 0.09 (0.23) 0.19 (0.40) 0.56 (1.08)
Sexual
Interest 2.61 (2.02) 3.89 (1.97) 3.28 (1.84) 2.75 (1.67) 2.51 (1.67)
DAYS 5 7 5 6 5
Pill Cycle ACTIVE PILL ■
CONTROL GROUP
PARAMETEF P1 P2 P3 P4 P5
Mood 12.83 (2.86) 15.57 (2.81) 15.69 (2.30) 14.90 (2.51) 14.12 (2.84)
Irritable 3.11 (1.78) 1.44 (1.40) 1.24 (1.19) 1.70 (1.52) 2.45 (1.73)
Energy 10.47 (2.74) 13.67 (3.19) 13.64 (2.59) 12.77 (2.73) 11.80 (2.94)
Tense
& Anxious 2.63 (1.76) 1.55 (1.42) 1.28 (1.34) 1.70 (1.61) 2.06 (1.83)
Breast
tenderness 2.09 (1.71) 0.11 (0.31) 0.19 (0.37) 0.93 (1.56) 2.40 (2.30)
^0c^wellinq 2.64 (1.81) 0.28 (0.60) 0.23 (0.46) 0.80 (1.06) 2.08 (1.81)
Period Pain 2.02 (1.39) 0.22 (0.93) 0.03 (0.10) 0.12 (0.38) 0.36 (0.68)
Sexual
Interest 2.47 (1.77) 4.27 (2.33) 3.86 (1.82) 3.37 (2.01) 2.64 (2.05)
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Figure 6.6 Comparison of monophasic , triphasic and control groups on
measures of mood , irritability , energy and tension & anxiety
divided by pill cycle phase ( double plotted ) .
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( Numbers in brackets inducate N values for sexual interest)
Figure 6.7 Comparison of monophasic , triphasic and control; groups on
measures of breast tenderness , body swelling , period type




OVERALL ANOVA SUMMARY TABLE ( F-VALUES ) FOR DATA
DIVIDED BY PILL CYCLE PHASE







ENERGY 0.85 42.16** 1.12






BODY SWELLING 0.48 114.38** 0.65




Degrees of Freedom 2 4 8
Key*-p<o.05; **-p<o.oi.
TABLE 6.16
THE EFFECT OF PILL CYCLE PHASE IN EACH GROUP
( F-VALUES FROM TWO-WAY ANOVA WITH REPEATED MEASURES )
PARAMETER TRIPHASIC MONOPHASIC CONTROL
MOOD 2.76* _ _ _ ★ ★7.83
★ ★
24.97
IRRITABLE 9.54** 10.10** 33.86**
ENERGY 10.06** **8.56 33.95**
TENSE & ANXIOUS 5.27** 6.68** 13.32**
BREASTrENDERNES£ 24.45** 7.06** 55.96**
BODY SWELLING 37.34** 27.52** 58.87**






Degrees of Freedom 4,476 ( 404)
Key ;- * p < 0.05 ; ** p<0.01
( Figures in brackets indicate DFe for sexual interest)
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TABLE 6.17
PAIRWISE COMPARISONS BETWEEN GROUPS ASSESSED











MOOD ns ns *
IRRITABLE ns ns ns
ENERGY ns ns ns
TENSE & ANXIOUS ns ns ns
3REASTtenderness * ns **
BODY SWELLING ns ns ns
PERIOD PAIN ns ns ns
SEXUAL INTEREST ns ns ns
Kgy ■- ns - not significant; * p<0.05; ** p<0.01.
shows a gradual decline in well-being. The symptom of breast tenderness ,
however reveals a slightly different pattern , with maximal scores occuring
before the pfw in both the control and triphasic groups whilst the monophasic
group exhibit peak scores during the pfw . Minimal values occured during
the first pill phase in all three groups .
Analyses of variance reveal highly significant overall phase effects on
all parameters , and no differences between the three groups on any
measure except breast tenderness . This the only parameter for which a
significant interaction between group and phase is seen reflecting the
difference in timing of maximal symptoms between the groups , as well as a
difference in absolute levels of severity .
Examination of phase effects within each group (table 6.16 ) reveals that
a strong cyclical pattern was indicated overall on all parameters.
On none of these measures were the triphasic group different from the
control group ( table 6.17 ) . However differences were apparent between
the monophasic and control groups on measures of mood and breast
tenderness . The latter of these parameters demonstrated a similar
difference between triphasic and monophasic groups .
Overall , then it can be said that no consistent differences have been
observed between the three groups on any of the parameters except mood
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and breast tenderness . In both cases the triphasic and control groups are
similar whilst the monophasic group is different from both .
6.3.4 NON-PARAMETRIC ANALYSIS
One of the major sources of error in estimating differences between
groups on the basis of symptom severity assessed by prospective subjective
data is the possibility of differential scale use between subjects and across
the study . In other words , a score of 6 on any 0-10 scale may represent a
severe symptom
experience to one subject but a relatively minor experience to another . This
source of error could conceivably explain apparent differences in severity on
parameters discussed in section 6.3.3 . An alternative way of examining the
data would be from a non-parametric standpoint , not involving the use of
absolute values but rather assigning scores to categories indicating an
average , better than average or worse than average experience of a
particular symptom on a particular day . Collective data within each group
would then demonstrate the proportion of the sample experiencing
symptoms or not at any timepoint . The practicalities of such a method
involve the imposition of a " baseline " or measure of central tendency onto
cyclical data and a definition of points to be considered as " peaks " or "
troughs " of experience . ( For a fuller discussion of cycle analysis in the
context of PMS research see Chapter Four). In this case , the baseline used
was the mean score over all usable data ( complete cycles only and
standardized to 28 days in the control group ) for each symptom for each
subject .The normal range of scores was defined as the mean plus or minus
one standard deviation for each symptom , all scores falling outwith this
range being classed as worse than normal or better than normal. Semantic
difficulties arise in the description of this analysis in that high scores on three
parameters i.e. mood , energy and sexual interest imply a better than normal
experience , that is a peak could be defined as " good " whereas a high
score on other parameters (irritability , tense & anxious , breast tenderness ,
body swelling , period pain ) indicates a worse than normal experience , i.e.
a peak could be described as " bad ". The converse of this being true of any
troughs in the data . In order to reduce confusion the data is described in two
ways - as " good " days and " bad " days , where the assignment of a good
day for instance implies a better than normal experience - or no experience -
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of a particular symptom rather than a peak or trough in the data . This
concept is described diagrammatically in figure 6.8 .
The frequencies of occurence of good days and bad days for each
parameter across the three groups is shown in figures 6.9 to 6.16 . All the
measured variables show frequency patterns which might be expected from
women reporting PMS . Bad days tended to occur before and during
menses, with good days peaking after menstruation .Several important
features may be extracted from an examination of these graphs
1 ) The three experimental groups are indistinguishable on the majority of
variables considered , that is the percentage of cycles which were good or
bad on a particular day is apparently unaffected by being an oral
contraceptive user. The major exceptions to this are breast tenderness and
sexual interest . In the former case , the monophasic group whilst exhibiting
the same pattern as the others , shows consistently lower frequencies of both
good days and bad days throughout the menstrual cycle . This might suggest
a larger subgroup of monophasic users who experience either no breast
tenderness or noncyclical breast tenderness than appears in the other
groups . In the case of sexual interest , the two pill using groups show a very
similar and almost flat pattern , although a peak of good days is apparent at
the beginning of the menstrual cycle . However the control group show a
rather more marked cyclical pattern , with a peak of bad days occuring
during menstruation .Thus it would appear that a postmenstrual increase in
sexual interest is present in all groups but that its presence is less marked in
the pill using groups due to the absence of a substantial menstrual decrease
in sexual interest . This phenomenon may be related to a stronger menstrual
sex taboo in the control subjects , or differing attitudes towards menstruation
in the three groups due to oc induced changes in the heaviness and
duration of menstrual bleeding ( N.B. there is no evidence from either the
non-parametric analysis or the previous analyses of any differences
between the groups in either the absolute severity or timing of occurence of
dysmenorrhea ) .
2 ) The pattern of occurence of each symptom is not necessarily
congruent with all other symptoms . In this respect there appears to be a
dichotomy between those variables which might be described as physical
i.e. breast tenderness , body swelling and period type pain , and those which
might be described as psychological i.e. mood , irritability , energy and












Figure 6.8. Diagrammatic representation of the definition of
of " Good Days " and " Bad Days "
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MOOD - " BAD " DAYS
Pill Cycle
MOOD - " GOOD " DAYS
60 i
Day of cycle
Key -o- Triphasic N = 83
Monophasic N = 86
-*• Control N = 121
Figure 6.9 Frequency distribution of " good " days and " bad " days by
cycle day on the measure of mood .
( Day 1 = first day of menstruation ).
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IRRITABILITY - " BAD " DAYS
IRRITABILITY - " GOOD " DAYS
Day of cycle
Key -o-Triphasic N = 83
Monophasic N = 86
Control N = 121
Figure 6.10 Frequency distribution of " good " days and " bad " days by
cycle day on the measure of irritability
( Day 1 = first day of menstruation )
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ENERGY - " BAD " DAYS
Pill Cycle
60 -1
ENERGY - " GOOD " DAYS
Day of cycle
Key -0- Triphasic N = 83
Monophasic N = 86
Control N = 121
Figure 6.11 Frequency distribution of " bad " days and " good "
days by cycle day on the measure of energy
( Day 1 = first day of menstruation )
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TENSION & ANXIETY - " BAD " DAYS
10
TENSION & ANXIETY - " GOOD " DAYS
70 n
Day of cycle
Kev -o- Triphasic N = 83
Monophasic N = 86
Control N = 121
Figure 6.12 Frequency of distribution of " bad " days and " good "
days by cycle day on the measure of tension & anxiety











-a- Triphasic N = 83
Monophasic N = 86
Control N = 121
Figure 6.13 Frequency distribution of " bad " days and " good "
days by cycle day on the measure of breast tendernes






BODY SWELLING - " GOOD " DAYS
100 n
Day of cycle
Kev Triphasic N = 83
Monophasic N = 86
"*• Control N = 121
Figure 6.14 Frequency distribution of " bad " days and " good "
days by cycle day on the measure of body swelling
( Day 1 = first day of menstruation )
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PERIOD TYPE PAIN - " BAD " DAYS














Kev -o Triphasic N = 83
Monophasic N = 86
Control N = 121
Figure 6.15 Frequency distribution of " good " days and " bad " days
by cycle day on the measure of period type pain
( Day 1 = first day of menstruation )
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Kev : - ■Q" Triphasic N = 65
Monophasic N = 73
Control N = 101
Figure 6.16 Frequency distribution of " good " days and " bad "
days by cycle day on the measure of sexual interest
( Day 1 = first day of menstruation )
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linked with menstruation showing a steep increase from about day 17 or 18
of the menstrual cycle and a precipitous decline during menstruation . The
psychological variables on the other hand show a clear but less dramatic
cyclical pattern with good days tending to peak at about day 11 or 12 with a
gradual decline to a peak of bad days at the beginning of menstruation.
3 ) As mentioned above , the variables examined here describe a
cyclical pattern . None except possibly period type pain , could be said to be
absent for most of the menstrual cycle and present only for the week before
or during menstruation , rather they are truly cyclical . Individual case
studies may reveal many different cycles which when considered collectively
produce the patterns seen here .
Statistical testing of non-parametric data of this kind is difficult. Each cycle
can potentially contribute a different amount of data to the final total e.g. one
cycle may
contain 5 bad days , wheras another contains 10 , due to the manner in
which the raw data were assessed . In order to reduce the error due to this
variability , scores were weighted to ensure that each cycle in fact
contributed one data point to the overall total . For example , if a cycle
contained 7 bad days , each of these was assigned a value of one-seventh ,
hence the total cycle score was one . If a cycle contained two bad days ,
each was assigned a score of one-half. These revised scores then replaced
the " bad " days in the numerical representation of the symptom pattern .
These weighted scores were collected for each cycle day, as the original
frequencies had been , and a Chi-square test of association between the
three groups was performed on the resultant frequencies . Three
parameters were chosen for this treatment , two on the basis of possible
group differences evident from the graphs , i.e. breast tenderness and
sexual interest , and one other, i. e. mood . The Chi-square test showed no
significant group differences on any of the parameters after the data had
been collapsed to cope with small cells ( Mood Chi-square = 2.23 , df = 6 ;
Breast tenderness Chi-square = 3.72 , df = 6 ; Sexual interest Chi-square =
3.21, df = 6 - see Appendix ).
6.3.5 ANALYSIS OF SYMPTOM PATTERNS
One of the sources of error in the description of data by means of
averages is the possibility of obscuring extreme subgroups within the data .
In this case , the discussion of overall average symptom scores or
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frequencies revealing no major group differences may be obscuring subtle
differences in the conformation of subgroups of symptom patterns within the
data . In order to assess this possibility fully , detailed analyses of each
individual would be required . However , a crude approximation can be
achieved if symptom scores in specific time phases are compared to each
other . In this case ratios were calculated between scores in the menstrual
and premenstrual phases and scores in the postmenstrual phase ( these
phases are defined in section 6.3.2 ) . In this analysis the overall data for
each woman was considered regardless of possible intrasubject variability
between cycles . On this basis each variable was categorized for each
woman according to the following schedule . A ratio of 1.26 to 1.49 ( or 0.51
to 0.99 if either score were zero ) was considered to be evidence of a mild
change . A ratio of > 1.5 ( or > 1.0 if either score were zero ) was cosidered
evidence of a severe change . If ratios of <1.25 ( or < 0.5 ) occurred then
the variable was considered to be noncyclical , and if a ratio reaching the
criteria occurred other than between the specified phases or in a different
direction , the variable was described as atypical . This schedule led to 10
possible pattern combinations i.e. mild premenstrual ( MP); severe
premenstrual ( SP ) ; mild menstrual ( MM ) ; severe menstrual ( SM ) ;
MP+MM ; MP+SM ; SP+MM ; SP+SM ; Noncyclicai and Atypical .Each
woman was categorised into one of these groups for each symptom .
Frequencies of occurrence of these categories for each variable in the three
groups were calculated (table 6.19 ). This frequency data was tested using
the Chi-square test of association . In order to do this , it was necessary to
collapse data thus avoiding small cell sizes . Hence the reduced categories
are premenstrual only ; menstrual only ; premenstrual + menstrual ; and
noncyclical + atypical . Graphical representations of the data can be seen in
figures 6.17 and 6.18 and the numerical data in table 6.20. Each of the
variables reveals a slightly different pattern . For instance in the case of
mood , a high incidence of atypical and noncyclical patterns is seen in all
three groups . However , body swelling shows a high premenstrual +
menstrual incidence , and period pain a high menstrual only incidence .
Three variables produced evidence suggestive of group differences on the
basis of Chi-square
i) Energy - The difference here is a relative excess of women in the
monophasic group experiencing menstrual only energy loss with
consequently lower frequencies in the premenstrual and premenstrual +
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TABLE 6.18
FREQUENCIES OF ALL SYMPTOM PATTERN CATEGORIES
TRIPHASIC GROUP
PARAMETER MP SP MM SM MP/MM MP/SM SP/MM SP/SM Atypical
Non
cvclical N
Mood 4 1 1 1 2 0 0 1 7 12 30
Irritable 1 1 2 0 1 1 2 13 4 4 30
Energy 6 0 1 0 2 4 0 3 3 10 30
Tense
& Anxious 2 4 1 0 0 1 2 9 4 6 30
Breast
tenderness 0 5 0 0 0 0 2 17 1 4 30
Body Swelling 0 1 1 1 1 0 1 23 1 0 30
Period Pain 1 0 2 15 0 1 1 7 0 2 30
Sexual Interest 2 2 1 6 0 2 2 5 3 1 24
MONOPHASIC GROUP
PARAMETER MP SP MM SM MP/MM MP/SM SP/MM SP/SM Atypical
Non
cvclical N
Mood 0 1 4 1 3 1 2 1 4 18 35
Irritable 0 1 1 8 0 2 1 15 7 0 35
Energy 2 1 8 4 0 1 2 0 2 15 35
Tense




1 1 2 0 2 0 12 4 13 35
Body,,Swellina 0 2 1 1 1 1 1 23 0 4 35
Period Pain 0 0 4 14 0 2 0 9 0 6 35
Sexual Interest 0 • 1 2 4 2 3 3 8 3 4 30
CONTROL GROUP
PARAMETER MP SP MM SM MP/MM MP/SM 3P/MM SP/SM atypical
Non
cvclical N
Mood 8 2 6 4 3 4 1 1 7 21 57
Irritable 2 5 2 2 2 4 3 31 5 1 57
Energy 8 5 8 6 2 3 2 3 3 17 57
Tense
. .& Anxious 3 3 4 6 0 2 3 22 6 8 57
Breast
tenderness 4 9 0 5 0 0 6 27 1 5 57
Body Swelling 3 3 0 2 2 2 4 36 2 3 57
Period Pain 0 0 4 29 1 6 0 9 0 8 57
Sexual Interest 2 6 1 3 1 5 5 14 6 6 49
Key : MP - mild premenstrual; SP - severe premenstrual
MM - mild menstrual ; SM - severe menstrual
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TABLE 6.19










T 5 (17.2%) 2 (6.9%) 3 (10.3%) 19 (65.5%)
M 1 (2.9%) 5 (14.3%) 7 (20.0%) 22 (62.8%)
C 10 (17.5%) 10 (17.5%) 9 (15.8%) 28 (49.1%)
IRRITABLE
T 2 (6.9%) 2 (6.9%) 17 (58.6%) 8 (27.6%)
M 1 (2.9%) 9 (25.7%) 18 (51.4%) 7 (20.0%)
C 7 (12.3%) 4 (7.0%) 40 (70.2%) 6(10.5%)
ENERGY
T 6 (20.7%) 1 (3.4%) 9 (31.0%) 13 (44.8%)
M 3 (8.6%) 12 (34.3%) 3 (8.6%) 18 (51.4%)




T 6 (20.7%) 1 (3.4%) 12 (41.4%) 10 (34.5%)
M 4 (11.4%) 7 (20.0%) 13 (37.1%) 11 (31.4%)
C 6 (10.5%) 10 (17.5%) 27 (47.4%) 14 (24.6%)
BREAST
TENDERNESS
T 5 (17.2%) 0 19 (65.5%) 5 (17.2%)
M 1 (2.8%) 3 (8.6%) 14 (40.0%) 17 (48.6%)
C 13 (22.8%) 5 (8.8%) 33 (57.9%) 6 (10.5%)
BODY
SWELLING
T 1 (3.4%) 2 (6.9%) 25 (86.1%) 1 (3.4%)
M 2 (5.7%) 3 (8.6%) 26 (74.3%) 4 (11.4%)
C 6 (10.5%) 2 (3.5%) 44 (77.2%) 5 (8.8%)
PERIOD
PAIN
T 1 (3.4%) 17 (58.6%) 9 (31.0%) 2 (6.9%)
M 0 18 (51.4%) 11 (31.4%) 6 (17.1%)
C 0 33 (57.9%) 16 (28.1%) 8 (14.0%)
SEXUAL
INTEREST
T 4 (16.7%) 7 (29.2%) 9 (37.5%) 4 (16.7%)
M 1 (3.3%) 6 (20.0%) 16 (53.3%) 7 (23.3%)
C 8 (16.3%) 4 (8.2%) 25 (51.0%) 12 (24.5%)
Key j - triphasic group; M - monophasic group; C - control group
247
Mood Irritability
Energy Tension & Anxiety
Kev P - Premenstrual only category ; M - Menstrual only category ;
P+M - Premenstrual + Menstrual category ;A+N - Atypical and noncyclical categc
■ Triphasic N = 30
0 Monophasic N = 35
H Control N = 57
Figure 6.17 Distribution of the four pattern categories for mood , irritability ,
energy and tension & anxiety , within the three hormonal group:
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Breast tenderness Body swelling
Period type pain Low sexual interest
Kev P - Premenstrual only category ; M - Menstrual only category ;
P+M - Premenstrual + Menstrual category ; A+N - Atypical and noncyclical category
g Triphasic N = 30 (24)
E3 Monophasic N = 35 ( 30 )
H Control N = 57 ( 49 )
( Figures in brackets indicate numbers for sexual interest)
Figure 6.18 Distribution of pattern categories for breast tenderness , body
swelling , period pain and low sexual interest within the three
hormonal groups .
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menstrual categories . This is in contrast to the triphasic group which shows
a marked low frequency in the menstrual only category with concomitant
increases in the premenstrual and premenstrual + menstrual categories . It
should also be noted that the majority of women in each group are
experiencing noncyclical or atypical changes in energy .
ii ) Irritability - In this case the majority in each group fall into the
premenstrual + menstrual category . A relative excess of monophasic group
members fall into the menstrual only category .
iii ) Breast Tenderness - In this case the majority of women in the
triphasic and control groups fall into the premenstrual + menstrual category .
However the majority of monophasic pill users are noncyclical , this
frequency being greatly in excess of the noncyclical frequencies in the other
two groups . There are concomitantly fewer monophasic women in the
premenstrual only and premenstrual + menstrual categories . The triphasic
and control groups being similar throughout.
The striking differences found between the groups by this analysis
suggest that other differences found on measures of breast tenderness are
due to the presence within the monophasic group of a large subgroup of
women who are not experiencing cyclical breast tenderness i.e. they either
have no breast symptoms or a chronic noncyclical level of breast pain .
6.4 DISCUSSION
In the introduction , three possible outcomes were suggested for this
study , on the basis of a hormonal role in cyclical mood changes in women .
They were
1 ) The two pill groups will produce similar data , but different from the
control group suggesting a role for both ovulation as such and luteal
hormones - or a non-hormonal side effect of oral contraceptive use .
2 ) The triphasic and control groups will produce similar data divergent
from the monophasic group , suggesting a role for changing hormone levels
, but not ovulation perse .
3 )The three groups will all produce similar data suggesting a lack of
importance of either ovulation or luteal hormones in the expression of
cyclical mood change .
It would appear that the data presented here largely support the latter
alternative .
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Most of the symptoms showed a high level of cyclicity . Noncyclical
subgroups were found in each of the experimental groups for those
symptoms in which a less obvious cyclical pattern was expressed e.g. mood.
Several factors emerged whichever method of analysis was employed ,
suggesting a lack of uniformity between symptoms . The three groups were
found to be almost indistinguishable on measures of irritability , energy ,
tension & anxiety , body swelling and , surprisingly , period pain . However,
measures of breast tenderness and mood were found to be more congruent
in the triphasic and control groups compared to the monophasic group .
Analysis of the data by menstrual cycle phase suggested a tendency for
monophasic users to experience some symptoms ( namely irritability ,
tension & anxiety , energy , body swelling and low sexual interest ) during
menstruation rather than before . This effect can be attributed to menses
itself rather than the pfw since it disappears when the data is analysed by pill
cycle phase . The possibility arises that monophasic users experience
menstruation in a different way either psychologically or physiologically from
the other two groups . This effect is supported by the discovery of an excess
of monophasic users falling into the menstrual only pattern category on
measures of energy and irritability .
Measures of tension & anxiety and sexual interest tended to show some
congruity between pill groups as opposed to the control group , although
these effects were never present to a significant degree . This effect ,
especially in the case of sexual interest , could be explicable by non-specific
effects of oc's on the length of menses or period pain . However the three
groups were surprisingly indistinguishable on the basis of period pain . An
alternative explanation is the psychological effect of oc's . Those women
who use an oc are almost completely free from the fear of pregnancy , hence
both they and their partners may feel more able to express their sexuality at
all times of the menstrual cycle . Tension and anxiety about a possible
pregnancy may also be removed from the premenstrual phase , suggesting
that this symptom is more closely associated with reproductive function than
PMS . The use of an oc may also result in very light menstrual bleeding ,
perhaps reducing the menstrual sex taboo for both partners . Arguably , the
coincident reduction in premenstrual tension & anxiety may be due to the
removal of the expectation of a period of sexual abstinence . The originally
hypothesized explanation for this type of result i.e. that ovulation and luteal
function are necessary for the expression of those symptoms which show
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similarity between the pill groups but not the control group , is then not the
only possible explanation for these results .
The parameters of breast tenderness and to a lesser extent mood , seem
to fall into the second hypothetical category . That is - similarity is present
between the triphasic and control groups and absent in the monophasic
group . In both cases this appears to be due to a large subgroup of women
who experience noncyclical mood and breast tenderness . In the former
case , the subgroup is found in all experimental groups . However , in the
case of breast tenderness , only the monophasic group showed the high
incidence of noncyclicity . This divergence between the two pill groups
makes alternative hypotheses on the basis of oc use unlikely . It would
appear to be the case that breast tenderness is more dependent for its
expression on luteal activity than are symptoms such as body swelling or
irritability .
These results add further weight to the idea of subtypes of PMS with
differing aetiologies , perhaps the assumption that cyclicity is the key to PMS
and that the individual symptoms are unimportant is wrong . These data
suggest that pill use is having an effect on the expression of cyclical
symptoms at two levels . Firstly all types of oc would seem to have similar
psychological effects on the perception of reproductive capacity with " knock
on " effects on the expression of sexual interest and premenstrual anxiety ,
coupled with physiological effects on menstrual function which may also
cause an alteration in the expression of sexual interest and anxiety .
Secondly the monophasic type of oc would appear to have an
endocrinological effect , flattening the expression of those symptoms which
are sensitive to luteal hormones i.e. breast tenderness .
Another aspect of importance in these results is the appearance of
subgroups within different pill taking samples . In the case of breast
tenderness , not all of the monophasic users demonstrated the same
response . Whilst the majority of them did not show any cyclical changes on
this measure , some of them still did . The causes of this diversity of response
are unknown . Possibly endocrinological studies of the subgroups of oc
users would reveal different levels of endogeneous hormone activity .
Potentially the most important effect shown in this study is the lack of
effect of long term oc use on symptoms of PMS such as irritability and body
swelling . The possibility exists that sufficient residual ovarian activity is
present in low-dose pill users to allow these symptoms to occur. This type of
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hypothesis shifts the emphasis from progesterone and the luteal phase
hormonal milieu to oestrogen and its fluctuating effects . At present there is
insufficient knowledge of the residual ovarian activity in low dose oc users to
allow a definite conclusion from the above data that ovarian activity is not a
prerequisite for the occurrence of those symptoms which do not differ
between experimental groups . However, this would appear to be a distinct
possibility .
6.5 SUMMARY
Cyclical symptoms do occur in all three experimental groups . The
expression of this cyclicity is however variable both between symptoms and
on occasion between groups . The most striking between group difference
occurs on measures of breast tenderness . In this case , the triphasic users
and the control group are virtually indistinguishable throughout the analysis .
However, the monophasic group , with their steady hormonal milieu , exhibit
a large and highly significant subgroup of women who are noncyclical in this
respect . Thus a role for cyclical ovarian hormones is implied in the
expression of breast tenderness although not for ovulation itself.
All other variables show consistent similarity across groups , reducing the
likeliehood of a dominant hormonal aetiology . There is a suggestion ,
however, that cyclical changes in sexual interest and tension & anxiety may
be suppressed by the use of either type of oral contraceptive . This may
indicate that ovulation is a prerequisite for these changes to occur, however
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7.1 INTRODUCTION
The primary aim of this research was to investigate the often cited
relationship between premenstrual symptoms and the ovarian cycle . It
cannot be said , from a review of the literature , that either of these two areas
of research are adequately delineated in their own right . Many unanswered
questions remain , both about the nature , and very existence of
premenstrual symptoms and about the controlling mechanisms behind the
ovarian cycle . In such a state of affairs , an attempt to elucidate the link
between them is arguably an attempt to run before we are able to walk.
However, the controversy which reigns about the role of the ovarian cycle in
the expression of female behaviour , and the widespread prescription of
hormonal remedies for PMS , makes just such an investigation imperative
from both theoretical and clinical viewpoints .
In Chapter Three , the major approaches to this area were discussed,
and it was seen that the investigation of symptom patterns in normal and
abnormal menstrual cycles had been neglected . If some factor inherent in
the normal ovarian cycle is responsible for the occurrence of premenstrual
symptoms , then arguably , disruption of the cycle may cause disruption of
the symptom pattern . In this thesis , the potential factors under investigation
were the endocrine event of ovulation and the concomitant changing levels
of oestrogen and progesterone . In order to simplify and rationalise the
investigations , six questions were formulated , dealing with specific effects
of various hormonal patterns on premenstrual symptoms .
1) Can premenstrual symptoms occur in the natural absence of ovulation?
2) Can premenstrual symptoms occur in naturally ovulatory and
anovulatory cycles in the same woman ?
3) Are premenstrual symptoms similar or different in totally ovulatory and
totally anovulatory women of the same age group ?
4) Can premenstrual symptoms occur in artificially anovulatory cycles ?
5) If premenstrual symptoms can occur in artificial menstrual cycles , are
they related to levels of exogenous steroids ?
6) Is symptom timing or severity related to the adequacy of corpus luteum
activity?
These questions can be divided into two categories ; those which can be
answered by an investigation of naturally occuring abnormal menstrual
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cycles , and those which can be addressed by the artificial manipulation of
the menstrual cycle . Hence , two complementary studies were instigated ,
whose design and results are described in Chapters Five and Six . In this
chapter an attempt will be made to answer the posed questions from the
results obtained , to relate these findings to previous research and to
discuss the aetiological implications with regard to premenstrual symptoms.
7.2 PREMENSTRUAL SYMPTOMS AND NATURALLY OCCURING
ABNORMAL MENSTRUAL CYCLES
In this study , the original intention was to compare symptomatically
normal and abnormal menstrual cycles in the same woman . Despite the
attempte made at recruitment in the appropriate age groups and categories ,
the number of abnormal cycles was disappointingly small . This may be due
in part to inappropriate selection criteria . For instance , more abnormal
cycles may have occurred in the perimenopausal group if subjects had been
selected on the basis of peripheral FSH levels rather than age alone ; or if
the recruitment poster had been directed more closely at women who had
recently experienced a change in their menstrual pattern . In this way it might
have been possible to identify truly perimenopausal , rather than middle-
aged women . Similarly in the post-partum group , it appeared that those
women who breast fed for a long time were more likely to ovulate and have
fairly normal luteal phases even before the first post-partum menstruation .
Hence , a higher frequency of abnormal cycles might have been seen if the
study had concentrated on women who intended to bottle feed or to stop
breast feeding fairly abruptly , at three months for instance. However ,
motivation for the study was fairly low in the post-partum group as a whole ,
and particularly among the bottle and short-term breast feeders . This may
be in part because the latter group were more likely to have other small
children at home or to be going back to full or part-time work , hence there
were other demands on their time . Another major interfering factor in this
group was the choice of contraceptive method . Although the women were
encouraged to use barrier methods for the course of the study , it was felt to
be neither ethical nor desirable to forbid the use of steroidal contraception if
the women felt this to be their only option . Hence , several of the datasets
are abbreviated or interrupted by the use of oral contraceptives . In total
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then , it would seem that the post-partum period may not be a particularly
appropriate focus for this type of research , although the relative
"unexpectedness" of the first post-partum menstruation may be useful from
a theoretical point of view1.
It should also be borne in mind that the women studied had not been
diagnosed as PMS sufferers , by anyone other than themselves . The
majority of them , as seen from the profiles in Chapter Five , cannot be said
to show a typical debilitating premenstrual pattern , suggestive of the classic
premenstrual syndrome . In this approach , the degree of symptomatology
experienced is relatively unimportant . However, any conclusions from the
study should be applied with caution to the aetiology or manifestation of
PMS . Such an extension is endorsing the assumption that mild , or arguably
normal , premenstrual symptoms are aetiologically similar to the PMS .
Three of the original six questions can however be approached from
these data, and they will be considered in turn .
i) Can premenstrual symptoms occur in the natural absence of
ovulation?
The small number of anovulatory cycles seen in this group makes data
interpretation difficult . Premenstrual symptoms did appear to occur in the
absence of ovulation in some cases , and no evidence emerged to suggest
that anovulatory cycles are necessarily symptomatically different from
ovulatory ones , except possibly in the case of breast tenderness . This
finding agrees with several previous research studies which have suggested
that ovulation itself makes no difference to the appearance of symptoms
1 A subjective impression was gained from talking to the women that the
first post-partum menstruation was possibly not as unexpected as theory
might suggest . The majority of them were reasonably well informed about
pregnancy and lactation and / or had had previous children . Hence , they
realised that they would start to menstruate after stopping breast feeding .
Although the actual date of menstruation was unknown , they were aware
at the appropriate time that they would bleed within the next week or so .
This factor was of course enhanced by the presence of a researcher
attempting to guess the time of return of ovarian activity . The
unexpectedness of the first bleed might have been increased by studying
all the women from delivery - although in some cases this would have
meant 9 months to a year of data collection before the study proper began ,
and would only really be feasible in combination with another research
project , e.g. a study of mood changes during lactation .
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(Adamopoulos , Loraine , Lunn , Coppen & Daly 1972 ; Andersen, Larsen ,
Steenstrup , Svendstrup & Nielsen 1977; Backstrom et al 1983 ) . hence , the
evidence would appear to be at odds with the assertion made by Magyar ,
Boyers , Marshall & Abraham ( 1979 ) , amongst others, that premenstrual
symptoms are indicative of ovulation .
ii) Can premenstrual symptoms occur in naturally ovulatory and
anovulatory cycles in the same woman : and if so - are they similar in type ,
intensity or duration?
As indicated above , the small number of anovulatory cycles seen makes
this question difficult to answer . However , it would appear that for all
symptoms except breast tenderness , the presence or absence of ovulation
in a particular individual has little or no effect on the occurrence , intensity or
duration of symptom experience . In the case of breast tenderness , levels
would appear to be less pronounced in anovulatory cycles and to be
associated with menstruation rather than the premenstrual phase . This
finding , however is not universal , with some degree of variability being
seen between consecutive ovulatory and consecutive anovulatory cycles .
iii) Is symptom timing or severity related to the adequacy of corpus luteum
activity ?
Two assessments were made of luteal phase adequacy in this study -
short luteal phase and inadequate luteal phase . The presence of either one
of these appeared to have little effect on the occurrence , timing or duration
of premenstrual symptoms , except in the case of breast tenderness .
Measures on this symptom were found to be either lower , and of a lesser
duration , than normal , or higher and more prolonged than usual in cycles
characterized by an inadequate luteal phase . However , cross-correlational
analyses of the relationship between symptoms and the absolute hormone
levels measured showed no significant correlations for any of the subjects
studied , suggesting that some other component of the ILP is involved .
Several features can be extracted from a consideration of this section of
data and the answers to the three questions above . Firstly : there would
appear to be considerable variability in terms of symptoms between
consecutive cycles , whether normal or abnormal , in the same subject .
Secondly : the symptoms observed cannot be assumed to follow parallel
paterns of occurrence in the same individual . In this study , breast
tenderness appeared to be at odds with all the other symptoms in both group
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and individual analyses; however, since only eight variables were
measured, the possibility must be considered that other symptoms may also
be different . Thirdly : there does not appear to be any systematic
relationship between symptom occurrence or otherwise and the
physiological event of ovulation in any of the women studied . Although
differences did occur between ovulatory and anovulatory cycles , they were
no larger than differences between consecutive normal cycles . This
statement would not appear to hol.d true for the measure of breast
tenderness , which did show a consistent diminution in anovulatory cycles .
Fourthly : the presence of a short luteal phase made no demonstrable
difference to symptom experience on any of the variables assessed either in
terms of timing of onset , intensity or duration of symptoms . Hence , luteal
phase length , and therefore the timing of ovulation , would not appear to be
related to symptom duration . Fifthly : The presence of an inadequate luteal
phase did appear to have a bearing on the experience of breast symptoms ,
although not on any of the others . Breast tenderness was either reduced
and confined to menstruation , or markedly increased in ILP cycles . Sixthly :
correlational analyses of all the individual subjects showed no relationship
between absolute hormone levels or ratios and symptom occurrence .
The potential reasons behind these observations range from the
methodological to the endocrinological. The possibility exists that the results
seen are misleading because none of the women showed classical PMS
type symptomatology . Hence , it could be argued that breast tenderness is
the only variable measured which can be considered to be part of the
syndrome . Therefore , the observation of lower levels of breast tenderness
in ILP and anovulatory cycles would have been parallelled by changes in
any other variable if these women had shown clear cyclical patterns on that
variable . Similarly , the results found may be an artefact of the type of
statistical analysis employed . The use of cycle division and ANOVA in such
a situation is fraught with the dual problems of serial dependency and small ,
differential group sizes ( see Chapter Four) . It would have been possible to
remove the serial dependency in the data , either partially , by detrending the
series , or completely by developing an ARIMA model from each dataset ,
performing the analysis on the " whitened " values . However, it is difficult to
conceptualise the relationship such values would have with time , or how
they could be divided into phases suitable for ANOVA . As indicated in
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Chapter Four , the probability is that ANOVA is not a suitable statistical
approach to this type of data , however , little alternative exists . Attempts
have been made throughout to draw conclusions on the basis of graphical
evidence , using inferential statistics only as a judgemental aid , in order to
reduce the influence of Type I errors , however they cannot be said to have
been entirely ruled out.
Another methodological explanation for these results arises from the fact
that anovulatory and deficient luteal phase cycles are abnormal , and as
such women who experience them , or are likely to experience them , could
be described as untypical . The possibility arises that the very abnormality ,
or transitional state , causing the deficient menstrual cycle may also be
associated with the disruption of mood and symptom patterns generally .
Hence , the demonstration of similarities or differences between apparently
normal and abnormal hormonal cycles in women during transitional phases
of their reproductive lives may have more to do with the state of the women
than the aetiology of premenstrual symptoms.
In summary , then , it would seem that this approach to PMS research is
not particularly cost effective in terms of producing a reasonable quantity of
abnormal menstrual cycles in an otherwise emotionally stable situation. The
applicability of findings from this study to women in situations other than the
perimenopause or the post partum period must be in doubt . Despite these
reservations, the effects seen would appear to be fairly clear. The variables
of mood , irritability , energy , tension, body swelling , period pain and sexual
interest are apparently unaffected by either ovulation or the absolute levels
of luteal phase steroids . Breast tenderness can be reduced in inadequate
(or absent) luteal phase cycles , although this effect is not due to a direct or
lagged relationship with ovarian steroids . Hence , some other explanation is
required for the appearance of premenstrual symptoms , vested either in
follicular phase endocrinology or some other unmeasured variable . In the
case of breast tenderness , there would appear to be a relationship with
some substance , other than the ovarian steroids , which is associated with
luteal phase adequacy . This factor may be present in the follicular phase, or
it may be some luteal factor not measured in this study .
260
7.3 PREMENSTRUAL SYMPTOMS AND ARTIFICIALLY
ABNORMAL MENSTRUAL CYCLES
In this study , a cross sectional approach was employed to compare
women using two different types of oral contraceptive, with a control group ,
matched for age , parity and occupation , on their daily ratings of eight
variables .
Recruitment was accomplished by selecting potential subjects from a
pool of respondents to a national magazine survey . Hence , one major
criticism which could be levelled at the study is the potentially biassed nature
of the original sample . There may be some characteristic of a woman who is
motivated to complete and return a magazine questionnaire which makes
her untypical of the average " woman on the Clapham Omnibus " . The
postal nature of both the original survey and this study , made any
assessment of personality characteristics an impossibility . The fairly low
response rate to the first approach also indicates that some caution should
be applied before the results are generalized to cover most women .
The artificial manipulator assessed in this study was the oral contraceptive
pill (oc) . As pointed out by Cullberg ( 1972 ) and discussed in Chapter Six ,
the psychological effects of oc's due to the prevention of pregnancy may to
some extent confound the pharmacological effects . From an
endocrinological point of view too , although the global action of oc's is
understood ( see Chapter Two ) , their precise effects , especially in the case
of the newer low-dose brands , on the ovarian cycle are not well
characterised . It would appear that some follicular development can occur in
some women - especially during the early pill-taking cycles . Attempts were
made in the study to control for these factors by studying only women who
had already been using the particular oc for some time ( >6 months ) , and
were therefore likely to be adjusted to it . This rationale can be criticized for
the exclusion of all those women who cannot tolerate oc's . Since , arguably,
these women are more sensitive to hormones , potentially we are excluding
the very women we should be studying . Further to this , by age-matching the
control group to the pill-users , we may well be including those women who
are more sensitive to exogeneous steroids , and potentially more likely to be
symptomatic . Hence , the theoretical possibility exists that the sampling
procedure used artificially distorted the rates of symptomatology seen . In
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practice , despite the low response rate , the number of women in the study
was probably sufficient to outweigh this effect. Although most of the women
in the control group had used an oral contraceptive in the past , they were
more likely to have given it up as a result of media fears about long-term side
effects than because they were unable to tolerate it.
No hormonal measures were assessed at any point during the study . The
initial assumptions were made that all women in the control group were
experiencing regular, normal , ovulatory cycles and all the women in the pill
taking groups were exclusively influenced by the exogeneous steroid . Since
the women were all in the 18 - 35 age group , this assumption is probably
reasonable in the case of the control group - although Metcalf & Mackenzie
(1980 ) have shown a higher than expected incidence of anovulatory cycles
in the early twenties age group , especially amongst students . The
assumption may not be so true in the pill taking groups however. Studies of
endogeneous hormone activity during long term low dose oc use are still
rare . Those studies which do exist suggest that some degree of subjective
variability is present after three months of pill use ( Kuhl , Gahn , Romberg ,
Marz & Taubert 1985 ) . The proportion of cycles in which follicular
development occurred being higher in the triphasic group ,36 % compared
to 18 % in the monophasic group . The question of whether this is a
transient effect - that some women take longer to adjust to the pill regime ,
but by , for instance , six months , follicular activity is absent in both groups
remains unanswered . However, studies of " missed pill conceptions " , e.g.
Guillebaud 1986 , suggest that considerable follicular activity can occur in
the pill free week ( pfw ) , and that this may lead to ovulation if pills are
missed , or not absorbed at either end of the pfw . So the assumption in this
case is probably wrong - the pill taking women , or at least a proportion of
them are not exclusively influenced by the exogeneous steroids , there may
be some endogeneous ovarian activity , especially during the pfw .
The statistical methods used to analyse this data are subject to the same
criticisms as those in Chapter Five - namely , the question of serial
dependency and the loss of information in the use of ANOVA . Although the
larger subject numbers in this study tend to reduce the error effects , concern
over the statistical methodology remains a pertinent consideration .
Two of the original six questions can be addressed by this study
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i ) Can premenstrual symptoms occur in artificially anovulatory cycles ? -
and if so , are they similar in type , severity , timing of onset or duration to
matched ovulatory cycles ?
The answer to this would appear to be yes , on all counts . All the
variables studied showed a premenstrual increase in the pill taking cycles ,
and for all of them except breast tenderness , the intensity , timing of onset
and duration was virtually indistinguishable from the control cycles . A
tendency was noted for symptoms to occur menstrually rather than
premenstrually in the monophasic group, particularly on measures of energy
and irritability . Having said this , however, subgroups of women were found
in all three categories who experienced noncyclical or atypical changes .
These groups were especially pronounced for measures of mood and breast
tenderness . Large noncyclical subgroups were found for mood in all three
experimental groups . However , in the case of breast tenderness only the
monophasic group showed a high incidence of noncyclicity . This factor
explained the observation of lower overall levels of breast tenderness seen
in the monophasic group ( see Chapter Six ) . Hence , there would appear
to be some divergence between symptoms and between individuals in
response to artificially anovulatory cycles ; although it can be said that all the
measured variables can occur in pill cycles and be expressed in the same
way as in control cycles , some symptoms , and specifically breast
tenderness , may be more likely to be reduced or absent in women using
monophasic pills .
ii ) If premenstrual symptoms can occur in artificial menstrual cycles ; are
they related to the levels of exogenous steroid ?
The answer to this question would appear to be no , on the basis of the
evidence seen here . Five phase analysis of all three groups showed no
differences in terms of timing or severity of any of the symptoms except
breast tenderness . Hence , it would not appear to be the case that
symptoms occur in association with , or in response to , exogenous or
endogenous steroid levels . As before , breast tenderness is slightly different
in this regard . In this case , the monophasic group - with constant
exogenous hormone levels experienced lower overall levels of breast
tenderness as described above .
The major findings of this study echo to a certain extent those of the study
of symptoms in naturally occuring abnormal cycles . Primarily - neither
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ovulation itself nor the " normal " luteal phase hormone pattern seem to be
prerequisites for symptom occurence on most of the variables measured .
Secondly - some divergence was seen in this study between symptoms ,
with breast tenderness being apparently more sensitive to differing steroid
patterns than other symptoms . Measures of sexual interest and tension &
anxiety tended to be more congruous in the pill groups as opposed to the
control group . As discussed in Chapter Six , this effect may be due in part to
the removal of the fear of pregnancy - reducing tension and allowing a freer
expression of sexuality . Lighter menstrual flow may also be implicated in
this observation . Thirdly - variability could also be discerned between
individuals , indicated by the presence of subgroups of women on all the
variables who show different symptom patterns .
Few research studies have been undertaken in this field, hence
comparisons are difficult to draw . Those which have been conducted on
long term oc users in a cross sectional manner, have tended to concentrate
on depression and negative affect, rather than the full range of premenstrual
symptoms . Forrest ( 1979 ) studied twelve women over one pill cycle , from
the point of view of oc related depression . He found essentially the same
mood pattern as described in this study, in users of low dose pills ( he does
not indicate which brands were used ) . The gradually increasing levels of
depression seen as the cycle progressed are related by Forrest to a
cumulative effect of exogenous steroid . However , since the same pattern
was seen in the present study control group , this hypothesis would appear
to lose validity .
A classic study was conducted by Paige ( 1973 ) , in an attempt to
differentiate the effects of different oc formulations on affective fluctuations .
In her study , the affective measures assessed were anxiety , hostility and
total negative affect derived from a content analysis of speech samples
obtained at four stages of the cycle . Hence , this study is not truly
comparable to the present research in which daily subjective ratings were
used . It should also be borne in mind that the subjects in this study were
using pills which would now be described as " high dose " in terms of
oestrogen content , and that the sequential pills followed a 15:5 day ratio
rather than the 6:5:10 day ratio more common today . Her results indicated
that fluctuations in negative affect do not occur in users of combination oral
contraceptives , The sequential group , although their numbers were small ,
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did show mild changes in total negative affect which mimicked those in
normal cycles . She cites this as evidence in support of the Grant & Pryse-
Davis ( 1968 ) hypothesis that the magnitude of premenstrual anger ,
depression and irritability is directly related to endometrial MAO activity , this
biochemical activity being suppressed in oc users . These results were not
replicated in the present study - although the reasons are difficult to
pinpoint. Arguably , the methods used by Paige to detect affective
fluctuations are more sensitive than subjective daily ratings - however , the
infrequency of collection clouds the issue . Since the speech samples were
only collected at four time points during the cycle , the possibility of slightly
different symptom timing or duration between the groups is neglected . The
dosages of pill used - most of them containing twice as much oestrogen per
tablet as modern pills , may also have had an effect , reducing the
likeliehood of endogenous follicular development . Hence , the effects seen
in the present study may be a reflection of some follicular or " luteal " phase
factor which was suppressed in previous research .
7.4 THE RELATIONSHIP BETWEEN PREMENSTRUAL
SYMPTOMS AND THE OVARIAN CYCLE
The two research studies described in this thesis are complementary both
to each other and to previous studies which have investigated the occurence
of premenstrual symptoms in normal menstrual cycles ( e.g. Backstrom et al
1983 ) . The message from all these varied approaches would seem to be
that the relationship between premenstrual symptoms in general and the
ovarian cycle is temporal rather than absolute in nature . That is - neither
the physiological event of ovulation nor specific levels of luteal phase
hormones appear to be related to symptom timing or severity . Secondary to
this observation are the findings of wide individual differences and
symptomatic differences both in terms of the patterns seen and in response
to the hormonal environment . The observation that breast tenderness
tended to be responsive to situations of relative hormonal abnormality in
both of the studies described is the clearest example of this . In the first study,
the lack of relationship between breast tenderness and absolute hormone
levels was clearly shown , despite the apparent effect of the presence of an
inadequate luteal phase . In the second study , the picture is rather less
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clear, largely because of the current state of ignorance about the level of
endogeneous ovarian activity experienced during low dose oral
contraceptive administration . Although this discussion has been geared
towards likening the triphasic regime to the normal cycle , hormonally ,
identifying the monophasic pill as being different - this may be an over
simplification . The triphasic regime , with its " pill free week " and abrupt
hormonal changes bears only a crude resemblance to the events of a
normal cycle. The point of similarity between the two , and divergence from
the monophasic group , is the presence of relatively elevated levels of
progestagen in the " luteal " phase in the former pair , with constant levels
being maintained in the latter case . Hence , the evidence from this study
would appear to suggest that some women respond to the absence of a
change in progesterone levels , or some associated factor, by a reduction ,
or by a loss of cyclicity , in breast symptoms .
It is perhaps useful to consider the results of this research in terms of the
"systems model " of PMS described by Backstrom & Bancroft ( 1985 ) and
reproduced in figure 1.4 . The hypotheses outlined in this model are well
supported by the results of these studies . The majority of symptoms in this
research appeared to be related to the ovarian cycle temporally ,
presumably by the "zeitgeber" influence of the regular menstrual cycle on
the central regulatory system . Hence , the absence of an absolute influence
of cyclical steroids on mood variables etc. is supported . In this study " body
swelling " - the only measure of bloating available , appeared to fit with
measures of mood change rather than breast tenderness . Arguably , this
may be an artefact of subjective assessment - producing a changing
measure of body image rather than bloatedness or water retention per se .
An objective assessment of this variable might find some concordance with
breast tenderness .
It would appear that breast tenderness is related more closely to changes
in ovarian steroid levels than the other variables measured . However , it
would be fair to say that the visualization of such a relationship as a direct
one is over simplistic . The evidence from the first study suggested that some
other factor associated with luteal phase activity might be involved . The
second study suggested that in some individuals breast symptoms may be
under the same control as mood symptoms , whilst in others , the key
aetiological factor may be associated with changing levels of luteal phase
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progesterone . In order to reconcile these two observations , it may be useful
to suggest that two seperate " syndromes " are being seen here . In one of
these , described as " PMS " for convenience , all of the symptoms ,
including mood and breast tenderness are caused by , or related to , some
central regulatory system , with the ovarian cycle being involved only at the
level of symptom timing . In the second " syndrome " , breast changes are
directly related to some aspect of the ovarian cycle , either changes in
cyclical steroids themselves or some other factor which is associated with
luteal function , the disruption of this factor leading to the reduction or
exacerbation of symptoms . This latter description sounds remarkably like a
phenomenon known as " cyclical mastalgia " , a syndrome whose aetiology
remains obscure but which is thought to be associated with altered breast
sensitivity to prolactin in response to ovarian steroids ( Mansel, Preece &
Hughes 1980 ; Kumar, Mansel , Hughes , Woodhead , Edwards , Scanlon &
Newcombe 1984 ).
So , in terms of the systems model, perhaps the term " peripheral effects "
should be removed and be replaced by " cyclical mastalgia " , whilst the
term "mood change " should be extended to cover all PMS symptoms .
Hence , the possibility arises that one of the characteristics of PMS , the
variability in symptom type seen between different women , may be due in
part at least to the inclusion under one umbrella of several different cyclical
syndromes with different aetiologies. The possibility that two or more of these
syndromes may co-exist in the same woman further complicates the issue .
This model would explain the large individual differences seen and the
differential response of symptoms to various treatments .
7.5 SUMMARY . CONCLUSIONS AND SUGGESTIONS FOR
FURTHER RESEARCH
The major findings derived from this thesis are as follows
i) There was no evidence , either from naturally occuring or artificially
manipulated abnormal menstrual cycles , to suggest that the appearance of
any of the premenstrual symptoms measured was related to the
physiological event of ovulation .
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ii) There was evidence from both of the studies to suggest that
premenstrual breast tenderness is related in some way to luteal phase
changes in some women .
iii)There was no evidence to suggest that any of the other symptoms
assessed were related , directly or indirectly , to absolute ovarian steroid
levels .
iv) Some considerable evidence arose to support the idea of symptom
variability both between individuals and between consecutive cycles in the
same individual .
v) The use of naturally occurring abnormal menstrual cycles in this type of
study would seem to be contraindicated in terms of its cost effectiveness and
applicability to women experiencing consistently normal cycles .
The main conclusion derived from these findings is that the term PMS
as it is currently used may possibly include several different "syndromes"
under its umbrella , some of which are directly related to ovarian steroid
levels , or concomitants of ovarian function , and some of which are linked to
the menstrual cycle in a purely temporal fashion .The case in point here is
the possibility that a subgroup of women who report PMS actually have a
condition known as " cyclical mastalgia " , either alone , with potentially
associated mood changes , or in combination with PMS .
Several suggestions for further research can be made , arising both from
this hypothesis and from the assumptions and inadequacies of this project.
i) One of the major stumbling blocks in the interpretation of this data has
been the lack of any robust and suitable statistical technique for the analysis
of long term serial data in a physiologically meaningful context . The
observation of individual variability also argues for a small N approach to the
PMS field in the future , rather than an attempt to derive information from the
superficial analysis of large groups of data, which have been inappropriately
aggregated . If this type of approach is to be useful , then some time should
be spent on developing an appropriate statistical approach - both in terms of
the clinical diagnosis of PMS and in terms of the broader investigation of
cyclical mood change .
ii) The first approach used in this thesis , i.e. the investigation of
symptoms in naturally abnormal cycles , would appear with hindsight not to
be particularly appropriate for this type of study . Abnormal cycles tend to be
a reflection of physiological transition or abnormality , and hence do not
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occur independently ; other physiological and psychological systems may
also be disrupted . Therefore , it was probably naive to expect that results
obtained from this study would be applicable to all women . If the aim of
further research is to investigate the relationship between symptoms and the
ovarian cycle , then a means of inducing consistent anovulatory cycles, e.g.
the oral contraceptive pill , in women who are not in any kind of transitional
state might be more profitable.
iii) The lack of knowledge about endogenous ovarian activity during low-
dose oc administration , particularly on a long term basis , makes the
interpretation of effects due to hormonal changes difficult . Basic research is
needed to assess precisely what is happening endocrinological^ in these
women - research which would also be useful in determining the dose
responsiveness , or otherwise , of long term side effects in years to come .
iv) The studies outlined above largely substantiate the Bancroft &
Backstrom (1985 ) model . Hence , further studies are indicated to test other
aspects of the model , for instance , the role of steroid feedback on the timing
of cyclical symptoms, and the precise role of ovarian steroids in breast
symptoms . The first of these could be investigated in women who use oral
contraceptive pills continuously, i.e. without a pill free week. In this study ,
either cyclical steroids could be removed altogether in users of monophasic
pills , or the cycle could be shortened to 21 days in users of triphasic pills . If
cyclical steroids are responsible for the timing of premenstrual symptoms ,
then the monophasic group would be expected to show random symptom
occurrence , whilst the triphasic group would have three weekly cycles .
In conclusion : most premenstrual symptoms would appear to be related
to the ovarian cycle temporally , although breast tenderness shows some
relationship to ovarian steroids themselves . Hence , the proposed model of
PMS is supported . Further studies are needed to investigate the precise
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THE NATURE OF DEFINITION
Firstly - a definition is a purely linguistic phenomenon . It is not
possible to define concepts such as " Premenstrual Syndrome " or "
work of art" , only linguistic objects ( e.g. words , phrases , stetements
etc. ) can be defined . Hence , it is necessary to rephrase the question
into - " how should we define the phrase premenstrual syndrome ? " or
" how should we define the term work of art ? ".
Secondly - definitions are conventions . That is - the meaning of a
word or phrase is not a natural attribute of that word which man discovers
, rather, meaning is given to a word by people who agree to let it have
that meaning (Salmon 1973 p. 122 ) . Usually conventions have grown
up gradually and informally over a length of time , however, they are not
necessarily static - as the language grows and changes , so the
convention about the meaning of a particular word may also grow and
change . Conventions can also occur formally when a new word is
assigned a definition or an existing word is given a more precise
definition to establish it within a particular context . Although defionitions
are conventions , it does not follow to say that one definition is as good
as any other . The purpose of the definition is important and some
conventions achieve their purpose better than others .
These two general points are important in establishing the
limitations of a definitional system . It is now possible to discuss the four
different types of definition .
i) The " Real" definition
The Real definition of a word is its objective meaning and can be
demonstrated with reference to the world around it . For instance , the
meaning of the word " dog " can be given by pointing at a variety of dogs
or by naming various dogs . This type of definition is limited by the fact
that words vcan only have the meanings that their users give them . A
real definition is only possible when there is no ambiguity in the object ,
or lack of unanimity in the users convention . For instance , it would be
possible to give a real definition of the term " work of art" by saying that
Van Gogh's " Sunflowers " and Constable's " Haywain " are both works
of art . This definition is not very useful however when the question " Is
Jackson Pollock's " No. 32 " a work of art ? " arises . This limitation
applies also to the application of a real definition to PMS . To say that x
and y have PMS is not very useful when we want to know whether z has
it.
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ii) The " Pure Stipulative " definition
In this case , a user endows a word or phrase with a particular
meaning by declaring the conditions under which s/he intends to use it
irrespective of how anyone else uses it. The concept is rather like that of
a floating joker in a card game , during which the " owner" of the joker
can play it as any card s/he chooses regardless of its actual face value or
how other players may wish to define it . This is the type of definition
which is usually used in PMS research . That is - each research group
stipulates its own meaning of PMS for the purpose of that particular study
, to a large extent irrespective of its use in other studies . Although this
type of definition is a beginning - and at least better than no definition at
all - the initial assignments can set restrictions on the further use of the
word and become meaningless if each user stipulates a slightly different
definition . The pure stipulative definition does not allow for growth or
change in the concepts behind the definition . For instance , the original
definition of Premenstrual Tension ( Frank 1931 ) was purely stipulative
and its limitations soon became apparent when symptoms other than
tension were identified , leading to the coining of the term Premenstrual
Syndrome .
iii) The " Pure Reportive " definition
This type of definition is more or less a reportive account of how
existing users of the word already use it. However, although this seems
the logical basis for definition , it falls down when there is any lack of
unanimity between users , and it necessitates defining a word in terms of
other words . In this type of definition , circular arguments can very
quickly develop . For example
a ) " Parent" has the same meaning as " Father or Mother "
b ) " Father" has the same meaning as " Male Parent"
c ) " Mother" has the same meaning as " Parent, but not Father"
To determine the meaning of the word " Father" we would
replace " parent" in ( b ) by its definition in ( a ) which gives :" Father"
has the same meaning as " Male (father or mother)". Thus buy using a
pure reportive definition a circular argument can develop in which words
are defined in terms of themselves . This occurs when the pure reportive
definition of PMS as "symptoms which regularly occur in the
premenstrual phase of the menstrual cycle " is used .
iv ) The " Reformatory " definition
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This is a hybrid between the purely stipulative and purely
reportive definitions . It occurs when someone stipulates that they will
use a word with a partial alteration to the ordinary usage . For instance ,
words such as " work " and " energy " are given precise definitions in
physics derived from their ordinary usage . This type of definition occurs
in PMS studies when a researcher stipulates symptoms occurring in " the
week before menses " rather than the " premenstrual phase ". If a
reportive definition is possible , then a reformatory derivation from it is
also feasible , and logical in certain circumstances . However, the
limitations applying to reportive definitions also apply here .
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THE PREGNANED1QL-3 - GLUCUR0N1DE ELISA
The concept behind ELISA is essentially similar to that behind RIA
( see Section 4.3.1 ) , however the former system is rather more flexible .
In the ELISA system , an enzyme label is used which can be attached to
either the antibody or antigen . The enzyme acts by converting a
substrate to a coloured product, the intensity of which can be measured .
Hence , the assay proceeds in a similar fashion up to the point of
seperation of bound and free , a procedure performed by a second
antibody technique , at this stage the substrate is added . The amount of
substrate which becomes coloured depends directly upon the amount of
enzyme present. This , however, is not the only difference between RIA
and ELISA . the second major difference is the immobilisation of either
the antidody or antigen onto a solid phase , where it can act as an
immunosorbent - " capturing " the corresponding antibody or antigen ,
and allowing rapid seperation of bound from free reagents by simple
washing procedures .
The procedure used in this study utilized an immobilised second
antibody technique , in which the second antibody ( in this case DARS )
is immobilized on the surface of plastic mictrotitre plate wells in order to "
capture " the first antibody. The first antibody , enzyme-labelled antigen
and samples are then added .
PROCEDURE
The microtitre plates used were Costar Serocluster EIA plates
supplied by Northumbrian Biologicals . These plates were coated with a
1:200 dilution of second antibody ( DARS ) in coating buffer ( 0.1 M
Carbonate buffer , pH 9.6 ) , added at the rate of 200 jil per well . The
plates were then sealed to prevent evaporation and stored at 4 degrees
centigrade overnight , to allow adsorption of second antibody to the well
surfaces . After adsorption , the DARS solution was " flicked " out of the
wells , and the plates washed three times in 0.1 % Tween 20 detergent.
This allowed all the remaining plate binding sites to be filled . The plates
were then rinsed repeatedly in distilled water , to remove any excess
Tween 20 , and blotted dry .
The reagents - samples , standards , first antibody and label were
all made up in assay buffer ( 0.1 M Phosphate gelatin saline , pH 7.4 ,
with a few drops of non-reactive dye , e.g. carmosine , to aid visibility on
the plates ). The label was Pregnanediol-3-glucuronide-Horseradish
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peroxidase, prepared by Mr. I Swanston , and added at a dilution of 1 :
10,000 . All other reagents were as per RIA . The plates were then sealed
as before and incubated for a minimum of 3 hours at room temperature ,
or overnight at 4 degrees centigrade .
In order to seperate bound from free , the assay incubate was "
flicked " out of the wells , the plates washed x5 with distilled water and
blotted dry . The substrate solution was then added . This solution is light
sensitive and therefore was added immediately after preparation . The
substrate udes was 5mM o-phenylenediamine / 0.03% Hydrogen
peroxide made up in 0.1 M Citrate phosphate buffer ( pH 5.0 ) . The
speed of the enzyme reaction is temperature dependent , therefore all
reagents (including the substrate buffer ) were at room temperature
before use . The solution was added at a rate of 200pl per well, and the
plates were immediately rendered in darkness by covering with
aluminium foil. They were allowed to incubate @ RT for 15 - 30 minutes .
After incubation 50jil of 2N Sulphuric acid was added per well to stop the
reaction and develop the final colour. The plates were then read on an
optical density platereader at OD 492 nm . Standard curves are plotted ,
and sample values calculated as in the RIA system .
Thanks are due to Mr. I Swanston , for his help in the preparation
of this appendix , the purification of the DARS used and the preparation
of the PdG-Horseradish peroxidase .
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4) OCCUPATION (or previous occupation)
4a) HUSBAND/PARTNER'S OCCUPATION
B) GYNAECOLOGICAL HISTORY
5) HOW OLD WERE YOU WHEN YOUR PERIODS STARTED?
6) WHAT WERE YOUR PERIODS LIKE DURING THE NEXT FIVE YEARS?
i (a) REGULAR □ ii (a) PAINLESS j j
(b) IRREGULAR [j (b) SLIGHTLY PAINFUL [j
(c) VERY IRREGULAR [J (c) MODERATELY PAINFUL [J
(d) VERY PAINFUL [j
7) HOW MANY DAYS DID YOUR PERIOD LAST DURING THOSE YEARS?
8) HOW LONG WAS YOUR CYCLE (from one period to the next) IN THOSE
YEARS?
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WHAT ARE YOUR PERIODS LIKE NOW?
i (a) REGULAR Q ii (a) PAINLESS M
(b) IRREGULAR Q (b) SLIGHTLY PAINFUL Lj
(c) VERY IRREGULAR Q (c) MODERATELY PAINFUL [J
(d) VERY PAINFUL F]
10) HOW MANY DAYS DOES YOUR PERIOD LAST NOW?
11) HOW LONG IS YOUR CYCLE (from one period to the next) NOW? ___
12) HOW MANY PREGNANCIES HAVE YOU HAD?
13) HOW MANY CHILDREN HAVE YOU HAD?
14) HOW OLD ARE THEY?
15) DID YOU HAVE ANY PROBLEMS DURING PREGNANCY OR CHILDBIRTH?
(a) NOT APPLICABLE [J
1st 2nd
PREGNANCIES
3rd 4th 5th 6th
(b) None □ □ □ □ □ □
(c) High Blood Pressure □ □ □ □ □ □
(d) Depression □ □ □ □ □ □
(e) Morning Sickness □ □ □ □ □ □
(f) Threatened Miscarriage □ □ □ □ □ □
(g) Normal Childbirth □ □ □ □ □ □
(h) Breach delivery □ □ □ □ □ □
(i) Forceps delivery □ □ □ □ □ □
(j) Caesarian delivery □ □ □ □ □ □
(k) Induced birth □ □ □ □ □ □
(1) Epidural Anaesthesia □ □ □ □ □ □
(m) Episiotomy □ □ □ □ □ □
(n) Other (please specify) □ □ □ □ □ □
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16) DID YOU BREASTFEED?
17) IF YES; HOW LONG FOR
18) DID YOU GET DEPRESSED DURING
(a) NOT APPLICABLE [J
(b) NOT DEPRESSED |_J
(c) DEPRESSED FOR SHORT
TIME DURING 1st WEEK |_J
(d) DEPRESSED FOR MORE THAN
_
A WEEK BUT NOT SEVERE [_J
(e) SEVERELY DEPRESSED BUT
DID NOT SEEK MEDICAL [_ ]
HELP
(f) SEVERELY DEPRESSED AND ■ j
SAW DOCTOR ABOUT IT
19) HAVE YOU EVER BEEN TOLD BY A DOCTOR THAT YOU HAVE ANY OF THE FOLLOWING?
(a) NOT APPLICABLE Lj
(b) MENORRHAGIA (heavy periods) j j
(c) AMENORRHEA (no periods for more than 6 months) j |
(d) FIBROIDS [J
(e) DYSFUNCTIONAL UTERINE BLEEDING [J
(f) ENDOMETRIOSIS [~j
(g) OLIGOMENORRHEA (few or scanty periods) I
(h) DYSMENORRHEA (painful periods) [_J
(i) POLYMENORRHEA (too many periods)
(j) PID (pelvic inflammatory disease) j I
(k) THRUSH, TRICHOMANIASIS etc. j~J
(1) VENEREAL DISEASE |_J
(m) OTHER (please specify) | |
FIRST SIX MONTHS AFTER CHILDBIRTH?
PREGNANCIES
2nd 3rd 4th 5th 6th
□ □ □ □ □
□ □ □ □ □
□ □ □ □ □
□ □ □ □ □
□ □ □ □ □
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C) CONTRACEPTIVE HISTORY
20) HAVE YOU EVER USED AN ORAL CONTRACEPTIVE?
(If NO please go to question 30)
(a) CURRENTLY USING Q
(b) LESS THAN 6 MONTHS AGO [J
(c) 6 MONTHS - 2 YEARS AGO [J
(d) 2-5 YEARS AGO [J
(e) MORE THAN 5 YEARS AGO [J
(f) CAN'T REMEMBER / DON'T KNOW [j
21) HOW OLD WERE YOU WHEN YOU FIRST STARTED USING THE PILL?
22) WHY DID YOU START USING THE PILL?
(a) FOR CONTRACEPTION ONLY '
(b) FOR PAINFUL PERIODS L]
(c) FOR HEAVY PERIODS [j
(d) FOR IRREGULAR PERIODS [j
(e) FOR PMS [J
(f) OTHER (please specify) [ j
23) HAVE YOU EVER HAD ANY SIDE FROM THE PILL? (please describe)
24) HAVE YOU ALWAYS USED THE SAME PILL?
25) IF NOT: WHY DID YOU CHANGE?
26) IF YOU ARE TAKING THE PILL A THE MOMENT, HOW LONG HAVE YOU BEEN
USING IT FOR?
27) IF YOU HAVE USED THE PILL IN THE PAST; WHY DID YOU STOP?
310
29) DID THE PILL HAVE ANY EFFECT ON YOUR PREMENSTRUAL SYMPTOMS?
(a) IMPROVED PREMENSTRUAL SYMPTOMS [j
(b) HAD NO EFFECT ON PREMENSTRUAL SYMPTOMS M
(c) MADE PREMENSTRUAL SYMPTOMS WORSE [j
(d) NOT SURE OR CAN'T REMEMBER [1
(e) DID NOT HAVE PMS AT THE TIME ;
(f) OTHER (please specify) u
30) IF YOU HAVE NEVER USED AN ORAL CONTRACEPTIVE, IS IT FOR ANY
PARTICULAR REASON?
(a) NO □
(b) FAMILY HISTORY OF THROMBOSIS etc. [j
(c) FEAR OF LONG TERM SIDE EFFECTS j_J
(d) PREFERRED OTHER FORMS OF CONTRACEPTION Q
(e) NEVER HAD ANY NEED FOR CONTRACEPTION [J
(f) PERSONAL MEDICAL HISTORY [j
(g) OTHER (please specify) j j
D) LIFE HISTORY
31) HAVE THERE BEEN ANY TIMES DURING YOUR LIFE WHEN YOU HAVE FELT
PARTICULARLY UNHAPPY OR DEPRESSED?
32) IF SO; WAS IT IN RELATION TO SOMETHING WHICH HAPPENED TO YOU
(e.g. bereavement, loss of job, house move etc)?
33) HOW LONG AGO WAS THAT EPISODE?
34) DID YOU FEEL BAD ENOUGH TO SEE YOUR DOCTOR ABOUT IT?
35) IF SO, DID HE/SHE GIVE YOU ANY TREATMENT?
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37) DO YOU HAVE ANY PERSISTENT MEDICAL CONDITIONS (e.g. Diabetes)?
38) IF SO; HOW MUCH DOES THIS INTERFERE WITH YOUR LIFE?
(a) NOT AT ALL [J
(b) VERY LITTLE [j
(c) QUITE A LOT u
(d) VERY DISABLING [J
39) HOW HAPPY IS THE RELATIONSHIP BETWEEN YOU AND YOUR PARTNER
AT THE MOMENT?
(a) NOT APPLICABLE: NO RELATIONSHIP [j
(b) VERY HAPPY [j
(c) FAIRLY HAPPY [j
(d) NOT VERY HAPPY [j
(e) NOT AT ALL HAPPY [j
40) ARE YOU PERSONALLY UNDERGOING ANY UNUSUAL STRESS AT THE MOMENT?
(a) YES, A GREAT DEAL OF STRESS Hj
(b) YES, SOME STRESS Q
(c) NO □
E) TREATMENT HISTORY
41) HAVE YOU TRIED ANY FORM OF TREATMENT FOR YOUR PMS?
(a) YES □
(b) NO Q



















a) Vit. B6 or Pyridoxine □ □ □ □ □ □
b) Oil of evening Primrose
or Efamol
□ □ □ □ □ □
c) Diuretics (water tablets) □ □ □ □ □ □
d) Duphaston □ □ □ □ □ □
e) Aspirin or Panadol □ □ □ □ □ □
f) Cyclogest suppositories □ □ □ □ □ □
g) Progesterone injection □ □ □ □ □ □
h) Primolut N □ □ □ □ □ □
i) Provera tablets □ □ □ □ □ □
j) Provera injections □ □ □ □ □ □
k) Bromocriptine (Parlodel) □ □ □ □ □ □
1) Danazol (Danol) □ □ □ □ □ □
m) Oral contraceptive
(state which one)
□ □ □ □ □ □
n) Oestrogen implant □ □ □ □ □ • □
7ould you be prepared to fill in a form describing how you feel each day for one or two
nonths? An example is enclosed together with an instruction sheet.
Yes □ No □
[f YES, please fill in the attached diary form describing how you felt yesterday, so
;hat we can check that the instructions have been sufficiently clear, and return it to
as together with the questionnaire.
Chank you very much for your help. I look forward to further contact with you.
IRS ANN WALKER
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INFORMAL DEMOGRAPHIC QUESTIONNAIRE / INTERVIEW
Subject Number :
Date of Birth : Age :
Marital Status :
Any other marriages ?
Date of marriage ( in order of marriage)
Date of divorce / seperation / widowhood
Age at leaving school
Any further education or training ?
Work outside the home ?
Job?
Full-time , Part-time , self employed ?
Is husband working ?
Who is the main breadwinner ?
Do you have any children ?
How old are they ?
Type of delivery
How many children did you want ?
Do all of your children live at home ?
Did you have any other pregnancies ?
Outcome ?
Did you have any problems in pregnancy ?
How did you feel in the first few days after each birth ?
And how were you in the first few months after each birth ?
Did you breastfeed ?
How long did you breastfeed fully ?
Did you enjoy breastfeeding ?
What method of contraception are you using now ?
How long have you been using this method ?
Are you satisfied with it ?
If not , why not ?
Have you ever used the pill ?
If not , why not ?
Which pill(s) were you on ?
When were you on it ?
How long did you take it ?
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Why did you stop ?
Do you smoke now ? How many a day ?
Did you have any side effects from the pill ?
What other methods have you used ?
Why did you stop using these methods ?
Do you have a regular menstrual cycle now ?
What is the normal number of days from the start of one period to the start
of the next ?
Does this vary ? From to days .
Has this ever been different ?
How many days was it then ?
Did this vary ?
When was this ? How long ago ?
What is your usual number of days of bleeding ?
Has this ever been different ? When ?
Does the number of days of bleeding vary from cycle to cycle ?
Do you have midcycle bleeding ?
How would you describe your bleeding ? Light / Medium / Heavy
Has this changed recently ?
Is there any known reason for this ?
Have you ever had flooding / passed clots ?
Do your periods interfere with your normal life ?
Have you ever been anaemic ?
Have you ever had a D & C ?
Do you have pain with your periods ?
How severe is this pain ?
How many of your periods are painful ?
Do you need to take medication for it ?
What do you take ?
How would you rate your physical health over the last 5 years ?
Any persistent conditions ?
How much does this interfere with ordinary life ?
Any major illnesses ?
Any operations ?
In the past five years , have there been any times when you have felt
particularly unhappy or not yourself ?
Were external factors relevant ?
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How severe was the episode ?
Was anyone a particular help to you at that time ?
Did you see your G.P.?
Any treatment ?
Did you see a psychiatrist ?
Any treatment ?
Were you admitted as an inpatient ?
How often ?
How often ?
How long for ?
Any treatment ?
Have there been any times in the past 5 years when you have been
particularly happy or unusually cheerful ?
Have you or your partner had any change in your job in the last year ?
Have you or your husband had any financial difficulties in the last year ?
Have you or any close relatives had any serious illnesses in the last year ?
Have you had any problems with your marriage in the last year ? Have you
moved , or had someone new living in your home in the last year ?
Have you or your family been involved with the law in the last year ?
Are there any other events not covered ?
Have you had anyone who has tried to help you with these or any other
difficulties you may have had ?
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APPENDIX FOUR
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Figure A-1 Comparison of mood , irritability and energy levels across 7
standardized cycle phases in normal / normal cycle pairs and
normal / anovulatory cycle pairs
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Figure A-2 Comparison of breast tenderness , body swelling and period pain
levels across 7 standardized cycle phases in normal / normal
cycle pairs and normal / anovulatory cycle pairs



















~I 1 1 1 1 1




Figure A -3 Comparison of tension & anxiety and sexual interest levels
across 7 standardized cycle phases in normal / normal cycle
pairs and normal / anovulatory cycle pairs .
( From Chapter Five )
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TABLE A - 1
THREE-WAY AND TWO-WAY ANOVA RESULTS FOR NORMAL AND
ANOVULATORY CYCLES BY STANDARDIZED CYCLE PHASE
0 Three-wav ANOVA.
G C GxC P GxP CxP GxCxP
Mood ns ns ns ns ns ns ns
Irritable ns ns ns ns ns ns ns






* ns ns ** T ** *
Body swelling ns ns ns
* * * ns T
Period pain Insufficient data
Sexual
interest ns
ns ns ■kit ns ns ns
\\) Two-wav ANOVA between normal cycles .
C P CxP P@C1 P@C2
Mood ns ns ns ns ns
Irritable ns T ns ns ns





tenderness ns * k ns
*★ **









iii ) Two-wav ANOVA between normal and anovulatory cycles .
C P CxP P@C1 P@C2
Mood ns ns ns ns ns
Irritable ns ns ns ns ns
Energy ns ns ns ns ns
Tense
& anxious Insufficient data
Breast .
tenderness
ns ns ns ns ns
Body swelling ns ns ns ns ns
Period pain Insufficient data
Sexual
xinterest
ns ns ns ns ns
Key ns- not significant ;T-trend ( p< 0.10 ); * - p < 0.05 ;
**
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Cycle phase
Normal Cycle
Short Luteal Phase Cycle
Figure A -4 Comparison of mood , irritability and energy levels across 7
standardized cycle phases in normal / normal cycle pairs and
normal / short luteal phase cycle pairs
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Short Luteal Phase Cycle
Figure A - 5 Comparison of breast tenderness , body swelling and period pain
scores across 7 standardized cycle phases in normal / normal
cycle pairs and normal / short luteal phase cycle pairs .
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Short Luteal Phase Cycle
Figure A - 6 Comparison of tension & anxiety and sexual interest scores
across 7 standardized cycle phases in normal / normal
cycle pairs and normal / short luteal phase cycle pairs .
( From Chapter Five )
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TABLE A-2
THREE-WAY AND TWO-WAY ANOVA RESULTS FOR NORMAL AND
SLP CYCLES BY STANDARDIZED CYCLE PHASE
i) Three-wav ANOVA.
G C GxC P GxP CxP GxCxP
Mood ns ns ns
*
ns ns ns
Irritable ns ns ns ns ns ns ns
Energy ns ns ns ns ns ns ns
Tense
& anxious ns T ns
ns ns ns ns
Breast
tenderness ns ns ns
★ *
ns ns ns
Body swelling ns ns ns T ns ns ns





interest ns ns ns T ns ns ns
in Two-wav ANOVA between normal cycles
C P CxP P@C1 P@C2
Mood ns ns ns ns ns
Irritable ns ns ns ns T
Energy ns ns ns ns ns
Tense



















iii ) Two-wav ANOVA between normal and SLP cycles
C P CxP P@C1 P@C2
Mood ns ns ns ns ns
Irritable ns ns ns ns ns
Energy ns ns ns ns ns
Tense
& anxious ns ns ns ns ns
Breast
,
tenderness ns ns ns ns ns
Body swelling ns ns ns ns ns
Period pain ns * * * ns
Sexual
xinterest ns ns ns ns ns
Key :- ns - not significant; T - trend ( p < 0.10) ; * - p < 0.05
**
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2 3 4 5 6 7
Cycle phase
Normal Cycle
■ Inadequate luteal phase cycle
Figure A-7 Comparison of mood , irritability and energy levels across 7
standardized cycle phases in normal / normal cycle pairs and
normal / inadequate luteal phase cycle pairs




Cycle phase Cycle phase
-*• Normal cycle Normal cycle
Normal cycle Inadequate luteal phase cycle
Figure A-8 Comparison of breast tenderness , body swelling and period
pain scores across 7 standardized cycle phases in normal /
normal cycle pairs and normal / inadequate luteal phase cycle
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1 2 3 4 5 6 7
Cycle phase
-m- Normal Cycle
Inadequate luteal phase cycle
Figure A-9 Comparison of tension & anxiety and sexual interest scores across
7 standardized cycle phases in normal / normal cycle pairs and
normal / inadequate luteal phase cycle pairs ( From Chapter Five ) .
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TABLE A-3
THREE-WAY AND TWO-WAY ANOVA RESULTS FOR NORMAL AND
ILP CYCLES BY STANDARDIZED CYCLE PHASE
i ) Three-wav ANOVA .
G C GxC P GxP CxP GxCxP
Mood ns ns ns ns ns ns ns
Irritable ns ns ns ns ns ns ns
Energy ns ns ns ns ns ns ns
Tense
& anxious ns
ns ns ns ns ns ns
Breast
tenderness ns
★ * ★* ** ns ns ns
Body swelling ns ns ns ** ns ns ns
Period pain ns ns ns * ★ ns ns T
Sexual
interest ns ns ns ns ns ns ns
ii ) Two-wav ANOVA between normal cycles .
C P CxP P@C1 P@C2
Mood ns ns ns ns ns
Irritable ns ★ ns T ns
Energy ns ns ■k k ns **
Tense
& anxious





Body swelling ns ** ns k **





iii ) Two-wav ANOVA between normal and ILP cycles .
C P CxP P@C1 P@C2
Mood ns ns ns ns ns
Irritable ns ns ns ns ns
Energy ns ns ns ns ns
Tense











Period pain ns ns ns ns ns
Sexual
4interest
ns ns ns ns ns
Kev : - ns-notsignificant; Ttrend (p<0.10); * -p<0.05;
**
- p < 0.01 ; G - Group ; C - Cycle ; P - Phase .
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TABLE A-4
PERCENTAGE OF CYCLES WITHIN EACH GROUP SHOWING































































































































































































































































































Number of cycles in each group Triphasic = 83 ( 65 )
Monophasic = 86 ( 73 )
Control = 121 (102)
( Figures in brackets indicate numbers for sexual interest)
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TABLE A-5
PERCENTAGE OF CYCLES WITHIN EACH GROUP SHOWING





































































































































































































































































































Number of cycles : Triphasic = 83 ( 65 )
Monophasic = 86 ( 73 )
Control = 121 (102)
( Figures in brackets indicate numbers for sexual interest)
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Table A-6 Chi-square results for section 6.3.4
Frequencies of " bad davs " within each group
Mood Triphasic Monophasic Control Total
Menses 20 (22.6) 22 (23.2 ) 37 (33.2 ) 79
Postmenstrual 25 (21.8 ) 23 ( 22.3 ) 28 (31.9 ) 76
Intermenstrual 16 ( 14.6) 14 ( 15.0) 21 (21.4) 51
Premenstrual 23 ( 24.9 ) 27 ( 25.5 ) 37(36.5) 87
Total 84 86 123 293
Chi-square = 2.23 , df = 6 , ns
tenderness Triphasic Monophasic Control Total
Menses 24 ( 22.6 ) 20 (19.2) 31 (33.2) 75
Postmenstrual 1 (3.6) 5(3.1 ) 6 (5.3) 12
Intermenstrual 12 ( 11.7) 9 (10.0) 18 ( 17.3) 39
J <
Premenstrual 37 (36.1 ) 29(30.7) 54 ( 53.2 ) 120
Total 74 63 109 246
Chi-square = 3.72 , df = 6 , ns
Sexual interest Triphasic Monophasic Control Total
Menses 13 (14.2 14 ( 15.6) 25 ( 22.2 ) 52
Postmenstrual 20 (17.5) 21 (19.2) 23 ( 27.3 ) 64
Intermenstrual 15 (13.7) 16 ( 15.0 ; 19 ( 21.3 ) 50
Premenstrual 15 ( 17.5) 18 ( 19.2 ) 31 ( 27.3 64
Total 63 69 98 230
Chi-square = 3.21 , df = 6 , ns
Key The menstrual , postmenstrual , intermenstrual and premenstrual
phases represent blocks of 5 , 11 ,6 and 6 days respectively ,
collapsed in this way because of small cell sizes
df - degrees of freedom
ns - not significant (i.e. p > 0.05 )
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Triph - Triphasic group , Monoph - Monophasic Group , Cont - Control Group
P - Premenstrual only symptom category
M - Menstrual only symptom category
P + M - Symptoms premenstrually and menstrually
A + N - Noncyclical and Atypical categories
Expected frequencies appear in brackets
336
